advise(e1,e2)	8	40	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	7	14	pediatric use the safety and effectiveness of pegasys , alone or in combination with copegus in patients below the age of 18 years have not been established .
None(e1,e2)	5	13	there have been reports of theophylline -related side-effects in patients on concomitant theophylline- quinolone therapy .
None(e1,e2)	71	92	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	25	49	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety_agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant_drugs .
effect(e1,e2)	2	10	gentamicin - methionine may protect against the ototoxic effects of gentamicin .
None(e1,e2)	8	19	antiretroviral agents : no drug interactions with other antiretroviral_medications have been identified that would warrant alteration of either the enfuvirtide dose or the dose of the other antiretroviral medication .
None(e1,e2)	17	21	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	39	74	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	9	14	if desipramine hydrochloride is to be combined with other psychotropic_agents such as tranquilizers or sedative /hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
effect(e1,e2)	14	32	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
effect(e1,e2)	6	23	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	32	51	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	1	5	- probenecid : pretreatment with probenecid reduces both the natriuresis and hyperreninemia produced by bumetanide .
None(e1,e2)	41	49	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	25	59	this drug may interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
mechanism(e1,e2)	11	40	binding to serum proteins : the following agents may either inhibit levothyroxine_sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	13	20	digoxin : in a study in 12 patients with congestive heart failure where ketoprofen and digoxin were concomitantly administered , ketoprofen did not alter the serum levels of digoxin .
None(e1,e2)	26	110	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	46	72	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	1	3	- isoniazid ( nydrazid ) ;
None(e1,e2)	0	18	lithium : increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ace inhibitor therapy .
None(e1,e2)	44	62	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	49	86	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	58	79	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
mechanism(e1,e2)	2	13	co-administration with efavirenz or fluconazole had a modest effect on the pharmacokinetics of azithromycin .
mechanism(e1,e2)	0	4	probenecid given concurrently increases naproxen anion plasma levels and extends its plasma half-life significantly .
None(e1,e2)	33	40	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	4	11	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	0	2	diphenoxylate_hcl and atropine_sulfate may interact with mao inhibitors in studies with male rats , diphenoxylate hydrochloride was found to inhibit the hepatic microsomal enzyme system at a dose of 2 mg/kg/day .
None(e1,e2)	16	19	methenamine therapy : urinary excretion of amphetamines is increased , and efficacy is reduced , by acidifying_agents used in methenamine therapy .
advise(e1,e2)	11	16	it is recommended that serum lithium levels be monitored frequently if prinivil is administered concomitantly with lithium .
None(e1,e2)	26	28	the following are examples of drugs known to inhibit the metabolism of other related benzodiazepines , presumably through inhibition of cyp3a : nefazodone , fluvoxamine , cimetidine , diltiazem , isoniazide , and some macrolide antibiotics .
None(e1,e2)	0	6	acetaminophen : a report of severe acetaminophen toxicity was reported in a patient receiving isoniazid .
None(e1,e2)	25	32	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle_relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	23	44	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	7	11	lithium generally should not be given with diuretics because they reduce lithium s renal clearance and add a high risk of lithium toxicity .
None(e1,e2)	30	38	no significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide , nifedipine , digoxin , warfarin , hydrochlorothiazide , and oral contraceptives in healthy volunteers , or given with enalapril to patients with heart failure ( nyha class ii and iii ) .
None(e1,e2)	43	45	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal_anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	21	34	iron supplements and foods fortified with iron concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron ( as feso4 ) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80 % and 31 % , respectively .
None(e1,e2)	1	7	both itraconazole and its major metabolite , hydroxyitraconazole , are inhibitors of the cytochrome p450 3a4 enzyme system .
None(e1,e2)	11	22	however , due to possible pharmacodynamic interactions , when co-administered with precedex , a reduction in dosage of precedex on the concomitant anesthetic , sedative , hypnotic or opioid may be required .
None(e1,e2)	7	32	this observed increase in the bioavailability of fexofenadine may be due to transport-related effects , such as p-glycoprotein . in vivo animal studies also suggest that in addition to enhancing absorption , ketoconazole decreases fexofenadine gastrointestinal secretion , while erythromycin may also decrease biliary excretion .
None(e1,e2)	12	61	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
effect(e1,e2)	6	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	25	28	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	17	21	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	51	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
None(e1,e2)	59	127	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	34	38	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
mechanism(e1,e2)	19	33	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	8	22	phenytoin , nicotine , and rifampin may decrease clozapine plasma levels , resulting in a decrease in effectiveness of a previously effective clozapine dose .
None(e1,e2)	27	36	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	11	35	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium_channel_blockers , beta blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	2	4	interconversion between caffeine and theophylline has been reported in preterm neonates .
None(e1,e2)	17	68	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	26	45	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
advise(e1,e2)	8	30	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	2	20	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	24	31	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
effect(e1,e2)	11	13	abased on reports of narcotic withdrawal syndrome in patients treated with nevirapine and methadone concurrently , and evidence of decreased plasma concentrations of methadone .
None(e1,e2)	32	46	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
None(e1,e2)	51	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	29	65	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	16	34	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic_agents ) or drugs which inhibit platelet function ( eg , aspirin and other non-steroidal anti-inflammatory drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
int(e1,e2)	0	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	15	39	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic_antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	4	12	co-administration of tacrolimus and bosentan resulted in markedly increased plasma concentrations of bosentan in animals .
None(e1,e2)	27	34	use lowest possible dose of atorvastatin with careful monitoring , or consider hmg-coa reductase inhibitors that are not primarily metabolized by cyp3a4 , such as pravastatin , fluvastatin , or rosuvastatin in combination with crixivan .
None(e1,e2)	0	2	antidiabetic_agents ( insulin , sulfonylureas ) : requirements for insulin or oral antidiabetic agents may be reduced in hypothyroid patients with diabetes mellitus and may subsequently increase with the initiation of thyroid hormone replacement therapy .
None(e1,e2)	9	28	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium_channel-blocking_drugs , and isoniazid .
effect(e1,e2)	5	14	co-administration : concomitant use of argatroban with antiplatelet agents , thrombolytics , and other anticoagulants may increase the risk of bleeding .
None(e1,e2)	9	59	medications can interfere with folate utilization , including : anticonvulsant_medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin_b12 and folic acid .
effect(e1,e2)	8	14	psychoactive drugs : hallucinations have been reported when toradol was used in patients taking psychoactive_drugs ( fluoxetine , thiothixene , alprazolam ) .
mechanism(e1,e2)	4	19	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	43	62	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	24	28	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	6	27	because changes in glucose concentrations with valdecoxib coadministration were within the normal variability and individual glucose concentrations were above or near 70 mg/dl , dose adjustment for glyburide ( 5 mg qd and 10 mg bid ) with valdecoxib coadministration ( up to 40 mg qd ) is not indicated .
None(e1,e2)	5	7	drugs that alter renal excretion ibuprofen : ibuprofen is known to affect renal function and , consequently , alter the renal excretion of other drugs .
None(e1,e2)	28	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	22	antidepressants : in vitro data indicate that nefazodone inhibits the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
advise(e1,e2)	4	11	patients using cyp3a4 metabolized statins should have cholesterol levels monitored after tracleer is initiated to see whether the statin dose needs adjustment .
advise(e1,e2)	7	9	plasma valproate concentration should be monitored when isoniazid and valproate are co administered , and appropriate dosage adjustments of valproate should be made .
None(e1,e2)	6	20	the effect of toradol on plasma lithium has not been studied , but cases of increased lithium plasma levels during toradol therapy have been reported .
effect(e1,e2)	6	66	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	11	antacids ( aluminum- or magnesium-containing ) : concomitant administration of 300-mg cefdinir capsules with 30 ml maalox tc suspension reduces the rate ( cmax ) and extent ( auc ) of absorption by approximately 40 % .
effect(e1,e2)	7	16	additionally , anti-malarial drugs , such as chloroquine and mefloquine , may antagonize the activity of carbamazepine .
None(e1,e2)	38	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	13	25	rifampicin : in a study in healthy volunteers , a six-day course of rifampicin at 600 mg/day followed by a single 5 mg dose of isradipine resulted in a reduction in isradipine levels to below detectable limits .
None(e1,e2)	44	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	38	58	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing_compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	14	18	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	0	7	flucytosine : while a synergistic relationship with amphotericin_b has been reported , concomitant use may increase the toxicity of flucytosine by possibly increasing its cellular uptake and/or impairing its renal excretion .
None(e1,e2)	0	23	ketoconazole - combined administration of racemic citalopram ( 40 mg ) and ketoconazole ( 200 mg ) decreased the cmax and auc of ketoconazole by 21 % and 10 % , respectively , and did not significantly affect the pharmacokinetics of citalopram .
None(e1,e2)	13	17	in rheumatoid arthritis , concomitant medications besides mtx were nonsteroidal anti-inflammatory agents , folic_acid , corticosteroids and/or narcotics .
effect(e1,e2)	10	16	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase ( mao ) inhibitors , tricyclic antidepressants or some antihistamines .
None(e1,e2)	34	39	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal_anti-inflammatory_agents ] is contraindicated .
None(e1,e2)	24	48	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	7	9	nursing mothers it is not known whether peginterferon or ribavirin or its components are excreted in human milk .
advise(e1,e2)	4	32	caution is advised when trisenox is coadministered with other medications that can prolong the qt interval ( e.g . certain antiarrhythmics or thioridazine ) or lead to electrolyte abnormalities ( such as diuretics or amphotericin b ) .
None(e1,e2)	31	34	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
int(e1,e2)	0	27	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	18	44	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	58	78	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	16	19	drugs metabolized by cytochrome p450 enzymes the drug interaction study evaluating the effect of grepafloxacin on theophylline indicates that grepafloxacin inhibits theophylline metabolism , which is mediated by cyp1a2 .
None(e1,e2)	21	73	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	14	16	other strong inhibitors of cyp3a4 ( e.g. , itraconazole , clarithromycin , nefazodone , troleandomycin , ritonavir , nelfinavir ) would be expected to behave similarly .
advise(e1,e2)	36	43	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
advise(e1,e2)	6	14	therefore , it is recommended that fluvoxamine tablets not be used in combination with maois , or within 14 days of discontinuing treatment with a maoi .
None(e1,e2)	9	13	the co-administration of natrecor with iv vasodilators such as nitroglycerin , nitroprusside , milrinone , or iv ace inhibitors has not been evaluated ( these drugs were not co-administered with natrecor in clinical trials ) .
None(e1,e2)	0	19	zidovudine should either be temporarily discontinued or decreased by 50 % when coadministered with probenecid on the day of vistide infusion .
advise(e1,e2)	24	47	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	54	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	23	32	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin_b , cyclosporine , non-steroidal anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
None(e1,e2)	24	30	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine_oxidase_(_mao_)_inhibitors , tricyclic antidepressants or some antihistamines .
None(e1,e2)	0	3	antipsychotic_drugs such as phenothiazines or haloperidol ;
None(e1,e2)	31	42	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	51	58	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	10	16	as with other antihypertensive agents , the antihypertensive effect of losartan may be blunted by the non-steroidal_anti-inflammatory_drug indomethacin
None(e1,e2)	8	10	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and/or some progestins , leading to possible decrease in contraceptive effectiveness .
None(e1,e2)	13	18	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid_products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	25	30	the risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine , fibric acid derivatives , niacin ( nicotinic_acid ) , erythromycin , azole_antifungals .
effect(e1,e2)	0	7	tricyclic_antidepressants may antagonize the hypotensive effects of clonidine .
None(e1,e2)	12	17	caution should be observed when anileridine is coadministered with other opioids , sedatives , phenothiazines , or anesthetics , as these agents may increase respiratory and circulatory depression .
None(e1,e2)	10	23	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
None(e1,e2)	0	36	triazolam - combined administration of racemic citalopram ( titrated to 40 mg/day for 28 days ) and the cyp3a4 substrate triazolam ( single dose of 0.25 mg ) did not significantly affect the pharmacokinetics of either citalopram or triazolam .
None(e1,e2)	33	43	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	1	9	analgesic/ anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
None(e1,e2)	22	33	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	1	6	potential terfenadine , astemizole , and cisapride interactions
None(e1,e2)	41	99	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	9	19	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract
None(e1,e2)	3	21	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	19	25	other drugs : in small groups of patients ( 7-10/interaction study ) , the concomitant administration of azathioprine , gold , chloroquine , d-penicillamine , prednisolone , doxycycline , or digitoxin did not significantly affect the peak levels and auc values of diclofenac .
None(e1,e2)	49	58	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	23	50	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical_steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	4	9	anticholinesterases ( neostgmine , physostigmine ) , lignocaine , quinine , procainamide can enhance toxicity and cause cardio respiratory depression .
None(e1,e2)	26	32	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	0	27	resins : since bile acid sequestrants may bind other drugs given concurrently , patients should take tricor at least 1 hour before or 4-6 hours after a bile_acid_binding_resin to avoid impeding its absorption .
None(e1,e2)	21	64	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	14	31	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	0	18	anticoagulants including coumarin derivatives , indandione derivatives , and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs ( nsaids ) , and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin .
None(e1,e2)	9	11	auranofin should not be used together with penicillamine ( depen , cuprimine ) , another arthritis medication .
None(e1,e2)	14	16	while all the selective serotonin reuptake inhibitors ( ssris ) , e. g. , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	2	25	interaction of gabitril with other drugs : cimetidine : co-administration of cimetidine ( 800 mg/day ) to patients taking tiagabine chronically had no effect on tiagabine pharmacokinetics .
None(e1,e2)	42	44	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium_chloride , folic acid , and acetaminophen .
None(e1,e2)	62	68	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	4	6	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	14	19	auranofin should be avoided by patients with a history of serious reaction to any gold_medication , including solganal and myochrysine .
None(e1,e2)	24	26	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine_oxidase_(_mao_)_inhibitors , tricyclic_antidepressants or some antihistamines .
None(e1,e2)	13	15	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	7	35	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	13	32	in a study in diabetics with microalbuminuria inspra 200 mg combined with the ace_inhibitor enalapril 10 mg increased the frequency of hyperkalemia ( serum potassium 5.5 meq/l ) from 17 % on enalapril alone to 38 % .
None(e1,e2)	9	11	aprepitant has been shown to induce the metabolism of s_(_-_)_warfarin and tolbutamide , which are metabolized through cyp2c9 .
None(e1,e2)	2	4	terfenadine , astemizole and cisapride are all metabolized by the cytochrome p450iiia4 isozyme , and it has been demonstrated that ketoconazole , a potent inhibitor of iiia4 , blocks the metabolism of these drugs , resulting in increased plasma concentrations of parent drug .
None(e1,e2)	108	127	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	35	87	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	5	8	in patients receiving mercaptopurine ( purinethol ) or azathioprine ( imuran ) , the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine .
None(e1,e2)	4	19	although concomitant use of clozapine and carbamazepine is not recommended , it should be noted that discontinuation of concomitant carbamazepine administration may result in an increase in clozapine plasma levels .
None(e1,e2)	16	21	the potentiating action of hydroxyzine must be considered when the drug is used in conjunction with central_nervous_system_depressants such as narcotics , non-narcotic_analgesics and barbiturates .
None(e1,e2)	7	11	lorazepam : coadministration of single doses of eszopiclone 3 mg and lorazepam 2 mg did not have clinically relevant effects on the pharmacodynamics or pharmacokinetics of either drug .
None(e1,e2)	8	10	protease inhibitors : in vitro data indicate that indinavir and ritonavir markedly inhibit the metabolism of cisapride which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	4	15	although the interaction between almotriptan and other potent cyp3a4 inhibitors ( e.g. , itraconazole , ritonavir , and erythromycin ) has not been studied , increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications .
advise(e1,e2)	4	37	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	15	17	the effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin , carbamazepine , and barbiturates , and the antituberculosis drug rifampin .
None(e1,e2)	57	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	0	7	alcohol : has a synergistic effect with aspirin in causing gastrointestinal bleeding .
None(e1,e2)	0	14	hormonal_contraceptives : it has not been established if there is a pharmacokinetic interaction between acitretin and combined oral contraceptives .
mechanism(e1,e2)	6	28	intestinal adsorbents ( e. g. , charcoal ) and digestive enzyme preparations containing carbohydrate-splitting enzymes ( e. g. , amylase , pancreatin ) may reduce the effect of acarbose and should not be taken concomitantly .
advise(e1,e2)	8	28	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	21	35	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis_preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	22	27	effects of felbatol on low-dose combination oral contraceptives a group of 24 nonsmoking , healthy white female volunteers established on an oral contraceptive regimen containing 30 mg ethinyl_estradiol and 75 mg gestodene for at least 3 months received 2400 mg/day of felbamate from midcycle ( day 15 ) to midcycle ( day 14 ) of two consecutive oral contraceptive cycles .
None(e1,e2)	13	40	if desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
None(e1,e2)	45	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	12	cholestyramine-concomitant intake of cholestyramine and vitamin k may reduce the absorption of vitamin_k .
None(e1,e2)	15	21	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	11	28	digoxin : the concomitant administration of dynacirc ( isradipine ) and digoxin in a single-dose pharmacokinetic study did not affect renal , nonrenal and total body clearance of digoxin .
None(e1,e2)	80	159	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
advise(e1,e2)	18	22	methadone levels may be decreased ; increased dosages may be required to prevent symptoms of opiate withdrawal . methadone maintained patients beginning nevirapine therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly .
None(e1,e2)	2	4	experience with nonsteroidal_anti-inflammatory_drugs ( nsaids ) suggests the potential for interactions with furosemide and ace inhibitors .
None(e1,e2)	34	36	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral_hydrate * ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	30	34	although it has not been established that there is an interaction between clozapine and benzodiazepines or other psychotropics , caution is advised when clozapine is initiated in patients taking a benzodiazepine or any other psychotropic_drug .
None(e1,e2)	15	17	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
advise(e1,e2)	2	4	patients receiving flurbiprofen and furosemide or other diuretics should be observed closely to determine if the desired effect is obtained .
None(e1,e2)	49	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	23	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	2	8	monitoring for amiodarone toxicity and serial measurement of amiodarone serum concentration during concomitant protease inhibitor therapy should be considered .
effect(e1,e2)	0	33	anticoagulants including coumarin derivatives , indandione derivatives , and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs ( nsaids ) , and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin .
None(e1,e2)	21	45	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	35	52	the results of a study of coadministration of ethambutol ( 50 mg/kg ) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20 % and 13 % , respectively , suggesting that the oral absorption of ethambutol may be reduced by these antacid products .
None(e1,e2)	25	30	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	5	7	to avoid this interaction , delavirdine or indinavir should be given 1 hour prior to dosing with videx .
effect(e1,e2)	5	7	ergotamine : concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia .
None(e1,e2)	20	31	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	18	23	no significant drug-drug pharmacokinetic ( or pharmacodynamic ) interactions have been found in interaction studies with hydrochlorothiazide , digoxin , warfarin , and nifedipine .
None(e1,e2)	21	42	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	12	22	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	10	13	acute symptoms should be treated with a short-acting , inhaled beta2-agonist such as salbutamol ( the physician should provide the patient with such medication and instruct the patient in how it should be used ) .
None(e1,e2)	0	14	skeletal_muscle_relaxants , nondepolarizing ( e.g. , tubocurarine ) : possible increased responsiveness to the muscle_relaxant .
None(e1,e2)	0	8	lithium_carbonate : the anorectic and stimulatory effects of amphetamines may be inhibited by lithium carbonate .
None(e1,e2)	25	40	clinical trials have indicated that pulmozyme can be effectively and safely used in conjunction with standard cystic fibrosis therapies including oral , inhaled and/or parenteral antibiotics , bronchodilators , enzyme supplements , vitamins , oral or inhaled corticosteroids , and analgesics .
mechanism(e1,e2)	18	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	9	16	in separate studies of patients receiving maintenance doses of warfarin , hydrochlorothiazide , or digoxin , irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin ( prothrombin time ) or pharmacokinetics of digoxin .
None(e1,e2)	29	37	because busulfan is eliminated from the body via conjugation with glutathione , use of acetaminophen prior to ( 72 hours ) or concurrent with busulfex may result in reduced busulfan clearance based upon the known property of acetaminophen to decrease glutathione levels in the blood and tissues .
mechanism(e1,e2)	18	22	antacids : in a single dose study ( n=6 ) , ingestion of an antacid containing 1.7-gram of magnesium_hydroxide with 500-mg of mefenamic_acid increased the cmax and auc of mefenamic acid by 125 % and 36 % , respectively . a number of compounds are inhibitors of cyp2c9 including fluconazole , lovastatin and trimethoprim .
None(e1,e2)	85	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	63	85	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	7	9	in a study involving healthy subjects receiving tambocor and propranolol concurrently , plasma flecainide levels were increased about 20 % and propranolol levels were increased about 30 % compared to control values .
None(e1,e2)	4	15	concomitant administration of an aluminum -containing antacid had no significant effect in the bioavailability of 6mna .
None(e1,e2)	24	38	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	0	4	mineral_oil -concomitant intake of mineral_oil and vitamin k may reduce the absorption of vitamin k .
None(e1,e2)	17	19	tablets : the benzodiazepines , including lorazepam , produce cns-depressant effects when administered with such medications as barbiturates or alcohol .
None(e1,e2)	6	26	theophylline : the effect of steady-state fluvoxamine l50 mg bid on the pharmacokinetics of a single dose of theophylline ( 375 mg ) as 442 mg aminophylline was evaluated in 12 healthy non-smoking , male volunteers .
mechanism(e1,e2)	21	33	in addition , results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
None(e1,e2)	26	38	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	13	37	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	94	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	6	46	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	44	58	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	10	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	97	113	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing_compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	38	48	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
advise(e1,e2)	0	14	isuprel should be used with caution , if at all , when potent inhalational anesthetics such as halothane are employed because of potential to sensitize the myocardium to effects of sympathomimetic amines .
None(e1,e2)	26	37	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	80	92	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	5	30	isoflurane or enflurane administered with nitrous_oxide /oxygen to achieve 1.25 mac [ minimum alveolar concentration ] may prolong the clinically effective duration of action of initial and maintenance doses of nimbex and decrease the required infusion rate of nimbex .
None(e1,e2)	6	8	in clinical studies , coadministration of welchol with atorvastatin , lovastatin , or simvastatin did not interfere with the lipid-lowering activity of the hmg-coa reductase inhibitor .
None(e1,e2)	0	2	cimetidine : cimetidine has been reported to produce clinically significant fluctuations in steady-state serum concentrations of various tricyclic antidepressants .
None(e1,e2)	33	43	although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of iopidine 0.5 % ophthalmic solution , the possibility of an additive or potentiating effect with cns_depressants ( alcohol , barbiturates , opiates , sedatives , anesthetics ) should be considered .
None(e1,e2)	5	25	in addition , oxcarbazepine and mhd induce a subgroup of the cytochrome p450 3a family ( cyp3a4 and cyp3a5 ) responsible for the metabolism of dihydropyridine_calcium_antagonists and oral contraceptives , resulting in a lower plasma concentration of these drugs .
None(e1,e2)	38	54	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing_compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	42	68	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	19	21	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim/ sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	11	43	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	0	54	cancidas reduced the blood auc0-12 of tacrolimus by approximately 20 % , peak blood concentration ( cmax ) by 16 % , and 12-hour blood concentration ( c12hr ) by 26 % in healthy subjects when tacrolimus ( 2 doses of 0.1 mg/kg 12 hours apart ) was administered on the 10th day of cancidas 70 mg daily , as compared to results from a control period in which tacrolimus was administered alone .
None(e1,e2)	49	52	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	0	16	carbamazepine : isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels carbamazepine levels should be determined prior to concurrent administration with isoniazid , signs and symptoms of carbamazepine toxicity should be monitored closely , and appropriate dosage adjustment of the anticonvulsant should be made .
None(e1,e2)	21	23	the concomitant use of transdermal fentanyl with ritonavir or other potent 3a4 inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
None(e1,e2)	7	25	zebeta should be used with care when myocardial_depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
mechanism(e1,e2)	16	42	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	31	43	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
mechanism(e1,e2)	12	14	elevated cyclosporine serum levels have been reported with the concomitant use of quinolones and cyclosporine .
mechanism(e1,e2)	2	24	therefore , esomeprazole may interfere with the absorption of drugs where gastric ph is an important determinant of bioavailability ( eg , ketoconazole , iron salts and digoxin ) .
None(e1,e2)	22	24	however , due to possible pharmacodynamic interactions , when co-administered with precedex , a reduction in dosage of precedex on the concomitant anesthetic , sedative , hypnotic or opioid may be required .
None(e1,e2)	20	28	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	27	40	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
mechanism(e1,e2)	20	29	in patients who have been reported to be well controlled on tricyclic antidepressants receiving concurrent cimetidine therapy , discontinuation of cimetidine has been reported to decrease established steady-state serum tricyclic_antidepressant levels and compromise their therapeutic effects .
effect(e1,e2)	8	27	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao_inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	11	13	considerable caution should be exercised if peganone is administered concurrently with phenurone ( phenacemide ) since paranoid symptoms have been reported during therapy with this combination .
None(e1,e2)	49	56	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	28	33	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	13	24	although trough citalopram plasma levels were unaffected , given the enzyme-inducing properties of carbamazepine , the possibility that carbamazepine might increase the clearance of escitalopram should be considered if the two drugs are coadministered .
None(e1,e2)	65	85	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	4	8	antibiotics ( e.g. , erythromycin , trimethoprim and sulfamethoxazole , amoxicillin ) .
None(e1,e2)	32	43	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic_blocking_agents , calcium channel blockers , antihistamines or h1-blocking agents , tricyclic_antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
None(e1,e2)	10	19	in addition , neuromuscular blocking action is enhanced by general anesthetics , local anesthetics like lidocaine , procaine , beta-blockers , metaclopramide , lithium carbonate , and terbutaline .
None(e1,e2)	10	24	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	22	24	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim/sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	28	41	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	14	stavudine and zidovudine ribavirin can antagonize the in vitro antiviral activity of stavudine and zidovudine against hiv .
advise(e1,e2)	11	23	drugs that induce hepatic enzymes such as phenobarbital , phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response .
advise(e1,e2)	4	7	nafazodone , fluvoxamine , cimetidine ( consider xanax dose reduction ) .
None(e1,e2)	1	18	magnesium/aluminum-containing antacid_products : absorption of zalcitabine is moderately reduced ( approximately 25 % ) when coadministered with magnesium/aluminum-containing antacid_products .
effect(e1,e2)	15	17	ketamine : marked hypertension and tachycardia have been reported in association with concomitant administration of levothyroxine_sodium and ketamine .
None(e1,e2)	49	65	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	42	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
None(e1,e2)	68	70	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	22	24	myocardial injury , including myocardial infarction , myocarditis , ventricular hypokinesia , and severe rhabdomyolysis appear to be increased in patients receiving proleukin and interferon-alfa concurrently .
None(e1,e2)	24	51	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	31	38	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	27	42	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	1	7	other cns_depressant_drugs ( e.g . barbiturates , tranquilizers , opioids and general anesthetics ) have additive or potentiating effects with inapsine .
None(e1,e2)	19	45	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle_relaxants birth control pills sleeping pills thyroid medications
mechanism(e1,e2)	0	14	ketoconazole at 400 mg daily ( the maximum approved prescription dose ) co-administered with tikosyn ( 500 mcg bid ) for 7 days has been shown to increase dofetilide cmax by 53 % in males and 97 % in females , and auc by 41 % in males and 69 % in females .
None(e1,e2)	18	40	drugs demonstrated to be cyp 3a inhibitors of possible clinical significance on the basis of clinical studies involving alprazolam ( caution is recommended during coadministration with alprazolam ) : coadministration of fluoxetine with alprazolam increased the maximum plasma concentration of alprazolam by 46 % , decreased clearance by 21 % , increased half-life by 17 % , and decreased measured psychomotor performance .
effect(e1,e2)	0	2	warfarin : meclofenamate_sodium enhances the effect of warfarin .
None(e1,e2)	20	27	as with other drugs that block angiotensin ii or its effects , concomitant use of potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , or salt substitutes containing potassium may lead to increases in serum potassium .
None(e1,e2)	30	65	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	3	49	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	41	47	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	44	97	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing_compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	6	10	ethoxzolamide may increase the action of tricyclics , amphetamines , procainamide , and quinidine .
None(e1,e2)	0	7	isoflurane or enflurane administered with nitrous oxide/ oxygen to achieve 1.25 mac [ minimum alveolar concentration ] may prolong the clinically effective duration of action of initial and maintenance doses of nimbex and decrease the required infusion rate of nimbex .
None(e1,e2)	14	16	single dose bioavailability studies in normal volunteers have failed to wshow an effect of aspirin on ibuprofen blood levels .
None(e1,e2)	38	81	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	28	30	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin_b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	10	18	pharmacokinetic data indicate that oral ketoconazole inhibits the metabolism of astemizole , resulting in elevated plasma levels of astemizole and its active metabolite desmethylastemizole which may prolong qt intervals .
None(e1,e2)	0	9	valproate : the addition of tiagabine to patients taking valproate chronically had no effect on tiagabine pharmacokinetics , but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8 % , which resulted in an increase of approximately 40 % in the free tiagabine concentration .
None(e1,e2)	39	65	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	39	55	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	26	41	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin_hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	0	10	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
mechanism(e1,e2)	5	15	the concomitant use of transdermal fentanyl with ritonavir or other potent 3a4 inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
mechanism(e1,e2)	8	20	antacids , kaolin-pectin , sulfasalazine , neomycin , cholestyramine , certain anticancer drugs , and metoclopramide may interfere with intestinal digoxin absorption , resulting in unexpectedly low serum concentrations .
None(e1,e2)	41	59	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	24	26	the following medications have been administered in clinical trials with simulect with no increase in adverse reactions : atg/alg , azathioprine , corticosteroids , cyclosporine , mycophenolate_mofetil , and muromonab-cd3 .
None(e1,e2)	15	37	- when bezalip or bezalip retard is used concurrently with anion-exchange resins ( e.g . cholestryramine ) , an interval of at least 2 hours should be maintained between the two medicines , since the absorption of bezalip or bezalip retard is impaired
None(e1,e2)	41	55	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	31	33	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	46	49	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	10	23	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
effect(e1,e2)	0	10	ethoxzolamide may increase the action of tricyclics , amphetamines , procainamide , and quinidine .
None(e1,e2)	62	70	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
advise(e1,e2)	4	15	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
None(e1,e2)	0	15	indomethacin - concomitant use of l-glutamine and indomethacin may ameliorate increased intestinal permeability caused by indomethacin .
None(e1,e2)	23	26	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	64	80	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin_sodium under-dosage .
None(e1,e2)	14	26	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim/sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	38	40	although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of iopidine 0.5 % ophthalmic solution , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , anesthetics ) should be considered .
None(e1,e2)	7	17	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
None(e1,e2)	12	21	there is limited experience with concomitant antihypertensive agents such as alpha-blockers , calcium_channel-blockers , ace inhibitors , and diuretics ( both thiazide -like and loop ) .
None(e1,e2)	21	23	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	0	15	leukocyte_transfusions : acute pulmonary toxicity has been reported in patients receiving intravenous amphotericin b and leukocyte_transfusions .
None(e1,e2)	11	37	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium_channel_blockers , beta blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	12	15	when therapeutic concentrations of furosemide , propranolol , dipyridamole , warfarin , quinidine , or naproxen were added to human plasma ( in vitro ) , the plasma protein binding of nicardipine hcl was not altered .
None(e1,e2)	4	22	if a patient requires tikosyn and anti-ulcer therapy , it is suggested that omeprazole , ranitidine , or antacids ( aluminum and magnesium_hydroxide s ) be used as alternatives to cimetidine , as these agents have no effect on the pharmacokinetic profile of tikosyn .
mechanism(e1,e2)	5	18	also , concomitant administration of quinolones with products containing iron , multivitamins containing zinc , or videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution may result in low urine levels .
mechanism(e1,e2)	31	33	drugs demonstrated to be cyp 3a inhibitors of possible clinical significance on the basis of clinical studies involving alprazolam ( caution is recommended during coadministration with alprazolam ) : coadministration of fluoxetine with alprazolam increased the maximum plasma concentration of alprazolam by 46 % , decreased clearance by 21 % , increased half-life by 17 % , and decreased measured psychomotor performance .
None(e1,e2)	97	111	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing_compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	29	64	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	100	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	13	certain drugs , including nonsteroidal anti-inflammatory agents ( nsaids ) , salicylates , monoamine_oxidase_inhibitors , and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic drugs .
None(e1,e2)	34	51	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	38	40	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	45	59	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	7	potassium-sparing diuretics ( spironolactone , amiloride , triamterene , and others ) or potassium supplements can increase the risk of hyperkalemia .
None(e1,e2)	22	49	this drug may interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine_oxidase_(_mao_)_inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	69	105	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	19	21	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic_agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	11	16	in separate studies of patients receiving maintenance doses of warfarin , hydrochlorothiazide , or digoxin , irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin ( prothrombin time ) or pharmacokinetics of digoxin .
None(e1,e2)	41	43	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop_diuretics , potassium_sparing_diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	14	16	the fraction of stadol ns absorbed is unaffected by the concomitant administration of a nasal_vasoconstrictor ( oxymetazoline ) , but the rate of absorption is decreased .
None(e1,e2)	25	36	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	37	41	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	69	81	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	52	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	35	although additional drug interaction studies have not been conducted , the most common medications used concomitantly with anagrelide in clinical trials were aspirin , acetaminophen , furosemide , iron , ranitidine , hydroxyurea , and allopurinol .
None(e1,e2)	0	14	metoclopramide : bioavailability is mildly reduced ( approximately 10 % ) when zalcitabine and metoclopramide are coadministered .
None(e1,e2)	64	66	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	9	30	these in vitro studies suggest that concomitant administration of zalcitabine and lamivudine in humans may result in sub-therapeutic concentrations of active phosphorylated zalcitabine , which may lead to a decreased antiretroviral effect of zalcitabine .
None(e1,e2)	23	65	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	28	40	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	107	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	75	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	44	70	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	154	162	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	46	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	9	patients receiving catecholamine-depleting drugs , such as reserpine or guanethidine , should be closely monitored , because the added beta-adrenergic blocking action of zebeta may produce excessive reduction of sympathetic activity .
None(e1,e2)	6	13	the adverse experience profile seen with kemstrotm was similar to that seen with baclofen tablets .
None(e1,e2)	8	24	in case of theophylline toxicity and/or elevated serum theophylline levels , the dose of theophylline should be reduced while the patient is receiving concomitant erythromycin therapy .
None(e1,e2)	27	41	in addition , results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
None(e1,e2)	9	21	co-administration of tikosyn with verapamil resulted in increases in dofetilide peak plasma levels of 42 % , although overall exposure to dofetilide was not significantly increased .
None(e1,e2)	93	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	5	lithium : inhibition of renal lithium clearance , leading to an increase in plasma lithium concentration , has been reported with some prostaglandin synthesis-inhibiting drugs .
None(e1,e2)	6	23	- a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	6	14	the possibility of hypotensive effects with lotensin can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with lotensin .
None(e1,e2)	3	12	drug/laboratory test interaction fosinopril may cause a false low measurement of serum digoxin levels with the digi- tab ria kit for digoxin .
None(e1,e2)	23	25	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	4	21	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	0	8	methotrexate : concomitant administration of methotrexate and some nsaids has been reported to reduce the clearance of methotrexate , enhancing the toxicity of methotrexate .
None(e1,e2)	74	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	30	43	if a patient requires tikosyn and anti-ulcer therapy , it is suggested that omeprazole , ranitidine , or antacids ( aluminum and magnesium hydroxides ) be used as alternatives to cimetidine , as these agents have no effect on the pharmacokinetic profile of tikosyn .
None(e1,e2)	31	35	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	7	57	dexbrompheniramine can interact with alcohol or other cns_depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	0	37	brovana , as with other beta2-agonists , should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors , tricyclic antidepressants , or drugs known to prolong the qtc interval because the action of adrenergic_agonists on the cardiovascular system may be potentiated by these agents .
None(e1,e2)	10	19	there is limited experience with concomitant antihypertensive agents such as alpha-blockers , calcium channel-blockers , ace inhibitors , and diuretics ( both thiazide-like and loop ) .
mechanism(e1,e2)	25	36	hepatic enzyme inducers , inhibitors and substrates : drugs which induce cytochrome p450 3a4 ( cyp 3a4 ) enzyme activity ( e.g. , barbiturates , phenytoin , carbamazepine , rifampin ) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased .
None(e1,e2)	15	22	cimetidine ) and many that are substrates for p450 2d6 ( many other antidepressants , phenothiazines , and the type 1c antiarrhythmics propafenone and flecainide ) .
None(e1,e2)	0	12	potassium supplements and potassium-sparing diuretics lotensin can attenuate potassium loss caused by thiazide_diuretics .
None(e1,e2)	69	127	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	14	84	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	36	48	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	12	14	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
mechanism(e1,e2)	3	32	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	16	35	metformin : in healthy subjects given single 500 mg doses of cephalexin and metformin , plasma metformin mean cmax and auc increased by an average of 34 % and 24 % , respectively , and metformin mean renal clearance decreased by 14 % .
None(e1,e2)	4	15	if a patient requires tikosyn and anti-ulcer therapy , it is suggested that omeprazole , ranitidine , or antacids ( aluminum and magnesium hydroxides ) be used as alternatives to cimetidine , as these agents have no effect on the pharmacokinetic profile of tikosyn .
effect(e1,e2)	22	36	brovana , as with other beta2-agonists , should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors , tricyclic_antidepressants , or drugs known to prolong the qtc interval because the action of adrenergic_agonists on the cardiovascular system may be potentiated by these agents .
None(e1,e2)	42	51	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	45	51	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	4	21	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	41	61	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	24	64	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	13	19	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , citalopram , escitalopram , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	4	10	therefore , administration of quinolones with antacids containing calcium , magnesium , or aluminum ;
None(e1,e2)	19	128	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	28	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
None(e1,e2)	35	42	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine_derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	9	45	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	11	22	a case report of one patient taking amiodarone 200 mg and indinavir 800 mg three times a day resulted in increases in amiodarone concentrations from 0.9 mg/l to 1.3 mg/l .
mechanism(e1,e2)	13	19	the reddish color is due to the formation of a nonabsorbable complex between cefdinir or its breakdown products and iron in the gastrointestinal tract .
None(e1,e2)	0	5	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid-associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
None(e1,e2)	21	26	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
None(e1,e2)	29	36	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	16	23	ritonavir and indinavir : upon concomitant administration of 5 mg of vardenafil with 600 mg bid ritonavir , the cmax and auc of ritonavir were reduced by approximately 20 % .
None(e1,e2)	2	8	these include probenecid , cholestyramine , and some antibiotics ( e.g . erythromycin , rifamipicin , ampicillin and chloramphenicol ) .
None(e1,e2)	29	75	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	40	60	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	17	21	potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( phenytoin , valproate , oral contraceptive , digoxin , warfarin , probenecid ) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients .
advise(e1,e2)	14	29	avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic_amine ( e.g. , epinephrine , norepinephrine ) , since it has been reported that tricyclic_antidepressants can potentiate the effects of catecholamines .
int(e1,e2)	0	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	30	35	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic_antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	14	25	therefore , it is recommended that fluvoxamine tablets not be used in combination with maois , or within 14 days of discontinuing treatment with a maoi .
int(e1,e2)	0	48	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine_oxidase_(_mao_)_inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	12	26	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	63	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	22	24	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	20	41	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	40	127	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	33	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	57	105	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	20	22	for comprehensive information concerning laboratory test alterations associated with ritonavir , physicians should refer to the complete prescribing information for norvir ( ritonavir ) .
effect(e1,e2)	2	4	use of prinivil with potassium-sparing_diuretics ( e.g. , spironolactone , triamterene , or amiloride ) , potassium supplements , or potassium-containing salt substitutes may lead to significant increases in serum potassium .
None(e1,e2)	0	5	human_growth_hormone - concomitant use of l-glutamine and human growth hormone may enhance nutrient absorption in those with severe short bowel syndrome .
None(e1,e2)	8	46	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
int(e1,e2)	0	7	diphenoxylate_hcl and atropine sulfate may interact with mao_inhibitors in studies with male rats , diphenoxylate hydrochloride was found to inhibit the hepatic microsomal enzyme system at a dose of 2 mg/kg/day .
None(e1,e2)	33	45	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide_antibiotics .
None(e1,e2)	6	27	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	10	12	antifungals : in vitro and/or in vivo data indicate that fluconazole , itraconazole , and oral ketoconazole markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	15	21	potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( phenytoin , valproate , oral contraceptive , digoxin , warfarin , probenecid ) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients .
None(e1,e2)	25	47	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis_kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	9	histamine_h2_antagonists : cimetidine inhibits cyp3a4 and can increase serum amiodarone levels .
effect(e1,e2)	1	15	if desipramine_hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/ hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
None(e1,e2)	5	21	aspirin : concomitant administration of aspirin with valdecoxib may result in an increased risk of gi ulceration and complications compared to valdecoxib alone .
None(e1,e2)	14	62	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	133	152	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	14	23	in a ten-subject study , coadministration of diltiazem ( 120 mg bid ) with lovastatin resulted in a 3-4 times increase in mean lovastatin auc and cmax vs. lovastatin alone ;
None(e1,e2)	31	33	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
mechanism(e1,e2)	18	95	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	10	14	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
effect(e1,e2)	6	94	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	5	41	in patients receiving mercaptopurine ( purinethol ) or azathioprine ( imuran ) , the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine .
None(e1,e2)	39	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	19	33	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
mechanism(e1,e2)	3	20	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
advise(e1,e2)	11	24	this time window is different than for other oral formulations of ciprofloxacin , which are usually administered 2 hours before or 6 hours after antacids .
None(e1,e2)	29	33	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	6	59	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	9	14	- lofexidine may enhance the cns depressive effects of alcohol , barbiturates and other sedatives
None(e1,e2)	23	29	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical_steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	8	21	in one man , the c max of terfenadine was 8.1 ng/ml with terfenadine alone and 7.2 ng/ml with terfenadine plus dirithromycin .
None(e1,e2)	44	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	20	naproxen : the concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of naproxen , but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite .
None(e1,e2)	2	9	clearance of hydrodolasetron decreased by about 27 % when dolasetron_mesylate was administered intravenously concomitantly with atenolol .
effect(e1,e2)	2	14	administration of epinephrine to patients receiving cyclopropane or halogenated hydrocarbon general anesthetics such as halothane which sensitize the myocardium , may induce cardiac arrhythmia..
None(e1,e2)	5	13	in vitro studies have shown casodex can displace coumarin anticoagulants , such as warfarin , from their protein-binding sites .
None(e1,e2)	0	9	antiarrhythmic_agents_,_class_i ( such as flecainide , lidocaine , or quinidine ) : concurrent use with arbutamine may have a proarrhythmic effect .
None(e1,e2)	57	78	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	3	8	erythromycin co-administration of felodipine ( plendil ) with erythromycin resulted in approximately 2.5- fold increase in the auc and cmax , and about 2- fold prolongation in the half- life of felodipine .
None(e1,e2)	40	57	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	30	56	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	2	8	pharmacokinetics of levetiracetam were also not affected by phenytoin .
None(e1,e2)	4	18	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	6	8	further , in clinical studies with proscar ( finasteride , 5 mg ) when used in older men who have benign prostatic hyperplasia ( bph ) , psa levels are decreased by approximately 50 % .
None(e1,e2)	12	22	concomitant single dose administration of valdecoxib 20 mg with multiple doses of ketoconazole and fluconazole produced a significant increase in exposure of valdecoxib .
None(e1,e2)	1	35	when bezalip or bezalip retard is used at the same time as other medicines or substances the following interactions must be taken into account : - bezalip and bezalip retard may enhance the action of anticoagulants_of_the_coumarin_type .
None(e1,e2)	0	13	phenobarbital toxicity has been reported to have occurred in a patient on chronic phenobarbital treatment following the initiation of diclofenac therapy .
None(e1,e2)	1	46	cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation , the discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin .
None(e1,e2)	45	61	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
advise(e1,e2)	4	6	therefore concomitant administration of itraconazole with cisapride is contraindicated .
None(e1,e2)	39	42	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine_oxidase_inhibitors and the tricyclic_antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	30	56	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	10	23	conversely , the administration of stadol ns ( 1 mg butorphanol qid ) did not alter the pharmacokinetics of a 300-mg dose of cimetidine .
None(e1,e2)	10	22	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	5	7	pharmacokinetic studies have demonstrated that omeprazole and erythromycin significantly increased the systemic exposure of cilostazol and/or its major metabolites .
None(e1,e2)	13	17	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	0	2	carbamazepine , clonazepam , ethosuximide
None(e1,e2)	10	41	in another drug interaction study , co-administration of orally inhaled ciclesonide and oral ketoconazole , a potent inhibitor of cytochrome p450 3a4 , increased the exposure ( auc ) of des-ciclesonide by approximately 3.6-fold at steady state , while levels of ciclesonide remained unchanged .
None(e1,e2)	7	45	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	22	24	a rare , but serious , constellation of symptoms , termed serotonin syndrome , has been reported with the concomitant use of selective_serotonin_reuptake_inhibitors ( ssris ) and agents for migraine therapy , such as imitrex ( sumatriptan succinate ) and dihydroergotamine .
None(e1,e2)	7	20	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	3	13	the co-administration of natrecor with iv vasodilators such as nitroglycerin , nitroprusside , milrinone , or iv ace inhibitors has not been evaluated ( these drugs were not co-administered with natrecor in clinical trials ) .
None(e1,e2)	72	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	65	116	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	3	5	the absorption of tetracycline , furosemide , penicillin g , hydrochlorothiazide , and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride ;
mechanism(e1,e2)	2	4	co-administration of anastrozole and tamoxifen resulted in a reduction of anastrozole plasma levels by 27 % compared with those achieved with anastrozole alone .
None(e1,e2)	15	17	drugs that cause significant sustained elevation in gastric ph ( histamine h2-receptor antagonists such as ranitidine or cimetidine ) may reduce plasma concentrations of iressa and therefore potentially may reduce efficacy .
None(e1,e2)	0	26	hormonal_contraceptives , including oral , injectable , transdermal , and implantable contraceptives : an interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive ortho-novum produced average decreases of norethindrone and ethinyl estradiol levels of 14 % and 31 % , respectively .
None(e1,e2)	11	20	antacid : the effect of an aluminum hydroxide- and magnesium hydroxide-containing antacid ( maalox ) * on the pharmacokinetics of capecitabine was investigated in 12 cancer patients .
None(e1,e2)	6	11	the antihypertensive effects of methyldopa , mecamylamine , reserpine , and veratrum_alkaloids may be reduced by sympathomimetics .
effect(e1,e2)	11	16	the antihypertensive effects of methyldopa , mecamylamine , reserpine , and veratrum_alkaloids may be reduced by sympathomimetics .
None(e1,e2)	42	85	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	28	30	ace inhibitors and angiotensin ii receptor antagonists ( hypertension ) - in clinical studies of patients with hypertension , the addition of inspra 50 to 100 mg to ace_inhibitors and angiotensin_ii_receptor_antagonists increased mean serum potassium slightly ( about 0.09-0.13 meq/l ) .
None(e1,e2)	12	18	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc . ) is indicated , reduction of the budesonide dose should be considered .
None(e1,e2)	6	20	effects of other antiepileptic drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
effect(e1,e2)	8	10	the safety and efficacy of concomitant use of revia and disulfiram is unknown , and the concomitant use of two potentially hepatotoxic medications is not ordinarily recommended unless the probable benefits outweigh the known risks .
None(e1,e2)	98	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	22	31	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase ( mao ) inhibitors , tricyclic_antidepressants or some antihistamines .
None(e1,e2)	32	41	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
effect(e1,e2)	12	14	the risk of hypoglycemia secondary to this mechanism may be increased if allopurinol and chlorpropamide are given concomitantly in the presence of renal insufficiency .
effect(e1,e2)	9	24	h1 and h2 blockers - although not reported , l-histidine , via its metabolism to histamine , might decrease the efficacy of h1 and h2_blockers .
None(e1,e2)	0	3	rifabutin , another rifamycin , is structurally similar to rifampin and may possibly have some of the same drug interactions as rifampin .
None(e1,e2)	15	19	the concurrent use of two or more drugs with anticholinergic activity -- such as an antipsychotic_drug ( eg , chlorpromazine ) , an antiparkinsonian drug ( eg , trihexyphenidyl ) , and/or a tricyclic antidepressant ( eg , amitriptyline ) -- commonly results in excessive anticholinergic effects , including dry mouth and associated dental complications , blurred vision , and , in patients exposed to high temperature and humidity , hyperpyrexia .
None(e1,e2)	68	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	25	31	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
advise(e1,e2)	11	13	therefore , prothrombin time should be carefully monitored in patients receiving itraconazole and coumarin -like drugs simultaneously .
None(e1,e2)	7	48	although glucocorticoids have been shown to reduce proleukin -induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with proleukin may reduce the antitumor effectiveness of proleukin and thus should be avoided . 12 beta-blockers and other antihypertensives may potentiate the hypotension seen with proleukin .
None(e1,e2)	28	59	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	17	19	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
advise(e1,e2)	31	35	however , because some quinolones have been reported to enhance the effects of warfarin or its derivatives , prothrombin time or other suitable anticoagulation test should be monitored closely if a quinolone_antimicrobial is administered with warfarin or its derivatives .
None(e1,e2)	8	10	multivitamins , or other products containing iron or zinc , antacids or sucralfate should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .
None(e1,e2)	22	32	antifungals : in vitro and/or in vivo data indicate that fluconazole , itraconazole , and oral ketoconazole markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	31	41	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	42	66	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	61	63	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	5	16	in a similar study with tamsulosin in healthy volunteers , 1 of 24 subjects dosed with vardenafil 20 mg and tamsulosin 0.4 mg separated by 6 hours experienced a standing systolic blood pressure below 85 mm hg .
effect(e1,e2)	5	7	warfarin : the effects of warfarin and nsaids on gi bleeding are synergistic , such that users of both drugs together have a risk of serious gi bleeding higher than users of either drug alone .
effect(e1,e2)	5	15	insulin or oral hypoglycemics : agents_with_b-blocking_properties may enhance the blood-sugar-reducing effect of insulin and oral hypoglycemics .
None(e1,e2)	22	30	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	45	66	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	11	13	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
mechanism(e1,e2)	0	20	antacids , kaolin-pectin , sulfasalazine , neomycin , cholestyramine , certain anticancer drugs , and metoclopramide may interfere with intestinal digoxin absorption , resulting in unexpectedly low serum concentrations .
None(e1,e2)	14	18	because severe hypoglycemia has been reported in patients concomitantly receiving oral miconazole ( an imidazole ) and oral hypoglycemic_agents , such a potential interaction involving the latter agents when used concomitantly with ketoconazole tablets ( an imidazole ) can not be ruled out .
None(e1,e2)	21	48	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine_oxidase_(_mao_)_inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	3	16	in vitro , buspirone does not displace tightly bound drugs like phenytoin , propranolol , and warfarin from serum proteins .
advise(e1,e2)	18	33	although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of iopidine 0.5 % ophthalmic solution , the possibility of an additive or potentiating effect with cns_depressants ( alcohol , barbiturates , opiates , sedatives , anesthetics ) should be considered .
None(e1,e2)	0	11	antacids : enteric coated aspirin should not be given concurrently with antacids , since an increase in the ph of the stomach may effect the enteric coating of the tablets .
None(e1,e2)	51	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	24	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	17	33	the concomitant use of transdermal fentanyl with ritonavir or other potent 3a4 inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
None(e1,e2)	39	64	aspirin/acetaminophen : pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between argatroban and concomitantly administered aspirin ( 162.5 mg orally given 26 and 2 hours prior to initiation of argatroban 1 g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of argatroban 1.5 g/kg/min . over 18 hours ) .
None(e1,e2)	2	8	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	1	28	- anabolic_steroids ( nandrolone [ e.g. , anabolin ] , oxandrolone [ e.g. , anavar ] , oxymetholone [ e.g. , anadrol ] , stanozolol [ e.g. , winstrol ] ) or
None(e1,e2)	2	20	potential for duloxetine to affect other drugs : drugs metabolized by cyp1a2 : in vitro drug interaction studies demonstrate that duloxetine does not induce cyp1a2 activity , and it is unlikely to have a clinically significant effect on the metabolism of cyp1a2 substrates .
None(e1,e2)	28	39	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic agents ) or drugs which inhibit platelet function ( eg , aspirin and other non-steroidal anti-inflammatory drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
None(e1,e2)	1	7	other antiarrhythmic_drugs ( eg , quinidine , procainamide , lidocaine , propranolol ) have occasionally been used concurrently with norpace .
mechanism(e1,e2)	2	8	ingestion of diclofenac may increase serum concentrations of digoxin and methotrexate and increase cyclosporine s nephrotoxicity .
None(e1,e2)	131	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	77	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	37	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	23	25	in psoriatic arthritis clinical trials , concomitant medications included mtx in approximately half of the patients as well as nonsteroidal anti-inflammatory agents , folic_acid and corticosteroids .
None(e1,e2)	8	29	ketoconazole ) , macrolide antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
effect(e1,e2)	9	38	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
mechanism(e1,e2)	6	17	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	0	30	diuretics : patients on diuretics , especially those in whom diuretic therapy was recently instituted , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with lotensin .
None(e1,e2)	0	4	fluoxetine , ocs , sertraline , diltiazem , macrolide antibiotics ( exercise caution ) .
mechanism(e1,e2)	8	16	drugs that inhibit cytochrome p450iid6 , such as quinidine , might increase the plasma concentrations of flecainide in patients that are on chronic flecainide therapy ;
None(e1,e2)	9	12	anticoagulants : ten patients who were stabilized on oral anticoagulants were given guanfacine , 1-2 mg/day , for 4 weeks .
None(e1,e2)	3	19	ace inhibitors and angiotensin_ii_receptor_antagonists ( hypertension ) - in clinical studies of patients with hypertension , the addition of inspra 50 to 100 mg to ace inhibitors and angiotensin ii receptor antagonists increased mean serum potassium slightly ( about 0.09-0.13 meq/l ) .
None(e1,e2)	8	34	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine-containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton pump inhibitors ( e.g. , lansoprazole , omeprazole ) .
None(e1,e2)	0	4	diuretics : patients on diuretics , especially those with intravascular volume depletion , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with fosinopril sodium .
mechanism(e1,e2)	18	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	20	thus agents likely to be concomitantly administered with chirocaine that are metabolized by this isoenzyme family may potentially interact with chirocaine .
None(e1,e2)	51	86	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	23	117	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	110	118	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	40	77	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
effect(e1,e2)	3	19	tablets : the benzodiazepines , including lorazepam , produce cns-depressant effects when administered with such medications as barbiturates or alcohol .
mechanism(e1,e2)	18	61	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	10	ketoconazole : co-administration of bosentan 125 mg b.i.d . and ketoconazole , a potent cyp3a4 inhibitor , increased the plasma concentrations of bosentan by approximately 2-fold .
None(e1,e2)	4	26	since higher doses of ketoconazole ( 400 mg daily ) may result in higher increases in cmax and auc , a single 2.5 mg dose of vardenafil should not be exceeded in a 24-hour period when used in combination with ketoconazole 400 mg daily .
None(e1,e2)	0	21	vitamin_a : because of the relationship of accutane to vitamin a , patients should be advised against taking vitamin supplements containing vitamin_a to avoid additive toxic effects
None(e1,e2)	4	8	coadministration of itraconazole and cyclosporine , tacrolimus or digoxin has led to increased plasma concentrations of the latter three drugs .
mechanism(e1,e2)	0	5	acetazolamide reduces urinary excretion of quinidine and may enhance its effect .
None(e1,e2)	32	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	65	75	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	14	in patients with chronic hepatitis c treated with pegasys in combination with copegus , pegasys treatment did not affect ribavirin distribution or clearance .
None(e1,e2)	31	40	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	14	16	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
mechanism(e1,e2)	22	28	at 24 hours postdose , a similar proportion of patients treated with methotrexate alone ( 94 % ) and subsequently treated with methotrexate co-administered with 75 mg of rofecoxib ( 88 % ) had methotrexate plasma concentrations below the measurable limit ( 5 ng/ml ) .
None(e1,e2)	55	63	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	2	warfarin : quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives .
effect(e1,e2)	6	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	32	48	corticosteroids : dexamethasone : aprepitant , when given as a regimen of 125mg with dexamethasone coadministered orally as 20 mg on day 1 , and aprepitant when given as 80 mg/day with dexamethasone coadministered orally as 8 mg on days 2 through 5 , increased the auc of dexamethasone , a cyp3a4 substrate by 2.2-fold , on days 1 and 5 .
None(e1,e2)	5	24	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .
None(e1,e2)	37	49	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline_salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth_subsalicylate ( pepto-bismol ) ;
None(e1,e2)	14	16	hydrochlorothiazide : a study in normal healthy volunteers has shown that concomitant administration of dynacirc ( isradipine ) and hydrochlorothiazide does not result in altered pharmacoktnetics of either drug .
None(e1,e2)	0	32	glyburide : in a randomized , multiple-dose crossover study , patients with type 2 diabetes were administered 120 mg starlix three times a day before meals for 1 day in combination with glyburide 10 mg daily .
None(e1,e2)	20	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	11	31	co-administration of cyp3a4 inhibitors ( eg , ketoconazole , itraconazole , erythromycin , grapefruit juice , cimetidine ) with felodipine may lead to several- fold increases in the plasma levels of felodipine , either due to an increase in bioavailability or due to a decrease in metabolism .
mechanism(e1,e2)	11	21	however , in the second study , administration of 12 g cholestyramine 1 hour before the evening meal and 0.3 mg cerivastatin_sodium approximately 4 hours after the same evening meal resulted in a decrease in the cerivastatin auc of less than 8 % , and a decrease in cmax of about 30 % when compared to dosing cerivastatin sodium alone .
None(e1,e2)	57	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	26	corresponding values for free valproate cmin concentrations were 7 3 , 9 4 , and 11 6 micrograms/ml for 0 , 1200 , and 2400 mg/day felbatol , respectively .
None(e1,e2)	9	17	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	65	69	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral_hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	40	75	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	10	24	because prostaglandins play an important role in hemostasis , and nsaids affect platelet function as well , concurrent therapy with all nsaids , including diclofenac , and warfarin requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required .
None(e1,e2)	12	26	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
mechanism(e1,e2)	18	31	interactions with other antiretroviral drugs : significant decreases in the auc of delavirdine ( 20 % ) and indinavir ( 84 % ) occurred following simultaneous administration of these agents with videx .
None(e1,e2)	0	4	lithium : increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ace inhibitor therapy .
int(e1,e2)	3	10	clinical studies with celecoxib have identified potentially significant interactions with fluconazole and lithium .
None(e1,e2)	3	14	while all the selective_serotonin_reuptake_inhibitors ( ssris ) , e.g. , citalopram , escitalopram , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	48	59	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
advise(e1,e2)	2	17	coadministration of alosetron and strong cyp3a4 inhibitors , such as clarithromycin , telithromycin , protease inhibitors , voriconazole , and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
None(e1,e2)	19	23	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
advise(e1,e2)	7	30	avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic amine ( e.g. , epinephrine , norepinephrine ) , since it has been reported that tricyclic_antidepressants can potentiate the effects of catecholamines .
None(e1,e2)	27	50	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth_subsalicylate ( pepto-bismol ) ;
None(e1,e2)	9	45	medications can interfere with folate utilization , including : anticonvulsant_medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
None(e1,e2)	11	16	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium_hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	39	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	6	12	clinical interaction studies with cimetidine and warfarin indicated that the coadministration of femara with these drugs does not result in clinically- significant drug interactions .
None(e1,e2)	19	56	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	18	20	no significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide , nifedipine , digoxin , warfarin , hydrochlorothiazide , and oral contraceptives in healthy volunteers , or given with enalapril to patients with heart failure ( nyha class ii and iii ) .
None(e1,e2)	2	17	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	0	28	phenytoin : in a single ( 400 mg ) and multiple dose ( 400 mg tid ) study of neurontin in epileptic patients ( n=8 ) maintained on phenytoin monotherapy for at least 2 months , gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics .
mechanism(e1,e2)	2	21	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and/or some progestins , leading to possible decrease in contraceptive effectiveness .
effect(e1,e2)	10	12	in clinical trials in patients undergoing ptca/pci , co-administration of angiomax with heparin , warfarin , thrombolytics or glycoprotein iib/iiia inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications .
None(e1,e2)	94	110	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	14	19	no interactions have been observed between nizatidine and theophylline , chlordiazepoxide , lorazepam , lidocaine , phenytoin , and warfarin .
effect(e1,e2)	14	21	dopamine d2 receptor antagonists ( e.g. , phenothiazines , butyrophenones , risperidone ) and isoniazid may reduce the therapeutic effects of levodopa .
None(e1,e2)	19	21	in addition to the interactions noted above , chronic ( 2 weeks ) oral cordarone administration impairs metabolism of phenytoin , dextromethorphan , and methotrexate .
None(e1,e2)	0	2	sedative / hypnotics : midazolam , triazolam
None(e1,e2)	27	31	effects of felbatol on low-dose combination oral contraceptives a group of 24 nonsmoking , healthy white female volunteers established on an oral contraceptive regimen containing 30 mg ethinyl_estradiol and 75 mg gestodene for at least 3 months received 2400 mg/day of felbamate from midcycle ( day 15 ) to midcycle ( day 14 ) of two consecutive oral contraceptive cycles .
effect(e1,e2)	9	33	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic_antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
effect(e1,e2)	6	13	ace inhibitors : reports suggest that nsaids may diminish the antihypertensive effect of ace_inhibitors .
effect(e1,e2)	9	21	dopamine d2 receptor antagonists ( e.g. , phenothiazines , butyrophenones , risperidone ) and isoniazid may reduce the therapeutic effects of levodopa .
None(e1,e2)	18	26	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf_blocking_agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	27	29	protein binding in vitro , diclofenac interferes minimally or not at all with the protein binding of salicylic acid ( 20 % decrease in binding ) , tolbutamide , prednisolone ( 10 % decrease in binding ) , or warfarin .
None(e1,e2)	0	3	salicylic_acid : combination hormonal_contraceptives may increase the clearance of salicylic acid .
None(e1,e2)	69	74	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	30	37	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline_salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	5	32	clinical trials have indicated that pulmozyme can be effectively and safely used in conjunction with standard cystic fibrosis therapies including oral , inhaled and/or parenteral antibiotics , bronchodilators , enzyme supplements , vitamins , oral or inhaled corticosteroids , and analgesics .
None(e1,e2)	0	3	aspirin : concomitant aspirin may decrease the metabolic clearance of nicotinic acid .
None(e1,e2)	12	16	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	7	18	probenecid may decrease renal tubular secretion of cephalosporins when used concurrently , resulting in increased and more prolonged cephalosporin blood levels .
None(e1,e2)	8	10	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	30	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	17	49	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
mechanism(e1,e2)	12	23	products containing calcium and other multivalent cations ( such as aluminum , magnesium , iron ) are likely to interfere with absorption of ibandronate .
None(e1,e2)	36	44	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	5	23	in a multiple-dose study , enoxacin caused a dose-related increase in the mean elimination half-life of caffeine , thereby decreasing the clearance of caffeine by up to 80 % and leading to a five-fold increase in the auc and the half-life of caffeine .
None(e1,e2)	0	45	cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation , the discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin .
None(e1,e2)	12	14	additive cns depression may occur when antihistamines are administered concomitantly with other cns_depressants including barbiturates , tranquilizers , and alcohol .
None(e1,e2)	13	17	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine_oxidase_inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
int(e1,e2)	0	24	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	20	26	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	51	64	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	5	7	tricyclic antidepressants ( amitriptyline , imipramine , nortriptyline ) : metabolism may be inhibited by combination hormonal contraceptives , increasing plasma levels of antidepressant ;
None(e1,e2)	20	30	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	7	12	immunosuppressive drugs , fibric acid derivatives , niacin ( nicotinic acid , erythromycin , azole antifungals : skeletal muscle .
None(e1,e2)	26	51	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	25	27	because eprosartan is not metabolized by the cytochrome p450 system , inhibitors of cyp450 enzyme would not be expected to affect its metabolism , and ketoconazole and fluconazole , potent inhibitors of cyp3a and 2c9 , respectively , have been shown to have no effect on eprosartan pharmacokinetics .
None(e1,e2)	2	18	interactions for vitamin_d_analogues ( vitamin d2 , vitamin d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;
None(e1,e2)	95	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	5	7	pre-treatment with the cyp3a4 inducer rifampicin decreased erlotinib auc by about 2/3 .
effect(e1,e2)	9	29	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	12	14	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	15	18	nabilone should be administered with caution to patients who are taking other psychoactive drugs or cns_depressants , including alcohol , barbiturates and narcotic analgesics , or to those with a history of psychiatric disorder ( including manic-depressive illness and schizophrenia ) .
None(e1,e2)	31	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	5	9	patients taking these drugs with lodosyn and levodopa or carbidopa -levodopa combination products should be carefully observed for loss of therapeutic response .
None(e1,e2)	5	13	fluothane augments the action of non-depolarising_muscle_relaxant s and the muscle relaxant effects of aminoglycosides .
None(e1,e2)	11	16	- a diuretic ( water pill ) such as hydrochlorothiazide ( hctz , hydrodiuril ) , chlorothiazide ( diuril ) , and others ;
None(e1,e2)	24	30	although additional drug interaction studies have not been conducted , the most common medications used concomitantly with anagrelide in clinical trials were aspirin , acetaminophen , furosemide , iron , ranitidine , hydroxyurea , and allopurinol .
mechanism(e1,e2)	10	29	however , a crossover study in healthy subjects receiving either tagamet 300 mg q.i.d . or 800 mg h.s . concomitantly with a 300 mg b.i.d . dosage of theophylline ( theo-dur , key pharmaceuticals , inc. ) demonstrated less alteration in steady-state theophylline peak serum levels with the 800 mg h.s . regimen , particularly in subjects aged 54 years and older .
None(e1,e2)	3	59	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	12	14	however , iloprost has the potential to increase the hypotensive effect of vasodilators and antihypertensive_agents .
None(e1,e2)	8	39	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	27	32	however , in a study of 12 normal subjects , concurrent administration of aspirin decreased ketoprofen protein binding and increased ketoprofen plasma clearance from 0.07 l/kg/h without aspirin to 0.11 l/kg/h with aspirin .
None(e1,e2)	8	30	however , because bleeding has been reported when ibuprofen and other nonsteroidal anti-inflammatory agents have been administered to patients on coumarin-type anticoagulants , the physician should be cautious when administering ibuprofen to patients on anticoagulants .
None(e1,e2)	4	12	laboratory tests response to plenaxis should be monitored by measuring serum total testosterone concentrations just prior to administration on day 29 and every 8 weeks thereafter .
None(e1,e2)	26	35	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine_derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	10	40	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	30	38	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	33	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	78	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	6	lithium_carbonate : the stimulatory effects of amphetamines may be inhibited by lithium carbonate .
None(e1,e2)	30	60	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	44	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	51	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	69	92	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	29	43	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	37	51	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	33	39	concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with proleukin may increase toxicity in these organ systems .
effect(e1,e2)	8	57	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	7	13	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid_products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
mechanism(e1,e2)	6	16	- drugs that may decrease plasma phenytoin concentrations include : carbamazepine , chronic alcohol abuse , reserpine
None(e1,e2)	38	40	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	49	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	28	30	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	35	94	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	2	aspirin / nonsteroidal_antiinflammatory_drug s ( nsaids )
None(e1,e2)	55	83	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex_sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	82	86	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	15	17	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	92	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	5	29	warfarin : co- administration of warfarin and cerivastatin to healthy volunteers did not result in any changes in prothrombin time or clotting factor vii when compared to co-administration of warfarin and placebo .
None(e1,e2)	18	20	an alternative non-cyp3a4 substrate hypnotic agent may be considered in patients taking cyp3a4 inducers such as rifampin , phenytoin , carbamazepine , and phenobarbital .
None(e1,e2)	6	26	the possibility of hypotensive effects with prinivil can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with prinivil .
None(e1,e2)	7	25	interaction of gabitril with other drugs : cimetidine : co-administration of cimetidine ( 800 mg/day ) to patients taking tiagabine chronically had no effect on tiagabine pharmacokinetics .
None(e1,e2)	20	31	ketoconazole ) , macrolide antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	21	31	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	28	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	0	10	amiodarone may suppress certain cyp450 enzymes , including cyp1a2 , cyp2c9 , cyp2d6 , and cyp3a4 .
None(e1,e2)	44	78	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	20	22	other concomitant therapies : in clinical trials , the safety profile in subjects treated with acamprosate concomitantly with anxiolytics , hypnotics and sedatives ( including benzodiazepines ) , or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications .
effect(e1,e2)	13	27	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	7	16	co-administration of cyp3a4 inhibitors ( eg , ketoconazole , itraconazole , erythromycin , grapefruit juice , cimetidine ) with felodipine may lead to several- fold increases in the plasma levels of felodipine , either due to an increase in bioavailability or due to a decrease in metabolism .
None(e1,e2)	21	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	4	influence of trileptal on aed concentration ( mean change , 90 % confidence interval )
None(e1,e2)	14	16	although not studied systematically in clinical trials , no drug interactions were observed when vecuronium , pancuronium , or atracurium were administered following varying degrees of recovery from single doses or infusions of nimbex .
None(e1,e2)	23	27	oral hypoglycemic agents : in one study , flurbiprofen was given to adult diabetics who were already receiving glyburide ( n=4 ) , metformin ( n=2 ) chlorpropamide with phenformin ( n= 3 ) or glyburide with phenformin ( n=6 ) .
None(e1,e2)	2	8	h1 and h2_blockers - although not reported , l-histidine , via its metabolism to histamine , might decrease the efficacy of h1 and h2 blockers .
None(e1,e2)	33	69	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	35	48	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	5	7	antacids : concomitant administration of antacids containing magnesium or aluminum with videx chewable/dispersible buffered tablets or pediatric powder for oral solution may potentiate adverse events associated with the antacid components .
None(e1,e2)	18	39	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	18	32	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	4	27	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	137	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	35	42	beta blockers : although the results of a clinical study did not indicate a safe problem associated with the administration of d.h.e . 45 ( dihydroergotamine mesylate ) injection , usp to subjects already receiving propranolol , there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine .
None(e1,e2)	3	25	resins : since bile_acid_sequestrants may bind other drugs given concurrently , patients should take tricor at least 1 hour before or 4-6 hours after a bile_acid_binding_resin to avoid impeding its absorption .
None(e1,e2)	0	12	ketoconazole : ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60 % , leading to increased risk of corticosteroid side effects .
None(e1,e2)	15	19	h2 blockers/proton pump inhibitors : long-term suppression of gastric acid secretion by h2 blockers or proton_pump_inhibitors ( eg , famotidine and omeprazole ) is likely to reduce dasatinib exposure .
None(e1,e2)	6	72	although there was no effect of aprepitant on the plasma auc of r ( + ) or s ( - ) warfarin determined on day 3 , there was a 34 % decrease in s ( - ) warfarin ( a cyp2c9 substrate ) trough concentration accompanied by a 14 % decrease in the prothrombin time ( reported as international normalized ratio or inr ) 5 days after completion of dosing with aprepitant .
None(e1,e2)	4	10	non-selective mao inhibitors including tranylcypromine_sulfate , phenelzine sulfate , and pargyline hc1 : concomitant use of l-tyrosine and non-selective mao inhibitors may cause hypertension .
None(e1,e2)	14	18	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim /sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	0	36	quinolone_antibiotic s : videx should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	61	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	5	27	probenecid : as with other b-lactam_antibiotics , renal excretion of loracarbef is inhibited by probenecid and resulted in an approximate 80 % increase in the auc for loracarbef .
None(e1,e2)	4	6	the antihypertensive effects of methyldopa , mecamylamine , reserpine , and veratrum alkaloids may be reduced by sympathomimetics .
None(e1,e2)	20	34	in order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with taxol should be premedicated with corticosteroids ( such as dexamethasone ) , diphen-hydramine and h2 antagonists ( such as cimetidine or ranitidine ) .
None(e1,e2)	12	19	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
advise(e1,e2)	8	10	it is recommended that the combination of intravenous dantrolene_sodium and calcium_channel_blockers , such as verapamil , not be used together during the management of malignant hyperthermia crisis until the relevance of these findings to humans is established .
None(e1,e2)	8	10	similarly , patients receiving the drug and a hydantoin , sulfonamide or sulfonylurea should be observed for signs of toxicity to these drugs .
None(e1,e2)	0	22	anticoagulants : coagulation parameters should be tested more frequently and monitored regularly during simultaneous administration of high doses of heparin , oral anticoagulants , or other drugs that may affect the blood coagulation system or the thrombocyte function .
None(e1,e2)	20	45	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium_channel_blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	4	12	anticoagulants : potentiation of warfarin -type ( cyp2c9 and cyp3a4 substrate ) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding .
None(e1,e2)	14	19	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	25	28	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin_b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	13	21	gleevec will increase plasmaconcentration of other cyp3a4 metabolized drugs ( e.g. , triazolo- benzodiazepines , dihydropyridine calcium channel blockers , certain hmg-coa_reductase_inhibitors , etc . ) .
None(e1,e2)	42	85	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	32	59	effects of felbatol on low-dose combination oral contraceptives a group of 24 nonsmoking , healthy white female volunteers established on an oral contraceptive regimen containing 30 mg ethinyl estradiol and 75 mg gestodene for at least 3 months received 2400 mg/day of felbamate from midcycle ( day 15 ) to midcycle ( day 14 ) of two consecutive oral contraceptive cycles .
mechanism(e1,e2)	2	4	co-administration of naltrexone with acamprosate produced a 25 % increase in auc and a 33 % increase in the cmax of acamprosate .
None(e1,e2)	51	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	16	62	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
mechanism(e1,e2)	2	7	atorvastatin : atorvastatin increases the auc for norethindrone and ethinyl estradiol .
None(e1,e2)	80	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	30	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
effect(e1,e2)	4	11	butyrophenones ( such as haloperidol ) and phenothiazines can suppress the dopamine rgic renal and mesenteric vasodilation induced with low dose dopamine infusion .
None(e1,e2)	27	33	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	26	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	2	25	cns-active drugs ethanol : sonata 10 mg potentiated the cns-impairing effects of ethanol 0.75 g/kg on balance testing and reaction time for 1 hour after ethanol administration and on the digit symbol substitution test ( dsst ) , symbol copying test , and the variability component of the divided attention test for 2.5 hours after ethanol administration .
None(e1,e2)	24	66	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	9	11	poor metabolizers have higher than expected plasma concentrations of tricyclic_antidepressants ( tcas ) when given usual doses .
None(e1,e2)	9	32	coadministration of single , oral doses of zaleplon with erythromycin ( 10 mg and 800 mg , respectively ) , a strong , selective cyp3a4 inhibitor produced a 34 % increase in zaleplon s maximal plasma concentrations and a 20 % increase in the area under the plasma concentration-time curve .
None(e1,e2)	3	11	certain drugs including thiazides , corticosteroids , thyroid products , and sympathomimetics may reduce the hypoglycemic action of starlix and other oral antidiabetic drugs .
None(e1,e2)	1	24	oral hypoglycemic_agents : in pharmacokinetic studies of mevacor in hypercholesterolemic noninsulin dependent diabetic patients , there was no drug interaction with glipizide or with chlorpropamide
None(e1,e2)	35	39	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	6	45	plasma levels of several closely related tricyclic_antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decreased by the concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with cmi as well .
None(e1,e2)	23	48	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical_steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics * ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
mechanism(e1,e2)	10	13	cytochrome p-450 inducers , such as phenytoin , carbamazepine and phenobarbital , induce clonazepam metabolism , causing an approximately 30 % decrease in plasma clonazepam levels .
None(e1,e2)	41	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	21	although the occurrence has not been reported with cefizox , nephrotoxicity has been reported following concomitant administration of other cephalosporins and aminoglycosides .
None(e1,e2)	127	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	56	72	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	17	27	during administration of multiple oral doses of tambocor to healthy subjects stabilized on a maintenance dose of digoxin , a 13 % -19 % increase in plasma digoxin levels occurred at six hours postdose .
effect(e1,e2)	10	31	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase ( mao ) inhibitors , tricyclic_antidepressants or some antihistamines .
effect(e1,e2)	7	18	in addition , the beneficial effects of levodopa in parkinsons disease have been reported to be reversed by phenytoin and papaverine .
effect(e1,e2)	8	11	seizures have been reported in patients taking another quinolone_class_antimicrobial and the nonsteroidal_anti-inflammatory_drug fenbufen concurrently .
None(e1,e2)	3	15	therapeutic concentrations of digoxin , warfarin , ibuprofen , naproxen , piroxicam , acetaminophen , phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding .
mechanism(e1,e2)	3	11	repeated doses of colestipol_hydrochloride given prior to a single dose of propranolol in human trials have been reported to decrease propranolol absorption .
None(e1,e2)	41	67	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	4	28	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium_channel_blocking_drugs , and isoniazid .
None(e1,e2)	1	11	mercaptopurine/ azathioprine : allopurinol inhibits the enzymatic oxidation of mercaptopurine and azathioprine to 6-thiouric acid .
None(e1,e2)	28	46	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin_k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	11	13	reported examples of this interaction include the following : immunosuppressives : cyclosporine ( cyp3a4 substrate ) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine , despite reduction in dose of cyclosporine .
None(e1,e2)	0	14	welchol was found to have no significant effect on the bioavailability of digoxin , lovastatin , metoprolol , quinidine , valproic acid , and warfarin .
None(e1,e2)	21	33	the concomitant use of transdermal fentanyl with ritonavir or other potent 3a4 inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
None(e1,e2)	26	43	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
None(e1,e2)	0	2	cimetidine : cimetidine has been demonstrated to interfere with the elimination of other quinolones .
None(e1,e2)	37	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	35	80	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	57	81	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	6	certain other antibiotics ( aminoglycosides and polymyxin ) have also been reported to interfere with the nerve transmission at the neuromuscular junction .
None(e1,e2)	14	19	in addition , under the influence of sympatholytic medicinal products such as beta-blockers , clonidine , guanethidine , and reserpine , the signs of hypoglycemia may be reduced or absent .
advise(e1,e2)	2	7	patients receiving flurbiprofen and furosemide or other diuretics should be observed closely to determine if the desired effect is obtained .
None(e1,e2)	0	7	analgesic /anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
None(e1,e2)	31	63	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	1	16	some drugs /substances are known to accelerate the metabolism of amiodarone by stimulating the synthesis of cyp3a4 ( enzyme induction ) .
None(e1,e2)	7	17	on the basis of the metabolism of bexarotene by cytochrome p450 3a4 , ketoconazole , itraconazole , erythromycin , gemfibrozil , grapefruit juice , and other inhibitors of cytochrome p450 3a4 would be expected to lead to an increase in plasma bexarotene concentrations .
None(e1,e2)	44	48	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	10	32	rifampin : following concomitant administration of a single dose of arava to subjects receiving multiple doses of rifampin , m1 peak levels were increased ( ~40 % ) over those seen when arava was given alone .
None(e1,e2)	29	33	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic_hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
effect(e1,e2)	25	42	in addition to bleeding associated with heparin and vitamin k antagonists , drugs that alter platelet function ( such as acetylsalicylic acid , dipyridamole and abciximab ) may increase the risk of bleeding if administered prior to , during , or after activase therapy .
None(e1,e2)	0	4	corticosteroids : dexamethasone : aprepitant , when given as a regimen of 125mg with dexamethasone coadministered orally as 20 mg on day 1 , and aprepitant when given as 80 mg/day with dexamethasone coadministered orally as 8 mg on days 2 through 5 , increased the auc of dexamethasone , a cyp3a4 substrate by 2.2-fold , on days 1 and 5 .
mechanism(e1,e2)	5	9	also , concomitant administration of quinolones with products containing iron , multivitamins containing zinc , or videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution may result in low urine levels .
None(e1,e2)	19	82	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	0	9	diclofenac : administration of morning and lunch doses of starlix 120 mg in combination with a single 75-mg dose of diclofenac in healthy volunteers resulted in no significant changes to the pharmacokinetics of either agent .
None(e1,e2)	48	74	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel_blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone_anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	29	32	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
advise(e1,e2)	12	29	multivitamins , or other products containing iron or zinc , antacids or sucralfate should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .
None(e1,e2)	9	15	the actions of the benzodiazepines may be potentiated by barbiturates , narcotics , phenothiazines , monoamine_oxidase_inhibitors or other antidepressants .
None(e1,e2)	11	15	non-steroidal anti-inflammatory agents : seizures have been reported in patients taking enoxacin concomitantly with the nonsteroidal_anti-inflammatory_drug fenbufen .
None(e1,e2)	28	32	although additional drug interaction studies have not been conducted , the most common medications used concomitantly with anagrelide in clinical trials were aspirin , acetaminophen , furosemide , iron , ranitidine , hydroxyurea , and allopurinol .
None(e1,e2)	6	21	warfarin : multiple oral doses of sonata ( 20 mg q24h for 13 days ) did not affect the pharmacokinetics of warfarin ( r+ ) - or ( s- ) -enantiomers or the pharmacodynamics ( prothrombin time ) following a single 25-mg oral dose of warfarin .
None(e1,e2)	6	19	although concomitant use of clozapine and carbamazepine is not recommended , it should be noted that discontinuation of concomitant carbamazepine administration may result in an increase in clozapine plasma levels .
None(e1,e2)	9	31	medications can interfere with folate utilization , including : anticonvulsant_medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
None(e1,e2)	14	16	there have been inconsistent reports regarding the effects of other drugs ( e.g. , quinine , penicillamine ) on serum digoxin concentration .
advise(e1,e2)	8	34	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	7	16	when itraconazole was coadministered with phenytoin , rifampin , or h2antagonists , reduced plasma concentrations of itraconazole were reported .
None(e1,e2)	26	34	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf_blocking_agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	38	48	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	4	antacids : enteric coated aspirin should not be given concurrently with antacids , since an increase in the ph of the stomach may effect the enteric coating of the tablets .
None(e1,e2)	19	24	in psoriatic arthritis clinical trials , concomitant medications included mtx in approximately half of the patients as well as nonsteroidal_anti-inflammatory_agents , folic acid and corticosteroids .
None(e1,e2)	0	16	nondepolarizing_muscle_relaxants : in postmarketing experience there have been reports of a possible interaction between toradoliv/im and nondepolarizing_muscle_relaxants that resulted in apnea .
None(e1,e2)	3	7	persons taking most antibiotics , methotrexate and pyrimethamine invalidate folic acid and vitamin b12 diagnostic blood assays .
None(e1,e2)	13	15	in patients in whom cyp3a4 inducers ( eg , dexamethasone , phenytoin , carbamazepine , rifampicin , phenobarbital ) are indicated , alternative agents with less enzyme induction potential should be used .
None(e1,e2)	11	35	since the pharmacokinetics of busulfex were studied in patients treated with phenytoin , the clearance of busulfex at the recommended dose may be lower and exposure ( auc ) higher in patients not treated with phenytoin .
None(e1,e2)	43	71	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	1	9	oral anticoagulant_agents : pharmacokinetic drug-drug interactions between argatroban and warfarin ( 7.5 mg single oral dose ) have not been demonstrated .
None(e1,e2)	40	42	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine_oxidase_inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	6	13	in many of these cases , buprenorphine was misused by self-injection of crushed subutex tablets .
None(e1,e2)	11	17	platelet inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
None(e1,e2)	2	21	when cholestyramine resin is given for long periods of time , concomitant supplementation with water-miscible ( or parenteral ) forms of fat-soluble_vitamins should be considered .
None(e1,e2)	19	22	the concurrent use of robinul injection with other anticholinergics or medications with anticholinergic activity , such as phenothiazines , antiparkinson_drugs , or tricyclic_antidepressants , may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects .
None(e1,e2)	65	81	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	7	18	poor metabolizers of debrisoquin : interactions of carvedilol with strong inhibitors of cyp2d6 ( such as quinidine , fluoxetine , paroxetine , and propafenone ) have not been studied , but these drugs would be expected to increase blood levels of the r ( + ) enantiomer of carvedilol .
effect(e1,e2)	3	8	digitalis glycosides : amphotericin_b -induced hypokalemia may potentiate digitalis toxicity .
mechanism(e1,e2)	3	6	even when an aminoglycoside and a penicillin -type drug are administered separately by different routes , a reduction in aminoglycoside serum half-life or serum levels has been reported in patients with impaired renal function and in some patients with normal renal function .
effect(e1,e2)	18	35	selective serotonin reuptake inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1_agonists .
None(e1,e2)	0	7	ganciclovir : the pharmacokinetics of foscarnet and ganciclovir were not altered in 13 patients receiving either concomitant therapy or daily alternating therapy for maintenance of cmv disease .
None(e1,e2)	25	75	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone_anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	1	7	- vitamin_k ( e.g. , aquamephyton , synkayvite ) use of sulfapyridine with these medicines may increase the chance of side effects affecting the blood
None(e1,e2)	12	33	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin_d .
None(e1,e2)	19	45	cimetidine , ranitidine : in normal volunteers ( n=9 ) , pretreatment with cimetidine or ranitidine did not affect flurbiprofen pharmacokinetics except that a small ( 13 % ) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with cimetidine .
None(e1,e2)	23	33	the concomitant use of transdermal fentanyl with ritonavir or other potent 3a4 inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
None(e1,e2)	44	91	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	19	43	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	27	46	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	5	9	cardiovascular agents ( e.g. , atenolol , hydrochlorothiazide , propranolol ) .
None(e1,e2)	4	16	since the pharmacokinetics of busulfex were studied in patients treated with phenytoin , the clearance of busulfex at the recommended dose may be lower and exposure ( auc ) higher in patients not treated with phenytoin .
None(e1,e2)	40	96	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	5	17	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	8	18	when used in external subcutaneous infusion pumps for insulin , novolog should not be mixed with any other insulins or diluent .
None(e1,e2)	39	65	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	28	37	the following drug interactions have been identified involving nizoral tablets and other drugs metabolized by the cytochrome p450 3a4 enzyme system : ketoconazole tablets inhibit the metabolism of terfenadine , resulting in an increased plasma concentration of terfenadine and a delay in the elimination of its acid metabolite .
None(e1,e2)	42	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	32	45	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin_b , cyclosporine , non-steroidal anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
None(e1,e2)	2	6	anticonvulsants : carbamazepine , phenobarbital , phenytoin
None(e1,e2)	47	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	66	95	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	96	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	59	63	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	9	11	- phenytoin ( e.g. , dilantin ) use of phenytoin with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of phenytoin
None(e1,e2)	26	56	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	27	54	paroxetine : coadministration of once daily doses of aprepitant , as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation , with paroxetine 20 mg once daily , resulted in a decrease in auc by approximately 25 % and cmax , by approximately 20 % of both aprepitant and paroxetine .
effect(e1,e2)	9	12	severe hypoglycemia has been reported in patients concomitantly receiving azole_antifungal_agents and oral hypoglycemic_agents .
None(e1,e2)	18	20	drugs whose absorption can be affected by the level of acidity in the stomach : drugs such as ketoconazole and itraconazole should be administered at least 2 hours prior to dosing with videx .
None(e1,e2)	0	16	ketoconazole did not affect the conversion of losartan to the active metabolite after intravenous administration of losartan , and erythromycin had no clinically significant effect after oral administration .
None(e1,e2)	110	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	22	34	in patients taking an anticonvulsant ( eg , valproic acid , carbamazepine , phenobarbital or phenytoin ) , the concomitant use of mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant .
None(e1,e2)	14	63	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic_acid .
None(e1,e2)	34	38	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	10	24	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
mechanism(e1,e2)	0	5	boric_acid may interact with the idoxuridine preparation causing a gritty substance to form or may interact with the preservative in the idoxuridine preparation causing a toxic effect in the eye .
None(e1,e2)	21	65	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	57	114	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	13	21	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	10	13	while it is not known whether this interaction occurs with fibrates other than gemfibrozil , myopathy and rhabdomyolysis have occasionally been associated with the use of fibrates alone , including clofibrate .
None(e1,e2)	11	75	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone_anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	10	39	in addition , studies in healthy volunteers have shown that tikosyn does not affect the pharmacokinetics or pharmacodynamics of warfarin , or the pharmacokinetics of propranolol ( 40 mg twice daily ) , phenytoin , theophylline , or oral contraceptives .
None(e1,e2)	4	23	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	4	23	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	26	72	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary_vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
int(e1,e2)	0	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	31	41	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	35	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	7	17	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
mechanism(e1,e2)	2	10	chlorpropamide : chlorpropamide s plasma half-life may be prolonged by allopurinol , since allopurinol and chlorpropamide may compete for excretion in the renal tubule .
None(e1,e2)	3	7	potassium-sparing diuretics ( spironolactone , amiloride , triamterene , and others ) or potassium supplements can increase the risk of hyperkalemia .
None(e1,e2)	35	41	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic agents ) or drugs which inhibit platelet function ( eg , aspirin and other non-steroidal anti-inflammatory drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
None(e1,e2)	31	45	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	6	8	based on the chemical resemblance of itraconazole and ketoconazole , coadministration of astemizole with itraconazole is contraindicated .
None(e1,e2)	0	31	central_nervous_system_depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	10	12	inhibitors or substrates of cyp2d6 ( i.e. , quinidine , selective_serotonin_reuptake_inhibitors [ ssris ] ) may increase the plasma concentration of doxepin when administered concomitantly .
effect(e1,e2)	6	26	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	17	23	- a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	63	65	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	19	25	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	5	15	there have been reports of theophylline -related side effects in patients on concomitant therapy with quinolones and theophylline .
effect(e1,e2)	2	11	coadministration of ethoxzolamide with other diuretics , amphotericin b , and corticosteroids may cause hypokalemia .
None(e1,e2)	39	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	4	22	urinary acidifying agents ( ammonium_chloride , sodium acid phosphate , etc . ) increase the concentration of the ionized species of the amphetamine molecule , thereby increasing urinary excretion .
None(e1,e2)	8	14	co-medications that induce cyp 3a4 ( e.g. , rifampicin , phenytoin , carbamazepine , phenobarbital , or st. john s wort ) may significantly decrease exposure to exemestane .
None(e1,e2)	54	74	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
mechanism(e1,e2)	11	46	binding to serum proteins : the following agents may either inhibit levothyroxine_sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic_acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	0	5	lithium - coadministration of racemic citalopram ( 40 mg/day for 10 days ) and lithium ( 30 mmol/day for 5 days ) had no significant effect on the pharmacokinetics of citalopram or lithium .
None(e1,e2)	5	7	in patients who have received muscle_relaxants , doxapram may temporarily mask the residual effects of muscle relaxant drugs .
effect(e1,e2)	12	23	however , there has been one report of prolonged prothrombin time when buspirone was added to the regimen of a patient treated with warfarin .
None(e1,e2)	12	28	at 24 hours postdose , a similar proportion of patients treated with methotrexate alone ( 94 % ) and subsequently treated with methotrexate co-administered with 75 mg of rofecoxib ( 88 % ) had methotrexate plasma concentrations below the measurable limit ( 5 ng/ml ) .
None(e1,e2)	36	46	oral contraceptives : aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl estradiol and 1 mg of norethindrone , decreased the auc of ethinyl_estradiol by 43 % , and decreased the auc of norethindrone by 8 % ;
None(e1,e2)	4	21	in clinical studies , tilade has been co-administered with other anti-asthma medications , including inhaled and oral bronchodilators , and inhaled corticosteroids , with no evidence of increased frequency of adverse events or laboratory abnormalities .
None(e1,e2)	38	44	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium_chloride , folic acid , and acetaminophen .
None(e1,e2)	6	14	amphotericin b or potassium-depleting diuretics ( benzothiadiazines and related drugs , ethacrynic acid and furosemide ) enhanced hypokalemia .
None(e1,e2)	14	22	the following agents may increase certain actions or side effects of anticholinergic drugs . amantadine antiarrhythmic agents of class ( e.g . quinidine ) , antihistamines antipsychotic agents ( e.g . phenothiazines ) , benzodiazepines .
None(e1,e2)	7	9	additive depressant effect when used with general anesthetics , sedatives , antianxiety drugs , hypnotics , alcohol , and other opiate analgesics .
advise(e1,e2)	15	22	drug-drug interactions given the primary cns effects of aripiprazole , caution should be used when abilify is taken in combination with other centrally_acting_drugs and alcohol .
None(e1,e2)	6	8	patients receiving other narcotic analgesics , antipsychotics , antianxiety_agents , or other cns depressants ( including alcohol ) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive cns depression .
None(e1,e2)	3	5	cimetidine co-administration of felodipine with cimetidine ( a non-specific cyp-450 inhibitor ) resulted in an increase of approximately 50 % in the auc and the cmax , of felodipine .
None(e1,e2)	24	51	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	13	20	coumarin anticoagulants altered coagulation parameters and/or bleeding have been reported in patients taking capecitabine concomitantly with coumarin-derivative anticoagulants such as warfarin and phenprocoumon .
None(e1,e2)	11	17	spontaneous reports of serotonin syndrome associated with co-administration of zyvox and serotonergic_agents , including antidepressants such as selective_serotonin_reuptake_inhibitors ( ssris ) , have been reported .
None(e1,e2)	17	46	in a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without propantheline ( an anticholinergic agent with multiple effects on the gi tract ) to healthy volunteers , the auc of clonazepam was 10 % lower and the cmax of clonazepam was 20 % lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone .
mechanism(e1,e2)	9	15	ampicillin : in a study of healthy volunteers , chloroquine significantly reduced the bioavailability of ampicillin .
None(e1,e2)	10	35	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	9	48	platelet inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin_sodium .
None(e1,e2)	5	7	saquinavir : the combination of hivid , saquinavir , and zdv has been studied ( as triple combination ) in adults .
advise(e1,e2)	5	29	caution should be taken when enablex is used concomitantly with medications that are predominantly metabolized by cyp2d6 and which have a narrow therapeutic window , such as flecainide , thioridazine and tricyclic antidepressants ( see clinical pharmacology ) .
None(e1,e2)	21	23	because there is a theoretical basis that these effects may be additive , use of ergotamine-containing or ergot-type medications ( like dihydroergotamine or methysergide ) and naratriptan within 24 hours is contraindicated .
None(e1,e2)	24	42	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	19	33	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	3	9	example inducers include aminoglutethimide , carbamazepine , nafcillin , nevirapine , phenobarbital , phenytoin , and rifamycins .
None(e1,e2)	4	18	these include probenecid , cholestyramine , and some antibiotics ( e.g . erythromycin , rifamipicin , ampicillin and chloramphenicol ) .
None(e1,e2)	11	14	the following agents may increase certain actions or side effects of anticholinergic_drugs . amantadine antiarrhythmic_agents of class ( e.g . quinidine ) , antihistamines antipsychotic agents ( e.g . phenothiazines ) , benzodiazepines .
effect(e1,e2)	2	22	patients taking revia may not benefit from opioid containing medicines , such as cough and cold preparations , antidiarrheal preparations , and opioid_analgesics .
mechanism(e1,e2)	6	11	probenecid : the oral combination of probenecid before intramuscular injection of pipracil produces an increase in piperacillin peak serum level of about 30 % .
None(e1,e2)	45	49	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type_1c_antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	34	36	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	33	45	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	16	34	digitalis : immediate release capsules : since there have been isolated reports of patients with elevated digoxin levels , and there is a possible interaction between digoxin and nifedipine , it is recommended that digoxin levels be monitored when initiating , adjusting , and discontinuing nifedipine to avoid possible over- or under-digitalization .
None(e1,e2)	17	46	cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation , the discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin .
None(e1,e2)	2	7	cholestyramine and charcoal administration of cholestyramine or activated_charcoal in patients ( n=13 ) and volunteers ( n=96 ) resulted in a rapid and significant decrease in plasma m1 ( the active metabolite of leflunomide ) concentration .
None(e1,e2)	9	15	in a phase i trial using escalating doses of taxol ( 110-200 mg/m2 ) and cisplatin ( 50 or 75 mg/m2 ) given as sequential infusions , myelosuppression was more profound when taxol was given after cisplatin than with the alternate sequence ( ie , taxol before cisplatin ) .
None(e1,e2)	19	27	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	5	10	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid-associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
None(e1,e2)	2	10	concomitantly administered iron -fortified infant formula ( 2.2 mg elemental iron /6 oz ) has no significant effect on cefdinir pharmacokinetics .
None(e1,e2)	1	10	and calcium_channel_antagonists e.g. , verapamil ) , cyp1a2 inducers ( omeprazole ) and cyp1a2 inhibitors ( furafylline and clarithromycin ) .
None(e1,e2)	13	32	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle_relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	9	15	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta_blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	24	26	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .
None(e1,e2)	13	22	methotrexate renal tubular transport of methotrexate may be inhibited by concomitant administration of ciprofloxacin , potentially leading to increased plasma levels of methotrexate .
advise(e1,e2)	12	18	although deferasirox has a lower affinity for aluminum than for iron , exjade should not be taken with aluminum -containing antacid preparations .
None(e1,e2)	8	19	and disulfiram when amitriptyline hcl is given with anticholinergic agents or sympathomimetic drugs , including epinephrine combined with local anesthetics , close supervision and careful adjustment of dosages are required .
None(e1,e2)	4	18	nonsteroidal anti-inflammatory drugs ( nsaids ) : the concomitant administration of a nonsteroidal anti inflammatory drug with a quinolone may increase the risks of cns stimulation and convulsions .
None(e1,e2)	21	66	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	17	73	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	26	38	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	24	30	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	13	19	the effects of medicinal products with similar properties such as inotropes milrinone , enoximone , amrinone , olprinone and cilostazol may be exacerbated by anagrelide .
None(e1,e2)	42	77	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	17	34	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
advise(e1,e2)	9	15	therefore , extreme caution should be exercised when administering dopamine_hcl to patients receiving cyclopropane or halogenated_hydrocarbon_anesthetics .
None(e1,e2)	5	7	in long surgical procedures during enflurane or isoflurane anesthesia , less frequent maintenance dosing , lower maintenance doses , or reduced infusion rates of nimbex may be necessary .
None(e1,e2)	0	2	geocillin ( carbenicillin_indanyl_sodium ) blood levels may be increased and prolonged by concurrent administration of probenecid .
None(e1,e2)	16	30	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	96	110	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	30	36	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	40	48	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	16	31	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	40	42	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	58	93	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic_acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	12	17	in vitro studies indicate that ertapenem does not inhibit p-glycoprotein-mediated transport of digoxin or vinblastine and that ertapenem is not a substrate for p-glycoprotein-mediated transport .
None(e1,e2)	0	11	theophylline -related adverse effects have occurred in patients when theophylline and enoxacin were coadministered .
None(e1,e2)	0	6	phenytoin : altered serum levels of phenytoin ( increased and decreased ) have been reported in patients receiving concomitant ciprofloxacin .
mechanism(e1,e2)	4	10	single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent , respectively .
advise(e1,e2)	5	7	caution should be exercised if tacrolimus and bosentan are used together .
None(e1,e2)	4	11	histamine h2 antagonists : cimetidine inhibits cyp3a4 and can increase serum amiodarone levels .
None(e1,e2)	14	21	plasma exposure ( auc ) to valdecoxib was increased 62 % when coadministered with fluconazole and 38 % when coadministered with ketoconazole .
None(e1,e2)	8	16	no drug interaction studies have been conducted for colazal , however the use of orally administered antibiotics could , theoretically , interfere with the release of mesalamine in the colon .
None(e1,e2)	46	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	21	26	because there is a theoretical basis that these effects may be additive , use of ergotamine-containing or ergot-type medications ( like dihydroergotamine or methysergide ) and axert within 24 hours of each other should be avoided .
None(e1,e2)	24	26	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	41	44	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic_antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	21	57	however , in the second study , administration of 12 g cholestyramine 1 hour before the evening meal and 0.3 mg cerivastatin_sodium approximately 4 hours after the same evening meal resulted in a decrease in the cerivastatin auc of less than 8 % , and a decrease in cmax of about 30 % when compared to dosing cerivastatin_sodium alone .
None(e1,e2)	8	46	in a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without propantheline ( an anticholinergic agent with multiple effects on the gi tract ) to healthy volunteers , the auc of clonazepam was 10 % lower and the cmax of clonazepam was 20 % lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone .
None(e1,e2)	6	13	antacid : the effect of an aluminum_hydroxide - and magnesium hydroxide-containing antacid ( maalox ) * on the pharmacokinetics of capecitabine was investigated in 12 cancer patients .
None(e1,e2)	87	111	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	71	95	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	9	23	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	2	5	ketoconazole/itraconazole , macrolides , including erythromycin
None(e1,e2)	28	44	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	16	22	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic_acid , and tolbutamide in vitro .
None(e1,e2)	42	46	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	1	14	- probenecid : pretreatment with probenecid reduces both the natriuresis and hyperreninemia produced by bumetanide .
None(e1,e2)	5	9	- phenytoin ( e.g. , dilantin ) use of phenytoin with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of phenytoin
None(e1,e2)	0	11	glibenclamide : in a study of 7 healthy male volunteers , acitretin treatment potentiated the blood glucose lowering effect of glibenclamide ( a sulfonylurea similar to chlorpropamide ) in 3 of the 7 subjects .
None(e1,e2)	9	13	also , concomitant administration of quinolones with products containing iron , multivitamins containing zinc , or videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution may result in low urine levels .
None(e1,e2)	33	71	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	47	49	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	16	38	although studies designed to examine drug interactions have not been done , it was noted that corticosteroid or acth treatment of relapses for periods of up to 28 days has been administered to patients ( n=180 ) receiving betaseron .
mechanism(e1,e2)	3	19	protease inhibitors : amprenavir , lopinavir , nelfinavir , and ritonavir have been shown to decrease plasma levels of combination_hormonal_contraceptives ;
None(e1,e2)	7	11	additive depressant effect when used with general anesthetics , sedatives , antianxiety_drugs , hypnotics , alcohol , and other opiate analgesics .
advise(e1,e2)	3	5	concomitant administration of gemfibrozil with targretin capsules is not recommended .
None(e1,e2)	53	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	44	68	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	0	10	antihistamines may partially counteract the anticoagulation effects of heparin or warfarin .
None(e1,e2)	102	120	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	5	10	the safety and efficacy of anakinra used in combination with humira has not been studied .
None(e1,e2)	102	104	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	35	39	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine_derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	16	26	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	22	macrolide_antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot alkaloid class , of which d.h.e . 45 ( dihydroergotamine_mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
None(e1,e2)	7	17	these agents include medications such as : anticoagulants , platelet inhibitors including acetylsalicylic acid , sali-cylates , nsaids ( including ketorolac tromethamine ) , dipyridamole , or sulfinpyrazone .
None(e1,e2)	17	26	the effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin , carbamazepine , and barbiturates , and the antituberculosis drug rifampin .
None(e1,e2)	24	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	3	66	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	35	38	ace inhibitors and angiotensin ii receptor antagonists ( congestive heart failure post-myocardial infarction ) - in ephesus , 3020 ( 91 % ) patients receiving inspra 25 to 50 mg also received ace inhibitors or angiotensin_ii_receptor_antagonists ( acei/ arb ) .
None(e1,e2)	18	33	concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with proleukin may increase toxicity in these organ systems .
None(e1,e2)	24	40	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	15	17	in patients in whom cyp3a4 inducers ( eg , dexamethasone , phenytoin , carbamazepine , rifampicin , phenobarbital ) are indicated , alternative agents with less enzyme induction potential should be used .
effect(e1,e2)	11	46	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal_muscle_relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	14	16	loratadine ( 10 mg once daily ) has been coadministered with therapeutic doses of erythromycin , cimetidine , and ketoconazole in controlled clinical pharmacology studies in adult volunteers .
None(e1,e2)	3	80	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	8	14	the pharmacokinetics of naltrexone and its major metabolite 6-beta-naltrexol were unaffected following co-administration with acamprosate .
mechanism(e1,e2)	7	9	( see clinical pharmacology ) coadministration of femara and tamoxifen 20 mg daily resulted in a reduction of letrozole plasma levels by 38 % on average .
None(e1,e2)	3	7	initial doses of adrenergic_agents , such as dopamine or epinephrine , should be reduced and titrated to achieve the desired response .
None(e1,e2)	18	72	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	0	10	chloral_hydrate may cause an increased prothrombin response by displacing the anticoagulant from protein binding sites or a diminished prothrombin response through increased metabolism of the unbound drug by hepatic enzyme induction , thus leading to inter-patient variation in ultimate prothrombin effect .
None(e1,e2)	20	30	the oral dexamethasone doses should be reduced by approximately 50 % when coadministered with aprepitant , to achieve exposures of dexamethasone similar to those obtained when it is given without aprepitant .
None(e1,e2)	9	12	certain antibiotic , cisplatin , cyclosporine , diuretic , foscarnet , and vaccines .
None(e1,e2)	1	24	serum infliximab concentrations appeared to be unaffected by baseline use of medications for the treatment of crohn s disease including corticosteroids , antibiotics ( metronidazole or ciprofloxacin ) and aminosalicylates .
None(e1,e2)	5	14	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	65	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	35	66	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	13	cimetidine : in a study in healthy volunteers , a one-week course of cimetidine at 400 mg b.i.d . with a single 5 mg dose of isradipine on the sixth day showed an increase in isradipine mean peak plasma concentrations ( 36 % ) and significant increase in area under the curve ( 50 % ) .
None(e1,e2)	7	10	saquinavir : the combination of hivid , saquinavir , and zdv has been studied ( as triple combination ) in adults .
None(e1,e2)	98	125	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	24	26	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	8	10	diltiazem plasma levels were not significantly affected by lovastatin or pravastatin .
None(e1,e2)	6	9	if iron supplements are required during omnicef therapy , omnicef should be taken at least 2 hours before or after the supplement .
effect(e1,e2)	8	43	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine_class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic_antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	1	40	oral contraceptive : based on auc and half-life , multiple-dose pharmacokinetic profiles of norethindrone and ethinyl estradiol following administration of tablets containing 2.5 mg of norethindrone acetate and 50 mcg of ethinyl estradiol were similar with and without coadministration of gabapentin ( 400 mg tid ;
None(e1,e2)	26	36	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
mechanism(e1,e2)	4	10	the daily dose of dexamethasone administered in clinical studies with aprepitant reflects an approximate 50 % reduction of the dose of dexamethasone .
None(e1,e2)	28	40	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic_acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	46	65	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin_k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	8	18	in addition to bleeding associated with heparin and vitamin_k_antagonists , drugs that alter platelet function ( such as acetylsalicylic_acid , dipyridamole and abciximab ) may increase the risk of bleeding if administered prior to , during , or after activase therapy .
None(e1,e2)	23	25	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	6	29	metoprolol - administration of 20 mg/day lexapro for 21 days in healthy volunteers resulted in a 50 % increase in cmax and 82 % increase in auc of the beta-adrenergic_blocker metoprolol ( given in a single dose of 100 mg ) .
None(e1,e2)	6	19	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	1	12	certain antibiotic , cisplatin , cyclosporine , diuretic , foscarnet , and vaccines .
None(e1,e2)	12	16	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	13	15	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum_hydroxide , magnesium_hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	17	76	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	12	31	when therapeutic concentrations of furosemide , propranolol , dipyridamole , warfarin , quinidine , or naproxen were added to human plasma ( in vitro ) , the plasma protein binding of nicardipine_hcl was not altered .
None(e1,e2)	13	21	h-2 antagonists : in studies with human volunteers , co-administration of cimetidine or ranitidine with ibuprofen had no substantive effect on ibuprofen serum concentrations .
None(e1,e2)	2	4	when other antiplatelet_agents or anticoagulants are used concomitantly , there is the potential for flolan to increase the risk of bleeding .
None(e1,e2)	17	30	although it has not been established that there is an interaction between clozapine and benzodiazepines or other psychotropics , caution is advised when clozapine is initiated in patients taking a benzodiazepine or any other psychotropic drug .
None(e1,e2)	21	25	data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , nicardipine , and nifedipine .
None(e1,e2)	51	75	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	35	42	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	48	94	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	6	17	the antihypertensive effects of methyldopa , mecamylamine , reserpine , and veratrum alkaloids may be reduced by sympathomimetics .
None(e1,e2)	5	12	use in conjunction with other antiepileptic_drugs : the addition of felbatol to antiepileptic_drugs ( aeds ) affects the steady-state plasma concentrations of aeds .
None(e1,e2)	0	34	ace_inhibitors and angiotensin ii receptor antagonists ( congestive heart failure post-myocardial infarction ) - in ephesus , 3020 ( 91 % ) patients receiving inspra 25 to 50 mg also received ace inhibitors or angiotensin_ii_receptor_antagonists ( acei/arb ) .
None(e1,e2)	10	20	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	14	20	avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic_amine ( e.g. , epinephrine , norepinephrine ) , since it has been reported that tricyclic antidepressants can potentiate the effects of catecholamines .
None(e1,e2)	85	98	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	22	25	oral hypoglycemic agents : in pharmacokinetic studies of mevacor in hypercholesterolemic noninsulin dependent diabetic patients , there was no drug interaction with glipizide or with chlorpropamide
None(e1,e2)	28	35	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	42	48	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	76	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	4	28	benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
None(e1,e2)	4	21	these increased exposures of norethindrone and ethinyl estradiol should be taken into consideration when selecting an oral contraceptive for women taking valdecoxib .
None(e1,e2)	46	68	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	4	24	it is recommended that buspirone_hydrochloride not be used concomitantly with mao inhibitors because the effects of concomitant administration of buspirone hcl with most other psychotropic_drugs have not been studied , the concomitant use of buspirone hcl with other cns-active drugs should be approached with caution .
None(e1,e2)	11	13	consequently , drugs with a low therapeutic margin , such as vitamin_k_antagonists , phenytoin , and theophylline , could have a delayed elimination and increases in their serum half-life leading to a toxic level .
None(e1,e2)	57	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	5	24	therefore , when hydrochlorothiazide and non-steroidal_anti-inflammatory_agents are used concomitantly , the patient should be observed closely to determine if the desired effect of the diuretic is obtained .
None(e1,e2)	0	8	naproxen had no effect on plasma levels of diflunisal .
None(e1,e2)	19	26	in general , these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride , including anti-arrhythmic_agents such as quinidine and procainamide , cardiac_glycosides and tricyclic anti-depressants .
None(e1,e2)	14	24	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	2	15	chlorpropamide : chlorpropamide s plasma half-life may be prolonged by allopurinol , since allopurinol and chlorpropamide may compete for excretion in the renal tubule .
None(e1,e2)	38	118	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	3	11	the clearance of salicylates may be increased with concurrent use of corticosteroids .
None(e1,e2)	35	44	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine_derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	38	40	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	10	25	garlic capsules garlic capsules should not be used while taking saquinavir ( fortovase ) as the sole protease inhibitor due to the risk of decreased saquinavir plasma concentrations .
None(e1,e2)	118	122	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	11	16	during clinical trials , iloprost was used concurrently with anticoagulants , diuretics , cardiac glycosides , calcium_channel_blockers , analgesics , antipyretics , nonsteroidal antiinflammatories , corticosteroids , and other medications .
None(e1,e2)	38	40	epidemiological studies of the case-control and cohort design that have demonstrated an association between use of psychotropic drugs that interfere with serotonin reuptake and the occurrence of upper gastrointestinal bleeding have also shown that concurrent use of an nsaid or aspirin potentiated the risk of bleeding .
None(e1,e2)	31	39	oral contraceptive : based on auc and half-life , multiple-dose pharmacokinetic profiles of norethindrone and ethinyl estradiol following administration of tablets containing 2.5 mg of norethindrone acetate and 50 mcg of ethinyl_estradiol were similar with and without coadministration of gabapentin ( 400 mg tid ;
None(e1,e2)	17	51	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	102	112	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	17	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	42	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	9	concomitant use of calcium supplements and l-lysine may increase calcium absorption
None(e1,e2)	19	25	although there was no clinical evidence in the vehicle-controlled studies of drug interactions with systemic antiretroviral agents , including protease_inhibitors , macrolide antibiotics , and azole_antifungals , the effect of panretin gel on the steady-state concentrations of these drugs is not known .
None(e1,e2)	92	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	23	44	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim /sulfamethoxazole or zidovudine .
None(e1,e2)	22	24	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	0	7	warfarin : the effects of aliskiren on warfarin pharmacokinetics have not been evaluated in a well-controlled clinical trial .
None(e1,e2)	0	14	acidifying_agents : gastrointestinal acidifying agents ( guanethidine , reserpine , glutamic acid hcl , ascorbic_acid , fruit juices , etc . ) lower absorption of amphetamines .
None(e1,e2)	24	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	68	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	0	21	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type_anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	11	15	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	0	18	intestinal_adsorbents ( e. g. , charcoal ) and digestive enzyme preparations containing carbohydrate-splitting enzymes ( e. g. , amylase , pancreatin ) may reduce the effect of acarbose and should not be taken concomitantly .
None(e1,e2)	2	5	co-administration with antifungal_agents such as ketoconazole or itraconazole is not recommended .
effect(e1,e2)	10	12	thiazide diuretics : the reports that the concomitant use of allopurinol and thiazide_diuretics may contribute to the enhancement of allopurinol toxicity in some patients have been reviewed in an attempt to establish a cause-and-effect relationship and a mechanism of causation .
None(e1,e2)	6	8	ethoxzolamide may increase the action of tricyclics , amphetamines , procainamide , and quinidine .
None(e1,e2)	65	84	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	25	33	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	23	39	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	36	57	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral_hydrate * ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	32	49	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	31	41	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	13	15	digoxin : in a study in 12 patients with congestive heart failure where ketoprofen and digoxin were concomitantly administered , ketoprofen did not alter the serum levels of digoxin .
None(e1,e2)	28	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	6	42	clinical experience with concomitant administration of bosentan and warfarin in patients with pulmonary arterial hypertension did not show clinically relevant changes in inr or warfarin dose ( baseline vs. end of the clinical studies ) , and the need to change the warfarin dose during the trials due to changes in inr or due to adverse events was similar among bosentan- and placebo-treated patients .
None(e1,e2)	6	17	the use of mao inhibitors or tricyclic_antidepressants with hydrocodone preparations may increase the effect of either the antidepressant or hydrocodone .
None(e1,e2)	29	37	oral hypoglycemic agents : in one study , flurbiprofen was given to adult diabetics who were already receiving glyburide ( n=4 ) , metformin ( n=2 ) chlorpropamide with phenformin ( n= 3 ) or glyburide with phenformin ( n=6 ) .
None(e1,e2)	0	8	fluoxetine , ocs , sertraline , diltiazem , macrolide_antibiotics ( exercise caution ) .
None(e1,e2)	8	68	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
advise(e1,e2)	3	21	patients currently receiving diltiazem therapy should be carefully monitored for a change in pharmacological effect when initiating and discontinuing therapy with cimetidine .
None(e1,e2)	0	2	trimethoprim / sulfamethoxazole ;
None(e1,e2)	2	15	phenobarbital or primidone : no formal pharmacokinetic studies have been performed examining the addition of tiagabine to regimens containing phenobarbital or primidone .
None(e1,e2)	14	17	there have been greater than 2-fold increases in previously stable plasma levels of other antidepressants , including nortriptyline , when fluoxetine hydrochloride has been administered in combination with these agents .
None(e1,e2)	57	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	6	methotrexate : ketoprofen , like other nsaids , may cause changes in the elimination of methotrexate leading to elevated serum levels of the drug and increased toxicity .
mechanism(e1,e2)	5	11	antacids : concomitant administration of antacids may reduce plasma levels of diflunisal .
None(e1,e2)	0	12	apomorphine - prior ingestion of diphenidol may decrease the emetic response to apomorphine in the treatment of poisoning .
None(e1,e2)	2	5	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	16	24	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
effect(e1,e2)	19	41	curariform muscle relaxants ( eg , tubocurarine ) and other drugs , including ether , succinylcholine , gallamine , decamethonium and sodium citrate , potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with coly-mycin_m parenteral .
effect(e1,e2)	3	17	toxicology studies of heroin -related deaths reveal frequent involvement of other central nervous system depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
advise(e1,e2)	13	33	although the interaction between almotriptan and other potent cyp3a4 inhibitors ( e.g. , itraconazole , ritonavir , and erythromycin ) has not been studied , increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications .
None(e1,e2)	16	22	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase ( mao ) inhibitors , tricyclic antidepressants or some antihistamines .
None(e1,e2)	8	15	pharmacokinetic studies indicate that administration of disulfiram or diazepam does not affect the pharmacokinetics of acamprosate .
None(e1,e2)	10	26	the physician is advised to monitor the plasma concentrations of itraconazole when any of these drugs is taken concurrently , and to increase the dose of itraconazole if necessary .
None(e1,e2)	3	10	while all the selective_serotonin_reuptake_inhibitors ( ssris ) , e.g. , citalopram , escitalopram , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	29	35	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	37	80	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	12	16	a 21 ( 17 ) % decrease in the steady-state auc of ganciclovir was observed when videx was administered 2 hours prior to ganciclovir , but not when the two drugs were administered simultaneously ( n = 12 ) .
None(e1,e2)	131	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	4	dopamine_d2_receptor_antagonists ( e.g. , phenothiazines , butyrophenones , risperidone ) and isoniazid may reduce the therapeutic effects of levodopa .
None(e1,e2)	0	28	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic_acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	25	35	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	21	31	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
mechanism(e1,e2)	2	11	ketoconazole : ketoconazole may inhibit both synthetic and catabolic enzymes of vitamin_d .
None(e1,e2)	4	8	when therapeutic concentrations of furosemide , propranolol , dipyridamole , warfarin , quinidine , or naproxen were added to human plasma ( in vitro ) , the plasma protein binding of nicardipine hcl was not altered .
None(e1,e2)	13	16	patients receiving other narcotic analgesics , antipsychotics , antianxiety agents , or other cns_depressants ( including alcohol ) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive cns depression .
None(e1,e2)	23	26	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
advise(e1,e2)	2	10	therefore , ketoconazole should be administered with caution with intranasal ciclesonide .
None(e1,e2)	23	63	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical_steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	0	21	h2_blockers /proton pump inhibitors : long-term suppression of gastric acid secretion by h2 blockers or proton pump inhibitors ( eg , famotidine and omeprazole ) is likely to reduce dasatinib exposure .
None(e1,e2)	8	15	and disulfiram when amitriptyline hcl is given with anticholinergic agents or sympathomimetic drugs , including epinephrine combined with local anesthetics , close supervision and careful adjustment of dosages are required .
None(e1,e2)	13	21	the gonadotropin levels may be transiently elevated by spironolactone , minimally elevated by levodopa , and suppressed by oral contraceptives and digoxin .
effect(e1,e2)	13	19	pimozide and celexa - in a controlled study , a single dose of pimozide 2 mg co-administered with racemic citalopram 40 mg given once daily for 11 days was associated with a mean increase in qtc values of approximately 10 msec compared to pimozide given alone .
None(e1,e2)	0	3	anticoagulants : combination hormonal_contraceptives may increase or decrease the effects of coumarin derivatives .
None(e1,e2)	13	35	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	22	34	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	0	14	valproate : tiagabine causes a slight decrease ( about 10 % ) in steady-state valproate concentrations .
None(e1,e2)	3	10	antiarrhythmics : other antiarrhythmic drugs , such as quinidine , procainamide , disopyramide , and phenytoin , have been used concurrently with amiodarone .
None(e1,e2)	118	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	70	80	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin_sodium under-dosage .
None(e1,e2)	21	39	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	23	25	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
mechanism(e1,e2)	0	3	acetazolamide may elevate cyclosporine levels .
None(e1,e2)	36	47	although glucocorticoids have been shown to reduce proleukin-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with proleukin may reduce the antitumor effectiveness of proleukin and thus should be avoided . 12 beta-blockers and other antihypertensives may potentiate the hypotension seen with proleukin .
None(e1,e2)	25	34	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	9	23	acetaminophen : in normal volunteers , concomitant administration of diflunisal and acetaminophen resulted in an approximate 50 % increase in plasma levels of acetaminophen .
None(e1,e2)	20	49	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	3	52	hypotension patients on diuretic therapy : patients on diuretics and especially those in whom diuretic therapy was recently instituted , as well as those on severe dietary salt restriction or dialysis , may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of captopril .
None(e1,e2)	6	8	pharmacokinetic studies indicate that administration of disulfiram or diazepam does not affect the pharmacokinetics of acamprosate .
None(e1,e2)	98	153	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	30	35	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine_derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	28	40	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	9	15	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
None(e1,e2)	81	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	28	84	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	7	11	the physician should be cautious when administering flurbiprofen to patients taking anticoagulants .
effect(e1,e2)	0	20	nabilone has been shown to have an additive cns depressant effect when given with either diazepam , secobarbitone sodium , alcohol or codeine .
None(e1,e2)	0	27	amitriptyline in combination with clonidine enhances the manifestation of corneal lesions in rats epidural injection clonidine may potentiate the cns-depressive effect of alcohol , barbiturates or other sedating_drugs .
None(e1,e2)	7	46	praziquantel : in the fed state , praziquantel ( 40 mg/kg ) increased mean maximum plasma concentration and area under the curve of albendazole sulfoxide by about 50 % in healthy subjects ( n=10 ) compared with a separate group of subjects ( n=6 ) given albendazole alone .
None(e1,e2)	27	29	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	32	34	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic_blocking_agents , calcium_channel_blockers , antihistamines or h1-blocking agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
None(e1,e2)	16	29	other concomitant therapy : although specific interaction studies were not performed , in clinical studies , cerivastatin_sodium was used concomitantly with angiotensin- converting enzyme ( ace ) inhibitors , betablockers , calcium-channel blockers , diuretics , and nonsteroidal anti-inflammatory drugs ( nsaids ) without evidence of clinically significant adverse interactions .
None(e1,e2)	24	32	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	2	10	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid-associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
None(e1,e2)	10	12	concomitant administration of alosetron and moderate cyp1a2 inhibitors , including quinolone_antibiotics and cimetidine , has not been evaluated , but should be avoided unless clinically necessary because of similar potential drug interactions .
None(e1,e2)	75	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	18	36	digoxin - in subjects who had received 21 days of 40 mg/day racemic citalopram , combined administration of citalopram and digoxin ( single dose of 1 mg ) did not significantly affect the pharmacokinetics of either citalopram or digoxin .
None(e1,e2)	8	10	ingestion of diclofenac may increase serum concentrations of digoxin and methotrexate and increase cyclosporine s nephrotoxicity .
None(e1,e2)	6	8	anesthetics/sedatives/hypnotics/opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
mechanism(e1,e2)	12	21	antibiotics : in vitro and/or in vivo data show that clarithromycin , erythromycin , and troleandomycin markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	26	37	evidence supporting the conclusion that it is inadvisable to co-administer fluvoxamine and diazepam is derived from a study in which healthy volunteers taking 150 mg/day of fluvoxamine were administered a single oral dose of 10 mg of diazepam .
None(e1,e2)	0	18	vitamin_a : because of the relationship of accutane to vitamin a , patients should be advised against taking vitamin_supplements containing vitamin a to avoid additive toxic effects
None(e1,e2)	5	18	thus , when nsaids and lithium are administered concurrently , subjects should be observed carefully for signs of lithium toxicity .
mechanism(e1,e2)	2	8	phenytoin : amphetamines may delay intestinal absorption of phenytoin ;
None(e1,e2)	1	27	because anafranil is highly bound to serum protein , the administration of anafranil to patients taking other drugs that are highly bound to protein ( e.g. , warfarin , digoxin ) may cause an increase in plasma concentrations of these drugs , potentially resulting in adverse effects .
None(e1,e2)	18	39	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	10	13	in a drug interaction study , co-administration of orally inhaled ciclesonide and oral erythromycin , an inhibitor of cytochrome p450 3a4 , had no effect on the pharmacokinetics of either des-ciclesonide or erythromycin .
None(e1,e2)	0	2	barbiturates , phenytoin , or rifampin increased metabolic clearance of fludrocortisone acetate because of the induction of hepatic enzymes .
None(e1,e2)	9	11	there was no evidence of any pharmacokinetic interactions between erbitux and irinotecan .
None(e1,e2)	40	48	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic blocking agents , calcium channel blockers , antihistamines or h1-blocking agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
None(e1,e2)	2	14	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
effect(e1,e2)	6	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	22	46	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	73	84	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	3	5	heparin , other anticoagulants , thrombolytics , and anti platelet agents are associated with an increase in bleeding .
advise(e1,e2)	4	35	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	40	53	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	4	11	urinary alkalinizers : decrease aspirin effectiveness by increasing the rate of salicylate renal excretion .
effect(e1,e2)	10	18	concomitant use of prostaglandin synthase inhibiting drugs , eg , indomethacin , may decrease the hypotensive effects of beta_blockers .
effect(e1,e2)	2	8	aminoglutethimide : aminoglutethimide may diminish adrenal suppression by corticosteroids .
None(e1,e2)	0	9	lotensin has been used concomitantly with beta-adrenergic-blocking agents , calcium-channel-blocking_agents , diuretics , digoxin , and hydralazine , without evidence of clinically important adverse interactions .
None(e1,e2)	0	7	warfarin : a single 125-mg dose of aprepitant was administered on day 1 and 80 mg/day on days 2 and 3 to healthy subjects who were stabilized on chronic warfarin therapy .
None(e1,e2)	24	70	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	1	5	- phenytoin ( e.g. , dilantin ) use of phenytoin with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of phenytoin
None(e1,e2)	0	10	theophylline : twelve healthy male volunteers were administered one 200-mg ceftibuten capsule twice daily for 6 days .
None(e1,e2)	55	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	27	33	in addition , results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
None(e1,e2)	0	2	potassium-sparing_diuretics ( spironolactone , amiloride , triamterene , and others ) or potassium supplements can increase the risk of hyperkalemia .
None(e1,e2)	11	20	erythromycin and clarithromycin ( and possibly other macrolide antibiotics ) and tetracycline may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .
None(e1,e2)	58	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	16	39	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan_kerastick for topical solution .
None(e1,e2)	67	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	21	46	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	8	in the duloxetine clinical trials database , three duloxetine -treated patients had liver injury as manifested by alt and total bilirubin elevations , with evidence of obstruction .
int(e1,e2)	61	66	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	139	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	49	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	6	11	studies to evaluate possible interactions between revia and drugs other than opiates have not been performed .
None(e1,e2)	49	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	15	25	quinidine : immediate release capsules : there have been rare reports of an interaction between quinidine and nifedipine ( with a decreased plasma level of quinidine ) .
None(e1,e2)	34	63	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	11	16	dosage adjustment may be required if cyclosporine , tacrolimus , or methylprednisolone are given concomitantly with nizoral tablets .
None(e1,e2)	34	38	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	0	13	duloxetine may have a clinically important interaction with the following other drugs : alcohol : when duloxetine and ethanol were administered several hours apart so that peak concentrations of each would coincide , duloxetine did not increase the impairment of mental and motor skills caused by alcohol .
None(e1,e2)	16	63	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	10	diltiazem plasma levels were not significantly affected by lovastatin or pravastatin .
effect(e1,e2)	4	15	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
None(e1,e2)	7	11	anticoagulants : while studies have not shown diclofenac to interact with anticoagulants_of_the_warfarin_type , caution should be exercised , nonetheless , since interactions have been seen with other nsaids .
mechanism(e1,e2)	1	12	other quinolones have demonstrated moderate to marked interference with the metabolism of caffeine , resulting in a reduced clearance , a prolongation of plasma half-life , and an increase in symptoms that accompany high levels of caffeine .
None(e1,e2)	46	78	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	78	117	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	10	24	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	40	114	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	56	67	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout_drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	32	44	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	0	16	nonsteroidal_anti-inflammatory_drugs ( nsaids ) : the concomitant administration of a nonsteroidal anti inflammatory drug with a quinolone may increase the risks of cns stimulation and convulsions .
None(e1,e2)	87	101	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	2	18	therefore , mao_inhibitors should be discontinued at least two weeks prior to the cautious initiation of therapy with sinequan .
None(e1,e2)	0	10	calcium_channel_blockers , dihydropyridine : e.g. , felodipine , nifedipine , nicardipine
effect(e1,e2)	0	4	amitriptyline in combination with clonidine enhances the manifestation of corneal lesions in rats epidural injection clonidine may potentiate the cns-depressive effect of alcohol , barbiturates or other sedating drugs .
None(e1,e2)	12	16	fenfluramine may increase slightly the effect of antihypertensive drugs , e.g. , guanethidine , methyldopa , reserpine .
effect(e1,e2)	9	12	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ;
effect(e1,e2)	9	13	there have been postmarketing reports of drug interactions when erythromycin is coadministered with cisapride , resulting in qt prolongation , cardiac arrythmias , ventricular tachycardia , ventricular fibrulation , and torsades de pointes , most like due to inhibition of hepatic metabolism of cisapride by erythromycin .
None(e1,e2)	15	18	atrovent inhalation aerosol has been used concomitantly with other drugs , including sympathomimetic bronchodilators , methylxanthines , and steroids , commonly used in the treatment of chronic obstructive pulmonary disease .
None(e1,e2)	24	28	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	4	17	concomitant administration with racemic citalopram citalopram - since escitalopram is the active isomer of racemic citalopram ( celexa ) , the two agents should not be coadministered .
None(e1,e2)	10	42	since zarontin ( ethosuximide ) may interact with concurrently administered antiepileptic_drugs , periodic serum level determinations of these drugs may be necessary ( eg , ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels ) .
None(e1,e2)	52	87	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	19	51	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
mechanism(e1,e2)	10	32	while no in vivo drug-drug interaction studies were conducted between estazolam and inducers of cyp3a , compounds that are potent cyp3a inducers ( such as carbamazepine , phenytoin , rifampin , and barbiturates ) would be expected to decrease estazolam concentrations .
None(e1,e2)	55	91	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	17	41	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	11	32	reported examples of this interaction include the following : immunosuppressives : cyclosporine ( cyp3a4 substrate ) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine , despite reduction in dose of cyclosporine .
None(e1,e2)	0	2	salicylates - salicylates in large doses may inhibit vitamin k epoxide reductase resulting in vitamin k deficiency .
None(e1,e2)	4	7	butyrophenones ( such as haloperidol ) and phenothiazines can suppress the dopaminergic renal and mesenteric vasodilation induced with low dose dopamine infusion .
None(e1,e2)	8	14	because of its lack of platelet effects , vioxx is not a substitute for aspirin for cardiovascular prophylaxis .
None(e1,e2)	13	17	bismuth : bismuth subsalicylate , given concomitantly with enoxacin or 60 minutes following enoxacin administration , decreased enoxacin bioavailability by approximately 25 % .
None(e1,e2)	35	114	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	50	60	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	28	36	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	29	52	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic_analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
effect(e1,e2)	0	14	antihistamines may have additive effects with alcohol and other cns depressants , e.g. , hypnotics , sedatives , tranquilizers , antianxiety agents .
None(e1,e2)	22	47	therefore , co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	6	16	tablets simultaneous administration of sucralfate and furosemide tablets may reduce the natriuretic and antihypertensive effects of furosemide .
None(e1,e2)	92	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	7	16	phenytoin : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking phenytoin with or without other enzyme- inducing aeds .
None(e1,e2)	71	111	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral_hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
mechanism(e1,e2)	3	26	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	59	67	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	35	45	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	11	17	more than 600 parkinsons disease patients in clinical trials have used selegiline in combination with entacapone and levodopa /dopa decarboxylase inhibitor .
None(e1,e2)	3	13	potassium-sparing diuretics ( spironolactone , amiloride , triamterene , and others ) or potassium supplements can increase the risk of hyperkalemia .
mechanism(e1,e2)	10	12	the interaction is a consequence of blocking hepatic metabolism of vardenafil by ritonavir , a highly potent cyp3a4 inhibitor , which also inhibits cyp2c9 .
None(e1,e2)	38	52	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
effect(e1,e2)	7	9	in some patients the combined use of indomethacin and diflunisal has been associated with fatal gastrointestinal hemorrhage .
None(e1,e2)	81	120	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	9	22	the concomitant use of other cyp3a4 inhibitors such as diltiazem and erythromycin with transdermal fentanyl may also result in an increase in fentanyl plasma concentrations , which could increase or prolong adverse drug effects and may cause serious respiratory depression .
None(e1,e2)	10	20	thiazide diuretics : the reports that the concomitant use of allopurinol and thiazide diuretics may contribute to the enhancement of allopurinol toxicity in some patients have been reviewed in an attempt to establish a cause-and-effect relationship and a mechanism of causation .
None(e1,e2)	8	10	limited clinical data in angina patients receiving concomitant bepridil_hydrochloride and digoxin therapy indicate no discernible changes in serum digoxin levels .
None(e1,e2)	0	14	anesthetics /sedatives/hypnotics/opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
effect(e1,e2)	7	20	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors , tricyclic antidepressants or phenothiazines may produce severe , prolonged hypotension or hypertension .
None(e1,e2)	0	2	broad-spectrum_antibiotics - broad-spectrum_antibiotics may sterilize the bowel and decrease the vitamin k contribution to the body by the intestinal microflora .
None(e1,e2)	65	110	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	108	122	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	33	53	because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis , it is particularly important that physicians query patients or their guardians carefully about benzodiazepine , alcohol and sedative use as part of the history prior to any procedure in which the use of romazicon is planned .
None(e1,e2)	37	42	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline_salicylate ( arthropan ) , magnesium_salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	14	26	caution should also be taken in concurrent or serial use of other aminoglycosides and polymyxins because they may enhance neomycin s nephrotoxicity and/or ototoxicity and potentiate neomycin_sulfate neuromuscular blocking effects .
None(e1,e2)	19	26	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	12	24	it is , however , possible that concomitant use of other known photosensitizing_agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
effect(e1,e2)	17	19	deaths from severe enterocolitis , diarrhea , and dehydration have been reported in elderly patients receiving weekly leucovorin and fluorouracil .
None(e1,e2)	30	41	in addition , results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
None(e1,e2)	44	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	20	22	ketoconazole ) , macrolide antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	45	49	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	21	25	in addition , results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
None(e1,e2)	12	19	in addition , under the influence of sympatholytic medicinal products such as beta-blockers , clonidine , guanethidine , and reserpine , the signs of hypoglycemia may be reduced or absent .
None(e1,e2)	4	28	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium_channel_blocking_drugs , and isoniazid .
None(e1,e2)	7	56	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	8	12	- vitamin k ( e.g. , aquamephyton , synkayvite ) use of sulfapyridine with these medicines may increase the chance of side effects affecting the blood
None(e1,e2)	0	6	caffeine theobromine grepafloxacin , like other quinolones , may inhibit the metabolism of caffeine and theobromine .
None(e1,e2)	19	46	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	18	70	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	30	51	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
effect(e1,e2)	40	46	when atropine and pralidoxime are used together , the signs of atropinization ( flushing , mydriasis , tachycardia , dryness of the mouth and nose ) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine .
None(e1,e2)	2	4	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	3	7	amphotericin b or corticosteroids or corticotropin ( acth )
None(e1,e2)	0	2	amantadine , tricyclic_antidepressants , and maois may increase anticholinergic effect of clidinium .
None(e1,e2)	41	77	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	14	26	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .
None(e1,e2)	6	24	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	35	39	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic agents ) or drugs which inhibit platelet function ( eg , aspirin and other non-steroidal anti-inflammatory drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
None(e1,e2)	5	16	seizure , associated with increased lidocaine concentrations , has been reported with concomitant administration of intravenous amiodarone .
None(e1,e2)	0	2	phenytoin / phenobarbital : the coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin d , but may reduce endogenous plasma levels of calcitriol/ergocalcitriol by accelerating metabolism .
None(e1,e2)	14	48	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	17	40	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	29	35	oral hypoglycemic agents : in one study , flurbiprofen was given to adult diabetics who were already receiving glyburide ( n=4 ) , metformin ( n=2 ) chlorpropamide with phenformin ( n= 3 ) or glyburide with phenformin ( n=6 ) .
mechanism(e1,e2)	0	14	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	2	19	coadministration of aprepitant with drugs that induce cyp3a4 activity may result in reduced plasma concentrations and decreased efficacy of aprepitant .
None(e1,e2)	12	28	several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine , clonidine , or similar agents , and such an effect may be anticipated with cmi because of its structural similarity to other tricyclic antidepressants .
None(e1,e2)	15	17	since animal studies suggest that the action of barbiturates may be prolonged by therapy with chlorpropamide , barbiturates should be employed with caution .
None(e1,e2)	80	116	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	14	24	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	3	23	the clearance of benzodiazepines metabolized by glucuronidation ( e. g. , lorazepam , oxazepam , temazepam ) is unlikely to be affected by fluvoxamine .
None(e1,e2)	0	21	rifabutin , another rifamycin , is structurally similar to rifampin and may possibly have some of the same drug interactions as rifampin .
None(e1,e2)	8	17	acarbose has been shown to change the bioavailabillty digoxin when they are co-administered , which may require digoxin dose adjustment .
mechanism(e1,e2)	0	6	aminosalicylic_acid may decrease the amount of digoxin ( lanoxin , lanoxicaps ) that gets absorbed into your body .
mechanism(e1,e2)	16	46	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	15	21	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic_agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	0	2	midazolam : aprepitant increased the auc of midazolam , a sensitive cyp3a4 substrate , by 2.3-fold on day 1 and 3.3-fold on day 5 , when a single oral dose of midazolam 2 mg was coadministered on day 1 and day 5 of a regimen of aprepitant 125 mg on day 1 and 80 mg/day on days 2 through 5 .
None(e1,e2)	21	25	hormonal contraceptives , including oral , injectable , transdermal , and implantable contraceptives : an interaction study demonstrated that co-administration of bosentan and the oral hormonal_contraceptive ortho-novum produced average decreases of norethindrone and ethinyl estradiol levels of 14 % and 31 % , respectively .
None(e1,e2)	44	76	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	26	76	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	5	29	increases in plasma levels of tricyclic_antidepressants , and in the frequency and severity of side effects , particularly anticholinergic , have been reported when cimetidine was added to the drug regimen .
None(e1,e2)	87	115	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	29	81	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	40	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	44	54	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	7	9	in patients taking furosemide , nifedipine , diltiazem , ace_inhibitors , verapamil , glyburide , propranolol , and various chemotherapy agents , no effect was shown on the clearance of hydrodolasetron .
None(e1,e2)	0	13	steroids enhance the renal toxicity of edetate calcium disodium in animals . 7 edetate_calcium_disodium interferes with the action of zinc insulin preparations by chelating the zinc . 7
advise(e1,e2)	4	15	patients already stabilized on valdecoxib should be closely monitored for loss of symptom control with phenytoin coadministration .
None(e1,e2)	20	33	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin_d .
None(e1,e2)	15	26	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	3	10	while all the selective_serotonin_reuptake_inhibitors ( ssris ) , e.g. , fluoxetine , sertraline , paroxetine , and fluvoxamine , inhibit p450 2d6 , they may vary in the extent of inhibition .
mechanism(e1,e2)	0	20	bosentan is also expected to reduce plasma concentrations of other statins that have significant metabolism by cyp3a4 , such as lovastatin and atorvastatin .
None(e1,e2)	70	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	6	55	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	17	34	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	14	35	because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis , it is particularly important that physicians query patients or their guardians carefully about benzodiazepine , alcohol and sedative use as part of the history prior to any procedure in which the use of romazicon is planned .
None(e1,e2)	2	4	diazepam : diazepam ( valium ) is a cyp 3a4 and cyp 2c19 substrate .
None(e1,e2)	2	8	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	0	21	warfarin : in a short-term controlled study in 14 normal volunteers , ketoprofen did not significantly interfere with the effect of warfarin on prothrombin time .
None(e1,e2)	62	77	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin_c ; warfarin sodium under-dosage .
effect(e1,e2)	18	20	there have been rare reports of significant respiratory depression , stupor and/or hypotension with the concomitant use of loxapine and lorazepam .
None(e1,e2)	6	33	when initiating a multi-day course of grepafloxacin in a patient maintained on theophylline , the theophylline maintenance dose should be halved for the period of concurrent use of grepafloxacin and monitoring of serum theophylline concentrations should be initiated as a guide to further dosage adjustments .
None(e1,e2)	12	34	hormonal contraceptives , including oral , injectable , transdermal , and implantable contraceptives : an interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive ortho-novum produced average decreases of norethindrone and ethinyl_estradiol levels of 14 % and 31 % , respectively .
None(e1,e2)	6	18	data from a randomized trial of hexalen and cisplatin plus or minus pyridoxine in ovarian cancer indicated that pyridoxine significantly reduced neurotoxicity ;
effect(e1,e2)	4	6	the concomitant use of beta-adrenergic_blocking_agents with digitalis and calcium antagonists may have additive effects on prolonging atrioventricular conduction time .
None(e1,e2)	16	22	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	0	6	aspirin : concomitant administration of low-dose aspirin with vioxx may result in an increased rate of gi ulceration or other complications , compared to use of vioxx alone .
None(e1,e2)	30	62	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	0	9	inomax has been administered with tolazoline , dopamine , dobutamine , steroids , surfactant , and high-frequency ventilation .
None(e1,e2)	0	5	aspirin : concurrent administration of aspirin and flurbiprofen resulted in 50 % lower serum flurbiprofen concentrations .
effect(e1,e2)	13	15	a study in 14 normal male and female volunteers suggests that coadministration of cisapride and ketoconazole can result in prolongation of the qt interval on the ecg .
None(e1,e2)	36	45	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	39	77	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin_c ; warfarin sodium under-dosage .
None(e1,e2)	55	85	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	15	21	drug interaction studies have shown that esomeprazole does not have any clinically significant interactions with phenytoin , warfarin , quinidine , clarithromycin or amoxicillin .
None(e1,e2)	67	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	25	53	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	1	3	- antihypertensives : bumetanide may potentiate the effect of various antihypertensive drugs , necessitating a reduction in the dosage of these drugs .
None(e1,e2)	17	19	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	18	28	oral contraceptives : valdecoxib ( 40 mg bid ) did not induce the metabolism of the combination oral contraceptive norethindrone/ethinyl estradiol ( 1 mg /35 mcg combination , ortho-novum 1/35 ) .
None(e1,e2)	0	21	anticoagulant therapy should be monitored , particularly during the first few weeks , after initiating therapy with bextra in patients receiving warfarin or similar agents .
advise(e1,e2)	15	24	nicardipine hcl usually does not alter the plasma levels of digoxin , however , serum digoxin levels should be evaluated after concomitant therapy with nicardipine_hcl is initiated .
None(e1,e2)	13	16	example inducers include aminoglutethimide , carbamazepine , nafcillin , nevirapine , phenobarbital , phenytoin , and rifamycins .
None(e1,e2)	18	22	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic_acid , and tolbutamide in vitro .
None(e1,e2)	49	57	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	5	while all the selective_serotonin_reuptake_inhibitors ( ssris ) , e.g. , citalopram , escitalopram , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	0	6	phenothiazines - taking piperazine and a phenothiazine together may increase the risk of convulsions ( seizures ) .
mechanism(e1,e2)	2	8	griseofulvin : griseofulvin may induce the metabolism of combination_hormonal_contraceptives causing menstrual changes ;
effect(e1,e2)	3	15	quinolones , including cinoxacin , may enhance the effects of oral anticoagulants , such as warfarin or its derivatives .
mechanism(e1,e2)	0	12	ketoconazole ( 200 mg once daily ) produced a 10-fold increase in vardenafil auc and a 4-fold increase in cmax when co-administered with vardenafil ( 5 mg ) in healthy volunteers .
None(e1,e2)	2	14	cns-active drugs ethanol an additive effect on psychomotor performance was seen with coadministration of eszopiclone and ethanol 0.70 g/kg for up to 4 hours after ethanol administration .
None(e1,e2)	21	46	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
effect(e1,e2)	6	35	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	44	78	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	15	19	the concomitant use of transdermal fentanyl with ritonavir or other potent 3a4 inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
None(e1,e2)	21	36	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	5	11	certain drugs including thiazides , corticosteroids , thyroid products , and sympathomimetics may reduce the hypoglycemic action of starlix and other oral antidiabetic drugs .
None(e1,e2)	38	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	13	although the interaction between almotriptan and other potent cyp3a4 inhibitors ( e.g. , itraconazole , ritonavir , and erythromycin ) has not been studied , increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications .
None(e1,e2)	26	40	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
mechanism(e1,e2)	10	19	protease inhibitors : amprenavir , lopinavir , nelfinavir , and ritonavir have been shown to decrease plasma levels of combination_hormonal_contraceptives ;
None(e1,e2)	8	23	methotrexate : concomitant administration of methotrexate and some nsaids has been reported to reduce the clearance of methotrexate , enhancing the toxicity of methotrexate .
None(e1,e2)	0	19	glyburide : in a randomized , multiple-dose crossover study , patients with type 2 diabetes were administered 120 mg starlix three times a day before meals for 1 day in combination with glyburide 10 mg daily .
None(e1,e2)	8	11	digoxin : the concomitant administration of dynacirc ( isradipine ) and digoxin in a single-dose pharmacokinetic study did not affect renal , nonrenal and total body clearance of digoxin .
None(e1,e2)	5	36	concomitant medications were grouped as ace_inhibitors , oral anticoagulants , calcium channel blockers , beta blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	6	15	inhibitors of cyp3a4 ( eg , ketoconazole ) or cyp2d6 ( eg , quinidine , fluoxetine , or paroxetine ) can inhibit aripiprazole elimination and cause increased blood levels .
None(e1,e2)	14	19	zidovudine should either be temporarily discontinued or decreased by 50 % when coadministered with probenecid on the day of vistide infusion .
None(e1,e2)	13	20	other drug interaction information digoxin : studies in healthy volunteers have shown that tikosyn does not affect the pharmacokinetics of digoxin .
None(e1,e2)	14	22	the concomitant use of other cyp3a4 inhibitors such as diltiazem and erythromycin with transdermal fentanyl may also result in an increase in fentanyl plasma concentrations , which could increase or prolong adverse drug effects and may cause serious respiratory depression .
None(e1,e2)	53	65	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	80	85	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	3	10	alprazolam : when fluvoxamine_maleate ( 100 mg qd ) and alprazolam ( 1 mg q.d . were co-administered to steady state , plasma concentration and other pharmacokinetics parameters ( auc , cmax , t1/2 , ) of alprazolam were approximately twice those observed when alprazolam was administered alone ;
None(e1,e2)	17	23	the risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine , fibric acid derivatives , niacin ( nicotinic acid ) , erythromycin , azole antifungals .
None(e1,e2)	12	16	may interact with the following : cholestyramine , colestipol ( use with thiazide_diuretics may prevent the diuretic from working properly ;
None(e1,e2)	16	39	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	22	76	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	83	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	6	42	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	31	33	however , in a well-controlled study of patients with lymphoma on combination therapy , allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide , doxorubicin , bleomycin , procarbazine and/or mechlorethamine .
None(e1,e2)	12	21	infusion requirements of nimbex in patients administered succinylcholine prior to infusions of nimbex were comparable to or slightly greater than when succinylcholine was not administered .
None(e1,e2)	40	42	if desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
mechanism(e1,e2)	5	11	warfarin : quinolones , including enoxacin , decrease the clearance of r-warfarin , the less active isomer of racemic warfarin .
effect(e1,e2)	8	17	the antihypertensive effects of methyldopa , mecamylamine , reserpine , and veratrum alkaloids may be reduced by sympathomimetics .
None(e1,e2)	19	47	phenytoin : in a single ( 400 mg ) and multiple dose ( 400 mg tid ) study of neurontin in epileptic patients ( n=8 ) maintained on phenytoin monotherapy for at least 2 months , gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics .
None(e1,e2)	13	37	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	4	6	after multiple dosing , interferon_beta-1a ( avonex 30 mcg im once weekly ) reduced tysabri clearance by approximately 30 % .
None(e1,e2)	0	43	monoamine_oxidase_(_mao_)_inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	105	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	8	10	may interact with wthionamide ( trecator-sc ) and isoniazid ( nydrazid ) .
None(e1,e2)	24	54	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
effect(e1,e2)	2	13	this allows bitolterol to open air passages , increasing the effectiveness of the steroid .
mechanism(e1,e2)	3	5	concomitant administration of norpace and quinidine resulted in slight increases in plasma disopyramide levels and slight decreases in plasma quinidine levels .
None(e1,e2)	98	142	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	12	mercaptopurine/azathioprine : allopurinol inhibits the enzymatic oxidation of mercaptopurine and azathioprine to 6-thiouric_acid .
mechanism(e1,e2)	3	11	the administration of guanfacine concomitantly with known microsomal enzyme inducer ( phenobarbital or phenytoin ) to two patients with renal impairment reportedly resulted in significant reductions in elimination half-life and plasma concentration .
None(e1,e2)	13	47	in vivo studies : nitrates : the blood pressure lowering effects of sublingual nitrates ( 0.4 mg ) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1 , 4 and 8 hours were potentiated by a 20 mg dose of vardenafil in healthy middle-aged subjects .
None(e1,e2)	3	20	adequate monitoring of theophylline plasma concentrations should be considered when therapy with vioxx is initiated or changed in patients receiving theophylline .
None(e1,e2)	32	56	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	0	12	lithium : in a study conducted in healthy subjects , mean steady-state lithium plasma levels increased approximately 17 % in subjects receiving lithium 450 mg bid with celebrex 200 mg bid as compared to subjects receiving lithium alone .
None(e1,e2)	15	17	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine_oxidase_inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
effect(e1,e2)	0	38	isoflurane or enflurane administered with nitrous oxide/oxygen to achieve 1.25 mac [ minimum alveolar concentration ] may prolong the clinically effective duration of action of initial and maintenance doses of nimbex and decrease the required infusion rate of nimbex .
None(e1,e2)	7	11	compounds tested in man include warfarin , theophylline , phenytoin , diazepam , aminopyrine and antipyrine .
mechanism(e1,e2)	13	15	there have been greater than two-fold increases of previously stable plasma levels of tricyclic_antidepressants when fluoxetine has been administered in combination with these agents .
None(e1,e2)	40	81	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	37	83	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	26	85	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole_antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	2	methotrexate : ketoprofen , like other nsaids , may cause changes in the elimination of methotrexate leading to elevated serum levels of the drug and increased toxicity .
advise(e1,e2)	0	7	lithium generally should not be given with diuretics because they reduce its renal clearance and add a high risk of lithium toxicity .
None(e1,e2)	11	16	in vitro , buspirone does not displace tightly bound drugs like phenytoin , propranolol , and warfarin from serum proteins .
None(e1,e2)	41	68	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	39	104	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	19	25	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	52	85	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	146	160	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	4	15	using calcium acetate with digitalis_glycosides ( heart medicine ) may cause hypercalcemia ( too much calcium in the blood ) , which could increase the chance of developing an irregular heartbeat .
None(e1,e2)	9	16	pharmacokinetic data from these patients demonstrated a decrease in paclitaxel clearance of approximately 33 % when taxol was administered following cisplatin .
None(e1,e2)	18	28	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	38	43	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
advise(e1,e2)	20	31	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc . ) is indicated , reduction of the budesonide dose should be considered .
None(e1,e2)	9	27	omeprazole : the rate and extent of absorption of ciprofloxacin was bioequivalent when proquin xr was given alone or when proquin xr was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion .
None(e1,e2)	14	19	concurrent use of butorphanol with central nervous system depressants ( e.g. , alcohol , barbiturates , tranquilizers , and antihistamines ) may result in increased central nervous system depressant effects .
None(e1,e2)	30	32	in a drug interaction study , co-administration of orally inhaled ciclesonide and oral erythromycin , an inhibitor of cytochrome p450 3a4 , had no effect on the pharmacokinetics of either des-ciclesonide or erythromycin .
None(e1,e2)	3	21	concomitant use of clozapine with other drugs metabolized by cytochrome p450 2d6 may require lower doses than usually prescribed for either clozapine or the other drug .
None(e1,e2)	21	23	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	66	70	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	1	12	anesthetics/ sedatives /hypnotics/opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
None(e1,e2)	2	10	effect of clonazepam on the pharmacokinetics of other drugs : clonazepam does not appear to alter the pharmacokinetics of phenytoin , carbamazepine , or phenobarbital .
None(e1,e2)	32	51	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	26	31	drugs demonstrated to be cyp 3a inhibitors of possible clinical significance on the basis of clinical studies involving alprazolam ( caution is recommended during coadministration with alprazolam ) : coadministration of fluoxetine with alprazolam increased the maximum plasma concentration of alprazolam by 46 % , decreased clearance by 21 % , increased half-life by 17 % , and decreased measured psychomotor performance .
mechanism(e1,e2)	9	17	corticosteroids : a relationship of functional antagonism exists between vitamin_d_analogues , which promote calcium absorption , and corticosteroids , which inhibit calcium absorption .
None(e1,e2)	6	26	aspirin : concomitant administration of low-dose aspirin with vioxx may result in an increased rate of gi ulceration or other complications , compared to use of vioxx alone .
None(e1,e2)	4	6	urinary acidifying agents ( ammonium_chloride , sodium_acid_phosphate , etc . ) increase the concentration of the ionized species of the amphetamine molecule , thereby increasing urinary excretion .
None(e1,e2)	4	19	it is recommended that buspirone_hydrochloride not be used concomitantly with mao inhibitors because the effects of concomitant administration of buspirone_hcl with most other psychotropic drugs have not been studied , the concomitant use of buspirone hcl with other cns-active drugs should be approached with caution .
None(e1,e2)	26	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	12	17	ssris : weakness hyperreflexia , and incoordination have been reported rarely when 5-ht1_agonists have been co-administered with ssris ( e. g .
None(e1,e2)	20	76	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	36	55	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral_hydrate * ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	26	61	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole_antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	17	39	theophylline vioxx 12.5 , 25 , and 50 mg administered once daily for 7 days increased plasma theophylline concentrations ( auc ( 0- ) ) by 38 to 60 % in healthy subjects administered a single 300-mg dose of theophylline .
None(e1,e2)	22	24	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	0	5	warfarin : the effect of valdecoxib on the anticoagulant effect of warfarin ( 1 - 8 mg/day ) was studied in healthy subjects by coadministration of bextra 40 mg bid for 7 days .
advise(e1,e2)	10	29	multivitamins , or other products containing iron or zinc , antacids or sucralfate should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .
None(e1,e2)	18	22	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide_diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
advise(e1,e2)	23	43	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	3	14	dose reduction of rifabutin to half the standard dose and a dose increase of crixivan to 1000 mg ( three 333-mg capsules ) every 8 hours are recommended when rifabutin and crixivan are coadministered .
None(e1,e2)	0	23	tricyclic_antidepressants have been reported to blunt the hypotensive effect of systemic clonidine.it is not known whether the concurrent use of these agents with alphagan_p in humans can lead to resulting interference with the iop lowering effect .
None(e1,e2)	22	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	3	5	the effect of keppra on probenecid was not studied .
effect(e1,e2)	9	46	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal_muscle_relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	4	24	for example , when vitamin_k_antagonists are administered concomitantly with nilutamide , prothrombin time should be carefully monitored and if necessary , the dosage of vitamin_k_antagonists should be reduced .
None(e1,e2)	8	12	based on the chemical resemblance of itraconazole and ketoconazole , coadministration of astemizole with itraconazole is contraindicated .
advise(e1,e2)	18	28	however , due to possible pharmacodynamic interactions , when co-administered with precedex , a reduction in dosage of precedex on the concomitant anesthetic , sedative , hypnotic or opioid may be required .
None(e1,e2)	28	68	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	4	13	during clinical trials , iloprost was used concurrently with anticoagulants , diuretics , cardiac_glycosides , calcium channel blockers , analgesics , antipyretics , nonsteroidal antiinflammatories , corticosteroids , and other medications .
None(e1,e2)	12	44	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium_chloride , folic acid , and acetaminophen .
None(e1,e2)	0	41	beta_blockers : although the results of a clinical study did not indicate a safe problem associated with the administration of d.h.e . 45 ( dihydroergotamine mesylate ) injection , usp to subjects already receiving propranolol , there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine .
None(e1,e2)	18	26	concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with proleukin may increase toxicity in these organ systems .
None(e1,e2)	76	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	80	147	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	4	21	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
None(e1,e2)	1	26	oral hypoglycemics : bepridil has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for insulin or oral hypoglycemic_agents .
None(e1,e2)	14	16	coadministration with compounds that are potent inducers of cyp3a4 ( eg , phenobarbital , phenytoin , dexamethasone , carbamazepine ) may result in decreased plasma levels of saquinavir .
None(e1,e2)	0	29	cimetidine - in subjects who had received 21 days of 40 mg/day racemic citalopram , combined administration of 400 mg/day cimetidine for 8 days resulted in an increase in citalopram auc and cmax of 43 % and 39 % , respectively .
None(e1,e2)	71	84	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral_hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	3	simvastatin and other statins : co-administration of bosentan decreased the plasma concentrations of simvastatin ( a cyp3a4 substrate ) , and its active -hydroxy acid metabolite , by approximately 50 % .
None(e1,e2)	39	83	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
mechanism(e1,e2)	4	28	therefore , coadministration of aprepitant with drugs that strongly induce cyp3a4 activity ( e.g. , rifampin , carbamazepine , phenytoin ) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of aprepitant .
effect(e1,e2)	13	29	- non-steroidal anti-inflammatory drugs : in some patients , the administration of a non-steroidal_anti-inflammatory_agent can reduce the diuretic , natriuretic , and antihypertensive effects of loop , potassium-sparing and thiazide_diuretics .
None(e1,e2)	91	127	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
advise(e1,e2)	14	42	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease_inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	33	51	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
mechanism(e1,e2)	7	24	phenytoin/phenobarbital : the coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin d , but may reduce endogenous plasma levels of calcitriol /ergocalcitriol by accelerating metabolism .
None(e1,e2)	2	4	co-administration with efavirenz or fluconazole had a modest effect on the pharmacokinetics of azithromycin .
None(e1,e2)	0	7	anticoagulants : while studies have not shown diclofenac to interact with anticoagulants of the warfarin type , caution should be exercised , nonetheless , since interactions have been seen with other nsaids .
None(e1,e2)	0	14	corticosteroids : dexamethasone : aprepitant , when given as a regimen of 125mg with dexamethasone coadministered orally as 20 mg on day 1 , and aprepitant when given as 80 mg/day with dexamethasone coadministered orally as 8 mg on days 2 through 5 , increased the auc of dexamethasone , a cyp3a4 substrate by 2.2-fold , on days 1 and 5 .
advise(e1,e2)	0	17	isuprel should be used with caution , if at all , when potent inhalational anesthetics such as halothane are employed because of potential to sensitize the myocardium to effects of sympathomimetic amines .
None(e1,e2)	8	14	there is a significant increase in exposure to imatinib when gleevec is coadministered with ketoconazole ( cyp3a4 inhibitor ) .
mechanism(e1,e2)	4	18	or with multivitamins containing zinc may substantially interfere with drug absorption and result in insufficient plasma and tissue quinolone concentrations .
None(e1,e2)	8	16	agents with decreased levels in the presence of carbamazepine due to induction of cytochrome p450 enzymes carbamazepine is known to induce cyp1a2 and cyp3a4 .
None(e1,e2)	135	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	22	32	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	7	10	include terfenadine , astemizole , cisapride , midazolam , and triazolam .
None(e1,e2)	31	41	ketoconazole : when a single 125-mg dose of aprepitant was administered on day5 of a 10-day regimen of 400 mg/day of ketoconazole , a strong cyp3a4 inhibitor , the auc of aprepitant increased approximately 5-fold and the mean terminal half-life of aprepitant increased approximately 3-fold .
None(e1,e2)	6	15	analgesic/anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
None(e1,e2)	9	34	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium_hydroxide s ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	10	15	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid-associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
mechanism(e1,e2)	19	28	however , other published reports describe modest elevations ( less than two-fold ) of clozapine and metabolite concentrations when clozapine was taken with paroxetine , fluoxetine , and sertraline .
None(e1,e2)	13	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	10	52	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	105	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	6	42	in addition to bleeding associated with heparin and vitamin k antagonists , drugs that alter platelet function ( such as acetylsalicylic acid , dipyridamole and abciximab ) may increase the risk of bleeding if administered prior to , during , or after activase therapy .
None(e1,e2)	33	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	32	80	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin_sodium under-dosage .
None(e1,e2)	5	7	while the effects of chronic phenytoin or carbamazepine therapy on the action of nimbex are unknown , slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher .
None(e1,e2)	7	14	immunosuppressive drugs , fibric acid derivatives , niacin ( nicotinic acid , erythromycin , azole_antifungals : skeletal muscle .
mechanism(e1,e2)	5	14	oral contraceptives : coadministration of atorvastatin and an oral contraceptive increased auc values for norethindrone and ethinyl estradiol by approximately 30 % and 20 % .
None(e1,e2)	7	18	studies in healthy volunteers have shown that acarbose has no effect on either the pharmacokinetics or pharmacodynamics of digoxin , nifedipine , propranolol , or ranitidine .
None(e1,e2)	5	29	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
mechanism(e1,e2)	11	41	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	14	16	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim/sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	21	36	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	89	92	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	8	17	the concurrent use of robinul injection with other anticholinergics or medications with anticholinergic activity , such as phenothiazines , antiparkinson drugs , or tricyclic antidepressants , may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects .
None(e1,e2)	0	2	beta-blockers ( metoprolol , propranolol ) serum concentrations and pharmacologic effects may be increased .
None(e1,e2)	78	114	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	65	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	7	25	since the concomitant administration of warfarin with amiodarone increases the prothrombin time by 100 % after 3 to 4 days , the dose of the anticoagulant should be reduced by one-third to one-half , and prothrombin times should be monitored closely .
None(e1,e2)	4	20	drugs that may decrease imatinib plasma concentrations : substances that are inducers of cyp3a4 activity may increase metabolism and decrease imatinib plasma concentrations .
None(e1,e2)	8	14	drugs which inhibit cyp 3a4 ( e.g. , ketoconazole , macrolide antibiotics such as erythromycin ) have the potential to result in increased plasma concentrations of corticosteroids .
None(e1,e2)	9	27	effects of other antiepilepsy drugs ( aeds ) on gabitril : carbamazepine : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking carbamazepine with or without other enzyme- inducing aeds .
None(e1,e2)	5	8	interactions for vitamin b3 ( niacin ) : antihypertensive therapy : nicotinic acid may potentiate the effects of ganglionic blocking agents and vasoactive drugs resulting in postural hypotension .
None(e1,e2)	16	22	because oral anticoagulants may interfere with the hepatic metabolism of phenytoin , toxic levels of the anticonvulsant may occur when an oral anticoagulant and phenytoin are administered concurrently .
None(e1,e2)	14	18	pharmacokinetic interaction studies with cetirizine in adults were conducted with pseudoephedrine , antipyrine , ketoconazole , erythromycin and azithromycin .
None(e1,e2)	12	34	however , in another study in healthy volunteers , the pharmacokinetics of butorphanol were significantly altered ( 29 % decrease in auc and 38 % decrease in cmax ) when a 1-mg dose of stadol_ns was administered 1 minute after a 20-mg dose of sumatriptan nasal spray .
advise(e1,e2)	4	40	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
int(e1,e2)	11	36	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
effect(e1,e2)	5	33	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	16	33	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone_classes_of_antipsychotic_agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	49	51	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	21	51	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	11	31	drug interactions : flupenthixol may interact with some drugs , like monoamine_oxidase_inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	8	54	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	9	14	talk to your doctor if you are taking certain antibiotics such as erythromycin , clarithromycin or azithromycin .
None(e1,e2)	32	38	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	21	32	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis_preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide_dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	6	28	since amiodarone is a substrate for cyp3a4 , there is the potential that the use of st. john s wort in patients receiving amiodarone could result in reduced amiodarone levels .
None(e1,e2)	2	31	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	39	85	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	17	20	these agents include medications such as : anticoagulants , platelet inhibitors including acetylsalicylic acid , sali-cylates , nsaids ( including ketorolac_tromethamine ) , dipyridamole , or sulfinpyrazone .
None(e1,e2)	31	39	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic agents ) or drugs which inhibit platelet function ( eg , aspirin and other non-steroidal_anti-inflammatory_drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
None(e1,e2)	0	41	central_nervous_system_depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
effect(e1,e2)	3	24	toxicology studies of heroin -related deaths reveal frequent involvement of other central nervous system depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
effect(e1,e2)	7	20	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	34	50	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	85	112	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	2	12	administration of thiazide_diuretics to hypoparathyroid patients who are concurrently being treated with dihydrotachysterol may cause hypercalcemia .
effect(e1,e2)	8	30	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	35	56	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	98	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	6	digoxin , methotrexate , cyclosporine : diclofenac , like other nsaids , may affect renal prostaglandins and increase the toxicity of certain drugs .
None(e1,e2)	21	31	however , it is considered to be unlikely that this decrease of phosphorylated lamivudine concentration is of clinical significance , as lamivudine is a more efficient substrate for deoxycytidine kinase than zalcitabine .
None(e1,e2)	98	152	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	1	29	if rifampicin therapy is required , isradipine concentrations and therapeutic effects are likely to be markedly reduced or abolished as a consequence of increased metabolism and higher clearance of isradipine .
None(e1,e2)	45	54	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
mechanism(e1,e2)	6	17	in a multiple dose study of theophylline ( 400 mg once daily for 3 days ) and cetirizine ( 20 mg once daily for 3 days ) , a 16 % decrease in the clearance of cetirizine was observed .
effect(e1,e2)	17	19	antihypertensive medications and vasodilators : the following adverse events were experienced more commonly in patients receiving concomitant antihypertensive_medications or vasodilators ( n = 94 ) compared to patients not receiving these concomitant drugs ( n = 456 ) : hypotension 10 % vs 4 % , myocardial infarction 3 % vs 1 % , serious pneumonia 5 % vs 3 % , serious falls 9 % vs 3 % , and bone and joint injuries 6 % vs 2 % .
None(e1,e2)	35	43	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	26	28	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
None(e1,e2)	6	8	during co-administration , systemic levels of tmp and smx were essentially unchanged .
None(e1,e2)	24	36	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	7	27	during administration of multiple oral doses of tambocor to healthy subjects stabilized on a maintenance dose of digoxin , a 13 % -19 % increase in plasma digoxin levels occurred at six hours postdose .
None(e1,e2)	2	15	lithium : ibuprofen produced an elevation of plasma lithium levels and a reduction in renal lithium clearance in a study of eleven normal volunteers .
None(e1,e2)	68	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	49	66	this drug may interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine_oxidase_(_mao_)_inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	22	34	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	69	110	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	2	ketoconazole : ketoconazole 400 mg daily did not have any clinically important effect on the pharmacokinetics of rofecoxib .
None(e1,e2)	6	11	amphotericin b or potassium-depleting diuretics ( benzothiadiazines and related drugs , ethacrynic_acid and furosemide ) enhanced hypokalemia .
None(e1,e2)	12	33	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	0	20	short-acting_beta2-agonists : aerosol bronchodilators of the short-acting adrenergic stimulant type may be used for relief of breakthrough symptoms while using formoterol .
mechanism(e1,e2)	11	24	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	36	52	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	69	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	6	8	co-treatment with the potent cyp3a4 inhibitor ketoconazole increases erlotinib auc by 2/3 .
None(e1,e2)	1	19	although betagan used alone has little or no effect on pupil size , mydriasis resulting from concomitant therapy with betagan and epinephrine may occur .
None(e1,e2)	17	33	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	14	46	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
None(e1,e2)	16	18	there have been reports of qtc prolongation , with or without tdp , in patients taking amiodarone when fluoroquinolones , macrolide antibiotics , or azoles were administered concomitantly .
None(e1,e2)	15	38	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	0	12	chlorpropamide : chlorpropamides plasma half-life may be prolonged by allopurinol , since allopurinol and chlorpropamide may compete for excretion in the renal tubule .
None(e1,e2)	23	30	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	76	118	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
effect(e1,e2)	8	30	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
None(e1,e2)	11	20	these results would seem to dictate against the clinical use of methotrexate with elspar , or during the period following elspar therapy when plasma asparagine levels are below normal .
None(e1,e2)	0	26	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
effect(e1,e2)	3	22	certain drugs including thiazides , corticosteroids , thyroid products , and sympathomimetics may reduce the hypoglycemic action of starlix and other oral antidiabetic_drugs .
None(e1,e2)	35	37	oral hypoglycemic agents : in one study , flurbiprofen was given to adult diabetics who were already receiving glyburide ( n=4 ) , metformin ( n=2 ) chlorpropamide with phenformin ( n= 3 ) or glyburide with phenformin ( n=6 ) .
None(e1,e2)	0	5	anticholinesterases : concomitant use of anticholinesterase_agents and corticosteroids may produce severe weakness in patients with myasthenia gravis .
None(e1,e2)	4	12	in these subjects , celecoxib did not alter the anticoagulant effect of warfarin as determined by prothrombin time .
None(e1,e2)	25	31	estazolam : interaction with drugs that inhibit metabolism via cytochrome p450 3a ( cyp3a ) : the metabolism of estazolam to the major circulating metabolite 4-hydroxy-estazolam and the metabolism of other triazolobenzodiazepines is catalyzed by cyp3a .
None(e1,e2)	15	31	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	0	18	tolazamide : a case of severe hypoglycemia has been reported in a type ii diabetic patient maintained on tolazamide ( 1 gm/day ) 11 days after the addition of doxepin ( 75 mg/day ) .
None(e1,e2)	25	27	other drugs : in small groups of patients ( 7-10/interaction study ) , the concomitant administration of azathioprine , gold , chloroquine , d-penicillamine , prednisolone , doxycycline , or digitoxin did not significantly affect the peak levels and auc values of diclofenac .
None(e1,e2)	26	28	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin_hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	39	55	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	10	15	no significant interactions with digoxin , hydrochlorothiazide , hydralazine , sulfinpyrazone , oral contraceptives , tolbutamide , or warfarin have been observed .
None(e1,e2)	121	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	16	18	poor metabolizers of debrisoquin : interactions of carvedilol with strong inhibitors of cyp2d6 ( such as quinidine , fluoxetine , paroxetine , and propafenone ) have not been studied , but these drugs would be expected to increase blood levels of the r ( + ) enantiomer of carvedilol .
None(e1,e2)	5	20	concurrent administration of hexalen and antidepressants_of_the_mao_inhibitor_class may cause severe orthostatic hypotension.cimetidine , an inhibitor of microsomal drug metabolism , increased altretamine s half-life and toxicity in a rat model .
None(e1,e2)	26	28	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	20	33	therophylline : a recent study has shown that concomitan administration of isoniazid and theophylline may cause elevated plasma levels of theophylline , and in some instances a slight decrease in the elimination of isoniazid .
None(e1,e2)	5	16	it is recommended that serum lithium levels be monitored frequently if prinivil is administered concomitantly with lithium .
None(e1,e2)	2	14	hydrochlorothiazide ( hctz ) alone or in combination with triamterene : concomitant use of hctz alone or in combination with triamterene is contraindicated .
None(e1,e2)	29	46	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic_hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic_acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	29	35	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	13	17	skeletal muscle relaxants : amphotericin b-induced hypokalemia may enhance the curariform effect of skeletal_muscle_relaxants ( e.g. , tubocurarine ) .
None(e1,e2)	3	18	thus , when vioxx and lithium are administered concurrently , subjects should be observed carefully for signs of lithium toxicity .
effect(e1,e2)	0	16	lincomycin has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular_blocking_agents .
None(e1,e2)	2	31	- a nonsteroidal_anti-inflammatory_drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
effect(e1,e2)	1	7	although glucocorticoids have been shown to reduce proleukin -induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with proleukin may reduce the antitumor effectiveness of proleukin and thus should be avoided . 12 beta-blockers and other antihypertensives may potentiate the hypotension seen with proleukin .
None(e1,e2)	26	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	88	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	21	43	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis_preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium_chloride , folic acid , and acetaminophen .
None(e1,e2)	2	21	co-administration of tikosyn with verapamil resulted in increases in dofetilide peak plasma levels of 42 % , although overall exposure to dofetilide was not significantly increased .
advise(e1,e2)	6	17	patients who have been treated with mao_inhibitors within two to three weeks prior to the administration of dopamine_hcl should receive initial doses of dopamine hcl no greater than one-tenth ( 1/10 ) of the usual dose .
None(e1,e2)	0	11	theophylline : as with some other quinolones , concurrent administration of ciprofloxacin with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life .
None(e1,e2)	50	69	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	9	quinidine : coadministration of a 10-mg single dose of aripiprazole with quinidine ( 166 mg/day for 13 days ) , a potent inhibitor of cyp2d6 , increased the auc of aripiprazole by 112 % but decreased the auc of its active metabolite , dehydroaripiprazole , by 35 % .
None(e1,e2)	17	27	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central_nervous_system_depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	15	19	therefore , coadministration of aprepitant with drugs that strongly induce cyp3a4 activity ( e.g. , rifampin , carbamazepine , phenytoin ) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of aprepitant .
None(e1,e2)	3	8	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract
mechanism(e1,e2)	2	8	mercaptopurine/azathioprine : allopurinol inhibits the enzymatic oxidation of mercaptopurine and azathioprine to 6-thiouric acid .
mechanism(e1,e2)	8	15	antacids or h 2 receptor antagonists : when dirithromycin is administered immediately following antacids or h_2_-receptor_antagonists , the absorption of dirithromycin is slightly enhanced .
None(e1,e2)	50	92	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	39	48	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide_diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	27	39	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	118	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	24	54	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	0	10	aminosalicylic_acid may decrease the amount of digoxin ( lanoxin , lanoxicaps ) that gets absorbed into your body .
None(e1,e2)	30	34	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	6	14	therefore , the concomitant administration of tracleer and glyburide is contraindicated , and alternative hypoglycemic_agents should be considered .
None(e1,e2)	16	37	if desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/ hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
None(e1,e2)	30	34	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	39	41	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	26	33	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide_dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	0	23	acetaminophen : in normal volunteers , concomitant administration of diflunisal and acetaminophen resulted in an approximate 50 % increase in plasma levels of acetaminophen .
None(e1,e2)	4	22	phenobarbital : coadministration of felbamate with phenobarbital causes an increase in phenobarbital plasma concentrations , in 12 otherwise healthy male volunteers ingesting phenobarbital , the steady-state trough ( cmin ) phenobarbital concentration was 14.2 micrograms/ml .
None(e1,e2)	24	30	benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
None(e1,e2)	16	39	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine_oxidase_inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	38	61	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	9	14	uricosuric agents : aspirin may decrease the effects of probenecid , sulfinpyrazone , and phenylbutazone .
None(e1,e2)	76	102	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	76	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	26	38	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	11	15	compounds tested in man include warfarin , theophylline , phenytoin , diazepam , aminopyrine and antipyrine .
mechanism(e1,e2)	2	6	coadministration of itraconazole and cyclosporine , tacrolimus or digoxin has led to increased plasma concentrations of the latter three drugs .
None(e1,e2)	35	59	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	2	11	nitroglycerin : dynacirc ( isradipine ) has been safely coadministered with nitroglycerin .
None(e1,e2)	10	12	other strong inhibitors of cyp3a4 ( e.g. , itraconazole , clarithromycin , nefazodone , troleandomycin , ritonavir , nelfinavir ) would be expected to behave similarly .
None(e1,e2)	35	37	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	3	31	erythromycin co-administration of felodipine ( plendil ) with erythromycin resulted in approximately 2.5- fold increase in the auc and cmax , and about 2- fold prolongation in the half- life of felodipine .
effect(e1,e2)	14	23	furosemide : clinical studies , as well as random observations , have shown that ibuprofen can reduce the natriuretic effect of furosemide and thiazides in some patients .
None(e1,e2)	85	105	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	8	15	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	10	20	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	65	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	37	41	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	0	2	digoxin : enoxacin may raise serum digoxin levels in some individuals .
None(e1,e2)	11	13	methotrexate : in an interaction study of rheumatoid arthritis patients taking methotrexate , celebrex did not have a significant effect on the pharmacokinetics of methotrexate .
None(e1,e2)	8	11	in clinical studies where patients were on chronic theophylline therapy , lomefloxacin had no measurable effect on the mean distribution of theophylline concentrations or the mean estimates of theophylline clearance .
None(e1,e2)	2	33	effects of erythromycin on felbatol the coadministration of erythromycin ( 1000 mg/day ) for 10 days did not alter the pharmacokinetic parameters of cmax , cmin , auc , ci/kg or tmax at felbamate daily doses of 3000 or 3600 mg/day in 10 otherwise healthy subjects with epilepsy .
None(e1,e2)	0	5	acebutolol , atenolol , and nadolol ( low hepatic clearance or no first-pass metabolism ) are unlikely to be affected .
None(e1,e2)	31	38	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	2	24	because the tetracyclines have been shown to depress plasma prothrombin activity , patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage .
effect(e1,e2)	3	5	in patients taking diclofenac and lithium concomitantly , lithium toxicity may develop .
None(e1,e2)	33	35	because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis , it is particularly important that physicians query patients or their guardians carefully about benzodiazepine , alcohol and sedative use as part of the history prior to any procedure in which the use of romazicon is planned .
None(e1,e2)	14	16	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	61	63	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	5	indomethacin - concomitant use of l-glutamine and indomethacin may ameliorate increased intestinal permeability caused by indomethacin .
None(e1,e2)	20	22	the clinical significance of this reduction is not known , hence zalcitabine is not recommended to be ingested simultaneously with magnesium /aluminum-containing antacids .
None(e1,e2)	14	17	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet_inhibitors ( acetylsalicylic acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .
None(e1,e2)	30	34	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium_hydroxide s ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	0	28	alcohol - although lexapro did not potentiate the cognitive and motor effects of alcohol in a clinical trial , as with other psychotropic medications , the use of alcohol by patients taking lexapro is not recommended .
None(e1,e2)	15	25	since apraclonidine may reduce pulse and blood pressure , caution in using drugs such as beta-blockers ( ophthalmic and systemic ) , antihypertensives , and cardiac_glycosides is advised .
None(e1,e2)	1	59	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	9	19	interactions for vitamin d analogues ( vitamin d2 , vitamin_d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;
None(e1,e2)	115	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	13	warfarin , digoxin , salicylate , and heparin the in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine ( 99.5 % control vs 99.3 % ) when ketorolac plasma concentrations reach 5 to10 m g/ml .
None(e1,e2)	96	114	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	31	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	7	19	interaction of gabitril with other drugs : cimetidine : co-administration of cimetidine ( 800 mg/day ) to patients taking tiagabine chronically had no effect on tiagabine pharmacokinetics .
None(e1,e2)	13	26	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
effect(e1,e2)	6	50	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	27	32	the iv methylprednisolone dose should be reduced by approximately 25 % , and the oral methylprednisolone dose should be reduced by approximately 50 % when coadministered with aprepitant to achieve exposures of methylprednisolone similar to those obtained when it is given without aprepitant .
None(e1,e2)	15	29	in order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with taxol should be premedicated with corticosteroids ( such as dexamethasone ) , diphen-hydramine and h2_antagonists ( such as cimetidine or ranitidine ) .
None(e1,e2)	8	11	the potential effects of increased plasma concentrations of midazolam or other benzodiazepines metabolized via cyp3a4 ( alprazolam , triazolam ) should be considered when coadministering these agents with aprepitant .
None(e1,e2)	50	52	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	12	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	56	76	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	7	10	no clinically significant effect of famotidine , valproate , or lithium was seen on the pharmacokinetics of aripiprazole ( see clinical pharmacology : drug- drug interactions ) .
None(e1,e2)	2	5	antihistamines : astemizole * , terfenadine * contraindicated due to potential for serious and/or life-threatening cardiac arrhythmias .
None(e1,e2)	10	27	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	0	6	tacrolimus : co-administration of tacrolimus and bosentan has not been studied in man .
None(e1,e2)	33	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	7	29	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
effect(e1,e2)	4	28	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	24	28	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
mechanism(e1,e2)	2	13	cimetidine : cimetidine has been demonstrated to interfere with the elimination of other quinolones .
None(e1,e2)	19	25	estazolam : interaction with drugs that inhibit metabolism via cytochrome p450 3a ( cyp3a ) : the metabolism of estazolam to the major circulating metabolite 4-hydroxy-estazolam and the metabolism of other triazolobenzodiazepines is catalyzed by cyp3a .
None(e1,e2)	16	36	in separate studies of patients receiving maintenance doses of warfarin , hydrochlorothiazide , or digoxin , irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin ( prothrombin time ) or pharmacokinetics of digoxin .
None(e1,e2)	32	40	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	13	22	patients receiving other narcotic analgesics , antipsychotics , antianxiety agents , or other cns_depressants ( including alcohol ) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive cns depression .
None(e1,e2)	2	38	carbamazepine : carbamazepine causes an approximate 50 % increase in the clearance of felbatol at steady state and , therefore , the addition of carbamazepine results in an approximate 40 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	21	23	due to high inter-patient variability and limited sampling , the extent of the increase in sn38 levels in patients receiving concurrent irinotecan and avastin is uncertain .
None(e1,e2)	14	16	experience with nonsteroidal anti-inflammatory drugs ( nsaids ) suggests the potential for interactions with furosemide and ace_inhibitors .
None(e1,e2)	0	28	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	100	122	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
mechanism(e1,e2)	2	8	methotrexate : piperacillin_sodium may reduce the excretion of methotrexate .
None(e1,e2)	17	21	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine_oxidase_inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
None(e1,e2)	9	24	a possible interaction between glyburide and ciprofloxacin , a fluoroquinolone_antibiotic , has been reported , resulting in a potentiation of the hypoglycemic action of glyburide .
effect(e1,e2)	20	27	the ecg changes and/or hypokalemia that may result from the administration of non-potassium sparing diuretics ( such as loop or thiazide_diuretics ) can be acutely worsened by beta-agonists , especially when the recommended dose of the beta-agonist is exceeded .
None(e1,e2)	133	147	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	37	45	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline_salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
effect(e1,e2)	2	7	diuretic : hydrochlorothiazide , given concomitantly with ketoprofen , produces a reduction in urinary potassium and chloride excretion compared to hydrochlorothiazide alone .
None(e1,e2)	95	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	11	15	platelet inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
None(e1,e2)	10	12	similarly , patients receiving the drug and a hydantoin , sulfonamide or sulfonylurea should be observed for signs of toxicity to these drugs .
mechanism(e1,e2)	9	14	the mechanism for this interaction probably is adsorption of nitrofurantoin onto the surface of magnesium_trisilicate .
None(e1,e2)	8	28	in a single subject given one dose of ciprofloxacin 2 hours after a dose of didanosine-placebo tablets , a greater than 50 % reduction in the auc of ciprofloxacin was observed .
None(e1,e2)	0	12	probenecid : as with other b-lactam antibiotics , co-administration of probenecid with cefditoren_pivoxil resulted in an increase in the plasma exposure of cefditoren , with a 49 % increase in mean cmax , a 122 % increase in mean auc , and a 53 % increase in half-life .
None(e1,e2)	28	109	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	3	furosemide : when aliskiren was co-administered with furosemide , the auc and cmax of furosemide were reduced by about 30 % and 50 % , respectively .
None(e1,e2)	8	10	oral anticoagulant agents : pharmacokinetic drug-drug interactions between argatroban and warfarin ( 7.5 mg single oral dose ) have not been demonstrated .
None(e1,e2)	25	34	coadministration of valdecoxib ( 40 mg bid ( day 1 ) and 40 mg qd ( days 2-7 ) ) with glyburide ( 10 mg glyburide bid ) resulted in 21 % increase in glyburide auc0-12 and a 16 % increase in glyburide cmax leading to a 16 % decrease in glucose auc0-24 .
mechanism(e1,e2)	6	46	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	85	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	4	7	warfarin , digoxin , salicylate , and heparin the in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine ( 99.5 % control vs 99.3 % ) when ketorolac plasma concentrations reach 5 to10 m g/ml .
None(e1,e2)	34	57	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	3	10	inhibition of renal lithium clearance leading to increases in plasma lithium concentrations has also been reported .
None(e1,e2)	5	15	digoxin : concomitant administration of erythromycin and digoxin has been reported to result in elevated digoxin serum levels .
None(e1,e2)	33	37	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic_antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	10	12	increased toxicity ( cns depression ) : cns depressants , mao_inhibitors , tricyclic_antidepressants , phenothiazines .
int(e1,e2)	0	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	10	22	there is limited experience with concomitant antihypertensive agents such as alpha-blockers , calcium channel-blockers , ace inhibitors , and diuretics ( both thiazide -like and loop ) .
None(e1,e2)	41	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	26	naproxen : coadministration ( n=18 ) of naproxen sodium capsules ( 250 mg ) with neurontin ( 125 mg ) appears to increase the amount of gabapentin absorbed by 12 % to 15 % .
None(e1,e2)	2	12	- a nonsteroidal_anti-inflammatory_drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	6	8	fluconazole , and the 5-ht3 antiemetics ondansetron ( zofran ) and granisetron ( kytril ) have all been used with busulfex .
None(e1,e2)	7	12	the absorption of tetracycline , furosemide , penicillin_g , hydrochlorothiazide , and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride ;
None(e1,e2)	0	26	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin_b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
None(e1,e2)	45	77	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	0	6	colestipol -concomitant intake of colestipol and vitamin_k may reduce the absorption of vitamin k .
mechanism(e1,e2)	6	15	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
effect(e1,e2)	9	32	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	15	20	there have been case reports of increased steady-state levels of quinidine , procainamide , and phenytoin during concomitant therapy with amiodarone .
advise(e1,e2)	23	30	although it has not been established that there is an interaction between clozapine and benzodiazepines or other psychotropics , caution is advised when clozapine is initiated in patients taking a benzodiazepine or any other psychotropic drug .
None(e1,e2)	92	114	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	23	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	10	42	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	16	33	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	6	7	specific effects of felbatol on other antiepileptic_drugs phenytoin : felbatol causes an increase in steady-state phenytoin plasma concentrations .
effect(e1,e2)	2	18	beta-blockers , clonidine , lithium salts , and alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin .
None(e1,e2)	13	15	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood_thinner s ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	0	4	butyrophenones ( such as haloperidol ) and phenothiazines can suppress the dopaminergic renal and mesenteric vasodilation induced with low dose dopamine infusion .
None(e1,e2)	20	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	2	25	cns-active drugs ethanol an additive effect on psychomotor performance was seen with coadministration of eszopiclone and ethanol 0.70 g/kg for up to 4 hours after ethanol administration .
None(e1,e2)	12	20	in general , most patients treated with dirithromycin who are receiving concomitant theophylline therapy may not require empiric adjustment of theophylline dosage or monitoring of theophylline plasma concentrations .
None(e1,e2)	10	14	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	34	76	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	42	70	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide_antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	59	85	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	43	45	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium_salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
effect(e1,e2)	2	20	therefore , hormonal_contraceptives , including oral , injectable , transdermal , and implantable forms , may not be reliable when tracleer is co-administered .
effect(e1,e2)	4	10	- concomitant use of tricyclic_antidepressants may reduce the efficacy of lofexidine .
None(e1,e2)	5	33	the concomitant use of transdermal fentanyl with ritonavir or other potent 3a4 inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
None(e1,e2)	22	24	during clinical trials , iloprost was used concurrently with anticoagulants , diuretics , cardiac glycosides , calcium channel blockers , analgesics , antipyretics , nonsteroidal_antiinflammatories , corticosteroids , and other medications .
None(e1,e2)	8	23	hormonal contraceptives co-administration of trileptal with an oral contraceptive has been shown to influence the plasma concentrations of the two hormonal components , ethinylestradiol ( ee ) and levonorgestrel ( lng ) .
None(e1,e2)	2	9	coadministration of digoxin did not influence the pharmacokinetics of levetiracetam .
effect(e1,e2)	9	11	spontaneous reports of serotonin syndrome associated with co-administration of zyvox and serotonergic_agents , including antidepressants such as selective serotonin reuptake inhibitors ( ssris ) , have been reported .
None(e1,e2)	31	33	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin_d .
None(e1,e2)	16	28	in separate studies of patients receiving maintenance doses of warfarin , hydrochlorothiazide , or digoxin , irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin ( prothrombin time ) or pharmacokinetics of digoxin .
None(e1,e2)	66	136	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	47	63	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	6	probenecid : the oral combination of probenecid before intramuscular injection of pipracil produces an increase in piperacillin peak serum level of about 30 % .
None(e1,e2)	0	9	lithium : increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ace inhibitor therapy .
None(e1,e2)	3	19	patients receiving other narcotic_analgesic s , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic antidepressants or other cns_depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	16	22	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	20	28	antiretroviral agents : no drug interactions with other antiretroviral medications have been identified that would warrant alteration of either the enfuvirtide dose or the dose of the other antiretroviral_medication .
None(e1,e2)	13	42	a clinical study in healthy male volunteers ( n=24 ) demonstrated that mixing novolog with nph human insulin immediately before injection produced some attenuation in the peak concentration of novolog , but that the time to peak and the total bioavailability of novolog were not significantly affected .
None(e1,e2)	6	22	concomitant use of prophylactic low dose heparin did not appear to affect safety , however , its effects on the efficacy of xigris have not been evaluated in an adequate and well-controlled clinical trial .
None(e1,e2)	0	11	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	9	27	benzthiazide may interact with alcohol , blood thinners , decongestant_drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
advise(e1,e2)	32	48	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
None(e1,e2)	0	29	naproxen : the concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of naproxen , but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite .
None(e1,e2)	18	20	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic acid , and tolbutamide in vitro .
None(e1,e2)	37	41	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	30	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	1	5	anesthetics/sedatives/hypnotics/ opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
None(e1,e2)	1	19	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract
None(e1,e2)	4	29	experience with co-administration of hmg-coa_reductase_inhibitors and fentanyl in patients is limited , therefore , consideration should be given to temporarily suspending use of hmg-coa reductase inhibitors in patients receiving fentanyl .
None(e1,e2)	49	67	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
advise(e1,e2)	8	44	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	69	73	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	28	136	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	11	34	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	0	3	potassium-sparing_diuretics such as spironolactone , triamterene , or amiloride , or potassium supplements should be given only for documented hypokalemia , and then with caution , since they may lead to a significant increase of serum potassium .
None(e1,e2)	17	19	drug interaction studies have shown that esomeprazole does not have any clinically significant interactions with phenytoin , warfarin , quinidine , clarithromycin or amoxicillin .
None(e1,e2)	2	4	nitroglycerin : dynacirc ( isradipine ) has been safely coadministered with nitroglycerin .
None(e1,e2)	2	7	probenecid or cimetidine : concomitant administration of probenecid or cimetidine decreases the elimination of zalcitabine , most likely by inhibition of renal tubular secretion of zalcitabine .
effect(e1,e2)	13	48	platelet inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin_sodium .
None(e1,e2)	58	70	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	24	28	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	21	27	in addition , results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
effect(e1,e2)	0	12	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic_analgesic s , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
None(e1,e2)	3	7	concomitant administration of kerlone with the oral anticoagulant warfarin has been shown not to potentiate the anticoagulant effect of warfarin .
None(e1,e2)	1	15	and disulfiram when amitriptyline hcl is given with anticholinergic agents or sympathomimetic drugs , including epinephrine combined with local anesthetics , close supervision and careful adjustment of dosages are required .
None(e1,e2)	0	2	skeletal_muscle_relaxants : amphotericin_b -induced hypokalemia may enhance the curariform effect of skeletal muscle relaxants ( e.g. , tubocurarine ) .
None(e1,e2)	35	58	the results of a study of coadministration of ethambutol ( 50 mg/kg ) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20 % and 13 % , respectively , suggesting that the oral absorption of ethambutol may be reduced by these antacid_products .
mechanism(e1,e2)	4	13	the oral bioavailability of enoxacin is reduced by 60 % with coadministration of ranitidine .
None(e1,e2)	42	58	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	23	27	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	4	20	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	46	118	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	25	eprosartan ( up to 400 mg b.i.d . or 800 mg q.d . ) doses have been safely used concomitantly with a thiazide diuretic ( hydrochlorothiazide ) .
None(e1,e2)	2	4	long acting nitrates : nifedipine may be safely co-administered with nitrates , but there have been no controlled studies to evaluate the antianginal effectiveness of this combination .
None(e1,e2)	81	118	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	15	18	in general , these are drugs that have one or more pharmacologic activities similar to bepridil_hydrochloride , including anti-arrhythmic_agents such as quinidine and procainamide , cardiac glycosides and tricyclic anti-depressants .
None(e1,e2)	27	30	use lowest possible dose of atorvastatin with careful monitoring , or consider hmg-coa reductase inhibitors that are not primarily metabolized by cyp3a4 , such as pravastatin , fluvastatin , or rosuvastatin in combination with crixivan .
None(e1,e2)	62	121	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
mechanism(e1,e2)	28	64	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	6	8	clidinium may decrease the effect of phenothiazines , levodopa , and ketoconazole .
None(e1,e2)	2	7	astemizole , bepridil , sparfloxacin , and terodiline .
None(e1,e2)	10	41	because prostaglandins play an important role in hemostasis , and nsaids affect platelet function as well , concurrent therapy with all nsaids , including diclofenac , and warfarin requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required .
None(e1,e2)	0	9	aspirin : celebrex can be used with low dose aspirin .
effect(e1,e2)	0	14	fenfluramine may increase slightly the effect of antihypertensive drugs , e.g. , guanethidine , methyldopa , reserpine .
None(e1,e2)	4	15	cyclosporine : administration of nonsteroial_anti-inflammatory_drugs concomitantly with cyclosporine has been associated with an increase in cyclosporine -induced toxicity , possibly due to decreased synthesis of renal prostacyclin .
None(e1,e2)	17	23	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	0	16	dolasetron_mesylate did not inhibit the antitumor activity of four chemotherapeutic agents ( cisplatin , 5-fluorouracil , doxorubicin , cyclophosphamide ) in four murine models .
None(e1,e2)	3	31	in patients taking furosemide , nifedipine , diltiazem , ace inhibitors , verapamil , glyburide , propranolol , and various chemotherapy agents , no effect was shown on the clearance of hydrodolasetron .
None(e1,e2)	19	21	in vitro data in human plasma indicate that doxazosin mesylate has no effect on protein binding of digoxin , warfarin , phenytoin or indomethacin .
mechanism(e1,e2)	8	14	this increase is due to the inhibition of celecoxib metabolism via p450 2c9 by fluconazole ( see clinical pharmacology - pharmacokinetics : metabolism ) .
None(e1,e2)	11	25	the following agents may increase certain actions or side effects of anticholinergic_drugs . amantadine antiarrhythmic agents of class ( e.g . quinidine ) , antihistamines antipsychotic_agents ( e.g . phenothiazines ) , benzodiazepines .
None(e1,e2)	16	18	other drug interactions : no pharmacokinetic interactions were observed between vardenafil and the following drugs : glyburide , warfarin , digoxin , maalox , and ranitidine .
None(e1,e2)	68	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	45	50	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic_acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
effect(e1,e2)	20	39	the concurrent use of two or more drugs with anticholinergic activity -- such as an antipsychotic drug ( eg , chlorpromazine ) , an antiparkinsonian drug ( eg , trihexyphenidyl ) , and/or a tricyclic antidepressant ( eg , amitriptyline ) -- commonly results in excessive anticholinergic effects , including dry mouth and associated dental complications , blurred vision , and , in patients exposed to high temperature and humidity , hyperpyrexia .
None(e1,e2)	35	46	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	13	compounds tested in man include warfarin , theophylline , phenytoin , diazepam , aminopyrine and antipyrine .
None(e1,e2)	0	9	lithium : diclofenac decreases lithium renal clearance and increases lithium plasma levels .
None(e1,e2)	0	27	steroids enhance the renal toxicity of edetate calcium disodium in animals . 7 edetate calcium disodium interferes with the action of zinc insulin preparations by chelating the zinc . 7
effect(e1,e2)	22	40	a rare , but serious , constellation of symptoms , termed serotonin syndrome , has been reported with the concomitant use of selective_serotonin_reuptake_inhibitors ( ssris ) and agents for migraine therapy , such as imitrex ( sumatriptan succinate ) and dihydroergotamine .
None(e1,e2)	9	15	in patients in whom cyp3a4 inducers ( eg , dexamethasone , phenytoin , carbamazepine , rifampicin , phenobarbital ) are indicated , alternative agents with less enzyme induction potential should be used .
None(e1,e2)	62	113	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	10	17	coadministration of alosetron and strong cyp3a4 inhibitors , such as clarithromycin , telithromycin , protease inhibitors , voriconazole , and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
None(e1,e2)	26	33	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	59	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	18	35	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	0	45	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	0	14	amiodarone or verapamil : the risk of myopathy/rhabdomyolysis is increased when either amiodarone or verapamil is used concomitantly with a closely related member of the hmg-coa reductase inhibitor class ( see warnings , myopathy/rhabdomyolysis ) .
None(e1,e2)	21	29	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace_inhibitors , disopyramide , fibrates , fluoxetine , mao_inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	38	63	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	27	44	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic_antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type_1c_antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
effect(e1,e2)	3	6	the effect of corticosteroids on oral anticoagulants is variable .
None(e1,e2)	11	23	codeine in combination with other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , or other cns depressants ( including alcohol ) has additive depressant effects .
advise(e1,e2)	9	13	special consideration should be given to the administration of ethyol in patients receiving antihypertensive_medications or other drugs that could cause or potentiate hypotension .
mechanism(e1,e2)	16	38	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	49	51	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
None(e1,e2)	8	15	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	58	62	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	11	13	co-medications that induce cyp3a4 ( e.g. , dexamethasone , phenytoin , carbamazepine , rifampin , phenobarbital or st .
None(e1,e2)	4	10	no significant interactions with digoxin , hydrochlorothiazide , hydralazine , sulfinpyrazone , oral contraceptives , tolbutamide , or warfarin have been observed .
None(e1,e2)	18	33	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	63	80	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	7	9	cardiovascular agents ( e.g. , atenolol , hydrochlorothiazide , propranolol ) .
None(e1,e2)	24	28	benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
None(e1,e2)	12	16	antifungals : in vitro and/or in vivo data indicate that fluconazole , itraconazole , and oral ketoconazole markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	23	25	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	13	37	tell your doctor if you are taking any of the following drugs : blood_thinner s ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	6	13	patients receiving other narcotic analgesics , antipsychotics , antianxiety agents , or other cns_depressants ( including alcohol ) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive cns depression .
None(e1,e2)	1	28	when bezalip or bezalip retard is used at the same time as other medicines or substances the following interactions must be taken into account : - bezalip and bezalip_retard may enhance the action of anticoagulants of the coumarin type .
None(e1,e2)	5	8	in patients taking diclofenac and lithium concomitantly , lithium toxicity may develop .
None(e1,e2)	22	31	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	1	21	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	2	13	interactions with mixed_agonist/antagonist_opioid_analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
effect(e1,e2)	8	13	prolonged recovery time may occur if barbiturates and/or narcotics are used concurrently with ketamine .
None(e1,e2)	69	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	23	27	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	15	23	the concomitant use of transdermal fentanyl with ritonavir or other potent 3a4 inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
None(e1,e2)	3	47	oral contraceptives : aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl estradiol and 1 mg of norethindrone , decreased the auc of ethinyl estradiol by 43 % , and decreased the auc of norethindrone by 8 % ;
effect(e1,e2)	5	10	in vitro mixing of an aminoglycoside with beta-lactamtype antibiotics ( penicillins or cephalosporins ) may result in a significant mutual inactivation .
None(e1,e2)	24	60	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	29	31	however , a crossover study in healthy subjects receiving either tagamet 300 mg q.i.d . or 800 mg h.s . concomitantly with a 300 mg b.i.d . dosage of theophylline ( theo-dur , key pharmaceuticals , inc. ) demonstrated less alteration in steady-state theophylline peak serum levels with the 800 mg h.s . regimen , particularly in subjects aged 54 years and older .
None(e1,e2)	78	96	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	69	94	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	1	23	oral contraceptives multiple doses of cefditoren pivoxil had no effect on the pharmacokinetics of ethinyl estradiol , the estrogenic component in most oral contraceptives .
None(e1,e2)	33	49	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	9	methotrexate : piperacillin sodium may reduce the excretion of methotrexate .
None(e1,e2)	23	31	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	0	23	glibenclamide : in a study of 7 healthy male volunteers , acitretin treatment potentiated the blood glucose lowering effect of glibenclamide ( a sulfonylurea similar to chlorpropamide ) in 3 of the 7 subjects .
None(e1,e2)	15	19	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen .in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
advise(e1,e2)	5	16	nevertheless , the effects of mefloquine on travelers receiving comedication , particularly diabetics or patients using anticoagulants , should be checked before departure .
None(e1,e2)	95	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	56	66	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	33	35	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	14	41	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure_agonist_opioid_analgesic such as levo-dromoran .
effect(e1,e2)	3	14	noncardioselective beta-blockers ( nadolol , porpranolol , timolol ) may exacerbate rebound hypertension when guanfacine is withdrawn .
None(e1,e2)	12	20	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	0	9	selective_serotonin_reuptake_inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
None(e1,e2)	1	5	when ertapenem is co-administered with probenecid ( 500 mg p.o . every 6 hours ) , probenecid competes for active tubular secretion and reduces the renal clearance of ertapenem .
mechanism(e1,e2)	2	8	phenytoin , nicotine , and rifampin may decrease clozapine plasma levels , resulting in a decrease in effectiveness of a previously effective clozapine dose .
None(e1,e2)	8	10	thrombolytic agents : the safety and effectiveness of argatroban with thrombolytic_agents have not been established .
None(e1,e2)	40	58	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	34	80	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin_sodium under-dosage .
None(e1,e2)	21	85	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	2	4	coadministration of astemizole with ketoconazole tablets is therefore contraindicated .
advise(e1,e2)	1	6	since barbiturates are potentiated by the anticholinesterases , they should be used cautiously in the treatment of convulsions .
None(e1,e2)	12	22	lithium : in a study conducted in healthy subjects , mean steady-state lithium plasma levels increased approximately 17 % in subjects receiving lithium 450 mg bid with celebrex 200 mg bid as compared to subjects receiving lithium alone .
effect(e1,e2)	9	16	additionally , anti-malarial drugs , such as chloroquine and mefloquine , may antagonize the activity of carbamazepine .
mechanism(e1,e2)	1	14	steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine_a .
None(e1,e2)	4	37	the similarity of the tysabri -associated adverse event profile between study 1 ( without co-administered avonex ) and study 2 ( with co-administered avonex ) indicates that this alteration in clearance does not necessitate reduction of the tysabri dose to maintain safety , general ) .
None(e1,e2)	7	35	inhibitors of this isoenzyme ( e.g. , macrolide_antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	0	2	amiodarone : amiodarone therapy alone can cause hypothyroidism or hyperthyroidism .
None(e1,e2)	61	65	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	26	cimetidine : in a study in healthy volunteers , a one-week course of cimetidine at 400 mg b.i.d . with a single 5 mg dose of isradipine on the sixth day showed an increase in isradipine mean peak plasma concentrations ( 36 % ) and significant increase in area under the curve ( 50 % ) .
None(e1,e2)	9	16	these would include a variety of preparations which contain androgens , estrogens , progestins , or glucocorticoids .
None(e1,e2)	16	20	antihistamines may have additive effects with alcohol and other cns depressants , e.g. , hypnotics , sedatives , tranquilizers , antianxiety_agents .
advise(e1,e2)	0	22	brovana , as with other beta2-agonists , should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors , tricyclic_antidepressants , or drugs known to prolong the qtc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents .
None(e1,e2)	23	28	both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when alfenta is administered in combination with other cns_depressants such as barbiturates , tranquilizers , opioids , or inhalation general anesthetics .
None(e1,e2)	26	52	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	48	69	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	15	29	although no clinical studies have been conducted , it is likely that the metabolism of levobupivacaine may be affected by the known cyp3a4 inducers ( such as phenytoin , phenobarbital , rifampin ) , cyp3a4 inhibitors ( azole antimycotics e.g. , ketoconazole ;
None(e1,e2)	24	46	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	4	42	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	10	26	carbamazepine : isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels carbamazepine levels should be determined prior to concurrent administration with isoniazid , signs and symptoms of carbamazepine toxicity should be monitored closely , and appropriate dosage adjustment of the anticonvulsant should be made .
None(e1,e2)	6	23	drug interaction studies have shown that esomeprazole does not have any clinically significant interactions with phenytoin , warfarin , quinidine , clarithromycin or amoxicillin .
None(e1,e2)	27	34	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot_alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	9	26	in vitro studies have shown no binding displacement between entacapone and other highly bound drugs , such as warfarin , salicylic acid , phenylbutazone , and diazepam .
effect(e1,e2)	6	76	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	22	26	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	3	23	patients on oral antidiabetic_agents receiving velcade treatment may require close monitoring of their blood glucose levels and adjustment of the dose of their antidiabetic_medication .
None(e1,e2)	26	54	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	17	63	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic_acid .
mechanism(e1,e2)	0	7	aminoglutethimide : may increase cyp metabolism of progestins leading to possible decrease in contraceptive effectiveness .
mechanism(e1,e2)	2	11	triazolam : erythromycin has been reported to decrease the clearance of triazolam and , thus , may increase the pharmacologic effect of triazolam .
None(e1,e2)	7	9	drugs decreasing heparin effect : digitalis , tetracyclines , nicotine , or antihistamines may partially counteract the anticoagulant action of heparin sodium .
None(e1,e2)	8	10	studies showed that diltiazem increased the auc of midazolam and triazolam by 3-4 fold and the cmax by 2-fold , compared to placebo .
None(e1,e2)	16	21	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	7	13	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	7	28	guardians of children who have been prescribed foradil should be alerted to the general concern regarding asthma therapy compliance , especially neglect of anti-inflammatory therapy and overuse of short-acting_beta2-agonists .
None(e1,e2)	0	3	antidiabetics : because corticosteroids may increase blood glucose concentrations , dosage adjustments of antidiabetic agents may be required .
None(e1,e2)	10	70	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	9	11	may interact anticoagulants ( altered hypo-prothrombinemic effect ) , barbiturates , rifampin and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of diethylstilbestrol ) , corticosteroids ( increased effect of corticosteroids ) .
effect(e1,e2)	4	6	the extent to which ssri - tca interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the ssri involved .
None(e1,e2)	11	13	- the action of sulphonylureas and insulin may be enhanced by bezalip or bezalip_retard .
None(e1,e2)	21	29	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	85	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
None(e1,e2)	85	112	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	13	33	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	41	43	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	14	haloperidol : haloperidol blocks dopamine receptors , thus inhibiting the central stimulant effects of amphetamines .
None(e1,e2)	55	112	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	4	9	however , co-administration of duloxetine with aluminum- and magnesium-containing antacids ( 51 meq ) or duloxetine with famotidine , had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose .
None(e1,e2)	14	19	in patients with chronic hepatitis c treated with pegasys in combination with copegus , pegasys treatment did not affect ribavirin distribution or clearance .
None(e1,e2)	3	17	like isoflurane , desflurane does not predispose to premature ventricular arrhythmias in the presence of exogenously infused epinephrine in swine .
None(e1,e2)	19	60	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin_b12 and folic acid .
None(e1,e2)	2	21	administration of diltiazem_hydrochloride concomitantly with propranolol in five normal volunteers resulted in increased propranolol levels in all subjects and bioavailability of propranolol was increased approximately 50 % .
effect(e1,e2)	0	4	propranolol : may decrease aspirins anti-inflammatory action by competing for the same receptors .
None(e1,e2)	10	15	in vitro studies demonstrated that the plasma protein binding of des-ciclesonide was not affected by warfarin or salicylic acid , indicating no potential for protein binding-based drug interactions .
None(e1,e2)	25	42	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	31	35	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	3	36	oral contraceptives : aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl estradiol and 1 mg of norethindrone , decreased the auc of ethinyl_estradiol by 43 % , and decreased the auc of norethindrone by 8 % ;
None(e1,e2)	4	11	the optimal dose of indinavir , when given in combination with efavirenz , is not known .
effect(e1,e2)	3	15	concomitant administration of mefloquine and other related compounds ( eg , quinine , quinidine and chloroquine ) may produce electrocardiographic abnormalities and increase the risk of convulsions .
None(e1,e2)	17	30	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	0	4	carbamazepine , clonazepam , ethosuximide
None(e1,e2)	66	80	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin_sodium under-dosage .
effect(e1,e2)	14	53	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	22	29	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	8	13	it is recommended to avoid concurrent administration of ethambutol with aluminum hydroxide containing antacids for at least 4 hours following ethambutol administration .
effect(e1,e2)	2	5	patients taking acamprosate concomitantly with antidepressants more commonly reported both weight gain and weight loss , compared with patients taking either medication alone .
mechanism(e1,e2)	5	17	protein binding in vitro , diclofenac interferes minimally or not at all with the protein binding of salicylic_acid ( 20 % decrease in binding ) , tolbutamide , prednisolone ( 10 % decrease in binding ) , or warfarin .
None(e1,e2)	3	7	ergot derivatives : dihydroergotamine , ergonovine , ergotamine , methylergonovine
None(e1,e2)	6	8	co-administration with antifungal agents such as ketoconazole or itraconazole is not recommended .
None(e1,e2)	25	39	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	16	18	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
effect(e1,e2)	6	14	acetaminophen : a report of severe acetaminophen toxicity was reported in a patient receiving isoniazid .
None(e1,e2)	3	7	therapeutic concentrations of digoxin , warfarin , ibuprofen , naproxen , piroxicam , acetaminophen , phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding .
None(e1,e2)	22	38	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate_hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine_oxidase_inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	2	26	antibiotics ( ampicillin , tetracycline ) : pregnancy has been reported following concomitant use , however , pharmacokinetic studies have not shown consistent effects with these antibiotics on plasma concentrations of synthetic steroids .
None(e1,e2)	0	6	b-adrenergic_blocking_agents : actions of some of beta-blocking_agents may be impaired when hypothyroid patients become euthyroid .
effect(e1,e2)	12	23	the possibility of hypotensive effects can be minimized by either discontinuing the diuretic or increasing salt intake prior to initiation of treatment with fosinopril_sodium .
None(e1,e2)	85	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	15	35	venlafaxine : coadministration of a single dose of zaleplon 10 mg and multiple doses of venlafaxine er ( extended release ) 150 mg did not result in any significant changes in the pharmacokinetics of either zaleplon or venlafaxine .
None(e1,e2)	12	16	aspirin/acetaminophen : pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between argatroban and concomitantly administered aspirin ( 162.5 mg orally given 26 and 2 hours prior to initiation of argatroban 1 g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of argatroban 1.5 g/kg/min . over 18 hours ) .
effect(e1,e2)	12	33	although the magnitude of changes in diazepam plasma exposure when coadministered with valdecoxib were not sufficient to warrant dosage adjustments , patients may experience enhanced sedative side effects caused by increased exposure of diazepam under this circumstance .
None(e1,e2)	72	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	16	28	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	11	21	notably , systemic exposure ( auc0-12 ) of dapsone hydroxylamine ( dha ) was more than doubled in the presence of tmp /smx .
None(e1,e2)	12	21	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta_blockers .
None(e1,e2)	9	11	fifteen to 30 minutes of exposure to 1.25 mac isoflurane or enflurane had minimal effects on the duration of action of initial doses of nimbex and therefore , no adjustment to the initial dose should be necessary when nimbex is administered shortly after initiation of volatile agents .
None(e1,e2)	9	11	limited data in patients receiving known enzyme inducers ( phenytoin , phenobarbital , carbamazepine ) indicate only a 30 % increase in the rate of flecainide elimination .
None(e1,e2)	24	26	however , due to possible pharmacodynamic interactions , when co-administered with precedex , a reduction in dosage of precedex on the concomitant anesthetic , sedative , hypnotic or opioid may be required .
None(e1,e2)	61	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	19	38	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	14	coumarin_anticoagulant s : in a small clinical trial in which lovastatin was administered to warfarin treated patients , no effect on prothrombin time was detected .
None(e1,e2)	15	30	although increased plasma concentrations ( c max and auc 0-24 hrs ) of desloratadine and 3-hydroxydesloratadine were observed , there were no clinically relevant changes in the safety profile of desloratadine , as assessed by electrocardiographic parameters ( including the corrected qt interval ) , clinical laboratory tests , vital signs , and adverse events .
None(e1,e2)	12	20	drug-drug interactions : no clinically significant drug interactions have been found with theophylline at a low dose , azithromycin , pseudoephedrine , ketoconazole , or erythromycin .
None(e1,e2)	111	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	15	18	inhibitors of cyp3a4 ( eg , ketoconazole ) or cyp2d6 ( eg , quinidine , fluoxetine , or paroxetine ) can inhibit aripiprazole elimination and cause increased blood levels .
None(e1,e2)	68	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	42	44	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
advise(e1,e2)	0	7	azlocillin should not be administered concomitantly with amikacin , ciprofloxacin , gentamicin , netilmicin , or tobramycin .
None(e1,e2)	36	56	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	7	46	midazolam : aprepitant increased the auc of midazolam , a sensitive cyp3a4 substrate , by 2.3-fold on day 1 and 3.3-fold on day 5 , when a single oral dose of midazolam 2 mg was coadministered on day 1 and day 5 of a regimen of aprepitant 125 mg on day 1 and 80 mg/day on days 2 through 5 .
None(e1,e2)	50	54	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic_acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	13	82	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	51	66	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	21	28	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium_channel-blocking_drugs , and isoniazid .
None(e1,e2)	24	80	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	19	77	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	11	39	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium_channel_blockers , beta blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop_diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
effect(e1,e2)	0	15	nabilone has been shown to have an additive cns depressant effect when given with either diazepam , secobarbitone sodium , alcohol or codeine .
None(e1,e2)	49	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	24	alpha-blockers : when vardenafil 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of terazosin , significant hypotension developed in a substantial number of subjects .
None(e1,e2)	18	20	therefore , co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	15	28	probenecid : as with other b-lactam antibiotics , renal excretion of loracarbef is inhibited by probenecid and resulted in an approximate 80 % increase in the auc for loracarbef .
None(e1,e2)	48	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	71	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	23	34	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	9	30	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	5	21	since the therapeutic range of theophylline is narrow theophylline serum levels should be monitored closely , and appropriate dosage adjustments of theophylline should be made .
None(e1,e2)	44	98	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	3	47	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic_antidepressants
None(e1,e2)	7	16	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	64	81	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	35	43	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin b , cyclosporine , non-steroidal anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
None(e1,e2)	16	20	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	33	40	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	21	29	h2 blockers/proton pump inhibitors : long-term suppression of gastric acid secretion by h2 blockers or proton pump inhibitors ( eg , famotidine and omeprazole ) is likely to reduce dasatinib exposure .
None(e1,e2)	69	95	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	37	49	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide_antibiotics .
None(e1,e2)	49	75	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	8	18	in vitro data in human plasma indicate that doxazosin_mesylate has no effect on protein binding of digoxin , warfarin , phenytoin or indomethacin .
None(e1,e2)	71	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	4	6	concurrent administration of a tnf_antagonist with orencia has been associated with an increased risk of serious infections and no significant additional efficacy over use of the tnf antagonists alone .
None(e1,e2)	6	24	cytochrome p-450 inducers , such as phenytoin , carbamazepine and phenobarbital , induce clonazepam metabolism , causing an approximately 30 % decrease in plasma clonazepam levels .
None(e1,e2)	43	57	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	21	25	in a study in 36 patients with mild to moderate hypertension where the antihypertensive effects of prinivil alone were compared to prinivil given concomitantly with indomethacin , the use of indomethacin was associated with a reduced antihypertensive effect , although the difference between the two regimens was not significant .
None(e1,e2)	28	43	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	25	28	may interact anticoagulants ( altered hypo-prothrombinemic effect ) , barbiturates , rifampin and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of diethylstilbestrol ) , corticosteroids ( increased effect of corticosteroids ) .
None(e1,e2)	15	19	- a sulfa-based drug such as sulfamethoxazole-trimethoprim ( bactrim , septra ) , sulfisoxazole ( gantrisin ) , or sulfasalazine ( azulfidine ) ;
None(e1,e2)	25	43	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety_agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic_antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	32	41	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
advise(e1,e2)	1	9	- lithium : generally should not be given with diuretics .
None(e1,e2)	32	34	drugs that may alter imatinib plasma concentrations drugs that may increase imatinib plasma concentrations : caution is recommended when administering gleevec with inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , erythromycin , clarithromycin ) .
None(e1,e2)	0	9	anticoagulants ( oral ) : in patients receiving oral anticoagulants , the coagulation times were increased in some cases .
effect(e1,e2)	9	42	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	0	40	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	15	22	- anabolic steroids ( nandrolone [ e.g. , anabolin ] , oxandrolone [ e.g. , anavar ] , oxymetholone [ e.g. , anadrol ] , stanozolol [ e.g. , winstrol ] ) or
None(e1,e2)	29	60	agents with increased levels in the presence of carbamazepine : equetrotm increases the plasma levels of the following agents : clomipramine hcl , phenytoin ( 6 ) , and primidone thus , if a patient has been titrated to a stable dosage on one of the agents in this category , and then begins a course of the treatment with equetrotm , it is reasonable to expect that a dose decrease for the concomitant agent may be necessary .
None(e1,e2)	29	83	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	6	19	in patients receiving concurrent therapy with clonidine , if therapy is to be discontinued , it is suggested that zebeta be discontinued for several days before the withdrawal of clonidine .
None(e1,e2)	10	31	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	11	13	anticholinergics : concurrent administration of certain anticholinergic compounds , such as belladonna_alkaloids and dicyclomine , would be expected to compromise the beneficial effects of cisapride .
None(e1,e2)	9	29	in vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the pk properties of anagrelide , nor does anagrelide affect the pk properties of digoxin or warfarin .
effect(e1,e2)	0	8	epinephrine may antagonize the neuron blockade produced by guanethidine resulting in decreased antihypertensive effect and requiring increased dosage of the latter .
effect(e1,e2)	6	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	5	10	it is desirable to monitor tca plasma levels whenever a tca is going to be coadministered with another drug known to be an inhibitor of p450 2d6 .
None(e1,e2)	35	37	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin_analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	71	119	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral_hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	10	21	because prostaglandins play an important role in hemostasis , and nsaids affect platelet function as well , concurrent therapy with all nsaids , including diclofenac , and warfarin requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required .
None(e1,e2)	23	30	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
None(e1,e2)	44	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	25	35	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	0	41	5ht3_antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	1	46	because eprosartan is not metabolized by the cytochrome p450 system , inhibitors of cyp450 enzyme would not be expected to affect its metabolism , and ketoconazole and fluconazole , potent inhibitors of cyp3a and 2c9 , respectively , have been shown to have no effect on eprosartan pharmacokinetics .
None(e1,e2)	77	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	10	24	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	20	41	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	2	4	astemizole , bepridil , sparfloxacin , and terodiline .
None(e1,e2)	12	14	other : there appears to be no pharmacokinetic interaction between acitretin and cimetidine , digoxin , or glyburide .
None(e1,e2)	14	20	no significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide , digoxin , warfarin , cimetidine and phenobarbital .
mechanism(e1,e2)	11	58	binding to serum proteins : the following agents may either inhibit levothyroxine_sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	8	29	probenecid : as with other b-lactam antibiotics , probenecid inhibits the renal excretion of cefdinir , resulting in an approximate doubling in a.c. a 54 % increase in peak cefdinir plasma levels , and a 50 % prolongation in the apparent elimination half-life .
None(e1,e2)	0	13	antidiabetic_drugs : ( oral agents and insulin ) - dosage adjustment of the antidiabetic_drug may be required .
None(e1,e2)	0	24	nsaids : in in vitro studies , m1 was shown to cause increases ranging from 13 - 50 % in the free fraction of diclofenac and ibuprofen at concentrations in the clinical range .
None(e1,e2)	45	59	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	46	66	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	2	monoamine_oxidase_inhibitors ( maois )
None(e1,e2)	0	12	diuretics : studies in normal volunteers have shown that flurbiprofen like other nonsteroidal_anti-inflammatory_drugs , can interfere with the effects of furosemide .
None(e1,e2)	46	62	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	17	prednisone /prednisolone : rofecoxib did not have any clinically important effect on the pharmacokinetics of prednisolone or prednisone .
None(e1,e2)	1	7	anesthetics/sedatives/hypnotics/ opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
None(e1,e2)	8	11	no data are available for the coadministration of invirase /ritonavir or fortovase /ritonavir and garlic capsules .
None(e1,e2)	0	11	antacids : concomitant administration of antacids containing magnesium or aluminum with videx chewable/dispersible buffered tablets or pediatric powder for oral solution may potentiate adverse events associated with the antacid components .
None(e1,e2)	69	104	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	10	30	while it is not known whether this interaction occurs with fibrates other than gemfibrozil , myopathy and rhabdomyolysis have occasionally been associated with the use of fibrates alone , including clofibrate .
None(e1,e2)	4	35	since the pharmacokinetics of busulfex were studied in patients treated with phenytoin , the clearance of busulfex at the recommended dose may be lower and exposure ( auc ) higher in patients not treated with phenytoin .
None(e1,e2)	110	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	16	warfarin : in subjects receiving warfarin , no significant change in clotting time was observed when grepafloxacin was coadministered .
None(e1,e2)	24	35	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic_antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	59	73	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa_reductase_inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone_anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	54	66	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	11	62	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	83	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	5	9	probenecid : as with other b-lactam_antibiotics , co-administration of probenecid with cefditoren pivoxil resulted in an increase in the plasma exposure of cefditoren , with a 49 % increase in mean cmax , a 122 % increase in mean auc , and a 53 % increase in half-life .
None(e1,e2)	13	21	no dose adjustment is necessary when simulect is added to triple-immunosuppression regimens including cyclosporine , corticosteroids , and either azathioprine or mycophenolate_mofetil .
None(e1,e2)	0	6	ketoconazole - combined administration of racemic citalopram ( 40 mg ) and ketoconazole ( 200 mg ) decreased the cmax and auc of ketoconazole by 21 % and 10 % , respectively , and did not significantly affect the pharmacokinetics of citalopram .
None(e1,e2)	112	116	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	39	45	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal_anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	93	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	32	35	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic_antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	4	33	warfarin , digoxin , salicylate , and heparin the in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine ( 99.5 % control vs 99.3 % ) when ketorolac plasma concentrations reach 5 to10 m g/ml .
None(e1,e2)	11	22	spontaneous reports of serotonin syndrome associated with co-administration of zyvox and serotonergic_agents , including antidepressants such as selective serotonin reuptake inhibitors ( ssris ) , have been reported .
effect(e1,e2)	14	21	furosemide : clinical studies , as well as random observations , have shown that ibuprofen can reduce the natriuretic effect of furosemide and thiazides in some patients .
None(e1,e2)	4	16	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	11	19	it is recommended that buspirone hydrochloride not be used concomitantly with mao_inhibitors because the effects of concomitant administration of buspirone_hcl with most other psychotropic drugs have not been studied , the concomitant use of buspirone hcl with other cns-active drugs should be approached with caution .
None(e1,e2)	26	94	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	41	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	6	14	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	23	25	in addition to bleeding associated with heparin and vitamin k antagonists , drugs that alter platelet function ( such as acetylsalicylic acid , dipyridamole and abciximab ) may increase the risk of bleeding if administered prior to , during , or after activase therapy .
mechanism(e1,e2)	3	9	concomitant administration of sonata ( 10 mg ) and cimetidine ( 800 mg ) produced an 85 % increase in the mean cmax and auc of zaleplon .
None(e1,e2)	0	32	lithium - coadministration of racemic citalopram ( 40 mg/day for 10 days ) and lithium ( 30 mmol/day for 5 days ) had no significant effect on the pharmacokinetics of citalopram or lithium .
None(e1,e2)	55	65	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	24	32	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	10	32	paroxetine ( 20 mg qd ) increased the concentration of duloxetine ( 40 mg qd ) by about 60 % , and greater degrees of inhibition are expected with higher doses of paroxetine .
None(e1,e2)	21	32	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic_agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	22	26	however , due to possible pharmacodynamic interactions , when co-administered with precedex , a reduction in dosage of precedex on the concomitant anesthetic , sedative , hypnotic or opioid may be required .
None(e1,e2)	11	14	care should be taken when using immunoanalytical methods to measure plasma phenytoin concentrations following cerebyx administration .
effect(e1,e2)	4	8	the concomitant use of beta-adrenergic_blocking_agents with digitalis and calcium_antagonist s may have additive effects on prolonging atrioventricular conduction time .
None(e1,e2)	5	7	cholestyramine and charcoal administration of cholestyramine or activated_charcoal in patients ( n=13 ) and volunteers ( n=96 ) resulted in a rapid and significant decrease in plasma m1 ( the active metabolite of leflunomide ) concentration .
None(e1,e2)	45	65	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	3	5	example inducers include aminoglutethimide , carbamazepine , nafcillin , nevirapine , phenobarbital , phenytoin , and rifamycins .
None(e1,e2)	31	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	44	52	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	26	62	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary_vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	3	13	while all the selective_serotonin_reuptake_inhibitors ( ssris ) , e. g. , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
mechanism(e1,e2)	0	17	aprepitant increased the auc of midazolam by 25 % on day 4 and decreased the auc of midazolam by 19 % on day 8 relative to the dosing of aprepitant on days 1 through 3 .
None(e1,e2)	4	22	the extent to which ssri -tcainteractions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the ssri involved .
None(e1,e2)	28	80	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	10	23	other drugs which may enhance the neuromuscular blocking action of nondepolarizing_agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	7	15	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist_analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
None(e1,e2)	10	27	because prostaglandins play an important role in hemostasis , and nsaids affect platelet function as well , concurrent therapy with all nsaids , including diclofenac , and warfarin requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required .
None(e1,e2)	53	75	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	33	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	28	30	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	0	2	anesthetics / sedatives /hypnotics/opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
effect(e1,e2)	14	44	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	0	20	central_nervous_system_depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	19	31	although there was no clinical evidence in the vehicle-controlled studies of drug interactions with systemic antiretroviral agents , including protease_inhibitors , macrolide antibiotics , and azole antifungals , the effect of panretin gel on the steady-state concentrations of these drugs is not known .
None(e1,e2)	38	42	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	25	62	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis_kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	22	43	if a patient requires tikosyn and anti-ulcer therapy , it is suggested that omeprazole , ranitidine , or antacids ( aluminum and magnesium_hydroxide s ) be used as alternatives to cimetidine , as these agents have no effect on the pharmacokinetic profile of tikosyn .
None(e1,e2)	13	18	the principal drugs given ( number of patients in parentheses ) were : cardiac_glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	21	50	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	20	51	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	83	97	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing_compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	5	14	it is recommended that plasma lithium levels be monitored when ketoprofen is coadministered with lithium .
None(e1,e2)	6	8	antiarrhythmics : amiodarone , bepridil , flecainide , propafenone , quinidine contraindicated due to potential for serious and/or life-threatening reactions .
None(e1,e2)	0	1	ethinyl_estradiol norethindrone
None(e1,e2)	19	48	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	1	32	when cancidas is co-administered with inducers of drug clearance , such as efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine , use of a daily dose of 70 mg of cancidas should be considered
None(e1,e2)	14	32	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
advise(e1,e2)	4	12	therefore , patients under methotrexate therapy should be carefully monitored when concomitant ciprofloxacin therapy is indicated .
None(e1,e2)	11	28	in patients who have been reported to be well controlled on tricyclic_antidepressants receiving concurrent cimetidine therapy , discontinuation of cimetidine has been reported to decrease established steady-state serum tricyclic_antidepressant levels and compromise their therapeutic effects .
None(e1,e2)	32	46	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic_blocking_agents , calcium channel blockers , antihistamines or h1-blocking agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
None(e1,e2)	11	14	binding to plasma protein is not significantly altered by diazepam , diphenylhydantoin , or phenylbutazone .
None(e1,e2)	69	71	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	14	other strong inhibitors of cyp3a4 ( e.g. , itraconazole , clarithromycin , nefazodone , troleandomycin , ritonavir , nelfinavir ) would be expected to behave similarly .
None(e1,e2)	0	19	curariform_muscle_relaxants ( eg , tubocurarine ) and other drugs , including ether , succinylcholine , gallamine , decamethonium and sodium_citrate , potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with coly-mycin m parenteral .
None(e1,e2)	0	9	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
None(e1,e2)	4	14	an immune response to campath may interfere with subsequent diagnostic serum tests that utilize antibodies
None(e1,e2)	12	14	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	72	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	66	143	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	20	antacid : the effect of an aluminum hydroxide- and magnesium_hydroxide -containing antacid ( maalox ) * on the pharmacokinetics of capecitabine was investigated in 12 cancer patients .
None(e1,e2)	26	50	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	5	12	therefore the , combination of anakinra with other tnf-blocking agents , including humira , may also result i n similar toxicities .
None(e1,e2)	5	11	- methotrexate ( e.g. , mexate ) use of methotrexate with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of methotrexate
None(e1,e2)	0	33	iron_supplements and foods fortified with iron concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron ( as feso4 ) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80 % and 31 % , respectively .
mechanism(e1,e2)	6	14	estrogens , including oral contraceptives : estrogens may decrease the hepatic metabolism of certain corticosteroids , thereby increasing their effect .
None(e1,e2)	96	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	28	since zarontin ( ethosuximide ) may interact with concurrently administered antiepileptic_drugs , periodic serum level determinations of these drugs may be necessary ( eg , ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels ) .
None(e1,e2)	4	5	fluconazole , and the 5-ht3_antiemetics ondansetron ( zofran ) and granisetron ( kytril ) have all been used with busulfex .
None(e1,e2)	0	13	theophylline : as with some other quinolones , concurrent administration of ciprofloxacin with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life .
None(e1,e2)	37	39	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	44	110	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	18	23	due to a theoretical risk of a pharmacodynamic interaction , use of ergotamine-containing or ergot-type medications ( like dihydroergotamine or methysergide ) and frova within 24 hours of each other should be avoided ( see a href= frova_od.htm # ci contraindications ) .
None(e1,e2)	24	37	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	0	12	cephalosporins -cephalosporins containing side chains of n-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin k deficiency and hypoprothrombinemia .
effect(e1,e2)	14	28	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine_antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	1	18	because escitalopram is metabolized by multiple enzyme systems , inhibition of a single enzyme may not appreciably decrease escitalopram clearance .
None(e1,e2)	18	20	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	12	29	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	6	8	administration of epinephrine to patients receiving cyclopropane or halogenated_hydrocarbon_general_anesthetics such as halothane which sensitize the myocardium , may induce cardiac arrhythmia..
None(e1,e2)	10	14	- lithium : lithium should generally not be given with diuretics ( such as bumetanide ) because they reduce its renal clearance and add a high risk of lithium toxicity .
None(e1,e2)	24	28	the following are examples of drugs known to inhibit the metabolism of other related benzodiazepines , presumably through inhibition of cyp3a : nefazodone , fluvoxamine , cimetidine , diltiazem , isoniazide , and some macrolide antibiotics .
None(e1,e2)	14	17	no interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa /dopa-decarboxylase inhibitor .
None(e1,e2)	119	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	16	25	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety_agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	11	23	the clearance of benzodiazepines metabolized by glucuronidation ( e. g. , lorazepam , oxazepam , temazepam ) is unlikely to be affected by fluvoxamine .
None(e1,e2)	127	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	13	antiarrhythmic agents , class i ( such as flecainide , lidocaine , or quinidine ) : concurrent use with arbutamine may have a proarrhythmic effect .
None(e1,e2)	21	25	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
None(e1,e2)	1	5	- nitrofurantoin ( e.g. , furadantin ) or
None(e1,e2)	17	34	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal_anti-inflammatory_agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	2	10	discontinuation of cimetidine in well-controlled patients receiving tricyclic antidepressants and cimetidine may decrease the plasma levels and efficacy of the antidepressants .
None(e1,e2)	18	95	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	0	9	corticosteroids and corticotropin ( acth ) : may potentiate amphotericin_b - induced hypokalemia which may predispose the patient to cardiac dysfunction .
None(e1,e2)	17	32	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	26	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
int(e1,e2)	0	6	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	16	25	concurrent use of butorphanol with central nervous system depressants ( e.g. , alcohol , barbiturates , tranquilizers , and antihistamines ) may result in increased central_nervous_system_depressant effects .
None(e1,e2)	28	31	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium_channel-blocking_drugs , and isoniazid .
None(e1,e2)	14	18	psychoactive drugs : hallucinations have been reported when toradol was used in patients taking psychoactive_drugs ( fluoxetine , thiothixene , alprazolam ) .
None(e1,e2)	112	120	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
effect(e1,e2)	3	18	the effectiveness of progestin -only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin , carbamazepine , and barbiturates , and the antituberculosis drug rifampin .
None(e1,e2)	36	59	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	39	67	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	4	8	d-amphetamine with desipramine or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain ;
mechanism(e1,e2)	4	14	in addition , other quinolones have been reported to decrease the cyp3a4-mediated metabolism of cyclosporine .
None(e1,e2)	20	22	nabilone has been shown to have an additive cns depressant effect when given with either diazepam , secobarbitone sodium , alcohol or codeine .
None(e1,e2)	37	41	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	26	40	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	17	30	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal_anti-inflammatory_agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	1	31	oral contraceptive : based on auc and half-life , multiple-dose pharmacokinetic profiles of norethindrone and ethinyl estradiol following administration of tablets containing 2.5 mg of norethindrone acetate and 50 mcg of ethinyl_estradiol were similar with and without coadministration of gabapentin ( 400 mg tid ;
None(e1,e2)	7	34	this observed increase in the bioavailability of fexofenadine may be due to transport-related effects , such as p-glycoprotein . in vivo animal studies also suggest that in addition to enhancing absorption , ketoconazole decreases fexofenadine gastrointestinal secretion , while erythromycin may also decrease biliary excretion .
None(e1,e2)	26	28	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	0	4	beta-adrenergic_blocking_agents : coadministration of beta-adrenergic_blocking_agents did not have any effect on either the safety or efficacy of ibutilide in the clinical trials .
None(e1,e2)	66	89	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	65	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	69	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	4	certain other antibiotics ( aminoglycosides and polymyxin ) have also been reported to interfere with the nerve transmission at the neuromuscular junction .
None(e1,e2)	20	44	levothyroxine sodium absorption : the following agents may bind and decrease absorption of levothyroxine sodium from the gastrointestinal tract : aluminum_hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous sulfate , sodium polystyrene sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
None(e1,e2)	27	29	both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when alfenta is administered in combination with other cns depressants such as barbiturates , tranquilizers , opioids , or inhalation general anesthetics .
None(e1,e2)	32	59	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
effect(e1,e2)	4	30	in patients receiving nonselective monoamine_oxidase_inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
mechanism(e1,e2)	41	46	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	0	18	warfarin : co-administration of bosentan 500 mg b.i.d . for 6 days decreased the plasma concentrations of both s-warfarin ( a cyp2c9 substrate ) and r-warfarin ( a cyp3a4 substrate ) by 29 and 38 % , respectively .
None(e1,e2)	2	8	- a monoamine_oxidase_inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	21	25	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type_anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	2	8	effects of gabitril on other antiepilepsy drugs ( aeds ) : phenytoin : tiagabine had no effect on the steady-state plasma concentrations of phenytoin in patients with epilepsy .
None(e1,e2)	5	15	tablet if a patient receiving clonidine_hydrochloride is also taking tricyclic antidepressants , the effect of clonidine may be reduced , thus necessitating an increase in dosage .
None(e1,e2)	21	41	ketoconazole : when a single 125-mg dose of aprepitant was administered on day5 of a 10-day regimen of 400 mg/day of ketoconazole , a strong cyp3a4 inhibitor , the auc of aprepitant increased approximately 5-fold and the mean terminal half-life of aprepitant increased approximately 3-fold .
None(e1,e2)	4	27	however , patients on digoxin may show elevations of digoxin concentrations after initiation of therapy with flolan , which may be clinically significant in patients prone to digoxin toxicity .
None(e1,e2)	16	44	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	19	35	in addition , studies in healthy volunteers have shown that tikosyn does not affect the pharmacokinetics or pharmacodynamics of warfarin , or the pharmacokinetics of propranolol ( 40 mg twice daily ) , phenytoin , theophylline , or oral contraceptives .
None(e1,e2)	102	106	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	1	18	cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation , the discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin .
None(e1,e2)	23	109	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	20	39	in patients receiving mercaptopurine ( purinethol ) or azathioprine ( imuran ) , the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine .
advise(e1,e2)	0	18	auranofin should be avoided by patients with a history of serious reaction to any gold medication , including solganal and myochrysine .
None(e1,e2)	24	36	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline_salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline_salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	82	84	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	144	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	34	62	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	9	35	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	29	43	however , a crossover study in healthy subjects receiving either tagamet 300 mg q.i.d . or 800 mg h.s . concomitantly with a 300 mg b.i.d . dosage of theophylline ( theo-dur , key pharmaceuticals , inc. ) demonstrated less alteration in steady-state theophylline peak serum levels with the 800 mg h.s . regimen , particularly in subjects aged 54 years and older .
None(e1,e2)	8	21	- a sulfa-based drug such as sulfamethoxazole-trimethoprim ( bactrim , septra ) , sulfisoxazole ( gantrisin ) , or sulfasalazine ( azulfidine ) ;
None(e1,e2)	17	40	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal_anti-inflammatory_agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine_oxidase_inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	5	7	certain antibiotics , especially the aminoglycosides and polymyxins ;
None(e1,e2)	11	26	warfarin : the effect of valdecoxib on the anticoagulant effect of warfarin ( 1 - 8 mg/day ) was studied in healthy subjects by coadministration of bextra 40 mg bid for 7 days .
None(e1,e2)	0	30	phenobarbital : coadministration of felbamate with phenobarbital causes an increase in phenobarbital plasma concentrations , in 12 otherwise healthy male volunteers ingesting phenobarbital , the steady-state trough ( cmin ) phenobarbital concentration was 14.2 micrograms/ml .
None(e1,e2)	26	34	digitalis : immediate release capsules : since there have been isolated reports of patients with elevated digoxin levels , and there is a possible interaction between digoxin and nifedipine , it is recommended that digoxin levels be monitored when initiating , adjusting , and discontinuing nifedipine to avoid possible over- or under-digitalization .
effect(e1,e2)	6	11	- the action of sulphonylureas and insulin may be enhanced by bezalip or bezalip retard .
None(e1,e2)	80	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	8	31	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	11	16	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium_channel_blockers , beta blockers , cardiac_glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	10	20	toxicology studies of heroin-related deaths reveal frequent involvement of other central_nervous_system_depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
None(e1,e2)	0	14	cimetidine : atorvastatin plasma concentrations and ldl-c reduction were not altered by coadministration of cimetidine .
None(e1,e2)	24	30	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
mechanism(e1,e2)	10	35	carbamazepine : in healthy subjects receiving the cyp3a4 inducer , carbamazepine , at 100 mg twice daily for 3 days and 200 mg twice daily for 17 days , systemic exposure ( auc ) to lapatinib was decreased approximately 72 % .
None(e1,e2)	3	25	however , since aspirin , nsaids , and bisphosphonates are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of aspirin or nsaids with ibandronate .
None(e1,e2)	34	38	limited clinical experience indicates that requirements for volatile inhalation anesthetics are reduced by 30 to 50 % for the first sixty ( 60 ) minutes following alfenta induction the concomitant use of erythromycin with alfenta can significantly inhibit alfenta clearance and may increase the risk of prolonged or delayed respiratory depression .
None(e1,e2)	13	15	no dose adjustment is necessary when simulect is added to triple-immunosuppression regimens including cyclosporine , corticosteroids , and either azathioprine or mycophenolate mofetil .
None(e1,e2)	1	5	- procainamide ( e.g. , pronestyl ) or
None(e1,e2)	6	25	may interact with the following : beta-adrenergic_blocking_agents ( these medicines may make your condition worse and prevent the adrenergic bronchodilators from working properly ) and disopyramide , quinidine , phenothiazines , and procainamide ( these medicines may increase the risk of heart problems ) .
None(e1,e2)	60	62	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	14	furosemide : clinical studies , as well as random observations , have shown that ibuprofen can reduce the natriuretic effect of furosemide and thiazides in some patients .
effect(e1,e2)	15	17	- antidiabetics , oral ( diabetes medicine you take by mouth ) use of oral antidiabetics with sulfapyridine may increase the chance of side effects affecting the blood and/or the side effects or oral antidiabetics
None(e1,e2)	9	42	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
mechanism(e1,e2)	0	21	urinary_acidifying_agents ( ammonium chloride , sodium acid phosphate , etc . ) increase the concentration of the ionized species of the amphetamine molecule , thereby increasing urinary excretion .
None(e1,e2)	0	2	aspirin : celebrex can be used with low dose aspirin .
None(e1,e2)	33	40	drugs demonstrated to be cyp 3a inhibitors of possible clinical significance on the basis of clinical studies involving alprazolam ( caution is recommended during coadministration with alprazolam ) : coadministration of fluoxetine with alprazolam increased the maximum plasma concentration of alprazolam by 46 % , decreased clearance by 21 % , increased half-life by 17 % , and decreased measured psychomotor performance .
None(e1,e2)	8	10	notably , systemic exposure ( auc0-12 ) of dapsone_hydroxylamine ( dha ) was more than doubled in the presence of tmp/smx .
None(e1,e2)	8	30	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	11	15	in patients in whom cyp3a4 inducers ( eg , dexamethasone , phenytoin , carbamazepine , rifampicin , phenobarbital ) are indicated , alternative agents with less enzyme induction potential should be used .
None(e1,e2)	13	45	there have been postmarketing reports of drug interactions when erythromycin is coadministered with cisapride , resulting in qt prolongation , cardiac arrythmias , ventricular tachycardia , ventricular fibrulation , and torsades de pointes , most like due to inhibition of hepatic metabolism of cisapride by erythromycin .
None(e1,e2)	49	51	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	27	43	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium_salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	7	14	phenytoin/phenobarbital : the coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin_d , but may reduce endogenous plasma levels of calcitriol/ergocalcitriol by accelerating metabolism .
None(e1,e2)	83	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	7	15	therapeutic concentrations of digoxin , warfarin , ibuprofen , naproxen , piroxicam , acetaminophen , phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding .
effect(e1,e2)	12	25	amiodarone or verapamil : the risk of myopathy/rhabdomyolysis is increased when either amiodarone or verapamil is used concomitantly with a closely related member of the hmg-coa_reductase_inhibitor_class ( see warnings , myopathy/rhabdomyolysis ) .
effect(e1,e2)	14	21	furosemide : clinical studies , as well as post-marketing observations , have shown that nsaids can reduce the natriuretic effect of furosemide and thiazides in some patients .
None(e1,e2)	15	17	more than 600 parkinsons disease patients in clinical trials have used selegiline in combination with entacapone and levodopa /dopa decarboxylase inhibitor .
mechanism(e1,e2)	20	23	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
effect(e1,e2)	6	13	- the action of sulphonylureas and insulin may be enhanced by bezalip or bezalip_retard .
None(e1,e2)	31	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	8	28	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
mechanism(e1,e2)	0	11	quinolones have also been shown to interfere with the metabolism of caffeine .
None(e1,e2)	40	79	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	13	15	in addition , neuromuscular blocking action is enhanced by general anesthetics , local anesthetics like lidocaine , procaine , beta-blockers , metaclopramide , lithium carbonate , and terbutaline .
None(e1,e2)	0	21	ketoconazole : when a single 125-mg dose of aprepitant was administered on day5 of a 10-day regimen of 400 mg/day of ketoconazole , a strong cyp3a4 inhibitor , the auc of aprepitant increased approximately 5-fold and the mean terminal half-life of aprepitant increased approximately 3-fold .
None(e1,e2)	6	20	there are no significant effects on cefdinir pharmacokinetics if the antacid is administered 2 hours before or 2 hours after cefdinir .
None(e1,e2)	8	16	however , co-administration of duloxetine with aluminum- and magnesium -containing antacids ( 51 meq ) or duloxetine with famotidine , had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose .
mechanism(e1,e2)	2	9	lithium : diclofenac decreases lithium renal clearance and increases lithium plasma levels .
None(e1,e2)	16	25	protease inhibitors : in vitro data indicate that indinavir and ritonavir markedly inhibit the metabolism of cisapride which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	13	36	preliminary animal and human studies have shown that small quantities of systemically administered leucovorin enter the csf primarily as 5-methyltetrahydro-folate and , in humans , remain 1 to 3 orders of magnitude lower than the usual methotrexate concentrations following intrathecal administration .
None(e1,e2)	14	28	however , other published reports describe modest elevations ( less than two-fold ) of clozapine and metabolite concentrations when clozapine was taken with paroxetine , fluoxetine , and sertraline .
None(e1,e2)	133	138	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	10	12	aspirin : as with other nsaids , concomitant administration of ponstel and aspirin is not generally recommended because of the potential of increased adverse effects .
None(e1,e2)	27	70	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic_acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
advise(e1,e2)	6	25	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	28	32	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	29	35	therefore , it is theoretically possible that lansoprazole may interfere with the absorption of drugs where gastric ph is an important determinant of bioavailability ( e.g . ketoconazole , ampicillin esters , iron salts , digoxin ) .
None(e1,e2)	11	15	the clearance of benzodiazepines metabolized by glucuronidation ( e. g. , lorazepam , oxazepam , temazepam ) is unlikely to be affected by fluvoxamine .
None(e1,e2)	11	43	a pharmacokinetic study evaluating the administration of a single dose of inspra 100 mg with ketoconazole 200 mg bid , a potent inhibitor of the cyp3a4 pathway , showed a 1.7-fold increase in cmax of eplerenone and a 5.4-fold increase in auc of eplerenone .
None(e1,e2)	3	15	the clearance of benzodiazepines metabolized by glucuronidation ( e. g. , lorazepam , oxazepam , temazepam ) is unlikely to be affected by fluvoxamine .
None(e1,e2)	5	7	drug interaction during pregnancy : cromolyn_sodium and isoproterenol were studied following subcutaneous injections in pregnant mice .
None(e1,e2)	44	47	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	22	72	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	9	35	drugs that have been associated with peripheral neuropathy include antiretroviral_nucleoside_analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	33	73	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	16	30	h2 receptor antagonists : cimetidine coadministration leads to an increased peak plasma concentration and auc of cisapride , there is no effect on cisapride absorption when it is coadministered with ranitidine .
None(e1,e2)	4	6	fluconazole and ketoconazole : ketoconazole and fluconazole are predominantly cyp 3a4 and 2c9 inhibitors , respectively .
None(e1,e2)	18	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	24	40	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
mechanism(e1,e2)	2	9	coadministration of propoxyphene decreased the maximum plasma concentration of alprazolam by 6 % , decreased clearance by 38 % , and increased half-life by 58 % .
None(e1,e2)	14	16	in addition , certain drugs that are metabolized by this isoenzyme , including many antidepressants ( tricyclic_antidepressants , selective serotonin reuptake inhibitors , and others ) , may inhibit the activity of this isoenzyme , and thus may make normal metab-olizers resemble poor metabolizers with regard to concomitant therapy with other drugs metabolized by this enzyme system , leading to drug interactions .
None(e1,e2)	27	30	other drugs : in small groups of patients ( 7-10/interaction study ) , the concomitant administration of azathioprine , gold , chloroquine , d-penicillamine , prednisolone , doxycycline , or digitoxin did not significantly affect the peak levels and auc values of diclofenac .
effect(e1,e2)	9	17	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors , tricyclic_antidepressants or phenothiazines may produce severe , prolonged hypotension or hypertension .
None(e1,e2)	28	35	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic_antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	12	20	welchol was found to have no significant effect on the bioavailability of digoxin , lovastatin , metoprolol , quinidine , valproic_acid , and warfarin .
None(e1,e2)	16	18	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	91	120	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	31	50	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	26	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	20	44	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	15	21	the benzodiazepines , including alprazolam , produce additive cns depressant effects when co-administered with other psychotropic_medications , anticonvulsants , antihistaminics , ethanol , and other drugs which themselves produce cns depression .
None(e1,e2)	0	20	lithium generally should not be given with diuretics because they reduce lithiums renal clearance and add a high risk of lithium toxicity .
effect(e1,e2)	20	22	exacerbation or the initial presentation of a number of autoimmune and inflammatory disorders has been observed following concurrent use of interferon-alfa and proleukin , including crescentic iga glomerulonephritis , oculo-bulbar myasthenia gravis , inflammatory arthritis , thyroiditis , bullous pemphigoid , and stevens-johnson syndrome .
mechanism(e1,e2)	4	23	and videx , ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution may substantially interfere with the absorption of quinolones , resulting in systemic levels considerably lower than desired .
None(e1,e2)	76	96	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	37	39	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	41	111	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	14	53	antacids : in a single dose study ( n=6 ) , ingestion of an antacid containing 1.7-gram of magnesium hydroxide with 500-mg of mefenamic acid increased the cmax and auc of mefenamic acid by 125 % and 36 % , respectively . a number of compounds are inhibitors of cyp2c9 including fluconazole , lovastatin and trimethoprim .
None(e1,e2)	8	18	pretreatment of healthy volunteers with multiple doses of rifampin followed by a single dose of gleevec , increased gleevec oral-dose clearance by 3.8-fold , which significantly ( p 0.05 ) decreased mean cmax and auc ( 0-8 ) .
None(e1,e2)	16	19	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	41	45	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal_anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	65	67	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	3	13	therapeutic concentrations of digoxin , warfarin , ibuprofen , naproxen , piroxicam , acetaminophen , phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding .
None(e1,e2)	14	22	in vitro binding studies with human serum proteins indicate that glipizide binds differently than tolbutamide and does not interact with salicylate or dicumarol .
None(e1,e2)	10	12	products containing calcium and other multivalent cations ( such as aluminum , magnesium , iron ) are likely to interfere with absorption of ibandronate .
None(e1,e2)	12	17	other : there appears to be no pharmacokinetic interaction between acitretin and cimetidine , digoxin , or glyburide .
mechanism(e1,e2)	18	24	although trough citalopram plasma levels were unaffected , given the enzyme-inducing properties of carbamazepine , the possibility that carbamazepine might increase the clearance of escitalopram should be considered if the two drugs are coadministered .
None(e1,e2)	44	66	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	29	35	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	3	14	phenytoin : if acitretin is given concurrently with phenytoin , the protein binding of phenytoin may be reduced .
None(e1,e2)	6	8	interactions for vitamin d analogues ( vitamin_d2 , vitamin_d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;
None(e1,e2)	37	63	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	21	rifabutin , another rifamycin , is structurally similar to rifampin and may possibly have some of the same drug interactions as rifampin .
None(e1,e2)	16	24	welchol was found to have no significant effect on the bioavailability of digoxin , lovastatin , metoprolol , quinidine , valproic acid , and warfarin .
advise(e1,e2)	17	28	since there have been conflicting results regarding the effect of digoxin levels , it is recommended that digoxin levels be monitored when initiating , adjusting , and discontinuing diltiazem_hydrochloride therapy to avoid possible over- or under-digitalization .
None(e1,e2)	17	41	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	6	12	observations from drug interaction studies with fortovase may not be predictive for invirase .
effect(e1,e2)	4	28	in patients receiving nonselective monoamine_oxidase_inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
None(e1,e2)	9	20	diclofenac : administration of morning and lunch doses of starlix 120 mg in combination with a single 75-mg dose of diclofenac in healthy volunteers resulted in no significant changes to the pharmacokinetics of either agent .
None(e1,e2)	34	51	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
advise(e1,e2)	2	13	if intravenous pentamidine is required to treat pneumocystis carinii pneumonia , treatment with hivid should be interrupted .
None(e1,e2)	0	7	warfarin : when healthy subjects were administered starlix 120 mg three times daily before meals for four days in combination with a single dose of warfarin 30 mg on day 2 , there were no alterations in the pharmacokinetics of either agent .
mechanism(e1,e2)	2	29	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	6	16	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	0	2	methotrexate : piperacillin_sodium may reduce the excretion of methotrexate .
None(e1,e2)	67	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	118	125	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	36	40	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot_derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	20	29	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	26	50	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics * ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	3	18	thus , when nsaids and lithium are administered concurrently , subjects should be observed carefully for signs of lithium toxicity .
advise(e1,e2)	4	12	it is recommended that gabapentin be taken at least 2 hours following maalox administration .
None(e1,e2)	1	7	analgesic/ anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
None(e1,e2)	12	20	h2 blockers/proton pump inhibitors : long-term suppression of gastric acid secretion by h2_blockers or proton pump inhibitors ( eg , famotidine and omeprazole ) is likely to reduce dasatinib exposure .
None(e1,e2)	25	27	in addition , results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
effect(e1,e2)	7	13	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine_oxidase_inhibitors or tricyclic antidepressants may produce severe , prolonged hypertension .
None(e1,e2)	0	6	naproxen , naproxen sodium and other nsaids have been reported to reduce the tubular secretion of methotrexate in an animal model , possibly increasing the toxicity of methotrexate .
None(e1,e2)	118	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	40	42	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	15	19	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , citalopram , escitalopram , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	74	122	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	24	49	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide_antibiotics .
None(e1,e2)	42	64	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	23	39	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	22	26	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	75	79	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	3	35	when atropine and pralidoxime are used together , the signs of atropinization ( flushing , mydriasis , tachycardia , dryness of the mouth and nose ) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine .
None(e1,e2)	17	29	cisapride should not be used concomitantly with other drugs known to prolong the qt interval : certain antiarrhythmics , including those of class ia ( such as quinidine and procainamide ) and class iii ( such as sotalol ) ;
None(e1,e2)	24	77	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	13	34	in patients taking an anticonvulsant ( eg , valproic acid , carbamazepine , phenobarbital or phenytoin ) , the concomitant use of mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant .
None(e1,e2)	28	34	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	11	39	no depressant effect on blood levels in humans was noted when colestipol_hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	30	32	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	10	19	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole_antifungal_agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	73	81	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	5	10	antidiabetic agents ( insulin , sulfonylureas ) : requirements for insulin or oral antidiabetic agents may be reduced in hypothyroid patients with diabetes mellitus and may subsequently increase with the initiation of thyroid hormone replacement therapy .
None(e1,e2)	39	49	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	51	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	18	35	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	20	as with other agents_with_b-blocking_properties , if coreg is to be administered orally with calcium channel blockers of the verapamil or diltiazem type , it is recommended that ecg and blood pressure be monitored .
None(e1,e2)	19	31	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	36	39	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal_anti-inflammatory_agents ] is contraindicated .
None(e1,e2)	11	25	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic_medications , or other drugs that produce cns depression .
None(e1,e2)	20	25	other drug interactions : no pharmacokinetic interactions were observed between vardenafil and the following drugs : glyburide , warfarin , digoxin , maalox , and ranitidine .
None(e1,e2)	34	38	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
advise(e1,e2)	7	12	if it is necessary to continue the diuretic , initiate therapy with prinivil at a dose of 5 mg daily , and provide close medical supervision after the initial dose until blood pressure has stabilized .
None(e1,e2)	15	40	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta_blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop_diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	0	28	propranolol : in a single dose study in normal volunteers , coadministration of propranolol had a small effect on the rate but no effect on the extent of isradipine bioavailability .
None(e1,e2)	39	76	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	5	7	macrolide antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot alkaloid class , of which d.h.e . 45 ( dihydroergotamine mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
None(e1,e2)	52	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	46	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal_muscle_relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	23	27	the daily dose of enablex should not exceed 7.5 mg when coadministered with potent cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , ritonavir , nelfinavir , clarithromycin and nefazadone ) .
None(e1,e2)	0	2	warfarin - vitamin_k can antagonize the effect of warfarin
None(e1,e2)	10	30	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	10	20	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot_derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	0	2	ergot_derivatives : dihydroergotamine , ergonovine , ergotamine , methylergonovine contraindicated due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .
None(e1,e2)	16	31	other concomitant therapy : although specific interaction studies were not performed , in clinical studies , cerivastatin_sodium was used concomitantly with angiotensin- converting enzyme ( ace ) inhibitors , betablockers , calcium-channel_blockers , diuretics , and nonsteroidal anti-inflammatory drugs ( nsaids ) without evidence of clinically significant adverse interactions .
advise(e1,e2)	7	12	methotrexate : caution should be used if diflunisal is administered concomitantly with methotrexate .
None(e1,e2)	87	95	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	1	5	sedatives/ hypnotics : triazolam , midazolam contraindicated due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression .
None(e1,e2)	3	6	drug-drug interactions between keppra and other antiepileptic_drugs ( aeds ) phenytoin keppra ( 3000 mg daily ) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy .
None(e1,e2)	21	29	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type_anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	33	48	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	22	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	15	22	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic_antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	43	46	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin b , cyclosporine , non-steroidal anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
None(e1,e2)	0	22	digoxin : concomitant administration of tiagabine did not affect the steady-state pharmacokinetics of digoxin or the mean daily trough serum level of digoxin .
None(e1,e2)	59	127	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	24	26	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline_salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	11	32	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	33	83	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	6	48	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	31	58	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	47	60	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic_acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	17	27	since the concomitant administration of these two drugs can lead to phenytoin intoxication , prior to administering disulfiram to a patient on phenytoin therapy , a baseline phenytoin serum level should be obtained .
None(e1,e2)	24	34	the following are examples of drugs known to inhibit the metabolism of other related benzodiazepines , presumably through inhibition of cyp3a : nefazodone , fluvoxamine , cimetidine , diltiazem , isoniazide , and some macrolide_antibiotics .
None(e1,e2)	19	28	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium_channel_blocking_drugs , and isoniazid .
None(e1,e2)	0	2	anesthetics /sedatives/hypnotics/ opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
mechanism(e1,e2)	16	22	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium_hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	44	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	9	15	pyrazolone derivatives ( phenylbutazone , oxyphenbutazone , and possibly dipyrone ) : concomitant administration with aspirin may increase the risk of gastrointestinal ulceration .
None(e1,e2)	3	8	blood levels of hydrodolasetron increased 24 % when dolasetron was coadministered with cimetidine ( nonselective inhibitor of cytochrome p-450 ) for 7 days , and decreased 28 % with coadministration of rifampin ( potent inducer of cytochrome p-450 ) for 7 days .
None(e1,e2)	0	35	metformin : in healthy subjects given single 500 mg doses of cephalexin and metformin , plasma metformin mean cmax and auc increased by an average of 34 % and 24 % , respectively , and metformin mean renal clearance decreased by 14 % .
None(e1,e2)	21	23	notably , systemic exposure ( auc0-12 ) of dapsone hydroxylamine ( dha ) was more than doubled in the presence of tmp / smx .
None(e1,e2)	5	9	example inducers include aminoglutethimide , carbamazepine , nafcillin , nevirapine , phenobarbital , phenytoin , and rifamycins .
None(e1,e2)	4	11	in patients taking an anticonvulsant ( eg , valproic acid , carbamazepine , phenobarbital or phenytoin ) , the concomitant use of mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant .
None(e1,e2)	1	15	- anticoagulants : interaction studies in humans have shown bumetanide to have no effect on warfarin metabolism or on plasma prothrombin activity .
None(e1,e2)	43	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	51	- a nonsteroidal_anti-inflammatory_drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
mechanism(e1,e2)	6	27	ketoconazole : in healthy subjects receiving ketoconazole , a cyp3a4 inhibitor , at 200 mg twice daily for 7 days , systemic exposure ( auc ) to lapatinib was increased to approximately 3.6-fold of control and half-life increased to 1.7-fold of control .
None(e1,e2)	9	11	therefore , agents affecting sympathetic activity ( e.g. , ganglionic_blocking_agents or adrenergic_neuron_blocking_agents ) should be used with caution .
None(e1,e2)	24	30	the following medications have been administered in clinical trials with simulect with no increase in adverse reactions : atg/alg , azathioprine , corticosteroids , cyclosporine , mycophenolate mofetil , and muromonab-cd3 .
None(e1,e2)	0	31	ace_inhibitors and angiotensin ii receptor antagonists ( congestive heart failure post-myocardial infarction ) - in ephesus , 3020 ( 91 % ) patients receiving inspra 25 to 50 mg also received ace_inhibitors or angiotensin ii receptor antagonists ( acei/arb ) .
None(e1,e2)	10	15	amiodarone may suppress certain cyp450 enzymes , including cyp1a2 , cyp2c9 , cyp2d6 , and cyp3a4 .
None(e1,e2)	17	23	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin_reuptake_inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	7	16	non-selective mao inhibitors including tranylcypromine sulfate , phenelzine_sulfate , and pargyline hc1 : concomitant use of l-tyrosine and non-selective mao inhibitors may cause hypertension .
None(e1,e2)	46	110	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	57	85	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	3	13	antidiabetic agents ( insulin , sulfonylureas ) : requirements for insulin or oral antidiabetic_agents may be reduced in hypothyroid patients with diabetes mellitus and may subsequently increase with the initiation of thyroid hormone replacement therapy .
None(e1,e2)	11	19	additive depressant effect when used with general anesthetics , sedatives , antianxiety_drugs , hypnotics , alcohol , and other opiate_analgesics .
None(e1,e2)	32	48	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	0	30	sumatriptan - there have been rare postmarketing reports describing patients with weakness , hyperreflexia , and incoordination following the use of a selective serotonin reuptake inhibitor ( ssri ) and sumatriptan .
None(e1,e2)	41	43	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	12	45	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	14	36	results of studies in multiple sclerosis patients taking tysabri and concomitant interferon beta-1a ( avonex 30 mcg im once weekly ) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate .
None(e1,e2)	24	37	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic_agents , such as disopyramide , are used concurrently .
None(e1,e2)	7	22	- a sulfa-based drug such as sulfamethoxazole- trimethoprim ( bactrim , septra ) , sulfisoxazole ( gantrisin ) , or sulfasalazine ( azulfidine ) ;
None(e1,e2)	10	26	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	14	22	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim/sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	0	6	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and/or some progestins , leading to possible decrease in contraceptive effectiveness .
mechanism(e1,e2)	7	18	cimetidine : co-administration with high doses of cimetidine [ 800 mg twice daily ] increased the cmax of rofecoxib by 21 % , the auc0-120hr by 23 % and the t1/2 by 15 % .
None(e1,e2)	51	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	26	47	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	13	18	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	0	16	methotrexate : an increased risk of hepatitis has been reported to result from combined use of methotrexate and etretinate .
None(e1,e2)	2	10	therefore , omnicef for oral suspension can be administered with iron -fortified infant formula .
None(e1,e2)	23	29	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
advise(e1,e2)	9	12	this interaction should be given consideration in patients taking vioxx concomitantly with ace_inhibitors .
None(e1,e2)	15	29	in patients who have been reported to be well controlled on tricyclic antidepressants receiving concurrent cimetidine therapy , discontinuation of cimetidine has been reported to decrease established steady-state serum tricyclic_antidepressant levels and compromise their therapeutic effects .
None(e1,e2)	5	14	selective serotonin reuptake inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
None(e1,e2)	12	19	thiazide diuretics : the reports that the concomitant use of allopurinol and thiazide_diuretics may contribute to the enhancement of allopurinol toxicity in some patients have been reviewed in an attempt to establish a cause-and-effect relationship and a mechanism of causation .
None(e1,e2)	24	41	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	22	24	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	12	14	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic acid , and tolbutamide in vitro .
None(e1,e2)	0	6	carbamazepine - combined administration of racemic citalopram ( 40 mg/day for 14 days ) and carbamazepine ( titrated to 400 mg/day for 35 days ) did not significantly affect the pharmacokinetics of carbamazepine , a cyp3a4 substrate .
None(e1,e2)	18	23	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin /flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
mechanism(e1,e2)	11	14	mao inhibitors maoi antidepressants , as well as a metabolite of furazolidone , slow amphetamine metabolism .
mechanism(e1,e2)	8	16	methotrexate : ibuprofen , as well as other nonsteroidal_anti-inflammatory_drugs , probably reduces the tubular secretion of methotrexate based on in vitro studies in rabbit kidney slices .
None(e1,e2)	8	10	phenobarbital : estimates of steady-state pharmacokinetic parameters for phenobarbital or gabapentin ( 300 mg tid ;
effect(e1,e2)	0	14	fluothane augments the action of non-depolarising muscle relaxants and the muscle relaxant effects of aminoglycosides .
None(e1,e2)	4	19	fluconazole , and the 5-ht3_antiemetics ondansetron ( zofran ) and granisetron ( kytril ) have all been used with busulfex .
None(e1,e2)	23	32	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	27	30	in addition , results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
None(e1,e2)	0	2	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
None(e1,e2)	30	33	these in vitro studies suggest that concomitant administration of zalcitabine and lamivudine in humans may result in sub-therapeutic concentrations of active phosphorylated zalcitabine , which may lead to a decreased antiretroviral effect of zalcitabine .
None(e1,e2)	8	10	anesthetics/sedatives/hypnotics/opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
None(e1,e2)	31	33	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	28	70	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	3	18	thus , when ibuprofen and lithium are administered concurrently , subjects should be observed carefully for signs of lithium toxicity .
None(e1,e2)	8	14	probenecid : concomitant administration of toradol oral and probenecid resulted in decreased clearance of ketorolac and significant increases in ketorolac plasma levels ( total auc increased approximately threefold from 5.4 to 17.8 m g/h/ml ) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours .
int(e1,e2)	0	49	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	49	56	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	40	42	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot_derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	24	38	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	16	24	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	2	12	products containing calcium and other multivalent cations ( such as aluminum , magnesium , iron ) are likely to interfere with absorption of ibandronate .
None(e1,e2)	29	42	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	0	33	propranolol to healthy volunteers under steady-state conditions had no relevant effect on either drug s bioavailability , auc and cmax , differences were 20 % between isradipine given singly and in combination with propranolol , and between propranolol given singly and in combination with isradipine .
None(e1,e2)	6	20	- a sulfa-based drug such as sulfamethoxazole -trimethoprim ( bactrim , septra ) , sulfisoxazole ( gantrisin ) , or sulfasalazine ( azulfidine ) ;
None(e1,e2)	33	37	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	30	32	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	38	48	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	33	51	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
effect(e1,e2)	3	28	cyclosporine : because cyclosporine can produce nephrotoxicity with decreases in creatinine clearance and rises in serum creatinine , and because renal excretion is the primary elimination route of fibrate_drugs including tricor , there is a risk that an interaction will lead to deterioration .
None(e1,e2)	21	38	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
advise(e1,e2)	19	30	avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic amine ( e.g. , epinephrine , norepinephrine ) , since it has been reported that tricyclic_antidepressants can potentiate the effects of catecholamines .
None(e1,e2)	1	14	elevated cyclosporine serum levels have been reported with the concomitant use of quinolones and cyclosporine .
None(e1,e2)	8	20	in a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without propantheline ( an anticholinergic_agent with multiple effects on the gi tract ) to healthy volunteers , the auc of clonazepam was 10 % lower and the cmax of clonazepam was 20 % lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone .
None(e1,e2)	3	21	the addition of tiagabine in a limited number of patients in three well-controlled studies caused no systematic changes in phenobarbital or primidone concentrations when compared to placebo .
None(e1,e2)	3	5	serum concentration of digoxin and digitoxin may increase when patients take antithyroid agents .
None(e1,e2)	0	17	nonsteroidal_anti-inflammatory_agents ( nsaids ) : concomitant use of aspirin ( or other nonsteroidal antiinflammatory agents ) and corticosteroids increases the risk of gastrointestinal side effects .
None(e1,e2)	80	114	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	15	17	the results of a study of coadministration of ethambutol ( 50 mg/kg ) with an aluminum_hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20 % and 13 % , respectively , suggesting that the oral absorption of ethambutol may be reduced by these antacid products .
None(e1,e2)	50	102	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	148	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	16	18	in addition , certain drugs that are metabolized by this isozyme , including many antidepressants ( clozapine , selective_serotonin_reuptake_inhibitors , and others ) , may inhibit the activity of this isozyme , and thus may make normal metabolizers resemble poor metabolizers with regard to concomitant therapy with other drugs metabolized by this enzyme system , leading to drug interaction .
None(e1,e2)	65	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	5	warfarin : in subjects receiving warfarin , no significant change in clotting time was observed when grepafloxacin was coadministered .
None(e1,e2)	16	26	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease_inhibitors , quinidine , and verapamil .
None(e1,e2)	48	55	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel_blockers , cardiac nitrates , diuretics , h2_antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	16	26	digitalis : immediate release capsules : since there have been isolated reports of patients with elevated digoxin levels , and there is a possible interaction between digoxin and nifedipine , it is recommended that digoxin levels be monitored when initiating , adjusting , and discontinuing nifedipine to avoid possible over- or under-digitalization .
None(e1,e2)	0	10	cephalosporins -cephalosporins containing side chains of n-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin k deficiency and hypoprothrombinemia .
advise(e1,e2)	0	14	auranofin should be avoided by patients with a history of serious reaction to any gold_medication , including solganal and myochrysine .
None(e1,e2)	33	37	propranolol to healthy volunteers under steady-state conditions had no relevant effect on either drug s bioavailability , auc and cmax , differences were 20 % between isradipine given singly and in combination with propranolol , and between propranolol given singly and in combination with isradipine .
int(e1,e2)	26	28	although it has not been definitively demonstrated that fluvoxamine is a potent iiia4 inhibitor , it is likely to be , given the substantial interaction of fluvoxamine with alprazolam .
None(e1,e2)	4	15	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	37	42	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	10	26	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	18	22	drug-drug interactions : no clinically significant drug interactions have been found with theophylline at a low dose , azithromycin , pseudoephedrine , ketoconazole , or erythromycin .
None(e1,e2)	0	11	dopamine_d2_receptor_antagonists ( e.g. , phenothiazines , butyrophenones , risperidone ) and isoniazid may reduce the therapeutic effects of levodopa .
None(e1,e2)	21	36	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	3	11	example inhibitors include azole_antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	19	25	an adequate period of observation must be provided for any patient in whom either long-acting benzodiazepines ( such as diazepam ) or large doses of short-acting_benzodiazepines ( such as 10 mg of midazolam ) have been used .
mechanism(e1,e2)	3	29	benzodiazepines : combination hormonal_contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	93	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	28	37	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic agents ) or drugs which inhibit platelet function ( eg , aspirin and other non-steroidal anti-inflammatory drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
None(e1,e2)	7	63	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	0	22	eprosartan ( up to 400 mg b.i.d . or 800 mg q.d . ) doses have been safely used concomitantly with a thiazide_diuretic ( hydrochlorothiazide ) .
None(e1,e2)	0	13	selective_serotonin_reuptake_inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
None(e1,e2)	13	15	- a sulfa-based drug such as sulfamethoxazole-trimethoprim ( bactrim , septra ) , sulfisoxazole ( gantrisin ) , or sulfasalazine ( azulfidine ) ;
None(e1,e2)	10	15	in addition , neuromuscular blocking action is enhanced by general anesthetics , local anesthetics like lidocaine , procaine , beta-blockers , metaclopramide , lithium carbonate , and terbutaline .
None(e1,e2)	71	105	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	24	44	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	4	7	cytokines ( interferon , interleukin ) : cytokines have been reported to induce both hyperthyroidism and hypothyroidism .
None(e1,e2)	146	153	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	1	valproate keppra ( 1500 mg twice daily ) did not alter the pharmacokinetics of valproate in healthy volunteers .
None(e1,e2)	28	56	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	7	insulin : a clinical study in 6 insulin -dependent diabetic patients demonstrated no effect of extraneal on insulin absorption from the peritoneal cavity or on insulins ability to control blood glucose when insulin was administered intraperitoneally with extraneal .
None(e1,e2)	2	4	effects of antacids on felbatol the rate and extent of absorption of a 2400 mg dose of felbatol as monotherapy given as tablets was not affected when coadministered with antacids .
None(e1,e2)	16	24	insulin : a clinical study in 6 insulin-dependent diabetic patients demonstrated no effect of extraneal on insulin absorption from the peritoneal cavity or on insulin s ability to control blood glucose when insulin was administered intraperitoneally with extraneal .
None(e1,e2)	85	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	4	15	analgesic/anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
None(e1,e2)	0	7	somatrem /somatropin : excessive concurrent use of thyroid_hormone may accelerate epiphyseal closure .
None(e1,e2)	53	57	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	30	34	the following are examples of drugs known to inhibit the metabolism of other related benzodiazepines , presumably through inhibition of cyp3a : nefazodone , fluvoxamine , cimetidine , diltiazem , isoniazide , and some macrolide_antibiotics .
effect(e1,e2)	0	7	acetazolamide may increase the effects of other folic_acid_antagonists .
None(e1,e2)	6	13	therefore , administration of quinolones with antacids containing calcium , magnesium , or aluminum ;
None(e1,e2)	9	11	co-medications that induce cyp3a4 ( e.g. , dexamethasone , phenytoin , carbamazepine , rifampin , phenobarbital or st .
effect(e1,e2)	22	36	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	9	15	in patients taking furosemide , nifedipine , diltiazem , ace_inhibitors , verapamil , glyburide , propranolol , and various chemotherapy agents , no effect was shown on the clearance of hydrodolasetron .
None(e1,e2)	10	35	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	41	57	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	6	20	other potentially important drug interactions : benzodiazepines : benzodiazepines metabolized by hepatic oxidation ( e.g. , alprazolam , midazolam , triazolam elc . ) should be used with caution because the clearance of these drugs is likely to be reduced by fluvoxamine .
None(e1,e2)	26	30	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine-containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton_pump_inhibitors ( e.g. , lansoprazole , omeprazole ) .
advise(e1,e2)	0	14	epinephrine also should be used cautiously with other drugs ( e.g. , digitalis , glycosides ) that sensitize the myocardium to the actions of sympathomimetic drugs .
None(e1,e2)	59	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
int(e1,e2)	0	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	2	38	interactions with mixed_agonist/antagonist_opioid_analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure_agonist_opioid_analgesic such as levo-dromoran .
None(e1,e2)	97	107	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing_compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	31	47	therefore , co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	2	10	coadministration of valdecoxib with doses higher than 40 mg qd omeprazole has not been studied .
None(e1,e2)	8	19	the concurrent use of robinul injection with other anticholinergics or medications with anticholinergic activity , such as phenothiazines , antiparkinson_drugs , or tricyclic antidepressants , may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects .
None(e1,e2)	16	64	aspirin/acetaminophen : pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between argatroban and concomitantly administered aspirin ( 162.5 mg orally given 26 and 2 hours prior to initiation of argatroban 1 g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of argatroban 1.5 g/kg/min . over 18 hours ) .
None(e1,e2)	0	25	quinidine : immediate release capsules : there have been rare reports of an interaction between quinidine and nifedipine ( with a decreased plasma level of quinidine ) .
None(e1,e2)	0	7	carbamazepine : steady-state trough plasma carbamazepine and carbamazepine_10_,_11_epoxide concentrations were not affected by concomitant gabapentin ( 400 mg tid ;
None(e1,e2)	0	10	phenobarbital : estimates of steady-state pharmacokinetic parameters for phenobarbital or gabapentin ( 300 mg tid ;
None(e1,e2)	23	31	the risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine , fibric acid derivatives , niacin ( nicotinic acid ) , erythromycin , azole_antifungals .
mechanism(e1,e2)	11	23	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
int(e1,e2)	7	15	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	10	18	dolasetron mesylate did not inhibit the antitumor activity of four chemotherapeutic_agents ( cisplatin , 5-fluorouracil , doxorubicin , cyclophosphamide ) in four murine models .
effect(e1,e2)	5	10	co-administration : concomitant use of argatroban with antiplatelet agents , thrombolytics , and other anticoagulants may increase the risk of bleeding .
mechanism(e1,e2)	0	5	acetazolamide decreases urinary excretion of amphetamine and may enhance the magnitude and duration of their effect .
None(e1,e2)	11	19	and disulfiram when amitriptyline hcl is given with anticholinergic agents or sympathomimetic drugs , including epinephrine combined with local anesthetics , close supervision and careful adjustment of dosages are required .
None(e1,e2)	8	32	in rats , simultaneous ingestion of disulfiram and nitrite in the diet for 78 weeks has been reported to cause tumors , and it has been suggested that disulfiram may react with nitrites in the rat stomach to form a nitrosamine , which is tumorigenic .
None(e1,e2)	2	21	effect of clonazepam on the pharmacokinetics of other drugs : clonazepam does not appear to alter the pharmacokinetics of phenytoin , carbamazepine , or phenobarbital .
None(e1,e2)	0	6	amantadine , tricyclic antidepressants , and maois may increase anticholinergic effect of clidinium .
None(e1,e2)	7	11	- a sulfa-based drug such as sulfamethoxazole- trimethoprim ( bactrim , septra ) , sulfisoxazole ( gantrisin ) , or sulfasalazine ( azulfidine ) ;
None(e1,e2)	8	10	absorption of tetracyclines is impaired by antacids containing aluminum , calcium , or magnesium , and iron-containing preparations .
None(e1,e2)	33	43	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide_dinitrate , morphine , atropine , heparin , protamine , potassium_chloride , folic acid , and acetaminophen .
None(e1,e2)	36	51	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	9	15	therefore , interactions could occur following concomitant administration of psychotropic_drugs ( e.g. , narcotics , analgesics , antiemetics , sedatives , tranquilizers ) .
None(e1,e2)	35	65	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	38	56	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing_compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	15	17	there have been no reported cases from spontaneous reports of drug interaction between ssris and d.h.e_._45 ( dihydroergotamine_mesylate ) injection , usp .
None(e1,e2)	14	33	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	33	41	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	14	other strong inhibitors of cyp3a4 ( e.g. , itraconazole , clarithromycin , nefazodone , troleandomycin , ritonavir , nelfinavir ) would be expected to behave similarly .
advise(e1,e2)	6	20	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
effect(e1,e2)	2	16	chlorpromazine : chlorpromazine blocks dopamine and norepinephrine receptors , thus inhibiting the central stimulant effects of amphetamines and can be used to treat amphetamine poisoning .
None(e1,e2)	15	23	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood_thinner s ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	28	123	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	3	19	concomitant administration of norpace and quinidine resulted in slight increases in plasma disopyramide levels and slight decreases in plasma quinidine levels .
None(e1,e2)	1	3	since zarontin ( ethosuximide ) may interact with concurrently administered antiepileptic drugs , periodic serum level determinations of these drugs may be necessary ( eg , ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels ) .
effect(e1,e2)	4	7	the pressor effects of ergomar and other vasoconstrictor_drugs can combine to cause dangerous hypertension .
None(e1,e2)	3	5	the effect of toradol on methotrexate clearance has not been studied .
None(e1,e2)	5	13	macrolide antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot_alkaloid_class , of which d.h.e . 45 ( dihydroergotamine mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
advise(e1,e2)	15	49	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	2	23	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
None(e1,e2)	28	58	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	23	these agents include medications such as : anticoagulants , platelet_inhibitors including acetylsalicylic acid , sali-cylates , nsaids ( including ketorolac tromethamine ) , dipyridamole , or sulfinpyrazone .
None(e1,e2)	8	20	although this interaction has not been reported with cinoxacin , caution should be exercised when cinoxacin is given concomitantly with caffeine -containing products .
None(e1,e2)	14	36	several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine , clonidine , or similar agents , and such an effect may be anticipated with cmi because of its structural similarity to other tricyclic_antidepressants .
None(e1,e2)	6	18	and calcium channel antagonists e.g. , verapamil ) , cyp1a2 inducers ( omeprazole ) and cyp1a2 inhibitors ( furafylline and clarithromycin ) .
None(e1,e2)	36	44	hepatic enzyme inducers , inhibitors and substrates : drugs which induce cytochrome p450 3a4 ( cyp 3a4 ) enzyme activity ( e.g. , barbiturates , phenytoin , carbamazepine , rifampin ) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased .
effect(e1,e2)	3	12	antidepressants , tricyclic amphetamines may enhance the activity of tricyclic antidepressants or sympathomimetic_agents ;
effect(e1,e2)	9	16	vasospastic reactions have been reported with therapeutic doses of ergotamine -containing drugs when co-administered with these antibiotics .
None(e1,e2)	21	38	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace_inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	16	19	oral anticoagulants : in some normal volunteers , the concomitant administration of diflunisal and warfarin , acenocoumarol , or phenprocoumon resulted in prolongation of prothrombin time .
None(e1,e2)	85	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	21	52	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	15	cimetidine ) and many that are substrates for p450 2d6 ( many other antidepressants , phenothiazines , and the type 1c antiarrhythmics propafenone and flecainide ) .
None(e1,e2)	8	14	in a study of schizophrenic patients who received clozapine under steady state conditions , fluvoxamine or paroxetine was added in 16 and 14 patients , respectively .
None(e1,e2)	39	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	43	55	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	114	127	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	0	6	cancidas reduced the blood auc0-12 of tacrolimus by approximately 20 % , peak blood concentration ( cmax ) by 16 % , and 12-hour blood concentration ( c12hr ) by 26 % in healthy subjects when tacrolimus ( 2 doses of 0.1 mg/kg 12 hours apart ) was administered on the 10th day of cancidas 70 mg daily , as compared to results from a control period in which tacrolimus was administered alone .
None(e1,e2)	2	19	if replacing clonidine by beta-blocker therapy , the introduction of beta blockers should be delayed for several days after clonidine administration has stopped .
advise(e1,e2)	4	6	although concomitant use of clozapine and carbamazepine is not recommended , it should be noted that discontinuation of concomitant carbamazepine administration may result in an increase in clozapine plasma levels .
None(e1,e2)	0	16	non-steroidal_anti-inflammatory_agents : seizures have been reported in patients taking enoxacin concomitantly with the nonsteroidal anti-inflammatory drug fenbufen .
None(e1,e2)	0	1	colchicine para-aminosalicylic_acid and heavy alcohol intake for longer than 2 weeks may produce malabsorption of vitamin b12 .
None(e1,e2)	20	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
None(e1,e2)	7	26	omeprazole : no clinically significant changes in lomefloxacin pharmacokinetics ( auc , c max , or t max ) were observed when a single dose of lomefloxacin 400 mg was given after multiple doses of omeprazole ( 20 mg qd ) in 13 healthy volunteers .
None(e1,e2)	13	33	duloxetine may have a clinically important interaction with the following other drugs : alcohol : when duloxetine and ethanol were administered several hours apart so that peak concentrations of each would coincide , duloxetine did not increase the impairment of mental and motor skills caused by alcohol .
None(e1,e2)	9	13	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	1	6	anesthetics/sedatives/ hypnotics /opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
None(e1,e2)	5	7	protease inhibitors : amprenavir , lopinavir , nelfinavir , and ritonavir have been shown to decrease plasma levels of combination hormonal contraceptives ;
None(e1,e2)	0	12	methotrexate : humira has been studied in rheumatoid arthritis patients taking concomitant mtx .
None(e1,e2)	7	11	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
mechanism(e1,e2)	5	24	increases in plasma levels of tricyclic_antidepressants , and in the frequency and severity of side effects , particularly anticholinergic , have been reported when cimetidine was added to the drug regimen .
None(e1,e2)	2	8	monitoring of cyclosporine levels and possible adjustment of cyclosporine dosage should be considered when these drugs are co-administered .
None(e1,e2)	4	6	while all the selective serotonin_reuptake_inhibitors ( ssris ) , e.g. , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	34	36	in vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds that induce , inhibit , or are metabolized by cytochrome p450 3a4 , such as cyclosporine , terfenadine , ketoconazole , erythromycin , and troleandomycin .
None(e1,e2)	0	46	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	59	110	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
advise(e1,e2)	9	14	nevertheless , caution is indicated in the co-administration of tcas with any of the ssris and also in switching from one class to the other .
None(e1,e2)	19	24	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	97	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	6	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	26	37	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin_b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin_b .
None(e1,e2)	18	22	certain drugs including thiazides , corticosteroids , thyroid products , and sympathomimetics may reduce the hypoglycemic action of starlix and other oral antidiabetic_drugs .
None(e1,e2)	29	31	although specific drug interaction studies have not been conducted with alphagan p , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , or anesthetics ) should be considered .
None(e1,e2)	3	6	potential terfenadine , astemizole , and cisapride interactions
None(e1,e2)	39	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	8	13	caffeine-related adverse effects have occurred in patients consuming caffeine while on therapy with enoxacin .
None(e1,e2)	13	24	cimetidine ) and many that are substrates for p450 2d6 ( many other antidepressants , phenothiazines , and the type 1c antiarrhythrnics propatenone and flecainide ) .
None(e1,e2)	3	37	ace inhibitors and angiotensin_ii_receptor_antagonists ( congestive heart failure post-myocardial infarction ) - in ephesus , 3020 ( 91 % ) patients receiving inspra 25 to 50 mg also received ace inhibitors or angiotensin ii receptor antagonists ( acei /arb ) .
None(e1,e2)	12	16	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	28	43	in another study with intravenous administration of midazolam , aprepitant was given as 125 mg on day 1 and 80 mg/day on days 2 and 3 , and midazolam 2 mg iv was given prior to the administration of the 3-day regimen of aprepitant and on days 4 , 8 , and 15 .
None(e1,e2)	44	81	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	35	58	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	11	20	the actions of the benzodiazepines may be potentiated by barbiturates , narcotics , phenothiazines , monoamine oxidase inhibitors or other antidepressants .
None(e1,e2)	11	23	no depressant effect on blood levels in humans was noted when colestipol_hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
mechanism(e1,e2)	0	32	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	9	20	hydrochlorothiazide ( hctz ) alone or in combination with triamterene : concomitant use of hctz alone or in combination with triamterene is contraindicated .
None(e1,e2)	35	40	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	6	11	the co-administration of natrecor with iv vasodilators such as nitroglycerin , nitroprusside , milrinone , or iv ace inhibitors has not been evaluated ( these drugs were not co-administered with natrecor in clinical trials ) .
None(e1,e2)	16	45	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle_relaxants birth control pills sleeping pills thyroid medications
mechanism(e1,e2)	7	15	tricyclic antidepressants ( amitriptyline , imipramine , nortriptyline ) : metabolism may be inhibited by combination_hormonal_contraceptives , increasing plasma levels of antidepressant ;
None(e1,e2)	28	30	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic_acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	0	6	acidifying_agents : gastrointestinal acidifying agents ( guanethidine , reserpine , glutamic acid hcl , ascorbic acid , fruit juices , etc . ) lower absorption of amphetamines .
None(e1,e2)	41	75	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone_anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	1	5	- methotrexate ( e.g. , mexate ) use of methotrexate with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of methotrexate
None(e1,e2)	18	20	other concomitant therapies : in clinical trials , the safety profile in subjects treated with acamprosate concomitantly with anxiolytics , hypnotics and sedatives ( including benzodiazepines ) , or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications .
mechanism(e1,e2)	18	57	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	4	antiarrhythmics : amiodarone , bepridil , flecainide , propafenone , quinidine contraindicated due to potential for serious and/or life-threatening reactions .
None(e1,e2)	7	22	the following drugs have been coadministered with kerlone and have not altered its pharmacokinetics : cimetidine , nifedipine , chlorthalidone , and hydrochlorothiazide .
None(e1,e2)	26	30	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	4	16	another study showed that alosetron had no clinically significant effect on plasma concentrations of the oral contraceptive_agents ethinyl estradiol and levonorgestrel ( cyp3a4 substrates ) .
effect(e1,e2)	7	15	methotrexate - there is one report that methotrexate may decrease the possible effectiveness of supplemental l-glutamine for chemotherapy-induced mucositis .
effect(e1,e2)	4	24	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	12	39	aspirin/acetaminophen : pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between argatroban and concomitantly administered aspirin ( 162.5 mg orally given 26 and 2 hours prior to initiation of argatroban 1 g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of argatroban 1.5 g/kg/min . over 18 hours ) .
mechanism(e1,e2)	34	41	cimetidine : a study in 6 healthy volunteers has shown a significant increase in peak nifedipine plasma levels ( 80 % ) and area-under-the-curve ( 74 % ) after a 1 week course of cimetidine at 1000 mg per day and nifedipine at 40 mg per day .
None(e1,e2)	6	10	- a steroid medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	26	28	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease_inhibitors , quinidine , and verapamil .
None(e1,e2)	69	83	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	7	paroxetine : coadministration of single doses of eszopiclone 3 mg and paroxetine 20 mg daily for 7 days produced no pharmacokinetic or pharmacodynamic interaction .
None(e1,e2)	0	18	duloxetine may have a clinically important interaction with the following other drugs : alcohol : when duloxetine and ethanol were administered several hours apart so that peak concentrations of each would coincide , duloxetine did not increase the impairment of mental and motor skills caused by alcohol .
advise(e1,e2)	0	12	ocupress should be used with caution in patients who are receiving a beta-adrenergic_blocking_agent orally because of the potential for additive effects on systemic beta-blockade .
None(e1,e2)	67	83	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	38	42	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine_oxidase_inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	27	39	ritonavir - combined administration of a single dose of ritonavir ( 600 mg ) , both a cyp3a4 substrate and a potent inhibitor of cyp3a4 , and escitalopram ( 20 mg ) did not affect the pharmacokinetics of either ritonavir or escitalopram .
None(e1,e2)	78	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	14	in vitro studies indicate that ertapenem does not inhibit p-glycoprotein-mediated transport of digoxin or vinblastine and that ertapenem is not a substrate for p-glycoprotein-mediated transport .
None(e1,e2)	15	17	the benzodiazepines , including alprazolam , produce additive cns depressant effects when co-administered with other psychotropic_medications , anticonvulsants , antihistaminics , ethanol , and other drugs which themselves produce cns depression .
None(e1,e2)	15	17	in addition , neuromuscular blocking action is enhanced by general anesthetics , local anesthetics like lidocaine , procaine , beta-blockers , metaclopramide , lithium carbonate , and terbutaline .
None(e1,e2)	14	52	hypotension patients on diuretic therapy : patients on diuretics and especially those in whom diuretic therapy was recently instituted , as well as those on severe dietary salt restriction or dialysis , may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of captopril .
None(e1,e2)	8	29	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	21	35	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	13	22	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid_products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	19	30	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	20	24	no significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide , nifedipine , digoxin , warfarin , hydrochlorothiazide , and oral contraceptives in healthy volunteers , or given with enalapril to patients with heart failure ( nyha class ii and iii ) .
advise(e1,e2)	6	8	the benefits and risks of using tricor with immunosuppressants and other potentially nephrotoxic agents should be carefully considered , and the lowest effective dose employed
None(e1,e2)	51	60	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
int(e1,e2)	0	41	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	2	noncardioselective_beta-blockers ( nadolol , porpranolol , timolol ) may exacerbate rebound hypertension when guanfacine is withdrawn .
None(e1,e2)	19	21	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	0	16	psychoactive_drugs : hallucinations have been reported when toradol was used in patients taking psychoactive drugs ( fluoxetine , thiothixene , alprazolam ) .
None(e1,e2)	70	75	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide_antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	3	15	insulin or oral hypoglycemics : agents with b-blocking properties may enhance the blood-sugar-reducing effect of insulin and oral hypoglycemics .
advise(e1,e2)	0	13	epinephrine should not be administered concomitantly with other sympathomimetic drugs ( such as isoproterenol ) because of possible additive effects and increased toxicity .
None(e1,e2)	4	12	these medications have included heparin , warfarin , beta-adrenergic receptor blockers , calcium_channel_antagonists , angiotensin converting enzyme inhibitors , intravenous and oral nitrates , ticlopidine , and aspirin .
None(e1,e2)	42	45	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide_antibiotics .
None(e1,e2)	17	34	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin_reuptake_inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	25	43	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	5	13	in patients receiving treatment with sprycel , close monitoring for toxicity and a sprycel dose reduction should be considered if systemic administration of a potent cyp3a4 inhibitor can not be avoided .
None(e1,e2)	96	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	9	14	these increases should be considered when selecting an oral contraceptive for a woman taking atorvastatin .
None(e1,e2)	11	27	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	7	16	additive depressant effect when used with general anesthetics , sedatives , antianxiety drugs , hypnotics , alcohol , and other opiate analgesics .
None(e1,e2)	20	33	therefore , co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	17	61	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	5	6	itraconazole ketoconazole erythromycin clarithromycin telithromycin hiv_protease_inhibitors nefazodone cyclosporine large quantities of grapefruit juice ( 1 quart daily )
None(e1,e2)	0	2	nitroglycerin : dynacirc ( isradipine ) has been safely coadministered with nitroglycerin .
None(e1,e2)	59	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	7	11	sinus bradycardia has been reported with oral amiodarone in combination with lidocaine ( cyp3a4 substrate ) given for local anesthesia .
None(e1,e2)	0	15	gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic_drugs .
None(e1,e2)	11	18	in evaluating the potential for interactions among co-administered antiepilepsy drugs ( aeds ) , whether or not an aed induces or does not induce metabolic enzymes is an important consideration .
None(e1,e2)	44	102	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	13	38	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
effect(e1,e2)	5	38	isoflurane or enflurane administered with nitrous_oxide /oxygen to achieve 1.25 mac [ minimum alveolar concentration ] may prolong the clinically effective duration of action of initial and maintenance doses of nimbex and decrease the required infusion rate of nimbex .
None(e1,e2)	2	22	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	8	27	however , since aspirin , nsaids , and bisphosphonates are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of aspirin or nsaids with ibandronate .
None(e1,e2)	12	14	amiodarone or verapamil : the risk of myopathy/rhabdomyolysis is increased when either amiodarone or verapamil is used concomitantly with a closely related member of the hmg-coa reductase inhibitor class ( see warnings , myopathy/rhabdomyolysis ) .
None(e1,e2)	34	70	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting_enzyme_(_ace_)_inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone_anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	36	68	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral_hydrate * ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine * ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
effect(e1,e2)	3	22	as with other antipsychotic_agents , it should be noted that haldol may be capable of potentiating cns depressants such as anesthetics , opiates , and alcohol .
effect(e1,e2)	5	13	anakinra : concurrent administration of anakinra ( an interleukin-1 antagonist ) and another tnf-blocking_agent has been associated with an increased risk of serious infections , an increased risk of neutropenia and no additional benefit compared to these medicinal products alone .
int(e1,e2)	0	65	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	58	75	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	9	cyclosporine - l-arginine may counteract the antinaturetic effect of cyclosporin .
None(e1,e2)	25	30	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	7	14	avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic_amine ( e.g. , epinephrine , norepinephrine ) , since it has been reported that tricyclic antidepressants can potentiate the effects of catecholamines .
mechanism(e1,e2)	3	11	plasma concentrations of quinolone_antibiotics are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	25	27	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	15	17	approximately 2/3 of the patients in the phase 3 study received either prophylactic low dose heparin ( unfractionated_heparin up to 15,000 units/day ) or prophylactic doses of low molecular weight heparins as indicated in the prescribing information for the specific products .
None(e1,e2)	26	30	benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
None(e1,e2)	2	7	likewise , gabapentin pharmacokinetics were unaltered by carbamazepine administration .
None(e1,e2)	8	16	the potential effects of increased plasma concentrations of midazolam or other benzodiazepines metabolized via cyp3a4 ( alprazolam , triazolam ) should be considered when coadministering these agents with aprepitant .
None(e1,e2)	40	85	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	0	7	phenytoin : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking phenytoin with or without other enzyme- inducing aeds .
None(e1,e2)	45	55	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	13	24	the effects of medicinal products with similar properties such as inotropes milrinone , enoximone , amrinone , olprinone and cilostazol may be exacerbated by anagrelide .
None(e1,e2)	56	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	65	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	6	11	the effects of mixing novolog with insulins of animal source or insulin preparations produced by other manufacturers have not been studied .
None(e1,e2)	5	8	concomitant medications were grouped as ace_inhibitors , oral anticoagulants , calcium channel blockers , beta blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	11	22	phenobarbital : coadministration of felbamate with phenobarbital causes an increase in phenobarbital plasma concentrations , in 12 otherwise healthy male volunteers ingesting phenobarbital , the steady-state trough ( cmin ) phenobarbital concentration was 14.2 micrograms/ml .
None(e1,e2)	102	104	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	1	13	although metoclopramide may increase the bioavailability of levodopa by increasing gastric emptying , metoclopramide may also adversely affect disease control by its dopamine receptor antagonistic properties .
None(e1,e2)	21	36	however , in the second study , administration of 12 g cholestyramine 1 hour before the evening meal and 0.3 mg cerivastatin_sodium approximately 4 hours after the same evening meal resulted in a decrease in the cerivastatin auc of less than 8 % , and a decrease in cmax of about 30 % when compared to dosing cerivastatin sodium alone .
None(e1,e2)	12	32	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	11	16	therefore , when meclofenamate sodium is given to a patient receiving warfarin , the dosage of warfarin should be reduced to prevent excessive prolongation of the prothrombin time .
None(e1,e2)	17	29	aprepitant increased the auc of midazolam by 25 % on day 4 and decreased the auc of midazolam by 19 % on day 8 relative to the dosing of aprepitant on days 1 through 3 .
None(e1,e2)	19	29	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	0	8	ketoconazole : when a single 125-mg dose of aprepitant was administered on day5 of a
effect(e1,e2)	0	21	erythromycin has been reported to decrease the clearance of triazolam and midazolam and thus may increase the pharmacologic effect of these benzodiazepines .
None(e1,e2)	2	33	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
advise(e1,e2)	13	20	patients should be warned of the potential danger of the intravenous self-administration of benzodiazepines while under treatment with suboxone or subutex .
None(e1,e2)	66	101	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	22	33	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	28	30	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine_oxidase_(_mao_)_inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	1	3	oral hypoglycemics : bepridil has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for insulin or oral hypoglycemic agents .
None(e1,e2)	13	40	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
effect(e1,e2)	9	39	concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with proleukin may increase toxicity in these organ systems .
None(e1,e2)	28	32	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	4	15	diminished urinary excretion of norfloxacin has been reported during the concomitant administration of probenecid and norfloxacin .
None(e1,e2)	63	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	40	46	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	20	35	it is recommended that buspirone hydrochloride not be used concomitantly with mao inhibitors because the effects of concomitant administration of buspirone_hcl with most other psychotropic drugs have not been studied , the concomitant use of buspirone_hcl with other cns-active drugs should be approached with caution .
None(e1,e2)	0	31	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	0	4	ketoconazole : co-administration of bosentan 125 mg b.i.d . and ketoconazole , a potent cyp3a4 inhibitor , increased the plasma concentrations of bosentan by approximately 2-fold .
None(e1,e2)	0	4	anticoagulants : potentiation of warfarin -type ( cyp2c9 and cyp3a4 substrate ) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding .
advise(e1,e2)	0	8	aspirin should be used cautiously in conjunction with corticosteroids in hypoprothrombinemia .
None(e1,e2)	31	36	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	2	4	or with multivitamins containing zinc may substantially interfere with drug absorption and result in insufficient plasma and tissue quinolone concentrations .
None(e1,e2)	93	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	14	24	insulin : a clinical study in 6 insulin-dependent diabetic patients demonstrated no effect of extraneal on insulin absorption from the peritoneal cavity or on insulin s ability to control blood glucose when insulin was administered intraperitoneally with extraneal .
None(e1,e2)	6	17	antihypertensive medications , other , especially diazoxide , or preanesthetic and anesthetic agents used in surgery or skeletal-muscle_relaxants , nondepolarizing , used in surgery
None(e1,e2)	38	49	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	37	39	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	16	23	however , the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline , interfere with the metabolism of caffeine , and enhance the effects of the oral anticoagulant warfarin and its derivatives , and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly .
None(e1,e2)	6	14	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	23	25	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	2	5	isoflurane or enflurane administered with nitrous_oxide /oxygen to achieve 1.25 mac [ minimum alveolar concentration ] may prolong the clinically effective duration of action of initial and maintenance doses of nimbex and decrease the required infusion rate of nimbex .
None(e1,e2)	74	112	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	23	33	toxicology studies of heroin-related deaths reveal frequent involvement of other central nervous system depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
None(e1,e2)	1	48	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	0	11	warfarin : the effect of celecoxib on the anti-coagulant effect of warfarin was studied in a group of healthy subjects receiving daily doses of 2-5 mg of warfarin .
None(e1,e2)	2	4	phenytoin , phenobarbital and carbamazepine are ge nerally classified as enzyme inducers ;
None(e1,e2)	31	60	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	22	42	effects of felbatol on low-dose combination oral contraceptives a group of 24 nonsmoking , healthy white female volunteers established on an oral contraceptive regimen containing 30 mg ethinyl estradiol and 75 mg gestodene for at least 3 months received 2400 mg/day of felbamate from midcycle ( day 15 ) to midcycle ( day 14 ) of two consecutive oral contraceptive cycles .
None(e1,e2)	7	9	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe , prolonged hypertension .
None(e1,e2)	63	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	10	19	effect of clonazepam on the pharmacokinetics of other drugs : clonazepam does not appear to alter the pharmacokinetics of phenytoin , carbamazepine , or phenobarbital .
effect(e1,e2)	9	18	corticosteroids : a relationship of functional antagonism exists between vitamin_d analogues , which promote calcium absorption , and corticosteroids , which inhibit calcium absorption .
effect(e1,e2)	16	18	methotrexate : an increased risk of hepatitis has been reported to result from combined use of methotrexate and etretinate .
None(e1,e2)	38	40	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	14	19	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim/ sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	71	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	71	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	7	13	cardiac effects of dopamine are antagonized by beta-adrenergic_blocking_agents , such as propranolol and metoprolol .
None(e1,e2)	7	14	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	2	31	antibiotics ( ampicillin , tetracycline ) : pregnancy has been reported following concomitant use , however , pharmacokinetic studies have not shown consistent effects with these antibiotics on plasma concentrations of synthetic_steroids .
None(e1,e2)	14	21	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine_antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	11	30	the following agents may increase certain actions or side effects of anticholinergic_drugs . amantadine antiarrhythmic agents of class ( e.g . quinidine ) , antihistamines antipsychotic agents ( e.g . phenothiazines ) , benzodiazepines .
effect(e1,e2)	9	36	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	32	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	2	9	drugs decreasing heparin effect : digitalis , tetracyclines , nicotine , or antihistamines may partially counteract the anticoagulant action of heparin sodium .
None(e1,e2)	0	5	diazepam : the co-administration of fluvoxamine tablets and diazepam is generally not advisable .
None(e1,e2)	8	18	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	40	56	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
effect(e1,e2)	10	15	there is one report suggesting that the concomitant use of trazodone_hydrochloride ( desyrel ) and buspirone_hcl may have caused 3- to 6-fold elevations on sgpt ( alt ) in a few patients .
None(e1,e2)	51	53	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	5	7	coadministration of ethoxzolamide with other diuretics , amphotericin_b , and corticosteroids may cause hypokalemia .
None(e1,e2)	68	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	5	7	digoxin : concomitant administration of erythromycin and digoxin has been reported to result in elevated digoxin serum levels .
None(e1,e2)	7	28	dopamine antagonists : since apomorphine is a dopamine_agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	14	16	caution in using concomitant drugs such as beta-blockers ( ophthalmic and systemic ) , anti-hypertensives and/or cardiac_glycosides is advised .
None(e1,e2)	33	42	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	21	73	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	58	60	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	34	61	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
mechanism(e1,e2)	19	40	macrolide antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot alkaloid class , of which d.h.e_._45 ( dihydroergotamine mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide_class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
None(e1,e2)	14	24	in addition to the interactions noted above , chronic ( 2 weeks ) oral cordarone administration impairs metabolism of phenytoin , dextromethorphan , and methotrexate .
None(e1,e2)	0	6	anticoagulants , oral : co-administration of corticosteroids and warfarin usually results in inhibition of response to warfarin , although there have been some conflicting reports .
None(e1,e2)	6	10	anesthetics/sedatives/hypnotics/opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
None(e1,e2)	14	22	administration of diltiazem hydrochloride concomitantly with propranolol in five normal volunteers resulted in increased propranolol levels in all subjects and bioavailability of propranolol was increased approximately 50 % .
None(e1,e2)	17	21	may lead to loss of virologic response and possible resistance to crixivan or to the class of protease_inhibitors or other coadministered antiretroviral_agents .
None(e1,e2)	33	41	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	10	34	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole_antifungal_agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	35	75	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	32	42	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	32	72	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	17	23	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	6	10	the patient was also chronically receiving phenytoin , phenobarbital , digoxin , and levothyroxine sodium .
effect(e1,e2)	8	25	in some patients , the administration of a non-_steroidal_antiinflammatory_agent can reduce the diuretic , natriuretic , and antihypertensive effects of loop , potassium- sparing and thiazide_diuretics .
None(e1,e2)	16	27	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	40	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	27	ketoconazole : in healthy subjects receiving ketoconazole , a cyp3a4 inhibitor , at 200 mg twice daily for 7 days , systemic exposure ( auc ) to lapatinib was increased to approximately 3.6-fold of control and half-life increased to 1.7-fold of control .
None(e1,e2)	18	20	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic_products , ace_inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	17	22	although additional drug interaction studies have not been conducted , the most common medications used concomitantly with anagrelide in clinical trials were aspirin , acetaminophen , furosemide , iron , ranitidine , hydroxyurea , and allopurinol .
mechanism(e1,e2)	6	12	ketoconazole - combined administration of racemic citalopram ( 40 mg ) and ketoconazole ( 200 mg ) decreased the cmax and auc of ketoconazole by 21 % and 10 % , respectively , and did not significantly affect the pharmacokinetics of citalopram .
None(e1,e2)	16	22	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	4	14	pharmacokinetic interaction studies with cetirizine in adults were conducted with pseudoephedrine , antipyrine , ketoconazole , erythromycin and azithromycin .
None(e1,e2)	45	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	13	22	digoxin : concomitant administration of tiagabine did not affect the steady-state pharmacokinetics of digoxin or the mean daily trough serum level of digoxin .
None(e1,e2)	0	10	coumarin_anticoagulant s : in a small clinical trial in which lovastatin was administered to warfarin treated patients , no effect on prothrombin time was detected .
None(e1,e2)	0	9	copaxone has not been formally evaluated in combination with interferon_beta .
None(e1,e2)	20	22	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	1	6	certain antibiotics , especially neomycin , streptomycin and kanamycin , have a mild but definite nondepolarizing blocking action which may accentuate neuromuscular block .
None(e1,e2)	18	32	cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation , the discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin .
None(e1,e2)	10	16	carbamazepine : isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels carbamazepine levels should be determined prior to concurrent administration with isoniazid , signs and symptoms of carbamazepine toxicity should be monitored closely , and appropriate dosage adjustment of the anticonvulsant should be made .
None(e1,e2)	57	71	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	107	123	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	13	22	alcohol - although lexapro did not potentiate the cognitive and motor effects of alcohol in a clinical trial , as with other psychotropic_medications , the use of alcohol by patients taking lexapro is not recommended .
None(e1,e2)	14	18	coadministration with compounds that are potent inducers of cyp3a4 ( eg , phenobarbital , phenytoin , dexamethasone , carbamazepine ) may result in decreased plasma levels of saquinavir .
None(e1,e2)	27	29	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	36	64	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	11	21	erythromycin has been reported to decrease the clearance of triazolam and midazolam and thus may increase the pharmacologic effect of these benzodiazepines .
None(e1,e2)	26	28	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	22	37	paclitaxel - in one report , l-glutamine at a dose of 10 grams three times daily , given 24 hours after receiving paclitaxel , appeared to prevent the development of myalgia and arthralgia , adverse reactions of paclitaxel .
None(e1,e2)	3	22	ace inhibitors and angiotensin_ii_receptor_antagonists ( congestive heart failure post-myocardial infarction ) - in ephesus , 3020 ( 91 % ) patients receiving inspra 25 to 50 mg also received ace inhibitors or angiotensin ii receptor antagonists ( acei/arb ) .
None(e1,e2)	53	59	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	11	43	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	11	35	no depressant effect on blood levels in humans was noted when colestipol_hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
mechanism(e1,e2)	8	17	in a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without propantheline ( an anticholinergic agent with multiple effects on the gi tract ) to healthy volunteers , the auc of clonazepam was 10 % lower and the cmax of clonazepam was 20 % lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone .
None(e1,e2)	2	25	drug-drug interactions albuterol - strattera should be administered with caution to patients being treated with systemically-administered ( oral or intravenous ) albuterol ( or other beta2_agonists ) because the action of albuterol on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure .
None(e1,e2)	0	13	lithium_carbonate ( 450 mg bid for 7 days ) had no effect on valdecoxib pharmacokinetics .
None(e1,e2)	0	7	selective_serotonin_reuptake_inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-htv agonists .
None(e1,e2)	36	51	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	2	43	- a nonsteroidal_anti-inflammatory_drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	17	27	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
mechanism(e1,e2)	16	50	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	24	37	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	27	29	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
mechanism(e1,e2)	11	16	antacids ( aluminum- or magnesium-containing ) : concomitant administration of 300-mg cefdinir capsules with 30 ml maalox_tc suspension reduces the rate ( cmax ) and extent ( auc ) of absorption by approximately 40 % .
None(e1,e2)	26	32	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	8	31	therefore , caution should be used when administering nitazoxanide concurrently with other highly plasma protein-bound drugs with narrow therapeutic indices , as competition for binding sites may occur ( e.g. , warfarin ) .
None(e1,e2)	10	53	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	0	21	digoxin : rofecoxib 75 mg once daily for 11 days does not alter the plasma concentration profile or renal elimination of digoxin after a single 0.5 mg oral dose .
advise(e1,e2)	8	21	it is not known if the effects of butorphanol are altered by concomitant medications that affect hepatic metabolism of drugs ( erythromycin , etc . ) , but physicians should be alert to the possibility that a smaller initial dose and longer intervals between doses may be needed .
effect(e1,e2)	15	23	the concurrent use of two or more drugs with anticholinergic activity -- such as an antipsychotic_drug ( eg , chlorpromazine ) , an antiparkinsonian_drug ( eg , trihexyphenidyl ) , and/or a tricyclic antidepressant ( eg , amitriptyline ) -- commonly results in excessive anticholinergic effects , including dry mouth and associated dental complications , blurred vision , and , in patients exposed to high temperature and humidity , hyperpyrexia .
None(e1,e2)	0	20	lithium generally should not be given with diuretics because they reduce its renal clearance and add a high risk of lithium toxicity .
None(e1,e2)	35	43	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	6	22	because cholestyramine binds bile acids , cholestyramine resin may interfere with normal fat digestion and absorption and thus may prevent absorption of fat_soluble_vitamins such as a , d , e , and k .
None(e1,e2)	5	7	since the concomitant administration of warfarin with amiodarone increases the prothrombin time by 100 % after 3 to 4 days , the dose of the anticoagulant should be reduced by one-third to one-half , and prothrombin times should be monitored closely .
None(e1,e2)	0	2	methotrexate : nsaids have been reported to competitively inhibit methotrexate accumulation in rabbit kidney slices .
None(e1,e2)	68	86	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	31	quinolone_antibiotic s : videx should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	16	28	digitalis : immediate release capsules : since there have been isolated reports of patients with elevated digoxin levels , and there is a possible interaction between digoxin and nifedipine , it is recommended that digoxin levels be monitored when initiating , adjusting , and discontinuing nifedipine to avoid possible over- or under-digitalization .
advise(e1,e2)	4	10	it is recommended that buspirone_hydrochloride not be used concomitantly with mao_inhibitors because the effects of concomitant administration of buspirone hcl with most other psychotropic drugs have not been studied , the concomitant use of buspirone hcl with other cns-active drugs should be approached with caution .
None(e1,e2)	12	25	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
mechanism(e1,e2)	16	20	pharmacokinetic data from these patients demonstrated a decrease in paclitaxel clearance of approximately 33 % when taxol was administered following cisplatin .
None(e1,e2)	0	15	insulin or oral hypoglycemics : agents with b-blocking properties may enhance the blood-sugar-reducing effect of insulin and oral hypoglycemics .
effect(e1,e2)	0	21	cyclopropane or halogenated hydrocarbon anesthetics increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered catecholamines , such as dopamine .
None(e1,e2)	95	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	12	45	this interaction , which has not been investigated using higher doses of fluvoxamine , may be more pronounced if a 300 mg daily dose is co-administered , particularly since fluvoxamine exhibits non-linear pharmacokinetics over the dosage range 100-300 mg . if alprazolam is co-administered with fluvoxamine tablets , the initial alprazolam dosage should be at least halved and titration to the lowest effective dose is recommended .
None(e1,e2)	90	98	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	17	22	in patients given very high doses ( 3900 mg ) of aspirin daily , increases in serum salicylate levels were seen when nizatidine , 150 mg b.i.d. , was administered concurrently .
None(e1,e2)	0	2	digoxin : digoxin concentrations are increased by about 15 % when digoxin and carvedilol are administered concomitantly .
None(e1,e2)	8	21	plasma concentrations ( auc 0-24 hrs ) of erythromycin decreased 15 % with coadministration of loratadine relative to that observed with erythromycin alone .
None(e1,e2)	39	43	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
mechanism(e1,e2)	10	29	while no in vivo drug-drug interaction studies were conducted between estazolam and inducers of cyp3a , compounds that are potent cyp3a inducers ( such as carbamazepine , phenytoin , rifampin , and barbiturates ) would be expected to decrease estazolam concentrations .
None(e1,e2)	0	2	antihypertensives : amphetamines may antagonize the hypotensive effects of antihypertensives .
None(e1,e2)	2	16	antacids , kaolin -pectin , sulfasalazine , neomycin , cholestyramine , certain anticancer drugs , and metoclopramide may interfere with intestinal digoxin absorption , resulting in unexpectedly low serum concentrations .
advise(e1,e2)	2	27	the iv methylprednisolone dose should be reduced by approximately 25 % , and the oral methylprednisolone dose should be reduced by approximately 50 % when coadministered with aprepitant to achieve exposures of methylprednisolone similar to those obtained when it is given without aprepitant .
None(e1,e2)	32	37	other concomitant therapy : although specific interaction studies were not performed , in clinical studies , cerivastatin sodium was used concomitantly with angiotensin- converting enzyme ( ace ) inhibitors , betablockers , calcium-channel_blockers , diuretics , and nonsteroidal_anti-inflammatory_drugs ( nsaids ) without evidence of clinically significant adverse interactions .
None(e1,e2)	18	20	welchol was found to have no significant effect on the bioavailability of digoxin , lovastatin , metoprolol , quinidine , valproic_acid , and warfarin .
None(e1,e2)	12	21	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	5	propanolol : the pharmacokinetics of almotriptan were not affected by coadministration of propranolol .
None(e1,e2)	28	30	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
mechanism(e1,e2)	3	12	benzodiazepines : combination hormonal_contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	29	39	protein binding in vitro , diclofenac interferes minimally or not at all with the protein binding of salicylic acid ( 20 % decrease in binding ) , tolbutamide , prednisolone ( 10 % decrease in binding ) , or warfarin .
None(e1,e2)	100	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	6	acetazolamide increases lithium excretion and the lithium may be decreased .
effect(e1,e2)	0	13	naproxen and other nsaids can reduce the antihypertensive effect of propranolol and other beta-blockers .
mechanism(e1,e2)	4	16	in addition , several aed s that are cytochrome p450 inducers can decrease plasma concentrations of oxcarbazepine and mhd .
None(e1,e2)	17	20	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot_derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	0	36	lithium : valdecoxib 40 mg bid for 7 days produced significant decreases in lithium serum clearance ( 25 % ) and renal clearance ( 30 % ) with a 34 % higher serum exposure compared to lithium alone .
None(e1,e2)	10	20	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc . ) is indicated , reduction of the budesonide dose should be considered .
mechanism(e1,e2)	2	9	when the stadol_ns was administered 30 minutes after the sumatriptan nasal spray , the auc of butorphanol increased 11 % and cmax decreased 18 % .
None(e1,e2)	12	13	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	2	6	synergism between xanthine_bronchodilators ( e.g. , theophylline ) , ephedrine , and other sympathomimetic bronchodilators has been reported .
None(e1,e2)	62	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	23	61	in three separate controlled , parallel group clinical pharmacology studies , desloratadine at the clinical dose of 5 mg has been coadministered with azithromycin 500 mg followed by 250 mg once daily for 4 days ( n=18 ) or with fluoxetine 20 mg once daily for 7 days after a 23 day pretreatment period with fluoxetine ( n=18 ) or with cimetidine 600 mg every 12 hours for 14 days ( n=18 ) under steady state conditions to normal healthy male and female volunteers .
None(e1,e2)	1	24	oral anticoagulants interaction studies with warfarin and acenocoumarol failed to identify any clinically important effects on the serum concentrations or clinical effects of these anticoagulants .
effect(e1,e2)	12	20	diuretics : studies in normal volunteers have shown that flurbiprofen like other nonsteroidal_anti-inflammatory_drugs , can interfere with the effects of furosemide .
None(e1,e2)	18	41	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	19	23	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	14	16	pharmacokinetic interaction studies with cetirizine in adults were conducted with pseudoephedrine , antipyrine , ketoconazole , erythromycin and azithromycin .
None(e1,e2)	127	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	18	38	no significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide , nifedipine , digoxin , warfarin , hydrochlorothiazide , and oral contraceptives in healthy volunteers , or given with enalapril to patients with heart failure ( nyha class ii and iii ) .
None(e1,e2)	16	76	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	11	17	may lead to loss of virologic response and possible resistance to crixivan or to the class of protease_inhibitors or other coadministered antiretroviral agents .
None(e1,e2)	0	2	acidifying_agents : gastrointestinal_acidifying_agents ( guanethidine , reserpine , glutamic acid hcl , ascorbic acid , fruit juices , etc . ) lower absorption of amphetamines .
mechanism(e1,e2)	0	17	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl_estradiol and/or some progestins , leading to possible decrease in contraceptive effectiveness .
None(e1,e2)	0	9	ketoconazole : co-administration of 200 mg twice-daily ketoconazole with aliskiren resulted in an approximate 80 % increase in plasma levels of aliskiren .
None(e1,e2)	0	21	valproate : a recent case study has shown a possible increase in the plasma level of valproate when co administered with isoniazid .
None(e1,e2)	11	13	drug-drug interactions in vitro studies using human liver microsomes indicate that fenofibrate and fenofibric_acid are not inhibitors of cytochrome ( cyp ) p450 isoforms cyp3a4 , cyp2d6 , cyp2e1 , or cyp1a2 .
mechanism(e1,e2)	5	13	serum theophylline concentrations increase when grepafloxacin is initiated in a patient maintained on theophylline .
None(e1,e2)	34	37	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine_oxidase_inhibitors , and beta_adrenergic_blocking_agents .
None(e1,e2)	36	42	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine_oxidase_inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	10	12	antidepressants , tricyclic : amphetamines may enhance the activity of tricyclic or sympathomimetic_agents ;
None(e1,e2)	38	51	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	3	13	the fraction of stadol_ns absorbed is unaffected by the concomitant administration of a nasal_vasoconstrictor ( oxymetazoline ) , but the rate of absorption is decreased .
effect(e1,e2)	8	10	nephrotoxicity has been reported following concomitant administration of aminoglycoside_antibiotics and cephalosporin_antibiotics .
None(e1,e2)	7	19	the concomitant use of transdermal fentanyl with ritonavir or other potent 3a4 inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
None(e1,e2)	4	6	clinical interaction studies with cimetidine and warfarin indicated that the coadministration of femara with these drugs does not result in clinically- significant drug interactions .
None(e1,e2)	0	21	magnesium : magnesium-containing preparations ( eg , antacids ) may cause hypermagnesemia and should therefore not be taken during therapy with vitamin_d by patients on chronic renal dialysis .
mechanism(e1,e2)	5	10	barbiturates , phenytoin , or rifampin increased metabolic clearance of fludrocortisone_acetate because of the induction of hepatic enzymes .
None(e1,e2)	6	10	however , co-administration of duloxetine with aluminum - and magnesium-containing antacids ( 51 meq ) or duloxetine with famotidine , had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose .
None(e1,e2)	40	42	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	53	61	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	13	17	the potential for drug interactions with emtriva has been studied in combination with indinavir , stavudine , famciclovir , and tenofovir disoproxil fumarate .
None(e1,e2)	4	18	although the interaction between almotriptan and other potent cyp3a4 inhibitors ( e.g. , itraconazole , ritonavir , and erythromycin ) has not been studied , increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications .
None(e1,e2)	19	23	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic_agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
None(e1,e2)	0	4	digoxin , methotrexate , cyclosporine : diclofenac , like other nsaids , may affect renal prostaglandins and increase the toxicity of certain drugs .
None(e1,e2)	55	129	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
None(e1,e2)	9	20	anticoagulants including coumarin derivatives , indandione derivatives , and platelet_aggregation_inhibitors such as nonsteroidal anti-inflammatory drugs ( nsaids ) , and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin .
None(e1,e2)	56	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	27	monoamine_oxidase_inhibitors and tricyclic antidepressants : foradil should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents .
None(e1,e2)	33	38	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	7	9	concomitant use of antihistamines with alcohol , tricyclic_antidepressants , barbiturates , or other central nervous system depressants may have an additive effect .
None(e1,e2)	6	12	hmg-coa reductase inhibitors : simvastatin ( cyp3a4 substrate ) in combination with amiodarone has been associated with reports of myopathy/rhabdomyolysis .
advise(e1,e2)	8	26	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	46	76	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	32	44	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	4	16	these include probenecid , cholestyramine , and some antibiotics ( e.g . erythromycin , rifamipicin , ampicillin and chloramphenicol ) .
None(e1,e2)	17	19	therefore , coadministration of aprepitant with drugs that strongly induce cyp3a4 activity ( e.g. , rifampin , carbamazepine , phenytoin ) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of aprepitant .
mechanism(e1,e2)	5	11	cimetidine , caffeine , and erythromycin may increase plasma levels of clozapine , potentially resulting in adverse effects .
None(e1,e2)	4	15	the similarity of the tysabri -associated adverse event profile between study 1 ( without co-administered avonex ) and study 2 ( with co-administered avonex ) indicates that this alteration in clearance does not necessitate reduction of the tysabri dose to maintain safety , general ) .
None(e1,e2)	0	2	ibuprofen - l-arginine may increase the absorption of ibuprofen if taken concomitantly .
None(e1,e2)	12	30	interactions with other cns agents : concurrent use of levo-dromoran with all central_nervous_system_depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic_antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	96	98	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	18	20	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	29	46	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin b , cyclosporine , non-steroidal anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
None(e1,e2)	8	14	there is no information regarding the effect on lamivudine pharmacokinetics of higher doses of tmp /smx such as those used to treat pneumocystis carinii pneumonia .
None(e1,e2)	5	38	concomitant medications were grouped as ace_inhibitors , oral anticoagulants , calcium channel blockers , beta blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	10	19	erythromycin use in patients who are receiving high doses of theophylline may be associated with an increase in serum theophylline levels and potential theophylline toxicity .
None(e1,e2)	11	15	and disulfiram when amitriptyline hcl is given with anticholinergic agents or sympathomimetic drugs , including epinephrine combined with local anesthetics , close supervision and careful adjustment of dosages are required .
effect(e1,e2)	17	21	lithium : increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ace_inhibitors during therapy with lithium .
None(e1,e2)	7	9	iron salts may reduce the bioavailability of carbidopa and levodopa .
None(e1,e2)	20	33	however , because bleeding has been reported when ibuprofen and other nonsteroidal anti-inflammatory agents have been administered to patients on coumarin-type_anticoagulants , the physician should be cautious when administering ibuprofen to patients on anticoagulants .
None(e1,e2)	41	49	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	21	52	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	78	111	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	1	3	both crixivan and atazanavir are associated with indirect ( unconjugated ) hyperbilirubinemia .
None(e1,e2)	28	31	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	44	116	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	40	44	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium_chloride , folic acid , and acetaminophen .
None(e1,e2)	42	44	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	22	32	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
mechanism(e1,e2)	4	18	warfarin : co-administration of bosentan 500 mg b.i.d . for 6 days decreased the plasma concentrations of both s-warfarin ( a cyp2c9 substrate ) and r-warfarin ( a cyp3a4 substrate ) by 29 and 38 % , respectively .
None(e1,e2)	7	24	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	0	12	labetalol_hcl has also been reported to produce a false positive test for amphetamine when screening urine for the presence of drugs using the commercially available assay methods toxi-lab a ( thin-layer chromatographic assay ) and emit-d.a.u . ( radioenzymatic assay ) .
None(e1,e2)	24	27	if the usual amounts of nondepolarizing relaxants are given , the time for recovery from neuromuscular blockade will be longer in the presence of enflurane than when halothane or nitrous oxide with a balanced technique are used .
None(e1,e2)	31	36	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	24	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	6	naproxen : the concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of naproxen , but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite .
None(e1,e2)	38	85	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	9	anticoagulants including coumarin derivatives , indandione derivatives , and platelet_aggregation_inhibitors such as nonsteroidal anti-inflammatory drugs ( nsaids ) , and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin .
None(e1,e2)	42	57	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	0	14	gleevec will increase plasmaconcentration of other cyp3a4 metabolized drugs ( e.g. , triazolo-benzodiazepines , dihydropyridine_calcium_channel_blockers , certain hmg-coa reductase inhibitors , etc . ) .
None(e1,e2)	0	5	cholestyramine increases enterohepatic elimination of amiodarone and may reduce its serum levels and t1/2 .
None(e1,e2)	33	48	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	35	37	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine_derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	0	6	immunosuppressive_drugs , fibric acid derivatives , niacin ( nicotinic acid , erythromycin , azole antifungals : skeletal muscle .
None(e1,e2)	0	2	chlorpromazine : chlorpromazine blocks dopamine and norepinephrine receptors , thus inhibiting the central stimulant effects of amphetamines and can be used to treat amphetamine poisoning .
None(e1,e2)	3	5	while all the selective_serotonin_reuptake_inhibitors ( ssris ) , e.g. , fluoxetine , sertraline , paroxetine , and fluvoxamine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	12	41	antihypertensives : amiodarone should be used with caution in patients receiving - receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
mechanism(e1,e2)	0	6	enoxacin interferes with the metabolism of theophylline resulting in a 42 % to 74 % dose-related decrease in theophylline clearance and a subsequent 260 % to 350 % increase in serum theophylline levels .
None(e1,e2)	19	115	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	12	administration of diltiazem_hydrochloride with digoxin in 24 healthy male subjects increased plasma digoxin concentrations approximately 20 % .
None(e1,e2)	51	54	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	12	18	caution should be exercised when the following drugs are administered concomitantly with lodosyn ( carbidopa ) given with levodopa or carbidopa-levodopa combination products .
None(e1,e2)	38	40	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
effect(e1,e2)	6	8	however , the concomitant use of argatroban and warfarin ( 5-7.5 mg initial oral dose followed by 2.5-6 mg/day orally for 6-10 days ) results in prolongation of the prothrombin time ( pt ) and international normalized ratio ( inr ) .
None(e1,e2)	48	56	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	2	4	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	5	11	warfarin : the effect of valdecoxib on the anticoagulant effect of warfarin ( 1 - 8 mg/day ) was studied in healthy subjects by coadministration of bextra 40 mg bid for 7 days .
None(e1,e2)	26	28	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic_acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
effect(e1,e2)	3	7	concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia .
None(e1,e2)	7	20	lithium generally should not be given with diuretics because they reduce lithiums renal clearance and add a high risk of lithium toxicity .
None(e1,e2)	6	29	the possibility of hypotensive effects with captopril can be minimized by either discontinuing the diuretic or increasing the salt intake approximately one week prior to initiation of treatment with captopril ( captopril tablets , usp ) or initiating therapy with small doses ( 6.25 or 12.5 mg ) .
None(e1,e2)	26	31	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	0	4	pyrantel ( e.g. , antiminth ) - taking piperazine and pyrantel together may decrease the effects of piperazine .
None(e1,e2)	10	36	- when bezalip or bezalip retard is used concurrently with anion-exchange_resins ( e.g . cholestryramine ) , an interval of at least 2 hours should be maintained between the two medicines , since the absorption of bezalip or bezalip retard is impaired
None(e1,e2)	3	9	ergot derivatives : dihydroergotamine , ergonovine , ergotamine , methylergonovine
int(e1,e2)	0	32	benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
None(e1,e2)	27	38	valproate : available data suggest that there is no significant effect of valproate on the clearance of felbatol at steady state , therefore , the addition of valproate is not expected to cause a clinically important effect on felbatol ( felbamate ) plasma concentrations .
None(e1,e2)	7	15	beta-adrenergic blocking agents : the effect of flurbiprofen on blood pressure response to propranolol and atenolol was evaluated in men with mild uncomplicated hypertension ( n = 10 ) .
None(e1,e2)	4	37	total body clearance of simulect was reduced by an average 22 % and 51 % when azathioprine and mycophenolate mofetil , respectively , were added to a regimen consisting of cyclosporine , usp ( modified ) and corticosteroids .
None(e1,e2)	0	2	nicotine : nicotine may provoke vasoconstriction in some patients , predisposing to a greater ischemic response to ergot therapy .
None(e1,e2)	42	84	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
mechanism(e1,e2)	11	37	binding to serum proteins : the following agents may either inhibit levothyroxine_sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing_compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	23	30	h2 receptor antagonists : cimetidine coadministration leads to an increased peak plasma concentration and auc of cisapride , there is no effect on cisapride absorption when it is coadministered with ranitidine .
None(e1,e2)	106	118	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	18	carbamazepine : felbatol causes a decrease in the steady-state carbamazepine plasma concentrations and an increase in the steady-state carbamazepine_epoxide plasma concentration .
None(e1,e2)	28	33	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	16	19	in addition , under the influence of sympatholytic medicinal products such as beta-blockers , clonidine , guanethidine , and reserpine , the signs of hypoglycemia may be reduced or absent .
None(e1,e2)	118	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	8	40	in addition to bleeding associated with heparin and vitamin_k_antagonists , drugs that alter platelet function ( such as acetylsalicylic acid , dipyridamole and abciximab ) may increase the risk of bleeding if administered prior to , during , or after activase therapy .
None(e1,e2)	17	21	drug interaction studies have shown that esomeprazole does not have any clinically significant interactions with phenytoin , warfarin , quinidine , clarithromycin or amoxicillin .
None(e1,e2)	28	32	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	2	8	ibuprofen - l-arginine may increase the absorption of ibuprofen if taken concomitantly .
None(e1,e2)	5	20	other drug interactions oral contraceptives keppra ( 500 mg twice daily ) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel , or of the luteinizing hormone and progesterone levels , indicating that impairment of contraceptive efficacy is unlikely .
None(e1,e2)	6	12	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	31	33	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic_antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	17	19	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	61	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	33	56	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout_drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	18	22	in a controlled clinical trial , a 20 % reduction of the phenytoin dose at the initiation of felbatol therapy resulted in phenytoin levels comparable to those prior to felbatol administration .
None(e1,e2)	27	29	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
mechanism(e1,e2)	36	41	a study in eight healthy volunteers has shown a 50 % increase in mean peak nimodipine plasma concentrations and a 90 % increase in mean area under the curve , after a one week course of cimetidine at 1,000 mg/day and nimodipine at 90 mg/day .
None(e1,e2)	9	13	during clinical trials , iloprost was used concurrently with anticoagulants , diuretics , cardiac_glycosides , calcium channel blockers , analgesics , antipyretics , nonsteroidal antiinflammatories , corticosteroids , and other medications .
None(e1,e2)	9	15	cephalosporins-cephalosporins containing side chains of n-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin k deficiency and hypoprothrombinemia .
None(e1,e2)	5	12	tetracyclines : concomitant treatment with accutane and tetracyclines should be avoided because accutane use has been associated with a number of cases of pseudotumor cerebri ( benign intracranial hypertension ) , some of which involved concomitant use of tetracyclines
effect(e1,e2)	0	10	cyclopentolate may interfere with the anti-glaucoma action of carbachol or pilocarpine ;
None(e1,e2)	13	28	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	57	129	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
None(e1,e2)	50	64	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	2	8	methotrexate : ibuprofen , as well as other nonsteroidal_anti-inflammatory_drugs , probably reduces the tubular secretion of methotrexate based on in vitro studies in rabbit kidney slices .
mechanism(e1,e2)	4	10	ketoconazole : co-administration of bosentan 125 mg b.i.d . and ketoconazole , a potent cyp3a4 inhibitor , increased the plasma concentrations of bosentan by approximately 2-fold .
None(e1,e2)	28	46	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	6	38	because changes in glucose concentrations with valdecoxib coadministration were within the normal variability and individual glucose concentrations were above or near 70 mg/dl , dose adjustment for glyburide ( 5 mg qd and 10 mg bid ) with valdecoxib coadministration ( up to 40 mg qd ) is not indicated .
None(e1,e2)	2	11	- a diuretic ( water pill ) such as hydrochlorothiazide ( hctz , hydrodiuril ) , chlorothiazide ( diuril ) , and others ;
None(e1,e2)	12	26	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease_inhibitors , quinidine , and verapamil .
None(e1,e2)	5	13	colestipol : plasma concentrations of atorvastatin decreased approximately 25 % when colestipol and atorvastatin were coadministered .
None(e1,e2)	12	18	the incidence of upper gastrointestinal events in patients concomitantly taking aspirin or nsaids was similar in patients taking ibandronate 2.5 mg daily ( 21.7 % ) and 150 mg once monthly ( 22.0 % ) .
None(e1,e2)	2	4	antacids containing aluminum_hydroxide and magnesium_hydroxide reduce the oral absorption of enoxacin by 75 % .
None(e1,e2)	124	148	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	8	phenobarbital : amphetamines may delay intestinal absorption of phenobarbital ;
None(e1,e2)	28	30	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	23	55	in three separate controlled , parallel group clinical pharmacology studies , desloratadine at the clinical dose of 5 mg has been coadministered with azithromycin 500 mg followed by 250 mg once daily for 4 days ( n=18 ) or with fluoxetine 20 mg once daily for 7 days after a 23 day pretreatment period with fluoxetine ( n=18 ) or with cimetidine 600 mg every 12 hours for 14 days ( n=18 ) under steady state conditions to normal healthy male and female volunteers .
mechanism(e1,e2)	11	13	digoxin : digoxin concentrations are increased by about 15 % when digoxin and carvedilol are administered concomitantly .
None(e1,e2)	11	40	drug interactions : flupenthixol may interact with some drugs , like monoamine_oxidase_inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	26	35	omeprazole : no clinically significant changes in lomefloxacin pharmacokinetics ( auc , c max , or t max ) were observed when a single dose of lomefloxacin 400 mg was given after multiple doses of omeprazole ( 20 mg qd ) in 13 healthy volunteers .
None(e1,e2)	69	125	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	29	49	warfarin : in a study in healthy volunteers , no clinically relevant pharmacokinetic or pharmacodynamic interaction between isradipine and racemic warfarin was seen when two single oral doses of warfarin ( 0.7 mg/kg body weight ) were administered during 11 days of multipledose treatment with 5 mg b.i.d . isradipine .
None(e1,e2)	15	22	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	0	39	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	30	32	although additional drug interaction studies have not been conducted , the most common medications used concomitantly with anagrelide in clinical trials were aspirin , acetaminophen , furosemide , iron , ranitidine , hydroxyurea , and allopurinol .
effect(e1,e2)	9	31	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	20	22	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	17	27	approximately 2/3 of the patients in the phase 3 study received either prophylactic low dose heparin ( unfractionated_heparin up to 15,000 units/day ) or prophylactic doses of low_molecular_weight_heparins as indicated in the prescribing information for the specific products .
None(e1,e2)	63	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	18	welchol was found to have no significant effect on the bioavailability of digoxin , lovastatin , metoprolol , quinidine , valproic acid , and warfarin .
None(e1,e2)	18	32	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	0	6	cimetidine : in the presence of cimetidine at 300 mg qid ( n=12 ) the mean apparent oral clearance of gabapentin fell by 14 % and creatinine clearance fell by 10 % .
None(e1,e2)	27	52	paroxetine : coadministration of once daily doses of aprepitant , as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation , with paroxetine 20 mg once daily , resulted in a decrease in auc by approximately 25 % and cmax , by approximately 20 % of both aprepitant and paroxetine .
None(e1,e2)	31	33	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	12	16	selective serotonin reuptake inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-htv agonists .
None(e1,e2)	23	25	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	7	17	ethanol : clinical evidence has shown that etretinate can be formed with concurrent ingestion of acitretin and ethanol .
None(e1,e2)	7	19	co-administration of cyp3a4 inhibitors ( eg , ketoconazole , itraconazole , erythromycin , grapefruit juice , cimetidine ) with felodipine may lead to several- fold increases in the plasma levels of felodipine , either due to an increase in bioavailability or due to a decrease in metabolism .
None(e1,e2)	26	107	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	24	29	oral contraceptives : aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl_estradiol and 1 mg of norethindrone , decreased the auc of ethinyl estradiol by 43 % , and decreased the auc of norethindrone by 8 % ;
None(e1,e2)	93	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	55	81	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	8	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	7	12	population pharmacokinetic analyses revealed that mtx , nsaids , corticosteroids , and tnf_blocking_agents did not influence abatacept clearance .
None(e1,e2)	24	63	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	105	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	32	concomitant administration of diflunisal and acetaminophen in dogs , but not in rats , at approximately 2 times the recommended maximum human therapeutic dose of each ( 40 to 52 mg/kg/day of diflunisal /acetaminophen ) resulted in greater gastrointestinal toxicity than when either drug was administered alone .
None(e1,e2)	2	5	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	26	34	the following are examples of drugs known to inhibit the metabolism of other related benzodiazepines , presumably through inhibition of cyp3a : nefazodone , fluvoxamine , cimetidine , diltiazem , isoniazide , and some macrolide_antibiotics .
None(e1,e2)	31	35	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic agents ) or drugs which inhibit platelet function ( eg , aspirin and other non-steroidal_anti-inflammatory_drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
mechanism(e1,e2)	4	13	hiv protease inhibitors : indinavir ( 800 mg t.i.d . ) co-administered with vardenafil 10 mg resulted in a 16-fold increase in vardenafil auc , a 7-fold increase in vardenafil cmax and a 2-fold increase in vardenafil half-life .
None(e1,e2)	31	54	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	44	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	8	12	blood levels of hydrodolasetron increased 24 % when dolasetron was coadministered with cimetidine ( nonselective inhibitor of cytochrome p-450 ) for 7 days , and decreased 28 % with coadministration of rifampin ( potent inducer of cytochrome p-450 ) for 7 days .
None(e1,e2)	59	70	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	17	20	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal_anti-inflammatory_agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	15	18	if a patient requires tikosyn and anti-ulcer therapy , it is suggested that omeprazole , ranitidine , or antacids ( aluminum and magnesium hydroxides ) be used as alternatives to cimetidine , as these agents have no effect on the pharmacokinetic profile of tikosyn .
None(e1,e2)	39	95	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	70	78	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease_inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	3	gemfibrozil other fibrates niacin ( nicotinic acid ) ( =1 g/day )
None(e1,e2)	33	57	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	16	19	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	0	4	fluconazole and ketoconazole : ketoconazole and fluconazole are predominantly cyp 3a4 and 2c9 inhibitors , respectively .
effect(e1,e2)	8	51	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	46	118	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	53	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	7	12	drugs decreasing heparin effect : digitalis , tetracyclines , nicotine , or antihistamines may partially counteract the anticoagulant action of heparin sodium .
None(e1,e2)	0	6	estrogens , including oral contraceptives : estrogens may decrease the hepatic metabolism of certain corticosteroids , thereby increasing their effect .
None(e1,e2)	46	52	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	13	curariform_muscle_relaxants ( eg , tubocurarine ) and other drugs , including ether , succinylcholine , gallamine , decamethonium and sodium citrate , potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with coly-mycin m parenteral .
None(e1,e2)	4	34	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	30	32	lithium - coadministration of racemic citalopram ( 40 mg/day for 10 days ) and lithium ( 30 mmol/day for 5 days ) had no significant effect on the pharmacokinetics of citalopram or lithium .
None(e1,e2)	5	16	drugs that inhibit cyp3a4 ( ketoconazole ) cyp3a4 is a major metabolic pathway for elimination of eszopiclone .
None(e1,e2)	13	21	theophylline : as with some other quinolones , concurrent administration of ciprofloxacin with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life .
None(e1,e2)	8	44	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
advise(e1,e2)	9	12	this interaction should be given consideration in patients taking bextra concomitantly with ace-inhibitors .
None(e1,e2)	2	7	drugs decreasing heparin effect : digitalis , tetracyclines , nicotine , or antihistamines may partially counteract the anticoagulant action of heparin sodium .
None(e1,e2)	19	23	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
None(e1,e2)	4	31	antibiotics ( ampicillin , tetracycline ) : pregnancy has been reported following concomitant use , however , pharmacokinetic studies have not shown consistent effects with these antibiotics on plasma concentrations of synthetic_steroids .
None(e1,e2)	30	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	25	amiodarone or verapamil : the risk of myopathy/rhabdomyolysis is increased when either amiodarone or verapamil is used concomitantly with a closely related member of the hmg-coa_reductase_inhibitor_class ( see warnings , myopathy/rhabdomyolysis ) .
None(e1,e2)	31	38	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	1	12	if desipramine_hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
None(e1,e2)	0	27	anticonvulsants : in a pharmacokinetic study , maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long-term anticonvulsant therapy ( eg , phenytoin , carbamazepine , or phenobarbital ) than in healthy volunteers .
None(e1,e2)	15	21	due to high inter-patient variability and limited sampling , the extent of the increase in sn38 levels in patients receiving concurrent irinotecan and avastin is uncertain .
effect(e1,e2)	0	14	clozapine may potentiate the hypotensive effects of antihypertensive drugs and the anticholinergic effects of atropine -type drugs .
None(e1,e2)	16	18	toxicology studies of heroin-related deaths reveal frequent involvement of other central nervous system depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
None(e1,e2)	18	25	other drug interactions : no pharmacokinetic interactions were observed between vardenafil and the following drugs : glyburide , warfarin , digoxin , maalox , and ranitidine .
None(e1,e2)	9	11	platelet inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
None(e1,e2)	21	63	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
mechanism(e1,e2)	18	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	16	23	phenytoin : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking phenytoin with or without other enzyme- inducing aeds .
advise(e1,e2)	6	34	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	1	8	cephalosporins- cephalosporins containing side chains of n-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin k deficiency and hypoprothrombinemia .
None(e1,e2)	35	84	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	45	59	this drug may interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
effect(e1,e2)	13	16	there is one report suggesting that the concomitant use of trazodone hydrochloride ( desyrel ) and buspirone_hcl may have caused 3- to 6-fold elevations on sgpt ( alt ) in a few patients .
None(e1,e2)	35	40	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	25	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	13	15	platelet inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
None(e1,e2)	10	23	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole_antifungal_agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	0	4	terfenadine , astemizole and cisapride are all metabolized by the cytochrome p450iiia4 isozyme , and it has been demonstrated that ketoconazole , a potent inhibitor of iiia4 , blocks the metabolism of these drugs , resulting in increased plasma concentrations of parent drug .
None(e1,e2)	13	30	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	29	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	12	22	nabilone should be administered with caution to patients who are taking other psychoactive_drugs or cns depressants , including alcohol , barbiturates and narcotic_analgesics , or to those with a history of psychiatric disorder ( including manic-depressive illness and schizophrenia ) .
None(e1,e2)	0	2	corticosteroids : dexamethasone : aprepitant , when given as a regimen of 125mg with dexamethasone coadministered orally as 20 mg on day 1 , and aprepitant when given as 80 mg/day with dexamethasone coadministered orally as 8 mg on days 2 through 5 , increased the auc of dexamethasone , a cyp3a4 substrate by 2.2-fold , on days 1 and 5 .
None(e1,e2)	13	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	37	65	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	30	34	drugs that may alter imatinib plasma concentrations drugs that may increase imatinib plasma concentrations : caution is recommended when administering gleevec with inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , erythromycin , clarithromycin ) .
None(e1,e2)	50	57	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	14	38	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	8	10	analgesic/anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
None(e1,e2)	0	2	sedatives / hypnotics : triazolam , midazolam contraindicated due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression .
None(e1,e2)	1	16	oral anticoagulants : in some normal volunteers , the concomitant administration of diflunisal and warfarin , acenocoumarol , or phenprocoumon resulted in prolongation of prothrombin time .
None(e1,e2)	110	118	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	29	co-administration of botox and aminoglycosides or other agents interfering with neuromuscular transmission ( e.g. , curare-like compounds ) should only be performed with caution as the effect of the toxin may be potentiated .
None(e1,e2)	9	31	drug interactions with antacids administration of 120 mg of fexofenadine_hydrochloride ( 2 x 60 mg capsule ) within 15 minutes of an aluminum and magnesium containing antacid ( maalox ) decreased fexofenadine auc by 41 % and cmax by 43 % .
None(e1,e2)	0	7	heparin_sodium injection should not be mixed with doxorubicin , droperidol , ciprofloxacin , or mitoxantrone , since it has been reported that these drugs are incompatible with heparin and a precipitate may form .
mechanism(e1,e2)	10	21	phenobarbital ( primidone ) : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking phenobarbital ( primidone ) with or without other enzyme-inducing aeds .
None(e1,e2)	24	40	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	1	18	oral contraceptives : valdecoxib ( 40 mg bid ) did not induce the metabolism of the combination oral contraceptive norethindrone/ethinyl estradiol ( 1 mg /35 mcg combination , ortho-novum 1/35 ) .
None(e1,e2)	0	9	vecuronium : when used in the perioperative period , piperacillin has been implicated in the prolongation of the neuromuscular blockade of vecuronium .
None(e1,e2)	1	21	although betagan used alone has little or no effect on pupil size , mydriasis resulting from concomitant therapy with betagan and epinephrine may occur .
None(e1,e2)	9	13	omeprazole : the rate and extent of absorption of ciprofloxacin was bioequivalent when proquin_xr was given alone or when proquin xr was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion .
None(e1,e2)	21	48	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	15	specific effects of felbatol on other antiepileptic_drugs phenytoin : felbatol causes an increase in steady-state phenytoin plasma concentrations .
effect(e1,e2)	31	34	for these reasons , it is felt that , in most subjects who have had an unsatisfactory lipid response to either drug alone , the possible benefits of combined therapy with lovastatin and a fibrate do not outweigh the risks of severe myopathy , rhabdomyolysis , and acute renal failure .
None(e1,e2)	25	45	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type_1c_antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	32	40	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot_derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	62	64	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	35	45	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type_1c_antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	4	6	interaction with phenytoin , lidocaine and theophylline has also been reported to produce adverse clinical effects .
None(e1,e2)	24	29	these medications have included heparin , warfarin , beta-adrenergic receptor blockers , calcium channel antagonists , angiotensin converting enzyme inhibitors , intravenous and oral nitrates , ticlopidine , and aspirin .
None(e1,e2)	15	22	in general , these are drugs that have one or more pharmacologic activities similar to bepridil_hydrochloride , including anti-arrhythmic agents such as quinidine and procainamide , cardiac glycosides and tricyclic anti-depressants .
None(e1,e2)	31	33	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	10	12	caution should be observed when anileridine is coadministered with other opioids , sedatives , phenothiazines , or anesthetics , as these agents may increase respiratory and circulatory depression .
None(e1,e2)	44	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	23	48	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	8	26	no drug interaction studies have been conducted for colazal , however the use of orally administered antibiotics could , theoretically , interfere with the release of mesalamine in the colon .
None(e1,e2)	50	65	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
effect(e1,e2)	13	29	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline_hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
None(e1,e2)	0	3	digoxin : some calcium_blockers may increase the concentration of digitalis preparations in the blood .
mechanism(e1,e2)	6	8	this small decrease in excretion of gabapentin by cimetidine is not expected to be of clinical importance .
None(e1,e2)	19	21	data from several studies , ie , timi-ii , isis-2 , currently do not suggest any clinical interaction between aspirin and beta_blockers in the acute myocardial infarction setting .
None(e1,e2)	22	36	other concomitant therapy : although specific interaction studies were not performed , in clinical studies , cerivastatin sodium was used concomitantly with angiotensin-_converting_enzyme_(_ace_)_inhibitors , betablockers , calcium-channel blockers , diuretics , and nonsteroidal anti-inflammatory drugs ( nsaids ) without evidence of clinically significant adverse interactions .
None(e1,e2)	2	31	midazolam : aprepitant increased the auc of midazolam , a sensitive cyp3a4 substrate , by 2.3-fold on day 1 and 3.3-fold on day 5 , when a single oral dose of midazolam 2 mg was coadministered on day 1 and day 5 of a regimen of aprepitant 125 mg on day 1 and 80 mg/day on days 2 through 5 .
effect(e1,e2)	4	30	as with some other nondepolarizing_neuromuscular_blocking_agents , the time of onset of neuromuscular block induced by nuromax is lengthened and the duration of block is shortened in patients receiving phenytoin or carbamazepine .
effect(e1,e2)	33	39	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	0	5	aspirin : concurrent administration of aspirin may lower meclofenamate sodium plasma levels , possibly by competing for protein-binding sites .
None(e1,e2)	22	30	if a patient requires tikosyn and anti-ulcer therapy , it is suggested that omeprazole , ranitidine , or antacids ( aluminum and magnesium_hydroxide s ) be used as alternatives to cimetidine , as these agents have no effect on the pharmacokinetic profile of tikosyn .
None(e1,e2)	4	6	in clinical studies with propecia ( finasteride , 1 mg ) in men 18-41 years of age , the mean value of serum prostate-specific antigen ( psa ) decreased from 0.7 ng/ml at baseline to 0.5 ng/ml at month 12 .
None(e1,e2)	0	31	midazolam : aprepitant increased the auc of midazolam , a sensitive cyp3a4 substrate , by 2.3-fold on day 1 and 3.3-fold on day 5 , when a single oral dose of midazolam 2 mg was coadministered on day 1 and day 5 of a regimen of aprepitant 125 mg on day 1 and 80 mg/day on days 2 through 5 .
None(e1,e2)	10	20	coadministration of oral contraceptives , diazepam , phenytoin , or quinidine did not seem to change the pharmacokinetic profile of esomeprazole .
None(e1,e2)	40	90	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	24	26	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim/sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	5	7	potassium-sparing diuretics ( spironolactone , amiloride , triamterene , and others ) or potassium supplements can increase the risk of hyperkalemia .
None(e1,e2)	3	5	the effect of gabapentin on cimetidine was not evaluated .
None(e1,e2)	49	78	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics * ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin_c ; warfarin sodium under-dosage .
None(e1,e2)	105	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	48	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
effect(e1,e2)	8	10	vitamin a : because of the relationship of accutane to vitamin_a , patients should be advised against taking vitamin supplements containing vitamin a to avoid additive toxic effects
None(e1,e2)	25	45	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta_blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
effect(e1,e2)	0	16	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
None(e1,e2)	0	22	furosemide : clinical studies , as well as post marketing observations , have shown that nsaids can reduce the natriuretic effect of furosemide and thiazides in some patients .
None(e1,e2)	83	85	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	8	paroxetine : coadministration of once daily doses of aprepitant , as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation , with paroxetine 20 mg once daily , resulted in a decrease in auc by approximately 25 % and cmax , by approximately 20 % of both aprepitant and paroxetine .
None(e1,e2)	11	34	although there have been no formal interaction studies other than with antipyrine , based on these in vivo and in vitro studies , it is unlikely that co-administration of a 1 mg dose of arimidex with other drugs will result in clinically significant drug inhibition of cytochrome p450-mediated metabolism of the other drugs .
None(e1,e2)	8	32	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	4	6	other reported interactions with amiodarone : fentanyl ( cyp3a4 substrate ) in combination with amiodarone may cause hypotension , bradycardia , and decreased cardiac output .
mechanism(e1,e2)	18	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	11	28	antacids : concomitant administration of antacids containing magnesium or aluminum with videx chewable/dispersible buffered tablets or pediatric powder for oral solution may potentiate adverse events associated with the antacid components .
None(e1,e2)	7	11	as noted below , a sub- for fluvoxamine in combination with alprazolam , a drug that is known to be metabolized by the iiia4 isozyme .
None(e1,e2)	21	33	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	21	25	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	0	14	antacid : when atorvastatin and maalox tc suspension were coadministered , plasma concentrations of atorvastatin decreased approximately 35 % .
advise(e1,e2)	7	17	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	15	19	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	12	19	the concurrent use of intravenously or orally administered methylxanthines ( e.g. , aminophylline , theophylline ) by patients receiving brovana has not been completely evaluated .
effect(e1,e2)	0	12	chloramphenicol has been shown to be antagonistic to beta-lactam antibiotics , including ceftazidime , based on in vitro studies and time kill curves with enteric gram-negative bacilli .
None(e1,e2)	3	18	concurrent administration of cimetidine and tricyclic antidepressants can produce clinically significant increases in the plasma levels of the tricyclic_antidepressants .
None(e1,e2)	7	20	- a sulfa-based drug such as sulfamethoxazole- trimethoprim ( bactrim , septra ) , sulfisoxazole ( gantrisin ) , or sulfasalazine ( azulfidine ) ;
None(e1,e2)	2	44	interactions with mixed_agonist/antagonist_opioid_analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
None(e1,e2)	5	24	oral anticoagulants interaction studies with warfarin and acenocoumarol failed to identify any clinically important effects on the serum concentrations or clinical effects of these anticoagulants .
None(e1,e2)	107	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	5	28	probenecid : as with other b-lactam_antibiotics , probenecid inhibits the renal excretion of cefdinir , resulting in an approximate doubling in a.c. a 54 % increase in peak cefdinir plasma levels , and a 50 % prolongation in the apparent elimination half-life .
None(e1,e2)	20	41	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure_agonist_opioid_analgesic such as levo-dromoran .
None(e1,e2)	56	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	41	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	18	27	effects of other antiepilepsy drugs ( aeds ) on gabitril : carbamazepine : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking carbamazepine with or without other enzyme- inducing aeds .
None(e1,e2)	22	24	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	30	37	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl_trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	68	80	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	12	26	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic acid , and tolbutamide in vitro .
None(e1,e2)	0	5	ace_inhibitors : concomitant use of ace_inhibitors may increase the risk of renal impairment , particularly in volume-depleted patients .
effect(e1,e2)	9	47	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta_adrenergic_blocking_agents .
None(e1,e2)	93	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	24	26	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	9	16	in rheumatoid arthritis , concomitant medications besides mtx were nonsteroidal_anti-inflammatory_agents , folic acid , corticosteroids and/or narcotics .
None(e1,e2)	24	44	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	15	23	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	2	45	carbamazepine : isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels carbamazepine levels should be determined prior to concurrent administration with isoniazid , signs and symptoms of carbamazepine toxicity should be monitored closely , and appropriate dosage adjustment of the anticonvulsant should be made .
None(e1,e2)	30	32	in in vivo studies , 10- to 30-mg/day doses of aripiprazole had no significant effect on metabolism by cyp2d6 ( dextromethorphan ) , cyp2c9 ( warfarin ) , cyp2c19 ( omeprazole , warfarin ) , and cyp3a4 ( dextromethorphan ) substrates .
None(e1,e2)	44	118	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
effect(e1,e2)	14	47	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	6	16	may interact with cefamandole naftate , cephalothin_sodium , magnesium sulfate , prednisolone sodium succinate , and prochlorperazine_edisylate .
None(e1,e2)	21	78	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	46	- a nonsteroidal_anti-inflammatory_drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	8	29	oral hypoglycemic agents : in one study , flurbiprofen was given to adult diabetics who were already receiving glyburide ( n=4 ) , metformin ( n=2 ) chlorpropamide with phenformin ( n= 3 ) or glyburide with phenformin ( n=6 ) .
effect(e1,e2)	7	14	when taken orally , imidazole compounds like ketoconazole may enhance the anticoagulant effect of coumarin -like drugs .
None(e1,e2)	5	11	cholestyramine-concomitant intake of cholestyramine and vitamin_k may reduce the absorption of vitamin_k .
None(e1,e2)	16	70	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	3	17	plasma exposure of diazepam ( 10 mg bid ) was increased by 28 % following administration of valdecoxib ( 40 mg bid ) for 12 days , while plasma exposure of valdecoxib ( 40 mg bid ) was not substantially increased following administration of diazepam ( 10 mg bid ) for 12 days .
None(e1,e2)	24	40	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	3	13	in vitro , buspirone does not displace tightly bound drugs like phenytoin , propranolol , and warfarin from serum proteins .
mechanism(e1,e2)	13	26	it is known that cyp1a2 is inhibited by several medicinal products , including fluvoxamine , and such medicinal products could theoretically adversely influence the clearance of anagrelide .
advise(e1,e2)	7	46	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist_analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
None(e1,e2)	105	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	0	8	crixivan may not be effective due to decreased indinavir concentrations in patients taking these agents concomitantly .
None(e1,e2)	16	31	in patients taking furosemide , nifedipine , diltiazem , ace inhibitors , verapamil , glyburide , propranolol , and various chemotherapy agents , no effect was shown on the clearance of hydrodolasetron .
None(e1,e2)	36	53	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	45	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	30	36	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	10	14	plasma concentrations of quinolone antibiotics are decreased when administered with antacids containing magnesium , calcium , or aluminum .
mechanism(e1,e2)	0	40	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	10	14	selective serotonin reuptake inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
None(e1,e2)	9	13	in a study involving healthy subjects receiving tambocor and propranolol concurrently , plasma flecainide levels were increased about 20 % and propranolol levels were increased about 30 % compared to control values .
None(e1,e2)	74	78	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	13	alcohol - although lexapro did not potentiate the cognitive and motor effects of alcohol in a clinical trial , as with other psychotropic medications , the use of alcohol by patients taking lexapro is not recommended .
None(e1,e2)	8	18	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , fluoxetine , seriraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	12	20	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic acid , and tolbutamide in vitro .
None(e1,e2)	7	13	potassium-sparing diuretics ( spironolactone , amiloride , triamterene , and others ) or potassium supplements can increase the risk of hyperkalemia .
None(e1,e2)	6	45	warfarin : multiple oral doses of sonata ( 20 mg q24h for 13 days ) did not affect the pharmacokinetics of warfarin ( r+ ) - or ( s- ) -enantiomers or the pharmacodynamics ( prothrombin time ) following a single 25-mg oral dose of warfarin .
None(e1,e2)	13	32	however , in a study of 12 normal subjects , concurrent administration of aspirin decreased ketoprofen protein binding and increased ketoprofen plasma clearance from 0.07 l/kg/h without aspirin to 0.11 l/kg/h with aspirin .
mechanism(e1,e2)	7	17	drugs that induce hepatic enzymes such as phenobarbital , phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response .
mechanism(e1,e2)	4	22	the plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decrease by concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and adjustment of the dosage of imipramine may therefore be necessary .
None(e1,e2)	31	42	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	41	44	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure_agonist_opioid_analgesic such as levo-dromoran .
None(e1,e2)	3	29	drug interactions with antacids administration of 120 mg of fexofenadine hydrochloride ( 2 x 60 mg capsule ) within 15 minutes of an aluminum and magnesium containing antacid ( maalox ) decreased fexofenadine auc by 41 % and cmax by 43 % .
None(e1,e2)	16	38	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	2	ace_inhibitors and angiotensin_ii_receptor_antagonists ( hypertension ) - in clinical studies of patients with hypertension , the addition of inspra 50 to 100 mg to ace inhibitors and angiotensin ii receptor antagonists increased mean serum potassium slightly ( about 0.09-0.13 meq/l ) .
None(e1,e2)	59	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	24	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	51	79	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta_blockers ( 10 ) .
None(e1,e2)	21	28	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
None(e1,e2)	37	39	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline_salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	7	9	ergotamine : concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia .
mechanism(e1,e2)	4	10	clofibric acid : combination hormonal_contraceptives may increase the clearance of clofibric_acid .
None(e1,e2)	15	20	other concomitant therapies : in clinical trials , the safety profile in subjects treated with acamprosate concomitantly with anxiolytics , hypnotics and sedatives ( including benzodiazepines ) , or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications .
None(e1,e2)	9	28	interactions for vitamin d analogues ( vitamin d2 , vitamin_d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat_soluble_vitamins ;
None(e1,e2)	2	12	methotrexate : humira has been studied in rheumatoid arthritis patients taking concomitant mtx .
None(e1,e2)	31	77	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	35	43	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	4	cyclosporine , hexobarbital and phenytoin concentrations .
None(e1,e2)	12	26	these agents include medications such as : anticoagulants , platelet inhibitors including acetylsalicylic_acid , sali-cylates , nsaids ( including ketorolac tromethamine ) , dipyridamole , or sulfinpyrazone .
None(e1,e2)	4	21	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	12	37	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal_anti-inflammatory_agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta_adrenergic_blocking_agents .
None(e1,e2)	8	59	in a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without propantheline ( an anticholinergic agent with multiple effects on the gi tract ) to healthy volunteers , the auc of clonazepam was 10 % lower and the cmax of clonazepam was 20 % lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone .
None(e1,e2)	3	10	mao inhibitors , narcotic_analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
None(e1,e2)	11	19	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
effect(e1,e2)	6	23	adrenergic agents : some individuals receiving zyvox may experience a reversible enhancement of the pressor response to indirect-acting sympathomimetic agents , vasopressor or dopaminergic_agents .
None(e1,e2)	29	31	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	14	18	selective serotonin reuptake inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
None(e1,e2)	29	46	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	15	17	platelet inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
effect(e1,e2)	8	10	edema has been reported in patients concomitantly receiving itraconazole and dihydropyridine_calcium_channel_blockers .
None(e1,e2)	7	13	inhibitors of this isoenzyme ( e.g. , macrolide_antibiotics , azole antifungal agents , protease_inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	0	11	quinidine : coadministration of a 10-mg single dose of aripiprazole with quinidine ( 166 mg/day for 13 days ) , a potent inhibitor of cyp2d6 , increased the auc of aripiprazole by 112 % but decreased the auc of its active metabolite , dehydroaripiprazole , by 35 % .
None(e1,e2)	36	47	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic_acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
mechanism(e1,e2)	0	9	diamox modifies phenytoin metabolism with increased serum levels of phenytoin .
None(e1,e2)	14	24	mao inhibitors : duragesic is not recommended for use in patients who have received maoi within 14 days because severe and unpredictable potentiation by mao_inhibitors has been reported with opioid analgesics
None(e1,e2)	2	18	another oral azole_antifungal , ketoconazole , inhibits the metabolism of astemizole , resulting in elevated plasma concentrations of astemizole and its active metabolite desmethylastermizole which may prolong qt intervals .
None(e1,e2)	29	37	cisapride should not be used concomitantly with other drugs known to prolong the qt interval : certain antiarrhythmics , including those of class ia ( such as quinidine and procainamide ) and class iii ( such as sotalol ) ;
None(e1,e2)	19	29	the risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine , fibric_acid_derivatives , niacin ( nicotinic acid ) , erythromycin , azole_antifungals .
None(e1,e2)	14	63	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	31	37	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	9	11	also , concomitant administration of quinolones with products containing iron , multivitamins containing zinc , or videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution may result in low urine levels .
None(e1,e2)	62	96	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing_compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	5	19	warfarin : quinolones , including enoxacin , decrease the clearance of r-warfarin , the less active isomer of racemic warfarin .
None(e1,e2)	0	5	amphotericin_b or potassium-depleting diuretics ( benzothiadiazines and related drugs , ethacrynic acid and furosemide ) enhanced hypokalemia .
None(e1,e2)	10	13	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	17	23	in vitro data in human plasma indicate that doxazosin mesylate has no effect on protein binding of digoxin , warfarin , phenytoin or indomethacin .
None(e1,e2)	19	25	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	0	5	probenecid : as with other b-lactam_antibiotics , renal excretion of loracarbef is inhibited by probenecid and resulted in an approximate 80 % increase in the auc for loracarbef .
effect(e1,e2)	9	11	death due to fulminant pancreatitis possibly related to intravenous pentamidine and hivid has been reported .
None(e1,e2)	2	10	products containing calcium and other multivalent cations ( such as aluminum , magnesium , iron ) are likely to interfere with absorption of ibandronate .
None(e1,e2)	8	26	aspirin : concomitant administration of low-dose aspirin with vioxx may result in an increased rate of gi ulceration or other complications , compared to use of vioxx alone .
None(e1,e2)	12	20	coadministration of alosetron and strong cyp3a4 inhibitors , such as clarithromycin , telithromycin , protease inhibitors , voriconazole , and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
mechanism(e1,e2)	6	18	plasma levels of several closely related tricyclic_antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decreased by the concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with cmi as well .
None(e1,e2)	6	32	benzthiazide may interact with alcohol , blood_thinner s , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
None(e1,e2)	26	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	33	39	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	4	6	table 1 changes in desloratadine and 3-hydroxydesloratadine pharmacokinetics in healthy male and female volunteers
None(e1,e2)	15	17	if desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative / hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
None(e1,e2)	21	114	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	1	43	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	1	4	some quinolones , including ciprofloxacin , have also been shown to interfere with the metabolism of caffeine .
None(e1,e2)	11	33	may interact anticoagulants ( altered hypo-prothrombinemic effect ) , barbiturates , rifampin and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of diethylstilbestrol ) , corticosteroids ( increased effect of corticosteroids ) .
None(e1,e2)	13	22	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid_products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	0	15	ethanol : clinical evidence has shown that etretinate can be formed with concurrent ingestion of acitretin and ethanol .
None(e1,e2)	27	44	in a placebo-controlled trial in normal volunteers , the administration of a single 1 mg dose of doxazosin on day 1 of a four-day regimen of oral cimetidine ( 400 mg twice daily ) resulted in a 10 % increase in mean auc of doxazosin ( p=0.006 ) , and a slight but not statistically significant increase in mean cmax and mean half-life of doxazosin .
None(e1,e2)	10	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	30	32	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	23	erythromycin use in patients who are receiving high doses of theophylline may be associated with an increase in serum theophylline levels and potential theophylline toxicity .
None(e1,e2)	41	51	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	57	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	34	49	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	19	35	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	3	13	concomitant administration of erythromycin and digoxin has been reported to result in elevated digoxin serum levels .
None(e1,e2)	20	26	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic acid , and tolbutamide in vitro .
None(e1,e2)	5	25	effects of felbatol on low-dose combination_oral_contraceptives a group of 24 nonsmoking , healthy white female volunteers established on an oral contraceptive regimen containing 30 mg ethinyl_estradiol and 75 mg gestodene for at least 3 months received 2400 mg/day of felbamate from midcycle ( day 15 ) to midcycle ( day 14 ) of two consecutive oral contraceptive cycles .
None(e1,e2)	21	48	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
None(e1,e2)	15	35	a pharmacokinetic study evaluating the administration of a single dose of inspra 100 mg with ketoconazole 200 mg bid , a potent inhibitor of the cyp3a4 pathway , showed a 1.7-fold increase in cmax of eplerenone and a 5.4-fold increase in auc of eplerenone .
None(e1,e2)	26	40	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	3	25	ace inhibitors and angiotensin_ii_receptor_antagonists ( hypertension ) - in clinical studies of patients with hypertension , the addition of inspra 50 to 100 mg to ace_inhibitors and angiotensin ii receptor antagonists increased mean serum potassium slightly ( about 0.09-0.13 meq/l ) .
None(e1,e2)	15	25	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	11	21	lithium generally should not be given with diuretics because they reduce lithium s renal clearance and add a high risk of lithium toxicity .
effect(e1,e2)	3	14	concomitant use of antihistamines with alcohol , tricyclic antidepressants , barbiturates , or other central_nervous_system_depressants may have an additive effect .
None(e1,e2)	17	31	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
mechanism(e1,e2)	10	21	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and/or some progestins , leading to possible decrease in contraceptive effectiveness .
advise(e1,e2)	0	8	apraclonidine should not be used in patients receiving mao_inhibitors ..
None(e1,e2)	2	23	corticosteroids , methylxanthines and diuretics : concomitant treatment with xanthine derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of beta2-agonists_.
None(e1,e2)	23	35	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	13	31	however , because some quinolones have been reported to enhance the effects of warfarin or its derivatives , prothrombin time or other suitable anticoagulation test should be monitored closely if a quinolone_antimicrobial is administered with warfarin or its derivatives .
None(e1,e2)	76	100	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	7	orlistat -orlistat may decrease the absorption of vitamin_k .
None(e1,e2)	102	160	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	35	42	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	0	21	eprosartan doses of up to 300 mg b.i.d . have been safely used concomitantly with sustained-release calcium channel blockers ( sustained-release nifedipine ) with no clinically significant adverse interactions .
None(e1,e2)	73	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	71	85	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	26	34	because nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of nalfon , the concomitant use of nalfon and salicylates is not recommended .
None(e1,e2)	6	26	in patients receiving nalfon and a steroid concomitantly , any reduction in steroid dosage should be gradual in order to avoid the possible complications of sudden steroid withdrawal .
None(e1,e2)	15	37	the similarity of the tysabri -associated adverse event profile between study 1 ( without co-administered avonex ) and study 2 ( with co-administered avonex ) indicates that this alteration in clearance does not necessitate reduction of the tysabri dose to maintain safety , general ) .
None(e1,e2)	50	52	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic_acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	0	4	antihistamines : astemizole* , terfenadine * contraindicated due to potential for serious and/or life-threatening cardiac arrhythmias .
None(e1,e2)	44	95	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	26	28	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	9	25	drugs that have been associated with peripheral neuropathy include antiretroviral_nucleoside_analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	3	24	in case of theophylline toxicity and/or elevated serum theophylline levels , the dose of theophylline should be reduced while the patient is receiving concomitant erythromycin therapy .
None(e1,e2)	67	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	4	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
None(e1,e2)	6	8	the concurrent use of tetracycline and penthrane ( methoxyflurane ) has been reported to result in fatal renal toxicity .
None(e1,e2)	21	27	the daily dose of enablex should not exceed 7.5 mg when coadministered with potent cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , ritonavir , nelfinavir , clarithromycin and nefazadone ) .
None(e1,e2)	13	20	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid_products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	12	16	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	56	59	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	42	76	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	52	62	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	35	83	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	20	22	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	29	49	may interact with addictive medications , especially central nervous system ( cns ) depressants with habituating potential ( prolonged concurrent use may increase the risk of habituation ) , alcohol or cns depression producing medications ( concurrent use may increase the cns depressant effects of either these medications or ethinamate ) .
None(e1,e2)	24	30	the following are examples of drugs known to inhibit the metabolism of other related benzodiazepines , presumably through inhibition of cyp3a : nefazodone , fluvoxamine , cimetidine , diltiazem , isoniazide , and some macrolide antibiotics .
None(e1,e2)	57	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	8	anabolic_steroids ( particularly c-17 alkylated androgens such as oxymetholone , methandrostenolone , norethandrolone , and similar compounds ) enhanced tendency toward edema .
None(e1,e2)	32	47	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta_adrenergic_blocking_agents .
effect(e1,e2)	14	41	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic_antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	9	15	therapeutic concentrations of digoxin , warfarin , ibuprofen , naproxen , piroxicam , acetaminophen , phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding .
None(e1,e2)	11	17	non-selective mao inhibitors including tranylcypromine sulfate , phenelzine sulfate , and pargyline hc1 : concomitant use of l-tyrosine and non-selective mao inhibitors may cause hypertension .
None(e1,e2)	0	10	aspirin : concomitant aspirin may decrease the metabolic clearance of nicotinic_acid .
None(e1,e2)	3	11	may interact with cefamandole_naftate , cephalothin sodium , magnesium sulfate , prednisolone_sodium_succinate , and prochlorperazine edisylate .
effect(e1,e2)	8	17	psychoactive drugs : hallucinations have been reported when toradol was used in patients taking psychoactive drugs ( fluoxetine , thiothixene , alprazolam ) .
None(e1,e2)	45	63	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	35	43	a pharmacokinetic study evaluating the administration of a single dose of inspra 100 mg with ketoconazole 200 mg bid , a potent inhibitor of the cyp3a4 pathway , showed a 1.7-fold increase in cmax of eplerenone and a 5.4-fold increase in auc of eplerenone .
mechanism(e1,e2)	0	10	mineral_oil interferes with the absorption of fat-soluble vitamins , including vitamin_d_preparations .
None(e1,e2)	0	38	digoxin - in subjects who had received 21 days of 40 mg/day racemic citalopram , combined administration of citalopram and digoxin ( single dose of 1 mg ) did not significantly affect the pharmacokinetics of either citalopram or digoxin .
None(e1,e2)	7	29	warfarin : a single 125-mg dose of aprepitant was administered on day 1 and 80 mg/day on days 2 and 3 to healthy subjects who were stabilized on chronic warfarin therapy .
None(e1,e2)	0	12	antihypertensives : amiodarone should be used with caution in patients receiving - receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	21	31	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	7	9	inhibitors of this isoenzyme ( e.g. , macrolide_antibiotics , azole_antifungal_agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	11	13	the following agents may increase certain actions or side effects of anticholinergic_drugs . amantadine antiarrhythmic agents of class ( e.g . quinidine ) , antihistamines antipsychotic agents ( e.g . phenothiazines ) , benzodiazepines .
None(e1,e2)	19	43	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	13	31	however , it is considered to be unlikely that this decrease of phosphorylated lamivudine concentration is of clinical significance , as lamivudine is a more efficient substrate for deoxycytidine kinase than zalcitabine .
None(e1,e2)	9	14	dopamine d2 receptor antagonists ( e.g. , phenothiazines , butyrophenones , risperidone ) and isoniazid may reduce the therapeutic effects of levodopa .
None(e1,e2)	93	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	32	49	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	6	8	no significant interactions were found between nisoldipine and warfarin or digoxin .
None(e1,e2)	1	28	oral hypoglycemic_agents : in one study , flurbiprofen was given to adult diabetics who were already receiving glyburide ( n=4 ) , metformin ( n=2 ) chlorpropamide with phenformin ( n= 3 ) or glyburide with phenformin ( n=6 ) .
None(e1,e2)	5	9	conversely , the administration of stadol_ns ( 1 mg butorphanol qid ) did not alter the pharmacokinetics of a 300-mg dose of cimetidine .
None(e1,e2)	20	22	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	11	37	results of studies in multiple sclerosis patients taking tysabri and concomitant interferon_beta-1a ( avonex 30 mcg im once weekly ) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer_acetate .
None(e1,e2)	13	40	oral contraceptive : based on auc and half-life , multiple-dose pharmacokinetic profiles of norethindrone and ethinyl estradiol following administration of tablets containing 2.5 mg of norethindrone acetate and 50 mcg of ethinyl estradiol were similar with and without coadministration of gabapentin ( 400 mg tid ;
None(e1,e2)	13	15	dolasetron mesylate did not inhibit the antitumor activity of four chemotherapeutic agents ( cisplatin , 5-fluorouracil , doxorubicin , cyclophosphamide ) in four murine models .
None(e1,e2)	0	4	warfarin , digoxin , salicylate , and heparin the in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine ( 99.5 % control vs 99.3 % ) when ketorolac plasma concentrations reach 5 to10 m g/ml .
None(e1,e2)	93	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	32	49	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	6	9	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract
None(e1,e2)	15	18	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic_antidepressants or other cns_depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	0	36	morphine : a literature article reported that when a 60-mg controlled-release morphine capsule was administered 2 hours prior to a 600-mg neurontin capsule ( n=12 ) , mean gabapentin auc increased by 44 % compared to gabapentin administered without morphine .
None(e1,e2)	0	21	ace_inhibitors and angiotensin ii receptor antagonists ( hypertension ) - in clinical studies of patients with hypertension , the addition of inspra 50 to 100 mg to ace inhibitors and angiotensin ii receptor antagonists increased mean serum potassium slightly ( about 0.09-0.13 meq/l ) .
None(e1,e2)	13	21	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	45	47	in a phase i trial using escalating doses of taxol ( 110-200 mg/m2 ) and cisplatin ( 50 or 75 mg/m2 ) given as sequential infusions , myelosuppression was more profound when taxol was given after cisplatin than with the alternate sequence ( ie , taxol before cisplatin ) .
None(e1,e2)	10	46	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
advise(e1,e2)	4	16	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	22	41	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	16	17	another study showed that alosetron had no clinically significant effect on plasma concentrations of the oral contraceptive_agents ethinyl_estradiol and levonorgestrel ( cyp3a4 substrates ) .
None(e1,e2)	36	62	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral_hydrate * ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	10	14	dolasetron mesylate did not inhibit the antitumor activity of four chemotherapeutic_agents ( cisplatin , 5-fluorouracil , doxorubicin , cyclophosphamide ) in four murine models .
advise(e1,e2)	2	43	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium_salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	1	30	since entecavir is primarily eliminated by the kidneys , coadministration of baraclude with drugs that reduce renal function or compete for active tubular secretion may increase serum concentrations of either entecavir or the coadministered drug .
None(e1,e2)	8	42	clinical experience with concomitant administration of bosentan and warfarin in patients with pulmonary arterial hypertension did not show clinically relevant changes in inr or warfarin dose ( baseline vs. end of the clinical studies ) , and the need to change the warfarin dose during the trials due to changes in inr or due to adverse events was similar among bosentan- and placebo-treated patients .
None(e1,e2)	70	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	29	44	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	3	nonsteroidal_antiinflammatory agents : aspirin is contraindicated in patients who are hypersensitive to nonsteroidal anti-inflammatory agents .
None(e1,e2)	0	32	paroxetine ( 20 mg qd ) increased the concentration of duloxetine ( 40 mg qd ) by about 60 % , and greater degrees of inhibition are expected with higher doses of paroxetine .
None(e1,e2)	35	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	58	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	32	63	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin_synthetase_inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	3	11	patients receiving other narcotic_analgesic s , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	20	22	agents with increased levels in the presence of carbamazepine : equetrotm increases the plasma levels of the following agents : clomipramine_hcl , phenytoin ( 6 ) , and primidone thus , if a patient has been titrated to a stable dosage on one of the agents in this category , and then begins a course of the treatment with equetrotm , it is reasonable to expect that a dose decrease for the concomitant agent may be necessary .
None(e1,e2)	26	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	11	31	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	3	16	specific effects of felbatol on other antiepileptic drugs phenytoin : felbatol causes an increase in steady-state phenytoin plasma concentrations .
None(e1,e2)	15	29	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
mechanism(e1,e2)	2	19	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	2	4	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and/or some progestins , leading to possible decrease in contraceptive effectiveness .
None(e1,e2)	13	15	the net effect of these interactions is summarized in the following table : aed aed felbatol
None(e1,e2)	29	31	the risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine , fibric acid derivatives , niacin ( nicotinic acid ) , erythromycin , azole_antifungals .
None(e1,e2)	66	130	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	15	21	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	66	160	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	40	42	hypotension was more likely to occur if the calcium antagonist were a dihydropyridine derivative , e.g. , nifedipine , while left ventricular failure and av conduction disturbances , including complete heart block , were more likely to occur with either verapamil or diltiazem .
None(e1,e2)	18	20	oral contraceptives : valdecoxib ( 40 mg bid ) did not induce the metabolism of the combination oral contraceptive norethindrone/ ethinyl_estradiol ( 1 mg /35 mcg combination , ortho-novum 1/35 ) .
None(e1,e2)	0	3	alprazolam : when fluvoxamine_maleate ( 100 mg qd ) and alprazolam ( 1 mg q.d . were co-administered to steady state , plasma concentration and other pharmacokinetics parameters ( auc , cmax , t1/2 , ) of alprazolam were approximately twice those observed when alprazolam was administered alone ;
advise(e1,e2)	7	29	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
effect(e1,e2)	11	24	the effects of medicinal products with similar properties such as inotropes milrinone , enoximone , amrinone , olprinone and cilostazol may be exacerbated by anagrelide .
None(e1,e2)	14	16	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	66	79	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	8	14	non-nucleoside reverse transcriptase inhibitors ( nnrtis ) : nevirapine may decrease plasma levels of combination_hormonal_contraceptives ;
None(e1,e2)	41	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	74	78	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	35	41	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic_antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	7	9	no interaction trials have been conducted with mepron and rifabutin .
None(e1,e2)	105	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	17	21	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
effect(e1,e2)	9	34	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	12	14	in controlled clinical trials of augmentin xr , 22 patients received concomitant allopurinol and augmentin_xr .
None(e1,e2)	20	26	the effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin , carbamazepine , and barbiturates , and the antituberculosis drug rifampin .
None(e1,e2)	3	15	antimycobacterial agents : rifampin contraindicated since the coadministration of this product with saquinavir in an antiretroviral regimen reduces the plasma concentrations of saquinavir .
None(e1,e2)	2	22	because oral anticoagulants may interfere with the hepatic metabolism of phenytoin , toxic levels of the anticonvulsant may occur when an oral anticoagulant and phenytoin are administered concurrently .
None(e1,e2)	5	38	tetracyclines : concomitant treatment with accutane and tetracyclines should be avoided because accutane use has been associated with a number of cases of pseudotumor cerebri ( benign intracranial hypertension ) , some of which involved concomitant use of tetracyclines
None(e1,e2)	56	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	16	19	coumarin anticoagulants altered coagulation parameters and/or bleeding have been reported in patients taking capecitabine concomitantly with coumarin-derivative_anticoagulants such as warfarin and phenprocoumon .
None(e1,e2)	0	19	phenytoin : in post-marketing experience , there have been reports of both increases and decreases in phenytoin levels with dexamethasone co-administration , leading to alterations in seizure control .
None(e1,e2)	4	11	the antihypertensive effects of methyldopa , mecamylamine , reserpine , and veratrum_alkaloids may be reduced by sympathomimetics .
None(e1,e2)	10	12	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	12	15	antibiotics : in vitro and/or in vivo data show that clarithromycin , erythromycin , and troleandomycin markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	18	22	studies in healthy volunteers have shown that acarbose has no effect on either the pharmacokinetics or pharmacodynamics of digoxin , nifedipine , propranolol , or ranitidine .
None(e1,e2)	23	45	praziquantel : in the fed state , praziquantel ( 40 mg/kg ) increased mean maximum plasma concentration and area under the curve of albendazole_sulfoxide by about 50 % in healthy subjects ( n=10 ) compared with a separate group of subjects ( n=6 ) given albendazole alone .
mechanism(e1,e2)	0	2	acetazolamide increases lithium excretion and the lithium may be decreased .
advise(e1,e2)	26	28	because of the potential for arava levels to continue to increase with multiple dosing , caution should be used if patients are to be receiving both arava and rifampin .
None(e1,e2)	12	22	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	55	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	16	metformin : in healthy subjects given single 500 mg doses of cephalexin and metformin , plasma metformin mean cmax and auc increased by an average of 34 % and 24 % , respectively , and metformin mean renal clearance decreased by 14 % .
None(e1,e2)	3	5	coadministration of oral contraceptives , diazepam , phenytoin , or quinidine did not seem to change the pharmacokinetic profile of esomeprazole .
None(e1,e2)	14	28	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	2	13	cimetidine , ranitidine : in normal volunteers ( n=9 ) , pretreatment with cimetidine or ranitidine did not affect flurbiprofen pharmacokinetics except that a small ( 13 % ) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with cimetidine .
None(e1,e2)	8	70	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	20	39	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	15	23	drug interaction studies have shown that esomeprazole does not have any clinically significant interactions with phenytoin , warfarin , quinidine , clarithromycin or amoxicillin .
None(e1,e2)	2	13	iodine or iodine excess may decrease the effect of carbimazole , and an iodine deficiency can increase the effect of carbimazole .
None(e1,e2)	0	3	cholestyramine and colestipol resins : absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins .
mechanism(e1,e2)	3	28	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	7	20	poor metabolizers of debrisoquin : interactions of carvedilol with strong inhibitors of cyp2d6 ( such as quinidine , fluoxetine , paroxetine , and propafenone ) have not been studied , but these drugs would be expected to increase blood levels of the r ( + ) enantiomer of carvedilol .
None(e1,e2)	40	48	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
int(e1,e2)	0	4	benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
None(e1,e2)	17	23	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	8	18	d-amphetamine with desipramine or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain ;
None(e1,e2)	19	21	no formal clinical studies have been conducted to assess if there is an interactive effect on bone loss between systemic_corticosteroids and accutane .
None(e1,e2)	4	12	clinical interaction studies with cimetidine and warfarin indicated that the coadministration of femara with these drugs does not result in clinically- significant drug interactions .
None(e1,e2)	14	48	corticosteroids : dexamethasone : aprepitant , when given as a regimen of 125mg with dexamethasone coadministered orally as 20 mg on day 1 , and aprepitant when given as 80 mg/day with dexamethasone coadministered orally as 8 mg on days 2 through 5 , increased the auc of dexamethasone , a cyp3a4 substrate by 2.2-fold , on days 1 and 5 .
None(e1,e2)	12	24	ethanol / nutrition / herb interactions : food : cns effects of caffeine may be enhanced if combination hormonal contraceptives are used concurrently with caffeine .
None(e1,e2)	39	51	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	23	- a nonsteroidal_anti-inflammatory_drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis_kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	4	10	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
None(e1,e2)	26	34	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine_oxidase_inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	11	15	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
None(e1,e2)	0	10	antiarrhythmics : other antiarrhythmic drugs , such as quinidine , procainamide , disopyramide , and phenytoin , have been used concurrently with amiodarone .
None(e1,e2)	0	9	phenytoin : serum phenytoin levels may be increased by aspirin .
None(e1,e2)	2	18	acetaminophen and methotrexate - l-methionine may decrease hepatic toxicity in those with acetaminophen overdosage or in those taking methotrexate .
None(e1,e2)	46	58	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin_k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	0	11	heparin_sodium injection should not be mixed with doxorubicin , droperidol , ciprofloxacin , or mitoxantrone , since it has been reported that these drugs are incompatible with heparin and a precipitate may form .
None(e1,e2)	116	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	5	probenecid : as with other b-lactam_antibiotics , probenecid inhibits the renal excretion of cefdinir , resulting in an approximate doubling in a.c. a 54 % increase in peak cefdinir plasma levels , and a 50 % prolongation in the apparent elimination half-life .
None(e1,e2)	8	22	results of studies in multiple sclerosis patients taking tysabri and concomitant interferon beta-1a ( avonex 30 mcg im once weekly ) or glatiramer_acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate .
None(e1,e2)	9	17	drugs that have been associated with peripheral neuropathy include antiretroviral_nucleoside_analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	55	83	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	1	19	and disulfiram when amitriptyline hcl is given with anticholinergic agents or sympathomimetic drugs , including epinephrine combined with local anesthetics , close supervision and careful adjustment of dosages are required .
None(e1,e2)	8	26	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	2	16	- a diuretic ( water pill ) such as hydrochlorothiazide ( hctz , hydrodiuril ) , chlorothiazide ( diuril ) , and others ;
None(e1,e2)	20	32	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	17	37	carbamazepine : coadministration of carbamazepine ( 200 mg bid ) , a potent cyp3a4 inducer , with aripiprazole ( 30 mg qd ) resulted in an approximate 70 % decrease in cmax and auc values of both aripiprazole and its active metabolite , dehydro-aripiprazole .
None(e1,e2)	17	31	plasma exposure of diazepam ( 10 mg bid ) was increased by 28 % following administration of valdecoxib ( 40 mg bid ) for 12 days , while plasma exposure of valdecoxib ( 40 mg bid ) was not substantially increased following administration of diazepam ( 10 mg bid ) for 12 days .
None(e1,e2)	12	20	nabilone should be administered with caution to patients who are taking other psychoactive_drugs or cns depressants , including alcohol , barbiturates and narcotic analgesics , or to those with a history of psychiatric disorder ( including manic-depressive illness and schizophrenia ) .
None(e1,e2)	22	34	the following are examples of drugs known to inhibit the metabolism of other related benzodiazepines , presumably through inhibition of cyp3a : nefazodone , fluvoxamine , cimetidine , diltiazem , isoniazide , and some macrolide_antibiotics .
advise(e1,e2)	2	27	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	1	7	include terfenadine , astemizole , cisapride , midazolam , and triazolam .
None(e1,e2)	12	20	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	41	59	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	4	26	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	7	22	because cholestyramine binds bile acids , cholestyramine resin may interfere with normal fat digestion and absorption and thus may prevent absorption of fat_soluble_vitamins such as a , d , e , and k .
None(e1,e2)	17	22	the following drugs have been coadministered with kerlone and have not altered its pharmacokinetics : cimetidine , nifedipine , chlorthalidone , and hydrochlorothiazide .
mechanism(e1,e2)	5	9	phenobarbital : it appears that phenobarbital may reduce plasma felbamate concentrations .
None(e1,e2)	32	40	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	33	42	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	11	13	amphotericin b or potassium-depleting diuretics ( benzothiadiazines and related drugs , ethacrynic_acid and furosemide ) enhanced hypokalemia .
None(e1,e2)	105	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	2	selective_serotonin_reuptake_inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
None(e1,e2)	64	77	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	19	156	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	23	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	49	85	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	14	29	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic_analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	5	7	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
None(e1,e2)	12	35	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	5	17	concurrent administration of cimetidine and tricyclic_antidepressants can produce clinically significant increases in the plasma levels of the tricyclic_antidepressants .
advise(e1,e2)	7	19	although no interaction between mao inhibitors and levo-dromoran has been observed , it is not recommended for use with mao_inhibitors .
None(e1,e2)	2	15	interactions with mixed_agonist/antagonist_opioid_analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
None(e1,e2)	66	84	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	17	30	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	107	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	9	non-selective_mao_inhibitors including tranylcypromine sulfate , phenelzine sulfate , and pargyline hc1 : concomitant use of l-tyrosine and non-selective mao inhibitors may cause hypertension .
None(e1,e2)	8	13	cholestyramine : the influence of the bile-acidsequestering agent cholestyramine on the pharmacokinetits of cerivastatin_sodium was evaluated in 12 healthy males in 2 separate randomized crossover studies .
None(e1,e2)	7	11	fenfluramine may increase slightly the effect of antihypertensive_drugs , e.g. , guanethidine , methyldopa , reserpine .
None(e1,e2)	33	41	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide_dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	25	31	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	1	65	aspirin/ acetaminophen : pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between argatroban and concomitantly administered aspirin ( 162.5 mg orally given 26 and 2 hours prior to initiation of argatroban 1 g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of argatroban 1.5 g/kg/min . over 18 hours ) .
None(e1,e2)	10	16	if combination therapy is initiated or withdrawn in conjunction with propranolol , an adjustment in the propranolol dose may be warranted .
None(e1,e2)	9	14	there was a small increase in plasma concentrations of capecitabine and one metabolite ( 5-dfcr ) ;
advise(e1,e2)	1	25	since apraclonidine may reduce pulse and blood pressure , caution in using drugs such as beta-blockers ( ophthalmic and systemic ) , antihypertensives , and cardiac_glycosides is advised .
None(e1,e2)	27	30	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	10	14	in 5 other schizophrenic patients treated with oral haloperidol and rifampin , discontinuation of rifampin produced a mean 3.3-fold increase in haloperidol concentrations .
None(e1,e2)	0	2	hmg-coa_reductase_inhibitor : atorvastatin
None(e1,e2)	46	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	13	loop_diuretics : furosemide administered concurrently with captopril does not alter the pharmacokinetics of captopril in renally impaired hypertensive patients .
None(e1,e2)	89	116	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
None(e1,e2)	75	86	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	8	alcohol : there was no significant difference between aripiprazole coadministered with ethanol and placebo coadministered with ethanol on performance of gross motor skills or stimulus response in healthy subjects .
None(e1,e2)	1	18	and calcium_channel_antagonists e.g. , verapamil ) , cyp1a2 inducers ( omeprazole ) and cyp1a2 inhibitors ( furafylline and clarithromycin ) .
None(e1,e2)	70	80	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	5	20	among 494 subjects who received angiomax in clinical trials and were tested for antibodies , 2 subjects had treatment-emergent positive bivalirudin antibody tests .
None(e1,e2)	10	26	evidence supporting the conclusion that it is inadvisable to co-administer fluvoxamine and diazepam is derived from a study in which healthy volunteers taking 150 mg/day of fluvoxamine were administered a single oral dose of 10 mg of diazepam .
None(e1,e2)	8	10	the patient was also chronically receiving phenytoin , phenobarbital , digoxin , and levothyroxine sodium .
None(e1,e2)	3	8	as with other cephalosporins , high concentrations of cefotetan may interfere with measurement of serum and urine creatinine levels by jaffe reaction and produce false increases in the levels of creatinine reported .
None(e1,e2)	21	45	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/ sulfamethoxazole or zidovudine .
None(e1,e2)	16	18	in studies in normal volunteers , there was no pharmacodynamic interaction between intravenous iloprost and either nifedipine , diltiazem , or captopril .
None(e1,e2)	71	117	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral_hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	15	23	codeine in combination with other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , or other cns depressants ( including alcohol ) has additive depressant effects .
None(e1,e2)	6	50	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	29	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
None(e1,e2)	6	8	drug-drug interactions between keppra and other antiepileptic_drugs ( aeds ) phenytoin keppra ( 3000 mg daily ) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy .
None(e1,e2)	7	19	discontinuation of cimetidine in well-controlled patients receiving tricyclic_antidepressants and cimetidine may decrease the plasma levels and efficacy of the antidepressants .
None(e1,e2)	26	51	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	53	67	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	11	17	as with other antipsychotic agents , it should be noted that haldol may be capable of potentiating cns_depressants such as anesthetics , opiates , and alcohol .
effect(e1,e2)	31	48	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic agents ) or drugs which inhibit platelet function ( eg , aspirin and other non-steroidal_anti-inflammatory_drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
None(e1,e2)	13	35	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine_derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	26	50	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
None(e1,e2)	19	33	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	30	64	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	16	23	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
effect(e1,e2)	4	12	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal_anti-inflammatory_agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	2	21	warfarin : eszopiclone 3 mg administered daily for 5 days did not affect the pharmacokinetics of ( r ) - or (_s_)_-warfarin , nor were there any changes in the pharmacodynamic profile ( prothrombin time ) following a single 25 mg oral dose of warfarin
None(e1,e2)	9	34	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	0	20	antacid : the effect of an aluminum hydroxide- and magnesium hydroxide-containing antacid ( maalox ) * on the pharmacokinetics of capecitabine was investigated in 12 cancer patients .
None(e1,e2)	53	59	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	5	24	phenytoin/phenobarbital : the coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin d , but may reduce endogenous plasma levels of calcitriol /ergocalcitriol by accelerating metabolism .
None(e1,e2)	8	35	the results of a study of coadministration of ethambutol ( 50 mg/kg ) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20 % and 13 % , respectively , suggesting that the oral absorption of ethambutol may be reduced by these antacid products .
None(e1,e2)	19	138	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	55	antacids : in a single dose study ( n=6 ) , ingestion of an antacid containing 1.7-gram of magnesium hydroxide with 500-mg of mefenamic acid increased the cmax and auc of mefenamic acid by 125 % and 36 % , respectively . a number of compounds are inhibitors of cyp2c9 including fluconazole , lovastatin and trimethoprim .
None(e1,e2)	33	47	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin_g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
mechanism(e1,e2)	0	10	bosentan is also expected to reduce plasma concentrations of other statins that have significant metabolism by cyp3a4 , such as lovastatin and atorvastatin .
None(e1,e2)	35	42	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	15	26	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
effect(e1,e2)	11	13	exaggerated hypertensive responses have been reported from the combined use of beta-adrenergic_antagonists and alpha-adrenergic_stimulants , including those contained in proprietary cold remedies and vasoconstrictive nasal drops .
None(e1,e2)	19	40	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	72	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	11	32	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	24	47	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	6	21	drug interaction studies have shown that esomeprazole does not have any clinically significant interactions with phenytoin , warfarin , quinidine , clarithromycin or amoxicillin .
None(e1,e2)	5	29	aprepitant increased the auc of midazolam by 25 % on day 4 and decreased the auc of midazolam by 19 % on day 8 relative to the dosing of aprepitant on days 1 through 3 .
None(e1,e2)	19	33	an adequate period of observation must be provided for any patient in whom either long-acting benzodiazepines ( such as diazepam ) or large doses of short-acting benzodiazepines ( such as 10 mg of midazolam ) have been used .
None(e1,e2)	7	28	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium_channel_blocking_drugs , and isoniazid .
effect(e1,e2)	22	33	anticoagulants including coumarin derivatives , indandione derivatives , and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs ( nsaids ) , and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin .
None(e1,e2)	10	21	the daily dose of dexamethasone administered in clinical studies with aprepitant reflects an approximate 50 % reduction of the dose of dexamethasone .
advise(e1,e2)	7	13	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	10	61	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	56	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	23	30	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	4	10	the concomitant use of h2_blockers or proton pump inhibitors with sprycel is not recommended .
None(e1,e2)	19	21	although there was no clinical evidence in the vehicle-controlled studies of drug interactions with systemic antiretroviral agents , including protease_inhibitors , macrolide_antibiotics , and azole antifungals , the effect of panretin gel on the steady-state concentrations of these drugs is not known .
None(e1,e2)	2	11	interactions for vitamin_d analogues ( vitamin d2 , vitamin d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;
None(e1,e2)	0	4	verapamil : coadministration of almotriptan and verapamil resulted in a 24 % increase in plasma concentrations of almotriptan .
None(e1,e2)	31	53	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	15	17	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	29	43	since zarontin ( ethosuximide ) may interact with concurrently administered antiepileptic drugs , periodic serum level determinations of these drugs may be necessary ( eg , ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels ) .
None(e1,e2)	77	80	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	8	12	however , no deleterious interactions were seen when romazicon was administered after narcotics , inhalational anesthetics , muscle relaxants and muscle relaxant antagonists administered in conjunction with sedation or anesthesia .
None(e1,e2)	7	14	similarly , the effects of phenytoin on phenobarbital , valproic acid and sodium plasma valproate concentrations are unpredictable
None(e1,e2)	18	50	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth_subsalicylate ( pepto-bismol ) ;
None(e1,e2)	2	20	the oral dexamethasone doses should be reduced by approximately 50 % when coadministered with aprepitant , to achieve exposures of dexamethasone similar to those obtained when it is given without aprepitant .
None(e1,e2)	0	2	cimetidine , ranitidine : in normal volunteers ( n=9 ) , pretreatment with cimetidine or ranitidine did not affect flurbiprofen pharmacokinetics except that a small ( 13 % ) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with cimetidine .
None(e1,e2)	42	94	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	73	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
effect(e1,e2)	10	12	nevertheless , the possibility of additive negative inotropic effects of beta_blockers and flecainide should be recognized .
None(e1,e2)	28	50	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
advise(e1,e2)	10	26	although specific drug interaction studies have not been conducted with alphagan_p , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , or anesthetics ) should be considered .
None(e1,e2)	21	63	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	61	71	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	27	34	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic_antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	10	12	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
advise(e1,e2)	0	9	cevimeline should be administered with caution to patients taking beta_adrenergic_antagonists , because of the possibility of conduction disturbances .
None(e1,e2)	11	35	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine -containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton pump inhibitors ( e.g. , lansoprazole , omeprazole ) .
None(e1,e2)	13	31	however , no clinically or statistically significant differences in prothrombin time ratio or warfarin enantiomer pharmacokinetics were observed in a small study of 7 healthy males who received both warfarin and lomefloxacin under steady-state conditions .
None(e1,e2)	30	39	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta_adrenergic_blocking_agents .
None(e1,e2)	96	112	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	75	77	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	53	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	13	25	limited data in patients receiving known enzyme inducers ( phenytoin , phenobarbital , carbamazepine ) indicate only a 30 % increase in the rate of flecainide elimination .
None(e1,e2)	1	5	if iron_supplements are required during omnicef therapy , omnicef should be taken at least 2 hours before or after the supplement .
None(e1,e2)	57	71	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	23	in psoriatic arthritis clinical trials , concomitant medications included mtx in approximately half of the patients as well as nonsteroidal anti-inflammatory agents , folic_acid and corticosteroids .
advise(e1,e2)	5	7	aspirin : concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin , resulting in lower plasma concentrations , peak plasma levels , and auc values .
None(e1,e2)	52	71	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	16	tablets simultaneous administration of sucralfate and furosemide tablets may reduce the natriuretic and antihypertensive effects of furosemide .
None(e1,e2)	11	63	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin_synthetase_inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	10	39	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	6	12	and calcium channel antagonists e.g. , verapamil ) , cyp1a2 inducers ( omeprazole ) and cyp1a2 inhibitors ( furafylline and clarithromycin ) .
None(e1,e2)	0	2	itraconazole ketoconazole erythromycin clarithromycin telithromycin hiv protease inhibitors nefazodone cyclosporine large quantities of grapefruit juice ( 1 quart daily )
None(e1,e2)	77	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	4	31	when therapeutic concentrations of furosemide , propranolol , dipyridamole , warfarin , quinidine , or naproxen were added to human plasma ( in vitro ) , the plasma protein binding of nicardipine_hcl was not altered .
None(e1,e2)	59	66	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	15	24	the effects of medicinal products with similar properties such as inotropes milrinone , enoximone , amrinone , olprinone and cilostazol may be exacerbated by anagrelide .
None(e1,e2)	62	81	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	57	107	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	78	128	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
None(e1,e2)	12	25	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
effect(e1,e2)	0	6	amphetamines may enhance the effects of tricyclic_antidepressants .
None(e1,e2)	0	2	propantheline and diphenoxylate , by decreasing gut motility , may increase digoxin absorption .
None(e1,e2)	34	51	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	73	77	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	2	10	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
None(e1,e2)	18	31	therefore , co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	13	17	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , fluoxetine , sertraline , paroxetine , and fluvoxamine , inhibit p450 2d6 , they may vary in the extent of inhibition .
mechanism(e1,e2)	19	73	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	3	25	example inhibitors include azole_antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease_inhibitors , quinidine , and verapamil .
None(e1,e2)	85	96	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	8	20	interactions may also occur with the following : anti-depressants /anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	4	6	amiodarone taken concomitantly with quinidine increases quinidine serum concentration by 33 % after two days .
None(e1,e2)	87	136	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	0	5	aminoglutethimide diminishes the effect of coumarin and warfarin .
None(e1,e2)	4	12	coadministration of terfenadine with itraconazole has led to elevated plasma concentrations of terfenadine , resulting in rare instances of life- threatening cardiac dysrhythmias and one death .
None(e1,e2)	17	20	in a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without propantheline ( an anticholinergic_agent with multiple effects on the gi tract ) to healthy volunteers , the auc of clonazepam was 10 % lower and the cmax of clonazepam was 20 % lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone .
mechanism(e1,e2)	11	25	binding to serum proteins : the following agents may either inhibit levothyroxine_sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	20	38	in in vivo studies , 10- to 30-mg/day doses of aripiprazole had no significant effect on metabolism by cyp2d6 ( dextromethorphan ) , cyp2c9 ( warfarin ) , cyp2c19 ( omeprazole , warfarin ) , and cyp3a4 ( dextromethorphan ) substrates .
None(e1,e2)	28	77	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	9	increased plasma concentrations of terfenadine , astemizole , and cisapride cause qt prolongation and have been associated with torsades de pointes-type ventricular tachycardia , sometimes fatal .
None(e1,e2)	21	32	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	32	34	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	11	27	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic_acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	9	13	inomax has been administered with tolazoline , dopamine , dobutamine , steroids , surfactant , and high-frequency ventilation .
mechanism(e1,e2)	18	39	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	14	interaction of gabitril with highly protein bound drugs : in vitro data showed that tiagabine is 96 % bound to human plasma protein and therefore has the potential to interact with other highly protein bound compounds .
None(e1,e2)	8	11	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine -containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton pump inhibitors ( e.g. , lansoprazole , omeprazole ) .
None(e1,e2)	2	10	another oral azole_antifungal , ketoconazole , inhibits the metabolism of astemizole , resulting in elevated plasma concentrations of astemizole and its active metabolite desmethylastermizole which may prolong qt intervals .
None(e1,e2)	3	27	drug interactions with antacids administration of 120 mg of fexofenadine hydrochloride ( 2 x 60 mg capsule ) within 15 minutes of an aluminum and magnesium containing antacid ( maalox ) decreased fexofenadine auc by 41 % and cmax by 43 % .
None(e1,e2)	118	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	14	25	amiodarone or verapamil : the risk of myopathy/rhabdomyolysis is increased when either amiodarone or verapamil is used concomitantly with a closely related member of the hmg-coa_reductase_inhibitor_class ( see warnings , myopathy/rhabdomyolysis ) .
None(e1,e2)	3	14	the pharmacokinetics of naltrexone and its major metabolite 6-beta-naltrexol were unaffected following co-administration with acamprosate .
None(e1,e2)	17	21	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	18	20	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	51	68	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	0	8	norepinephrine : amphetamines enhance the adrenergic effect of norepinephrine .
None(e1,e2)	3	56	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	3	5	certain antibiotic , cisplatin , cyclosporine , diuretic , foscarnet , and vaccines .
None(e1,e2)	28	95	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	18	24	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine_oxidase_(_mao_)_inhibitors , tricyclic antidepressants or some antihistamines .
None(e1,e2)	28	44	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic_acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal_anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	0	36	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid-associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
None(e1,e2)	6	15	pharmacokinetic studies indicate that administration of disulfiram or diazepam does not affect the pharmacokinetics of acamprosate .
mechanism(e1,e2)	9	13	- drugs that may either increase or decrease plasma phenytoin concentrations include : phenobarbital , vaiproic acid , and sodium valproate .
None(e1,e2)	45	52	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	3	9	patients receiving other narcotic_analgesic s , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	0	17	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	16	23	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
None(e1,e2)	17	41	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central_nervous_system_depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	15	18	- anabolic steroids ( nandrolone [ e.g. , anabolin ] , oxandrolone [ e.g. , anavar ] , oxymetholone [ e.g. , anadrol ] , stanozolol [ e.g. , winstrol ] ) or
None(e1,e2)	24	37	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	41	53	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
mechanism(e1,e2)	0	26	aprepitant , when given as a regimen of 125 mg on day 1 and 80 mg/day on days 2 and 3 , increased the auc of methylprednisolone , a cyp3a4 substrate , by 1.34-fold on day 1 and by 2.5-fold on day 3 , when methylprednisolone was coadministered intravenously as 125 mg on day 1 and orally as 40 mg on days 2 and 3 .
None(e1,e2)	10	13	reports suggest that nsaids may diminish the antihypertensive effect of ace_inhibitors , including lisinopril .
None(e1,e2)	17	25	as with other antipsychotic agents , it should be noted that haldol may be capable of potentiating cns_depressants such as anesthetics , opiates , and alcohol .
None(e1,e2)	18	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	30	38	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	102	118	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	1	84	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	14	18	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	8	17	- a steroid medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	9	17	phase ii clinical trial data , where iressa and vinorelbine have been used concomitantly , indicate that iressa may exacerbate the neutropenic effect of vinorelbine .
effect(e1,e2)	0	2	acetazolamide and sodium_bicarbonate used concurrently increases the risk of renal calculus formation .
None(e1,e2)	0	12	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	15	19	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	3	9	standard therapy includes antibiotics , such as penicillin and gentamicin ;
None(e1,e2)	17	31	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	55	77	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin_c ; warfarin sodium under-dosage .
None(e1,e2)	21	24	in addition to the interactions noted above , chronic ( 2 weeks ) oral cordarone administration impairs metabolism of phenytoin , dextromethorphan , and methotrexate .
None(e1,e2)	3	12	infusion requirements of nimbex in patients administered succinylcholine prior to infusions of nimbex were comparable to or slightly greater than when succinylcholine was not administered .
None(e1,e2)	16	24	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
mechanism(e1,e2)	5	11	drugs such as troleandomycin and ketoconazole may inhibit the metabolism of corticosteroids and thus decrease their clearance .
None(e1,e2)	3	22	ergot derivatives : dihydroergotamine , ergonovine , ergotamine , methylergonovine contraindicated due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .
None(e1,e2)	0	2	antacids ( aluminum - or magnesium-containing ) : concomitant administration of 300-mg cefdinir capsules with 30 ml maalox tc suspension reduces the rate ( cmax ) and extent ( auc ) of absorption by approximately 40 % .
None(e1,e2)	13	27	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid_products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium_channel-blocking_drugs , and isoniazid .
None(e1,e2)	5	19	probenecid : concomitant administration of toradol oral and probenecid resulted in decreased clearance of ketorolac and significant increases in ketorolac plasma levels ( total auc increased approximately threefold from 5.4 to 17.8 m g/h/ml ) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours .
None(e1,e2)	0	19	phenobarbital toxicity has been reported to have occurred in a patient on chronic phenobarbital treatment following the initiation of diclofenac therapy .
None(e1,e2)	4	7	astemizole , bepridil , sparfloxacin , and terodiline .
None(e1,e2)	9	12	anticoagulants including coumarin derivatives , indandione derivatives , and platelet_aggregation_inhibitors such as nonsteroidal_anti-inflammatory_drugs ( nsaids ) , and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin .
None(e1,e2)	9	33	if desipramine hydrochloride is to be combined with other psychotropic_agents such as tranquilizers or sedative/hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
None(e1,e2)	26	35	although additional drug interaction studies have not been conducted , the most common medications used concomitantly with anagrelide in clinical trials were aspirin , acetaminophen , furosemide , iron , ranitidine , hydroxyurea , and allopurinol .
None(e1,e2)	5	22	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	23	39	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	9	16	azlocillin should not be administered concomitantly with amikacin , ciprofloxacin , gentamicin , netilmicin , or tobramycin .
None(e1,e2)	11	13	investigations into the effect of acitretin on the protein binding of anticoagulants_of_the_coumarin_type ( warfarin ) revealed no interaction .
None(e1,e2)	9	13	drugs that have been associated with peripheral neuropathy include antiretroviral_nucleoside_analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	4	17	verapamil : coadministration of almotriptan and verapamil resulted in a 24 % increase in plasma concentrations of almotriptan .
None(e1,e2)	57	120	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	15	19	curariform muscle relaxants ( eg , tubocurarine ) and other drugs , including ether , succinylcholine , gallamine , decamethonium and sodium citrate , potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with coly-mycin m parenteral .
None(e1,e2)	15	29	- anabolic steroids ( nandrolone [ e.g. , anabolin ] , oxandrolone [ e.g. , anavar ] , oxymetholone [ e.g. , anadrol ] , stanozolol [ e.g. , winstrol ] ) or
None(e1,e2)	4	11	drugs that may alter imatinib plasma concentrations drugs that may increase imatinib plasma concentrations : caution is recommended when administering gleevec with inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , erythromycin , clarithromycin ) .
None(e1,e2)	16	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	74	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
None(e1,e2)	34	42	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	33	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	31	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	4	17	other depressasnts such as alcohol , barbiturates , and maois may enhance cns depression when administered with ethchlorvynol .
None(e1,e2)	6	18	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
None(e1,e2)	33	38	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
effect(e1,e2)	4	15	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
None(e1,e2)	3	5	immunosuppressive drugs , fibric_acid_derivatives , niacin ( nicotinic acid , erythromycin , azole antifungals : skeletal muscle .
None(e1,e2)	77	83	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	10	95	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	4	6	no significant interactions with digoxin , hydrochlorothiazide , hydralazine , sulfinpyrazone , oral contraceptives , tolbutamide , or warfarin have been observed .
None(e1,e2)	0	36	phenytoin : in a single ( 400 mg ) and multiple dose ( 400 mg tid ) study of neurontin in epileptic patients ( n=8 ) maintained on phenytoin monotherapy for at least 2 months , gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics .
None(e1,e2)	23	42	other drugs : in small groups of patients ( 7-10/interaction study ) , the concomitant administration of azathioprine , gold , chloroquine , d-penicillamine , prednisolone , doxycycline , or digitoxin did not significantly affect the peak levels and auc values of diclofenac .
None(e1,e2)	59	95	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	12	danazol : the risk of myopathy/rhabdomyolysis is increased by concomitant administration of danazol particularly with higher doses of lovastatin ( see warnings , myopathy/rhabdomyolysis ) .
mechanism(e1,e2)	6	19	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	0	21	cimetidine is reported to reduce hepatic metabolism of certain tricyclic antidepressants , thereby delaying elimination and increasing steady-state concentrations of these drugs .
None(e1,e2)	0	25	ritonavir ( 600 mg b.i.d . ) co-administered with vardenafil 5 mg resulted in a 49-fold increase in vardenafil auc and a 13-fold increase in vardenafil cmax .
None(e1,e2)	29	59	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	0	15	quinidine : immediate release capsules : there have been rare reports of an interaction between quinidine and nifedipine ( with a decreased plasma level of quinidine ) .
None(e1,e2)	41	61	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	30	32	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	2	12	coadministration of terfenadine with itraconazole has led to elevated plasma concentrations of terfenadine , resulting in rare instances of life- threatening cardiac dysrhythmias and one death .
None(e1,e2)	0	9	phenobarbital : it appears that phenobarbital may reduce plasma felbamate concentrations .
None(e1,e2)	20	30	may interact with the following : beta-adrenergic blocking agents ( these medicines may make your condition worse and prevent the adrenergic_bronchodilators from working properly ) and disopyramide , quinidine , phenothiazines , and procainamide ( these medicines may increase the risk of heart problems ) .
None(e1,e2)	40	94	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	17	plasma concentrations of quinolone antibiotics are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	7	11	specific studies have confirmed these effects with sevoflurane , isoflurane , propofol , alfentanil , and midazolam .
None(e1,e2)	33	40	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	13	lithium_carbonate : the anorectic and stimulatory effects of amphetamines may be inhibited by lithium_carbonate .
effect(e1,e2)	6	118	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	45	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	5	7	carbamazepine : steady-state trough plasma carbamazepine and carbamazepine_10_,_11_epoxide concentrations were not affected by concomitant gabapentin ( 400 mg tid ;
None(e1,e2)	28	65	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	57	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	24	28	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
effect(e1,e2)	4	12	the hypotensive effect of sodium_nitroprusside is augmented by that of most other hypotensive_drugs , including ganglionic blocking agents , negative inotropic agents , and inhaled anesthetics .
None(e1,e2)	2	5	barbiturates , phenytoin , or rifampin increased metabolic clearance of fludrocortisone acetate because of the induction of hepatic enzymes .
None(e1,e2)	0	2	antibiotics : macrolide_antibiotics have been reported to cause a significant decrease in corticosteroid clearance .
None(e1,e2)	11	13	the clearance of benzodiazepines metabolized by glucuronidation ( e. g. , lorazepam , oxazepam , temazepam ) is unlikely to be affected by fluvoxamine .
None(e1,e2)	15	55	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood_thinner s ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex_sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	15	21	plasma concentrations ( auc 0-24 hrs ) of erythromycin decreased 15 % with coadministration of loratadine relative to that observed with erythromycin alone .
None(e1,e2)	14	18	caution should be exercised when the following drugs are administered concomitantly with lodosyn ( carbidopa ) given with levodopa or carbidopa-levodopa combination products .
None(e1,e2)	0	7	ketoconazole : potential interaction of ketoconazole and isoniazid may exist .
None(e1,e2)	49	65	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	5	8	this drug may interact with alcohol or other cns_depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	16	24	the potentiating action of hydroxyzine must be considered when the drug is used in conjunction with central_nervous_system_depressants such as narcotics , non-narcotic analgesics and barbiturates .
None(e1,e2)	7	13	dopamine antagonists : since apomorphine is a dopamine_agonist , it is possible that dopamine_antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	4	12	elevated serum levels of cyclosporine have been reported with concomitant use of cyclosporine with norfloxacin .
None(e1,e2)	4	19	if replacing clonidine by beta-blocker therapy , the introduction of beta blockers should be delayed for several days after clonidine administration has stopped .
None(e1,e2)	15	36	in order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with taxol should be premedicated with corticosteroids ( such as dexamethasone ) , diphen-hydramine and h2 antagonists ( such as cimetidine or ranitidine ) .
None(e1,e2)	38	44	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	26	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	0	12	lithium : nonsteroidal anti-inflammatory agents have been reported to increase steadystate plasma lithium levels .
None(e1,e2)	0	10	morphine : combination hormonal contraceptives may increase the clearance of morphine .
None(e1,e2)	24	79	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	28	34	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine_oxidase_inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	35	47	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	21	36	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	9	28	interactions may also occur with the following : anti-depressants/ anti-anxiety_drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	7	12	although deferasirox has a lower affinity for aluminum than for iron , exjade should not be taken with aluminum-containing antacid preparations .
None(e1,e2)	9	15	- anticoagulants : interaction studies in humans have shown bumetanide to have no effect on warfarin metabolism or on plasma prothrombin activity .
None(e1,e2)	13	15	there have been no reported cases from spontaneous reports of drug interaction between ssris and d.h.e_._45 ( dihydroergotamine mesylate ) injection , usp .
None(e1,e2)	14	30	the oral dexamethasone doses should be reduced by approximately 50 % when coadministered with aprepitant , to achieve exposures of dexamethasone similar to those obtained when it is given without aprepitant .
None(e1,e2)	54	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	0	7	hemabate may augment the activity of other oxytocic_agents .
None(e1,e2)	22	31	methadone levels may be decreased ; increased dosages may be required to prevent symptoms of opiate withdrawal . methadone maintained patients beginning nevirapine therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly .
None(e1,e2)	13	55	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex_sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	11	20	drug interactions : flupenthixol may interact with some drugs , like monoamine_oxidase_inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	62	103	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	27	53	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic_acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	15	17	the use of dextromethorphan hydrobromide may result in additive cns depressant effects when coadministered with alcohol , antihistamines , psychotropics or other drugs that produce cns depression .
None(e1,e2)	35	50	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine_derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
mechanism(e1,e2)	15	17	although not observed in this study , adverse effects could potentially arise from co-administration of cephalexin and metformin by inhibition of tubular secretion via organic cationic transporter systems .
None(e1,e2)	26	32	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin_hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	10	12	antiarrhythmics : other antiarrhythmic drugs , such as quinidine , procainamide , disopyramide , and phenytoin , have been used concurrently with amiodarone .
None(e1,e2)	6	8	the concomitant administration of exjade and aluminum -containing antacid_preparations has not been formally studied .
None(e1,e2)	10	18	since bacteriostatic drugs may interfere with the bactericidal action of penicillin , it is advisable to avoid giving tetracyclines in conjunction with penicillin .
None(e1,e2)	34	38	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	15	51	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
mechanism(e1,e2)	0	3	ketoconazole increased mean alosetron plasma concentrations ( auc ) by 29 % .
effect(e1,e2)	1	7	- lofexidine may enhance the effects of anti-hypertensive_drug therapy
None(e1,e2)	3	9	heparin : since heparin is contraindicated in patients with heparin -induced thrombocytopenia , the co-administration of argatroban and heparin is unlikely for this indication .
None(e1,e2)	16	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	14	40	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	3	9	in patients taking furosemide , nifedipine , diltiazem , ace_inhibitors , verapamil , glyburide , propranolol , and various chemotherapy agents , no effect was shown on the clearance of hydrodolasetron .
None(e1,e2)	0	9	hydrochlorothiazide ( hctz ) alone or in combination with triamterene : concomitant use of hctz alone or in combination with triamterene is contraindicated .
None(e1,e2)	34	56	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	13	31	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	3	73	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
mechanism(e1,e2)	8	31	blood levels of hydrodolasetron increased 24 % when dolasetron was coadministered with cimetidine ( nonselective inhibitor of cytochrome p-450 ) for 7 days , and decreased 28 % with coadministration of rifampin ( potent inducer of cytochrome p-450 ) for 7 days .
None(e1,e2)	9	18	probenecid : probenecid interferes with renal tubular secretion of ciprofloxacin and produces an increase in the level of ciprofloxacin in serum .
None(e1,e2)	6	12	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	2	9	nevirapine and rifampin should not beadministered concomitantly becausedecreases in nevirapine plasmaconcentrations may reduce the efficacy ofthe drug .
None(e1,e2)	18	38	although studies designed to examine drug interactions have not been done , it was noted that corticosteroid or acth treatment of relapses for periods of up to 28 days has been administered to patients ( n=180 ) receiving betaseron .
None(e1,e2)	15	33	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	11	30	quinidine : coadministration of a 10-mg single dose of aripiprazole with quinidine ( 166 mg/day for 13 days ) , a potent inhibitor of cyp2d6 , increased the auc of aripiprazole by 112 % but decreased the auc of its active metabolite , dehydroaripiprazole , by 35 % .
None(e1,e2)	1	28	when ertapenem is co-administered with probenecid ( 500 mg p.o . every 6 hours ) , probenecid competes for active tubular secretion and reduces the renal clearance of ertapenem .
None(e1,e2)	28	30	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	16	20	poor metabolizers of debrisoquin : interactions of carvedilol with strong inhibitors of cyp2d6 ( such as quinidine , fluoxetine , paroxetine , and propafenone ) have not been studied , but these drugs would be expected to increase blood levels of the r ( + ) enantiomer of carvedilol .
None(e1,e2)	83	127	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	4	12	in healthy volunteers , exjade had no effect on the pharmacokinetics of digoxin .
None(e1,e2)	12	24	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	49	73	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	23	26	glibenclamide : in a study of 7 healthy male volunteers , acitretin treatment potentiated the blood glucose lowering effect of glibenclamide ( a sulfonylurea similar to chlorpropamide ) in 3 of the 7 subjects .
None(e1,e2)	26	30	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf_blocking_agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	4	15	- anabolic steroids ( nandrolone [ e.g. , anabolin ] , oxandrolone [ e.g. , anavar ] , oxymetholone [ e.g. , anadrol ] , stanozolol [ e.g. , winstrol ] ) or
None(e1,e2)	32	40	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	9	16	example inducers include aminoglutethimide , carbamazepine , nafcillin , nevirapine , phenobarbital , phenytoin , and rifamycins .
None(e1,e2)	35	49	beta blockers : although the results of a clinical study did not indicate a safe problem associated with the administration of d.h.e . 45 ( dihydroergotamine mesylate ) injection , usp to subjects already receiving propranolol , there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine .
None(e1,e2)	62	80	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	8	20	fluconazole , and the 5-ht3 antiemetics ondansetron ( zofran ) and granisetron ( kytril ) have all been used with busulfex .
mechanism(e1,e2)	15	26	acidifying agents : gastrointestinal acidifying agents ( guanethidine , reserpine , glutamic acid hcl , ascorbic_acid , fruit juices , etc . ) lower absorption of amphetamines .
None(e1,e2)	20	23	glibenclamide : in a study of 7 healthy male volunteers , acitretin treatment potentiated the blood glucose lowering effect of glibenclamide ( a sulfonylurea similar to chlorpropamide ) in 3 of the 7 subjects .
None(e1,e2)	80	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	6	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
effect(e1,e2)	3	11	patients treated with nalfon may be resistant to the effects of loop_diuretics .
None(e1,e2)	17	30	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
int(e1,e2)	0	37	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	6	10	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	47	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	83	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	11	clidinium may decrease the effect of phenothiazines , levodopa , and ketoconazole .
None(e1,e2)	23	27	other drugs : in small groups of patients ( 7-10/interaction study ) , the concomitant administration of azathioprine , gold , chloroquine , d-penicillamine , prednisolone , doxycycline , or digitoxin did not significantly affect the peak levels and auc values of diclofenac .
None(e1,e2)	49	71	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics * ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	4	26	these medications have included heparin , warfarin , beta-adrenergic receptor blockers , calcium channel antagonists , angiotensin converting enzyme inhibitors , intravenous and oral nitrates , ticlopidine , and aspirin .
None(e1,e2)	41	81	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	9	43	most cases of serious or fatal adverse events involving levo-dromoran reported to the manufacturer or the fda have involved either the administration of large initial doses or too frequent doses of the drug to nonopioid tolerant patients , or the simultaneous administration of levorphanol with other drugs affecting respiration .
None(e1,e2)	14	33	because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis , it is particularly important that physicians query patients or their guardians carefully about benzodiazepine , alcohol and sedative use as part of the history prior to any procedure in which the use of romazicon is planned .
None(e1,e2)	87	104	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	43	61	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
effect(e1,e2)	4	23	although not studied with alosetron , inhibition of n-acetyltransferase may have clinically relevant consequences for drugs such as isoniazid , procainamide , and hydralazine .
None(e1,e2)	16	44	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	30	53	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	13	18	inhibitors of cyp3a4 ( eg , ketoconazole ) or cyp2d6 ( eg , quinidine , fluoxetine , or paroxetine ) can inhibit aripiprazole elimination and cause increased blood levels .
None(e1,e2)	14	24	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	17	23	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
effect(e1,e2)	8	11	lithium toxicity was usually reversible upon discontinuation of lithium and the ace_inhibitor .
None(e1,e2)	30	39	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	2	9	cimetidine : cimetidine does not affect the pharmacokinetics of fosfomycin when coadministered with monurol .
None(e1,e2)	0	12	leukocyte_transfusions : acute pulmonary toxicity has been reported in patients receiving intravenous amphotericin_b and leukocyte transfusions .
effect(e1,e2)	6	47	platelet inhibitors : drugs such as acetylsalicylic_acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin_sodium .
None(e1,e2)	83	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	9	15	in a study with concomitant administration of aspirin and fosinopril_sodium , the bioavailability of unbound fosinoprilat was not altered .
None(e1,e2)	96	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	16	33	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	6	10	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	13	28	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	17	34	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	10	27	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	18	26	theophylline : the effect of steady-state fluvoxamine l50 mg bid on the pharmacokinetics of a single dose of theophylline ( 375 mg ) as 442 mg aminophylline was evaluated in 12 healthy non-smoking , male volunteers .
None(e1,e2)	21	23	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	5	12	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	0	14	quinidine and procainamide doses should be reduced by one-third when either is administered with amiodarone .
None(e1,e2)	32	53	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	14	20	therefore , interactions could occur following concomitant administration of psychotropic drugs ( e.g. , narcotics , analgesics , antiemetics , sedatives , tranquilizers ) .
None(e1,e2)	11	27	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	53	66	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	3	26	the pharmacokinetics of terfenadine and its acid metabolite and the electrocardiographic qt c interval were measured during both periods : with terfenadine alone , and with terfenadine plus dirithromycin .
None(e1,e2)	0	15	methotrexate - there is one report that methotrexate may decrease the possible effectiveness of supplemental l-glutamine for chemotherapy-induced mucositis .
None(e1,e2)	8	27	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	8	29	however , since aspirin , nsaids , and bisphosphonates are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of aspirin or nsaids with ibandronate .
None(e1,e2)	42	58	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	24	26	physiological changes resulting from smoking cessation , with or without nicotine replacement , may alter the pharmacokinetics of certain concomitant medications , such as tricyclic_antidepressants and theophylline .
None(e1,e2)	18	47	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta blockers , cardiac_glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide_diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	114	125	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
advise(e1,e2)	28	32	alcohol - although lexapro did not potentiate the cognitive and motor effects of alcohol in a clinical trial , as with other psychotropic medications , the use of alcohol by patients taking lexapro is not recommended .
int(e1,e2)	61	74	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	75	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	13	22	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum_hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	11	13	in patients in whom cyp3a4 inducers ( eg , dexamethasone , phenytoin , carbamazepine , rifampicin , phenobarbital ) are indicated , alternative agents with less enzyme induction potential should be used .
None(e1,e2)	11	46	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium_channel_blockers , beta blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide_diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	13	78	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	36	38	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	117	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	16	chlorpromazine : chlorpromazine blocks dopamine and norepinephrine reuptake , thus inhibiting the central stimulant effects of amphetamines , and can be used to treat amphetamine poisoning .
None(e1,e2)	56	60	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	42	45	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine_oxidase_inhibitors , and beta_adrenergic_blocking_agents .
None(e1,e2)	12	35	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	48	54	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	6	27	although concomitant use of clozapine and carbamazepine is not recommended , it should be noted that discontinuation of concomitant carbamazepine administration may result in an increase in clozapine plasma levels .
None(e1,e2)	0	25	aprepitant is unlikely to interact with drugs that are substrates for the p-glycoprotein transporter , as demonstrated by the lack of interaction of aprepitant with digoxin in a clinical drug interaction study .
None(e1,e2)	14	33	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease_inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	71	96	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral_hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing_compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
effect(e1,e2)	17	20	non-selective mao inhibitors including tranylcypromine sulfate , phenelzine sulfate , and pargyline hc1 : concomitant use of l-tyrosine and non-selective mao_inhibitors may cause hypertension .
None(e1,e2)	17	19	curariform muscle relaxants ( eg , tubocurarine ) and other drugs , including ether , succinylcholine , gallamine , decamethonium and sodium citrate , potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with coly-mycin m parenteral .
None(e1,e2)	24	46	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	4	7	urinary alkalinizing agents ( acetazolamide , some thiazides ) increase the concentration of the non-ionized species of the amphetamine molecule , thereby decreasing urinary excretion .
None(e1,e2)	71	90	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral_hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	33	44	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	32	40	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	12	18	selective serotonin reuptake inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
None(e1,e2)	39	97	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing_compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	2	62	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	7	15	compounds tested in man include warfarin , theophylline , phenytoin , diazepam , aminopyrine and antipyrine .
effect(e1,e2)	5	10	moreover , as noted with alprazolam , the effect of fluvoxamine may even be more pronounced when it is administered at higher doses .
mechanism(e1,e2)	0	20	gleevec will increase plasmaconcentration of other cyp3a4 metabolized drugs ( e.g. , triazolo-benzodiazepines , dihydropyridine calcium channel blockers , certain hmg-coa_reductase_inhibitors , etc . ) .
None(e1,e2)	52	69	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	14	52	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	8	27	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	102	108	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	29	36	although glucocorticoids have been shown to reduce proleukin-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with proleukin may reduce the antitumor effectiveness of proleukin and thus should be avoided . 12 beta-blockers and other antihypertensives may potentiate the hypotension seen with proleukin .
None(e1,e2)	45	46	cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation , the discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin .
None(e1,e2)	18	22	because of the risk of serious ventricular arrhythmias and sudden death potentially associated with elevated plasma levels of thioridazine , duloxetine and thioridazine should not be co-administered .
None(e1,e2)	11	15	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic_antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	8	18	data from a randomized trial of hexalen and cisplatin plus or minus pyridoxine in ovarian cancer indicated that pyridoxine significantly reduced neurotoxicity ;
None(e1,e2)	51	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	19	21	no dose adjustment is necessary when simulect is added to triple-immunosuppression regimens including cyclosporine , corticosteroids , and either azathioprine or mycophenolate_mofetil .
None(e1,e2)	0	2	somatrem / somatropin : excessive concurrent use of thyroid hormone may accelerate epiphyseal closure .
effect(e1,e2)	9	17	other depressasnts such as alcohol , barbiturates , and maois may enhance cns depression when administered with ethchlorvynol .
None(e1,e2)	29	41	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	51	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	12	similarly , patients receiving the drug and a hydantoin , sulfonamide or sulfonylurea should be observed for signs of toxicity to these drugs .
advise(e1,e2)	0	12	celebrex should be introduced at the lowest recommended dose in patients receiving fluconazole .
None(e1,e2)	11	37	because severe hypoglycemia has been reported in patients concomitantly receiving oral miconazole ( an imidazole ) and oral hypoglycemic agents , such a potential interaction involving the latter agents when used concomitantly with ketoconazole tablets ( an imidazole ) can not be ruled out .
None(e1,e2)	17	33	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	51	59	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
mechanism(e1,e2)	7	19	protease inhibitors : amprenavir , lopinavir , nelfinavir , and ritonavir have been shown to decrease plasma levels of combination_hormonal_contraceptives ;
None(e1,e2)	98	116	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	37	49	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	7	25	in general , most patients treated with dirithromycin who are receiving concomitant theophylline therapy may not require empiric adjustment of theophylline dosage or monitoring of theophylline plasma concentrations .
None(e1,e2)	15	31	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	0	6	adrenergic_blockers adrenergic blockers are inhibited by amphetamines .
None(e1,e2)	0	7	tambocor has been administered to patients receiving digitalis_preparations or beta-adrenergic blocking agents without adverse effects .
None(e1,e2)	8	35	venlafaxine : coadministration of a single dose of zaleplon 10 mg and multiple doses of venlafaxine er ( extended release ) 150 mg did not result in any significant changes in the pharmacokinetics of either zaleplon or venlafaxine .
None(e1,e2)	20	41	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	21	29	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	0	14	mao_inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic_agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
None(e1,e2)	31	65	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	14	16	diphenhydramine hydrochloride has additive effects with alcohol and other cns depressants ( hypnotics , sedatives , tranquilizers , etc ) .
None(e1,e2)	40	53	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot_derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	23	42	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	19	93	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	11	25	- anabolic steroids ( nandrolone [ e.g. , anabolin ] , oxandrolone [ e.g. , anavar ] , oxymetholone [ e.g. , anadrol ] , stanozolol [ e.g. , winstrol ] ) or
effect(e1,e2)	14	22	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	34	41	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	0	5	allopurinol : the auc of didanosine was increased about 4-fold when allopurinol at 300 mg/day was coadministered with a single 200-mg dose of videx to two patients with renal impairment ( clcr=15 and 18 ml/min ) .
None(e1,e2)	7	10	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	6	20	data from in vitro studies of alprazolam suggest a possible drug interaction with alprazolam for the following : sertraline and paroxetine .
None(e1,e2)	11	30	since entecavir is primarily eliminated by the kidneys , coadministration of baraclude with drugs that reduce renal function or compete for active tubular secretion may increase serum concentrations of either entecavir or the coadministered drug .
None(e1,e2)	14	23	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	35	112	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	63	70	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	30	38	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	15	28	therefore , coadministration of aprepitant with drugs that strongly induce cyp3a4 activity ( e.g. , rifampin , carbamazepine , phenytoin ) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of aprepitant .
None(e1,e2)	46	105	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	11	anticonvulsants : in a pharmacokinetic study , maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long-term anticonvulsant therapy ( eg , phenytoin , carbamazepine , or phenobarbital ) than in healthy volunteers .
None(e1,e2)	12	23	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	13	22	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial_agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	23	37	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin b , cyclosporine , non-steroidal_anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
None(e1,e2)	4	8	the safety of using stadol_ns and imitrex ( sumatriptan ) nasal spray during the same episode of migraine has not been established .
None(e1,e2)	63	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	18	however , co-administration of duloxetine with aluminum- and magnesium -containing antacids ( 51 meq ) or duloxetine with famotidine , had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose .
advise(e1,e2)	7	17	because moderate cyp3a4 inhibitors ( e.g. , diltiazem ) result in 2-fold increase in plasma concentrations of aprepitant , concomitant administration should also be approached with caution .
None(e1,e2)	5	12	selective serotonin reuptake inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
None(e1,e2)	6	13	the patient was also chronically receiving phenytoin , phenobarbital , digoxin , and levothyroxine_sodium .
None(e1,e2)	5	13	concomitant treatment with methylxanthines ( aminophylline , theophylline ) , steroids , or diuretics may potentiate any hypokalemic effect of adrenergic agonists .
effect(e1,e2)	6	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	8	phenytoin : if acitretin is given concurrently with phenytoin , the protein binding of phenytoin may be reduced .
None(e1,e2)	35	46	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	0	24	ethanol / nutrition / herb interactions : food : cns effects of caffeine may be enhanced if combination hormonal contraceptives are used concurrently with caffeine .
None(e1,e2)	23	41	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	49	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	8	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	36	49	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral_hydrate * ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics * ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
mechanism(e1,e2)	4	16	h2 receptor antagonists : cimetidine coadministration leads to an increased peak plasma concentration and auc of cisapride , there is no effect on cisapride absorption when it is coadministered with ranitidine .
None(e1,e2)	22	30	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	35	37	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin b , cyclosporine , non-steroidal_anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
None(e1,e2)	37	75	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	10	mercaptopurine/azathioprine : allopurinol inhibits the enzymatic oxidation of mercaptopurine and azathioprine to 6-thiouric acid .
None(e1,e2)	16	34	other concomitant therapy : although specific interaction studies were not performed , in clinical studies , cerivastatin_sodium was used concomitantly with angiotensin- converting enzyme ( ace ) inhibitors , betablockers , calcium-channel blockers , diuretics , and nonsteroidal anti-inflammatory drugs ( nsaids ) without evidence of clinically significant adverse interactions .
None(e1,e2)	9	15	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic_antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	5	28	because of the potential for arava levels to continue to increase with multiple dosing , caution should be used if patients are to be receiving both arava and rifampin .
None(e1,e2)	2	18	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
None(e1,e2)	7	23	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	28	40	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
effect(e1,e2)	6	112	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	30	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	7	32	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	25	39	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	107	143	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	40	52	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	21	28	the pharmacokinetics of terfenadine and its acid metabolite and the electrocardiographic qt c interval were measured during both periods : with terfenadine alone , and with terfenadine plus dirithromycin .
None(e1,e2)	32	38	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing_compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	33	50	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide_dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	25	27	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	10	18	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
None(e1,e2)	0	9	caffeine -related adverse effects have occurred in patients consuming caffeine while on therapy with enoxacin .
None(e1,e2)	5	9	- methotrexate ( e.g. , mexate ) use of methotrexate with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of methotrexate
None(e1,e2)	69	108	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	29	33	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	0	10	cyclosporine : combination hormonal contraceptives may inhibit the metabolism of cyclosporine , leading to increased plasma concentrations ;
None(e1,e2)	95	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	2	23	sumatriptan : sumatriptan has been reported to cause coronary artery vasospasm , and its effect could be additive with d.h.e . 45 ( dihydroergotamine_mesylate ) injection , usp .
None(e1,e2)	1	5	oral contraceptives : coadministration of atorvastatin and an oral contraceptive increased auc values for norethindrone and ethinyl estradiol by approximately 30 % and 20 % .
effect(e1,e2)	5	7	antagonism has been demonstrated between clindamycin and erythromycin in vitro .
None(e1,e2)	22	27	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	0	3	oxytocin or other oxytocics ( concurrent use with dinoprost may result in uterine hypertonus , possibly causing uterine rupture or cervical laceration , especially in the absence of adequate cervical dilatation ;
None(e1,e2)	25	28	a similar association , though less marked , has been suggested with barbiturates , phenyl-butazone , phenytoin sodium , carbamazepine and possibly with griseofulvin , ampicillin , and tetracyclines ( 72 )
None(e1,e2)	14	32	an adequate period of observation must be provided for any patient in whom either long-acting_benzodiazepines ( such as diazepam ) or large doses of short-acting benzodiazepines ( such as 10 mg of midazolam ) have been used .
None(e1,e2)	17	38	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
effect(e1,e2)	8	29	cytotoxic agents : enhanced bone marrow suppression by cyclophosphamide and other cytotoxic agents has been reported among patients with neoplastic disease , except leukemia , in the presence of allopurinol .
None(e1,e2)	25	27	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis_kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	5	isoflurane , enflurane , and halothane decrease the ed50 of nuromax by 30 % to 45 % .
None(e1,e2)	26	57	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	10	35	in renal and cardiac transplant recipients , a reduction of cyclosporine dose ranging from 15 % to 48 % was necessary to maintain cyclosporine trough concentrations similar to those seen prior to the addition of diltiazem .
None(e1,e2)	69	71	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
advise(e1,e2)	19	25	therefore , close monitoring of prothrombin time is recommended and adjustment of the anticoagulant dose may be necessary when eulexin capsules are administered concomitantly with warfarin .
None(e1,e2)	11	45	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta_blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	23	29	cimetidine ( 400 mg b.i.d . ) had no effect on vardenafil bioavailability ( auc ) and maximum concentration ( cmax ) of vardenafil when co-administered with 20 mg vardenafil in healthy volunteers .
mechanism(e1,e2)	9	11	hydrochlorothiazide : in normal volunteers , concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide .
None(e1,e2)	67	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	20	62	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium_channel_blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	32	64	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	2	10	interactions for vitamin_b3 ( niacin ) : antihypertensive therapy : nicotinic_acid may potentiate the effects of ganglionic blocking agents and vasoactive drugs resulting in postural hypotension .
None(e1,e2)	5	10	in vitro data suggest that itraconazole , when compared to ketoconazole , has a less pronounced effect on the biotransformation system responsible for the metabolism of astemizole .
None(e1,e2)	110	120	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	12	15	however , no deleterious interactions were seen when romazicon was administered after narcotics , inhalational anesthetics , muscle relaxants and muscle relaxant antagonists administered in conjunction with sedation or anesthesia .
None(e1,e2)	0	8	sulindac : the concomitant administration of diflunisal and sulindac in normal volunteers resulted in lowering of the plasma levels of the active sulindac sulfide metabolite by approximately one-third .
None(e1,e2)	21	94	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	17	compounds that have been tested in man include antipyrine , digoxin , propranolol , theophylline , and warfarin and no clinically meaningful interactions were found .
advise(e1,e2)	2	18	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	17	22	because there is a theoretical basis that these effects may be additive , use of ergotamine-containing or ergot-type_medications ( like dihydroergotamine or methysergide ) and axert within 24 hours of each other should be avoided .
None(e1,e2)	16	18	coadministration with compounds that are potent inducers of cyp3a4 ( eg , phenobarbital , phenytoin , dexamethasone , carbamazepine ) may result in decreased plasma levels of saquinavir .
None(e1,e2)	9	11	anabolic steroids ( particularly c-17 alkylated androgens such as oxymetholone , methandrostenolone , norethandrolone , and similar compounds ) enhanced tendency toward edema .
effect(e1,e2)	5	18	certain drugs including thiazides , corticosteroids , thyroid products , and sympathomimetics may reduce the hypoglycemic action of starlix and other oral antidiabetic drugs .
mechanism(e1,e2)	5	39	protein binding in vitro , diclofenac interferes minimally or not at all with the protein binding of salicylic acid ( 20 % decrease in binding ) , tolbutamide , prednisolone ( 10 % decrease in binding ) , or warfarin .
None(e1,e2)	0	11	probenecid : the oral combination of probenecid before intramuscular injection of pipracil produces an increase in piperacillin peak serum level of about 30 % .
None(e1,e2)	12	34	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
effect(e1,e2)	6	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	45	65	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
advise(e1,e2)	17	26	therefore , such combined treatment should be approached with caution and patients should be monitored closely when clozapine is combined with these drugs , particularly with fluvoxamine .
None(e1,e2)	4	13	analgesic/anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
advise(e1,e2)	0	18	dostinex should not be administered concurrently with d2-antagonists , such as phenothiazines , butyrophenones , thioxanthines , or metoclopramide .
None(e1,e2)	0	17	terfenadine : no clinically significant changes occurred in heart rate or corrected qt intervals , or in terfenadine metabolite or lomefloxacin pharmacokinetics , during concurrent administration of lomefloxacin and terfenadine at steady-state in 28 healthy males .
None(e1,e2)	35	48	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin b , cyclosporine , non-steroidal anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
None(e1,e2)	18	20	administration of rifampin concomitantly with oral amiodarone has been shown to result in decreases in serum concentrations of amiodarone and desethylamiodarone .
None(e1,e2)	16	54	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	2	4	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
effect(e1,e2)	0	13	diphenhydramine_hydrochloride has additive effects with alcohol and other cns depressants ( hypnotics , sedatives , tranquilizers , etc ) .
None(e1,e2)	33	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	41	95	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	83	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	32	35	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
advise(e1,e2)	5	7	nucleoside analogues didanosine co-administration of copegus and didanosine is not recommended .
None(e1,e2)	3	33	concomitant administration of diflunisal and acetaminophen in dogs , but not in rats , at approximately 2 times the recommended maximum human therapeutic dose of each ( 40 to 52 mg/kg/day of diflunisal/ acetaminophen ) resulted in greater gastrointestinal toxicity than when either drug was administered alone .
None(e1,e2)	3	19	ketoconazole ) , macrolide_antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	17	28	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	10	21	avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic amine ( e.g. , epinephrine , norepinephrine ) , since it has been reported that tricyclic antidepressants can potentiate the effects of catecholamines .
None(e1,e2)	0	27	coumarin-type_anticoagulants : several short-term controlled studies failed to wshow that ibuprofen significantly affected prothrombin times or a variety of other clotting factors when administered to individuals on coumarin-type_anticoagulants .
None(e1,e2)	32	44	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	92	94	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	11	22	may lead to loss of virologic response and possible resistance to crixivan or to the class of protease inhibitors or other coadministered antiretroviral_agents .
None(e1,e2)	14	31	drugs that inhibit cyp3a4 cyp3a4 is a minor metabolic pathway for the elimination of zaleplon because the sum of desethylzaleplon ( formed via cyp3a4 in vitro ) and its metabolites , 5-oxo-desethylzaleplon and 5-oxo-desethylzaleplon glucuronide , account for only 9 % of the urinary recovery of a zaleplon dose .
None(e1,e2)	25	29	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	34	77	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin_c ; warfarin sodium under-dosage .
None(e1,e2)	88	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	12	14	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	62	66	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	41	80	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	29	31	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	13	25	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid_products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	26	29	these medications have included heparin , warfarin , beta-adrenergic receptor blockers , calcium channel antagonists , angiotensin converting enzyme inhibitors , intravenous and oral nitrates , ticlopidine , and aspirin .
None(e1,e2)	9	11	persons taking most antibiotics , methotrexate and pyrimethamine invalidate folic_acid and vitamin_b12 diagnostic blood assays .
effect(e1,e2)	8	18	these results suggest that the analgesic effect of stadol_ns may be diminished when it is administered shortly after sumatriptan nasal spray , but by 30 minutes any such reduction in effect should be minimal .
None(e1,e2)	6	19	the use of mao inhibitors or tricyclic_antidepressants with hydrocodone preparations may increase the effect of either the antidepressant or hydrocodone .
None(e1,e2)	13	32	the principal drugs given ( number of patients in parentheses ) were : cardiac_glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	15	23	- a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	53	64	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	21	31	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
mechanism(e1,e2)	6	9	these studies indicate that ketoconazole or erythromycin co-administration enhances fexofenadine gastrointestinal absorption .
None(e1,e2)	106	110	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	3	5	the use of nuromax before succinylcholine to attenuate some of the side effects of succinylcholine has not been studied .
None(e1,e2)	11	17	in patients in whom cyp3a4 inducers ( eg , dexamethasone , phenytoin , carbamazepine , rifampicin , phenobarbital ) are indicated , alternative agents with less enzyme induction potential should be used .
None(e1,e2)	8	15	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , citalopram , escitalopram , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
mechanism(e1,e2)	6	22	inhibitors of cyp3a4 ( eg , ketoconazole ) or cyp2d6 ( eg , quinidine , fluoxetine , or paroxetine ) can inhibit aripiprazole elimination and cause increased blood levels .
None(e1,e2)	53	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	14	20	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	6	29	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	15	41	cimetidine : a study in 6 healthy volunteers has shown a significant increase in peak nifedipine plasma levels ( 80 % ) and area-under-the-curve ( 74 % ) after a 1 week course of cimetidine at 1000 mg per day and nifedipine at 40 mg per day .
None(e1,e2)	0	5	ketoconazole : potential interaction of ketoconazole and isoniazid may exist .
None(e1,e2)	26	30	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	0	13	anakinra : concurrent administration of anakinra ( an interleukin-1 antagonist ) and another tnf-blocking_agent has been associated with an increased risk of serious infections , an increased risk of neutropenia and no additional benefit compared to these medicinal products alone .
None(e1,e2)	78	85	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	2	protease_inhibitor : atazanavir
None(e1,e2)	5	13	concurrent use of butorphanol with central_nervous_system_depressants ( e.g. , alcohol , barbiturates , tranquilizers , and antihistamines ) may result in increased central nervous system depressant effects .
None(e1,e2)	33	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	30	35	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine_derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	30	36	oral contraceptives : aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl estradiol and 1 mg of norethindrone , decreased the auc of ethinyl_estradiol by 43 % , and decreased the auc of norethindrone by 8 % ;
None(e1,e2)	3	7	mao inhibitors , narcotic_analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
None(e1,e2)	5	8	if antacids are required during omnicef therapy , omnicef should be taken at least 2 hours before or after the antacid .
None(e1,e2)	15	19	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
mechanism(e1,e2)	1	21	when duloxetine was administered ( at a dose of 60 mg bid ) in conjunction with a single 50-mg dose of desipramine , a cyp2d6 substrate , the auc of desipramine increased 3-fold .
None(e1,e2)	57	94	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	12	ace-inhibitors : reports suggest that nsaids may diminish the antihypertensive effect of ace-inhibitors .
mechanism(e1,e2)	0	4	colchicine is inhibited by acidifying_agents .
None(e1,e2)	13	42	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	76	108	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	2	12	coadministration of valdecoxib and ortho-novum 1/35 increased the exposure of norethindrone and ethinyl_estradiol by 20 % and 34 % , respectively .
None(e1,e2)	18	24	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	18	24	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	2	12	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
effect(e1,e2)	9	40	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	20	46	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	16	20	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin_sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
None(e1,e2)	32	70	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	22	26	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine-containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton_pump_inhibitors ( e.g. , lansoprazole , omeprazole ) .
effect(e1,e2)	3	8	the use of mao_inhibitors or tricyclic antidepressants with hydrocodone preparations may increase the effect of either the antidepressant or hydrocodone .
None(e1,e2)	17	21	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	17	51	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	32	52	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	0	11	selegiline : combination hormonal contraceptives may increase the serum concentration of selegiline .
None(e1,e2)	22	38	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	14	45	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	16	20	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	3	35	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	42	59	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	21	23	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
None(e1,e2)	7	16	it is suggested that in patients receiving dopamine_hcl , alternatives to phenytoin should be used if anticonvulsant therapy is needed .
None(e1,e2)	23	25	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
None(e1,e2)	2	4	interaction with phenytoin , lidocaine and theophylline has also been reported to produce adverse clinical effects .
None(e1,e2)	19	24	oral contraceptives : aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl_estradiol and 1 mg of norethindrone , decreased the auc of ethinyl estradiol by 43 % , and decreased the auc of norethindrone by 8 % ;
None(e1,e2)	15	21	- a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	8	21	in clinical studies where patients were on chronic theophylline therapy , lomefloxacin had no measurable effect on the mean distribution of theophylline concentrations or the mean estimates of theophylline clearance .
None(e1,e2)	26	28	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
None(e1,e2)	65	120	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	62	101	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
mechanism(e1,e2)	1	13	oral anticoagulants may potentiate the hypoglycemic action of hypoglycemic agents , eg , tolbutamide and chlorpropamide , by inhibiting their metabolism in the liver .
None(e1,e2)	8	12	when therapeutic concentrations of furosemide , propranolol , dipyridamole , warfarin , quinidine , or naproxen were added to human plasma ( in vitro ) , the plasma protein binding of nicardipine hcl was not altered .
None(e1,e2)	0	22	paclitaxel - in one report , l-glutamine at a dose of 10 grams three times daily , given 24 hours after receiving paclitaxel , appeared to prevent the development of myalgia and arthralgia , adverse reactions of paclitaxel .
None(e1,e2)	52	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	22	patients taking revia may not benefit from opioid containing medicines , such as cough and cold preparations , antidiarrheal preparations , and opioid_analgesics .
None(e1,e2)	12	24	vardenafil ( 20 mg ) did not potentiate the hypotensive effects of alcohol during the 4-hour observation period in healthy volunteers when administered with alcohol ( 0.5 g/kg body weight ) .
effect(e1,e2)	0	11	codeine in combination with other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , or other cns depressants ( including alcohol ) has additive depressant effects .
None(e1,e2)	35	45	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	3	5	other drug interactions cimetidine , erythromycin and dextropropoxyphene had no effect on the pharmacokinetics of mhd .
effect(e1,e2)	7	9	two percent of patients treated concurrently with kineret and etanercept developed neutropenia ( anc 1 x 109/l ) .
None(e1,e2)	31	33	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	10	63	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	11	13	drug interactions : a . drugs enhancing heparin effect : oral anticoagulants : heparin_sodium may prolong the one-stage prothrombin time .
None(e1,e2)	12	14	welchol was found to have no significant effect on the bioavailability of digoxin , lovastatin , metoprolol , quinidine , valproic acid , and warfarin .
None(e1,e2)	11	17	the co-administration of natrecor with iv vasodilators such as nitroglycerin , nitroprusside , milrinone , or iv ace_inhibitors has not been evaluated ( these drugs were not co-administered with natrecor in clinical trials ) .
None(e1,e2)	57	114	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	15	17	because lithium may enhance the serotonergic effects of escitalopram , caution should be exercised when lexapro and lithium are coadministered .
advise(e1,e2)	4	9	- when bezalip or bezalip_retard is used concurrently with anion-exchange_resins ( e.g . cholestryramine ) , an interval of at least 2 hours should be maintained between the two medicines , since the absorption of bezalip or bezalip retard is impaired
None(e1,e2)	1	15	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide_diuretics and reducing diuretic absorption from the gastrointestinal tract
advise(e1,e2)	0	11	chirocaine should be used with caution in patients receiving other local anesthetics or agents structurally related to amide-type local anesthetics since the toxic effects of these drugs could be additive .
effect(e1,e2)	8	26	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
None(e1,e2)	12	14	fenfluramine may increase slightly the effect of antihypertensive drugs , e.g. , guanethidine , methyldopa , reserpine .
None(e1,e2)	11	17	use of prinivil with potassium-sparing diuretics ( e.g. , spironolactone , triamterene , or amiloride ) , potassium supplements , or potassium-containing salt substitutes may lead to significant increases in serum potassium .
None(e1,e2)	6	23	in clinical studies , coadministration of welchol with atorvastatin , lovastatin , or simvastatin did not interfere with the lipid-lowering activity of the hmg-coa_reductase_inhibitor .
None(e1,e2)	7	13	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist_analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
effect(e1,e2)	14	16	there have been reports of theophylline-related side effects in patients on concomitant therapy with norfloxacin and theophylline .
None(e1,e2)	38	51	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	17	49	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
mechanism(e1,e2)	0	2	propranolol increases hydralazine s serum concentrations .
None(e1,e2)	5	13	potassium-sparing diuretics ( spironolactone , amiloride , triamterene , and others ) or potassium supplements can increase the risk of hyperkalemia .
None(e1,e2)	31	44	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	9	13	example inducers include aminoglutethimide , carbamazepine , nafcillin , nevirapine , phenobarbital , phenytoin , and rifamycins .
None(e1,e2)	0	17	ethanol / nutrition / herb interactions : food : cns effects of caffeine may be enhanced if combination_hormonal_contraceptives are used concurrently with caffeine .
None(e1,e2)	76	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	23	in clinical studies , coadministration of welchol with atorvastatin , lovastatin , or simvastatin did not interfere with the lipid-lowering activity of the hmg-coa_reductase_inhibitor .
None(e1,e2)	13	21	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
None(e1,e2)	0	21	alcohol : it should be borne in mind that alcohol ingestion may increase the danger inherent in any intentional or unintentional sinequan overdosage .
None(e1,e2)	10	55	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	43	77	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	31	59	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	0	45	multivitamins , or other products containing iron or zinc , antacids or sucralfate should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .
None(e1,e2)	10	33	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin_d .
advise(e1,e2)	12	22	it is recommended not to exceed a single 5 mg dose of vardenafil in a 24-hour period when used in combination with erythromycin .
None(e1,e2)	19	33	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
int(e1,e2)	13	20	data from in vitro studies of alprazolam suggest a possible drug interaction with alprazolam for the following : sertraline and paroxetine .
advise(e1,e2)	8	32	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
advise(e1,e2)	6	9	wait 2 weeks after stopping an mao_inhibitor before starting escitalopram .
None(e1,e2)	49	68	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	8	multivitamins , or other products containing iron or zinc , antacids or sucralfate should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .
None(e1,e2)	15	86	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood_thinner s ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	94	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	15	nicardipine hcl usually does not alter the plasma levels of digoxin , however , serum digoxin levels should be evaluated after concomitant therapy with nicardipine hcl is initiated .
None(e1,e2)	9	21	ketoconazole : co-administration of 200 mg twice-daily ketoconazole with aliskiren resulted in an approximate 80 % increase in plasma levels of aliskiren .
None(e1,e2)	28	32	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	3	31	effects of other antiepileptic_drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	42	69	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	25	rifampin : co-administration of vioxx with rifampin 600 mg daily , a potent inducer of hepatic metabolism , produced an approximate 50 % decrease in rofecoxib plasma concentrations .
None(e1,e2)	22	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	2	4	antibiotics ( ampicillin , tetracycline ) : pregnancy has been reported following concomitant use , however , pharmacokinetic studies have not shown consistent effects with these antibiotics on plasma concentrations of synthetic steroids .
None(e1,e2)	4	6	anticonvulsants : carbamazepine , phenobarbital , phenytoin
None(e1,e2)	24	28	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	12	18	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	13	30	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	42	59	effects of felbatol on low-dose combination oral contraceptives a group of 24 nonsmoking , healthy white female volunteers established on an oral contraceptive regimen containing 30 mg ethinyl estradiol and 75 mg gestodene for at least 3 months received 2400 mg/day of felbamate from midcycle ( day 15 ) to midcycle ( day 14 ) of two consecutive oral contraceptive cycles .
effect(e1,e2)	16	28	a direct causal relationship has not been established , but physicians should consider the possibility that diclofenac may alter a diabetic patient s response to insulin or oral hypoglycemic_agents .
None(e1,e2)	4	26	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	6	24	particular caution should be observed with digitalis_preparations since there are conflicting results for the effect of colestipol hydrochloride on the availability of digoxin and digitoxin .
None(e1,e2)	21	59	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	0	2	hiv_protease_inhibitors : indinavir ( 800 mg t.i.d . ) co-administered with vardenafil 10 mg resulted in a 16-fold increase in vardenafil auc , a 7-fold increase in vardenafil cmax and a 2-fold increase in vardenafil half-life .
None(e1,e2)	50	52	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
effect(e1,e2)	0	12	tetracycline , a bacteriostatic antibiotic , may antagonize the bactericidal effect of penicillin and concurrent use of these drugs should be avoided .
None(e1,e2)	73	79	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	4	anticholinesterases ( neostgmine , physostigmine ) , lignocaine , quinine , procainamide can enhance toxicity and cause cardio respiratory depression .
effect(e1,e2)	2	9	corticosteroids and corticotropin ( acth ) : may potentiate amphotericin_b - induced hypokalemia which may predispose the patient to cardiac dysfunction .
None(e1,e2)	6	11	fluconazole , and the 5-ht3 antiemetics ondansetron ( zofran ) and granisetron ( kytril ) have all been used with busulfex .
None(e1,e2)	11	18	the potential effects of increased plasma concentrations of midazolam or other benzodiazepines metabolized via cyp3a4 ( alprazolam , triazolam ) should be considered when coadministering these agents with aprepitant .
None(e1,e2)	0	5	methenamine therapy urinary excretion of amphetamines is increased , and efficacy is reduced by acidifying agents used in methenamine therapy .
None(e1,e2)	35	46	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
effect(e1,e2)	7	15	in a study in diabetics with microalbuminuria inspra 200 mg combined with the ace inhibitor enalapril 10 mg increased the frequency of hyperkalemia ( serum potassium 5.5 meq/l ) from 17 % on enalapril alone to 38 % .
None(e1,e2)	9	24	during clinical trials , iloprost was used concurrently with anticoagulants , diuretics , cardiac glycosides , calcium channel blockers , analgesics , antipyretics , nonsteroidal_antiinflammatories , corticosteroids , and other medications .
None(e1,e2)	5	8	erythromycin co-administration of felodipine ( plendil ) with erythromycin resulted in approximately 2.5- fold increase in the auc and cmax , and about 2- fold prolongation in the half- life of felodipine .
None(e1,e2)	21	68	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
effect(e1,e2)	4	24	the potentiating action of hydroxyzine must be considered when the drug is used in conjunction with central nervous system depressants such as narcotics , non-narcotic_analgesics and barbiturates .
None(e1,e2)	38	48	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	51	63	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	9	11	azlocillin should not be administered concomitantly with amikacin , ciprofloxacin , gentamicin , netilmicin , or tobramycin .
None(e1,e2)	22	37	the following drug interactions have been identified involving nizoral tablets and other drugs metabolized by the cytochrome p450 3a4 enzyme system : ketoconazole tablets inhibit the metabolism of terfenadine , resulting in an increased plasma concentration of terfenadine and a delay in the elimination of its acid metabolite .
None(e1,e2)	30	38	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux_sodium .
None(e1,e2)	2	38	- a nonsteroidal_anti-inflammatory_drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	13	16	in studies in normal volunteers , there was no pharmacodynamic interaction between intravenous iloprost and either nifedipine , diltiazem , or captopril .
effect(e1,e2)	4	13	- the action of sulphonylureas and insulin may be enhanced by bezalip or bezalip_retard .
None(e1,e2)	1	2	since cholestyramine resin may bind other drugs given concurrently , it is recommended that patients take other drugs at least 1 hour before or 4 to 6 hours after cholestyramine resin ( or at as great an interval as possible ) to avoid impeding their absorption .
None(e1,e2)	3	17	antihypertensive medications and vasodilators : the following adverse events were experienced more commonly in patients receiving concomitant antihypertensive_medications or vasodilators ( n = 94 ) compared to patients not receiving these concomitant drugs ( n = 456 ) : hypotension 10 % vs 4 % , myocardial infarction 3 % vs 1 % , serious pneumonia 5 % vs 3 % , serious falls 9 % vs 3 % , and bone and joint injuries 6 % vs 2 % .
None(e1,e2)	35	52	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	78	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	15	22	because there is a theoretical basis that these effects may be additive , use of ergotamine -containing or ergot-type medications ( like dihydroergotamine or methysergide ) and axert within 24 hours of each other should be avoided .
None(e1,e2)	28	45	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	0	39	central_nervous_system_depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
effect(e1,e2)	9	11	these in vitro studies suggest that concomitant administration of zalcitabine and lamivudine in humans may result in sub-therapeutic concentrations of active phosphorylated zalcitabine , which may lead to a decreased antiretroviral effect of zalcitabine .
None(e1,e2)	9	15	diphenhydramine hydrochloride has additive effects with alcohol and other cns_depressants ( hypnotics , sedatives , tranquilizers , etc ) .
None(e1,e2)	45	48	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal_anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	2	18	administration of rifampin concomitantly with oral amiodarone has been shown to result in decreases in serum concentrations of amiodarone and desethylamiodarone .
None(e1,e2)	23	26	in vitro studies have shown no binding displacement between entacapone and other highly bound drugs , such as warfarin , salicylic acid , phenylbutazone , and diazepam .
None(e1,e2)	21	25	hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose proleukin and antineoplastic agents , specifically , dacarbazine , cis-platinum , tamoxifen and interferon-alfa .
None(e1,e2)	57	59	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	32	41	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	8	13	concomitant crohn s disease medications were antibiotics , antivirals , corticosteroids , 6-mp/ aza and aminosalicylates .
None(e1,e2)	12	15	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid-associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
None(e1,e2)	2	10	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
mechanism(e1,e2)	0	5	aprepitant increased the auc of midazolam by 25 % on day 4 and decreased the auc of midazolam by 19 % on day 8 relative to the dosing of aprepitant on days 1 through 3 .
None(e1,e2)	14	19	probenecid : concomitant administration of toradol oral and probenecid resulted in decreased clearance of ketorolac and significant increases in ketorolac plasma levels ( total auc increased approximately threefold from 5.4 to 17.8 m g/h/ml ) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours .
None(e1,e2)	2	4	another oral azole_antifungal , ketoconazole , inhibits the metabolism of astemizole , resulting in elevated plasma concentrations of astemizole and its active metabolite desmethylastermizole which may prolong qt intervals .
None(e1,e2)	5	16	example inducers include aminoglutethimide , carbamazepine , nafcillin , nevirapine , phenobarbital , phenytoin , and rifamycins .
None(e1,e2)	0	9	aspirin : animal studies wshow that aspirin given with nonsteroidal_anti-inflammatory_agents , including ibuprofen , yields a net decrease in anti-inflammatory activity with lowered blood levels of the non-aspirin drug .
None(e1,e2)	21	50	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth_subsalicylate ( pepto-bismol ) ;
None(e1,e2)	26	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
advise(e1,e2)	8	24	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	13	39	tell your doctor if you are taking any of the following drugs : blood_thinner s ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
effect(e1,e2)	0	14	pyrazolone_derivatives ( phenylbutazone , oxyphenbutazone , and possibly dipyrone ) : concomitant administration with aspirin may increase the risk of gastrointestinal ulceration .
None(e1,e2)	0	37	methotrexate vioxx 12.5 , 25 , and 50 mg , each dose administered once daily for 7 days , had no effect on the plasma concentration of methotrexate as measured by auc0-24hr in patients receiving single weekly methotrexate doses of 7.5 to 20 mg for rheumatoid arthritis .
None(e1,e2)	26	71	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	26	58	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	22	31	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	14	27	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	45	51	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type_1c_antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	30	43	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl_trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium_chloride , folic acid , and acetaminophen .
None(e1,e2)	26	69	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine * ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	30	39	aspirin/acetaminophen : pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between argatroban and concomitantly administered aspirin ( 162.5 mg orally given 26 and 2 hours prior to initiation of argatroban 1 g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of argatroban 1.5 g/kg/min . over 18 hours ) .
None(e1,e2)	70	80	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	0	7	furosemide : when aliskiren was co-administered with furosemide , the auc and cmax of furosemide were reduced by about 30 % and 50 % , respectively .
effect(e1,e2)	1	13	several tricyclic_antidepressants have been reported to block the pharmacologic effects of guanethidine , clonidine , or similar agents , and such an effect may be anticipated with cmi because of its structural similarity to other tricyclic antidepressants .
None(e1,e2)	4	20	lithium : increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ace_inhibitor therapy .
None(e1,e2)	27	62	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic_acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin_synthetase_inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	7	11	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	7	26	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	23	89	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	40	59	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	3	9	drug interactions with antacids administration of 120 mg of fexofenadine_hydrochloride ( 2 x 60 mg capsule ) within 15 minutes of an aluminum and magnesium containing antacid ( maalox ) decreased fexofenadine auc by 41 % and cmax by 43 % .
mechanism(e1,e2)	14	20	there have been greater than 2-fold increases in previously stable plasma levels of other antidepressants , including nortriptyline , when fluoxetine_hydrochloride has been administered in combination with these agents .
effect(e1,e2)	10	33	other drugs which may enhance the neuromuscular blocking action of nondepolarizing_agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	10	14	morphine pharmacokinetic parameter values were not affected by administration of neurontin 2 hours after morphine .
None(e1,e2)	0	5	leucovorin : the concentration of 5-fluorouracil is increased and its toxicity may be enhanced by leucovorin .
None(e1,e2)	13	17	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
None(e1,e2)	26	65	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	6	14	digoxin : when multiple doses of atorvastatin and digoxin were coadministered , steady-state plasma digoxin concentrations increased by approximately 20 % .
int(e1,e2)	0	24	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	7	11	drug-drug interactions have not been observed between argatroban and digoxin or erythromycin .
None(e1,e2)	46	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	2	41	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
advise(e1,e2)	2	14	coadministration of alosetron and strong cyp3a4 inhibitors , such as clarithromycin , telithromycin , protease_inhibitors , voriconazole , and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
None(e1,e2)	10	12	although there is little published information on concomitant administration of lidocaine and bretylium_tosylate , these drugs are often administered concurrently without any evidence of interactions resulting in adverse effects or diminished efficacy .
None(e1,e2)	77	85	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	17	42	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	116	120	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	44	56	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	7	28	in a ten-subject study , coadministration of diltiazem ( 120 mg bid ) with lovastatin resulted in a 3-4 times increase in mean lovastatin auc and cmax vs. lovastatin alone ;
None(e1,e2)	3	15	concomitant administration of targretin capsules and gemfibrozil resulted in substantial increases in plasma concentrations of bexarotene , probably at least partially related to cytochrome p450 3a4 inhibition by gemfibrozil .
None(e1,e2)	0	26	propranolol to healthy volunteers under steady-state conditions had no relevant effect on either drug s bioavailability , auc and cmax , differences were 20 % between isradipine given singly and in combination with propranolol , and between propranolol given singly and in combination with isradipine .
None(e1,e2)	13	15	in patients taking an anticonvulsant ( eg , valproic acid , carbamazepine , phenobarbital or phenytoin ) , the concomitant use of mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant .
None(e1,e2)	9	11	isocarboxazid should be administered with caution to patients receiving antabuse ( disulfiram , wyeth-ayerst laboratories ) .
None(e1,e2)	10	24	cytochrome p-450 inducers , such as phenytoin , carbamazepine and phenobarbital , induce clonazepam metabolism , causing an approximately 30 % decrease in plasma clonazepam levels .
mechanism(e1,e2)	5	27	protein binding in vitro , diclofenac interferes minimally or not at all with the protein binding of salicylic acid ( 20 % decrease in binding ) , tolbutamide , prednisolone ( 10 % decrease in binding ) , or warfarin .
None(e1,e2)	57	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
int(e1,e2)	7	21	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
mechanism(e1,e2)	3	17	the absorption of lymecycline may be affected by the simultaneous administration of indigestion remedies , iron or zinc supplements .
None(e1,e2)	0	6	hmg-coa_reductase_inhibitors : the combined use of tricor and hmg-coa reductase inhibitors should be avoided unless the benefit of further alterations in lipid levels is likely to outweigh the increased risk of this drug combination .
None(e1,e2)	23	46	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	18	20	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	24	29	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	0	21	furosemide : clinical studies , as well as post-marketing observations , have shown that nsaids can reduce the natriuretic effect of furosemide and thiazides in some patients .
advise(e1,e2)	12	47	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
None(e1,e2)	20	39	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	3	12	mao inhibitors , narcotic_analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
None(e1,e2)	23	29	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	25	43	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
effect(e1,e2)	12	16	oral anticoagulants : in some normal volunteers , the concomitant administration of diflunisal and warfarin , acenocoumarol , or phenprocoumon resulted in prolongation of prothrombin time .
None(e1,e2)	20	22	the following medications have been administered in clinical trials with simulect with no increase in adverse reactions : atg/alg , azathioprine , corticosteroids , cyclosporine , mycophenolate mofetil , and muromonab-cd3 .
None(e1,e2)	16	32	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	23	25	aprepitant is unlikely to interact with drugs that are substrates for the p-glycoprotein transporter , as demonstrated by the lack of interaction of aprepitant with digoxin in a clinical drug interaction study .
None(e1,e2)	34	62	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	17	19	the concomitant use of transdermal fentanyl with ritonavir or other potent 3a4 inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
None(e1,e2)	0	23	warfarin : anticoagulant activity should be monitored , particularly in the first few days after initiating or changing vioxx therapy in patients receiving warfarin or similar agents , since these patients are at an increased risk of bleeding complications .
None(e1,e2)	15	45	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	46	62	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
effect(e1,e2)	37	50	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic agents ) or drugs which inhibit platelet function ( eg , aspirin and other non-steroidal anti-inflammatory drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
effect(e1,e2)	8	19	psychoactive drugs : hallucinations have been reported when toradol was used in patients taking psychoactive drugs ( fluoxetine , thiothixene , alprazolam ) .
None(e1,e2)	49	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	12	19	concomitant administration of norpace and quinidine resulted in slight increases in plasma disopyramide levels and slight decreases in plasma quinidine levels .
advise(e1,e2)	0	31	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
None(e1,e2)	12	29	in a controlled clinical trial , a 20 % reduction of the phenytoin dose at the initiation of felbatol therapy resulted in phenytoin levels comparable to those prior to felbatol administration .
None(e1,e2)	9	13	immunosuppressive drugs , fibric acid derivatives , niacin ( nicotinic_acid , erythromycin , azole_antifungals : skeletal muscle .
None(e1,e2)	41	80	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	7	16	azlocillin should not be administered concomitantly with amikacin , ciprofloxacin , gentamicin , netilmicin , or tobramycin .
None(e1,e2)	18	27	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
None(e1,e2)	6	12	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	4	anticonvulsants : carbamazepine , phenobarbital , phenytoin
None(e1,e2)	0	31	methadone levels may be decreased ; increased dosages may be required to prevent symptoms of opiate withdrawal . methadone maintained patients beginning nevirapine therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly .
None(e1,e2)	35	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	32	46	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	30	78	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	55	108	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	28	113	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	97	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	33	52	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	87	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	33	114	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	3	12	adequate monitoring of theophylline plasma concentrations should be considered when therapy with vioxx is initiated or changed in patients receiving theophylline .
None(e1,e2)	18	38	digoxin - in subjects who had received 21 days of 40 mg/day racemic citalopram , combined administration of citalopram and digoxin ( single dose of 1 mg ) did not significantly affect the pharmacokinetics of either citalopram or digoxin .
None(e1,e2)	21	26	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	21	45	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	16	20	substances that are potent inhibitors of cyp3a4 activity ( eg , ketoconazole and itraconazole ) decrease gefitinib metabolism and increase gefitinib plasma concentrations .
None(e1,e2)	21	25	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace_inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
mechanism(e1,e2)	9	21	in addition , higher-than expected steady-state serum concentrations of tricyclic_antidepressants have been observed when therapy is initiated in patients already taking cimetidine .
None(e1,e2)	4	27	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
None(e1,e2)	2	19	ethanol or triazolam : no significant differences were observed in the pharmacokinetics of triazolam ( 0.125 mg ) and tiagabine ( 10 mg ) when given together as a single dose .
None(e1,e2)	80	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	7	17	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic_antidepressants may produce severe , prolonged hypertension .
None(e1,e2)	0	7	saquinavir : the combination of hivid , saquinavir , and zdv has been studied ( as triple combination ) in adults .
effect(e1,e2)	11	18	non-steroidal anti-inflammatory agents : seizures have been reported in patients taking enoxacin concomitantly with the nonsteroidal anti-inflammatory drug fenbufen .
None(e1,e2)	13	19	compounds in these categories result in a decreased efficacy of bromocriptine mesylate : phenothiazines , haloperidol , metoclopramide , pimozide .
None(e1,e2)	0	24	amitriptyline in combination with clonidine enhances the manifestation of corneal lesions in rats epidural injection clonidine may potentiate the cns-depressive effect of alcohol , barbiturates or other sedating drugs .
None(e1,e2)	30	41	in another drug interaction study , co-administration of orally inhaled ciclesonide and oral ketoconazole , a potent inhibitor of cytochrome p450 3a4 , increased the exposure ( auc ) of des-ciclesonide by approximately 3.6-fold at steady state , while levels of ciclesonide remained unchanged .
None(e1,e2)	28	115	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	15	48	platelet inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin_sodium .
None(e1,e2)	25	34	the following agents may increase certain actions or side effects of anticholinergic drugs . amantadine antiarrhythmic agents of class ( e.g . quinidine ) , antihistamines antipsychotic agents ( e.g . phenothiazines ) , benzodiazepines .
None(e1,e2)	0	14	valproate keppra ( 1500 mg twice daily ) did not alter the pharmacokinetics of valproate in healthy volunteers .
None(e1,e2)	11	27	no depressant effect on blood levels in humans was noted when colestipol_hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	25	35	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	72	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
None(e1,e2)	51	75	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	6	9	data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , nicardipine , and nifedipine .
None(e1,e2)	24	62	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
advise(e1,e2)	10	13	nonetheless , individual patients may require additional titration of their theophylline dosage when lansoprazole is started or stopped to ensure clinically effective blood levels .
None(e1,e2)	19	21	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	0	4	tacrolimus : co-administration of tacrolimus and bosentan has not been studied in man .
None(e1,e2)	14	51	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
None(e1,e2)	14	27	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	6	11	drug/laboratory test interactions as with other penicillins , the administration of pipracil may result in a false-positive reaction for glucose in the urine using a copper-reduction method .
None(e1,e2)	7	13	binding to plasma proteins is reduced by warfarin and clotibrate and increased by tolbutamide .
None(e1,e2)	1	63	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	30	48	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	53	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	39	44	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	38	40	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal_muscle_relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	12	14	although these results do not indicate a significant interaction between toradol and warfarin or heparin , the administration of toradol to patients taking anticoagulants should be done extremely cautiously , and patients should be closely monitored .
None(e1,e2)	90	105	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	11	21	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine -containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton pump inhibitors ( e.g. , lansoprazole , omeprazole ) .
None(e1,e2)	25	27	however , in a well-controlled study of patients with lymphoma on combination therapy , allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide , doxorubicin , bleomycin , procarbazine and/or mechlorethamine .
mechanism(e1,e2)	18	55	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	19	although the occurrence has not been reported with cefizox , nephrotoxicity has been reported following concomitant administration of other cephalosporins and aminoglycosides .
None(e1,e2)	15	28	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	33	76	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	17	21	nabilone has been shown to have an additive cns depressant effect when given with either diazepam , secobarbitone_sodium , alcohol or codeine .
None(e1,e2)	18	23	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide_diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
effect(e1,e2)	10	14	in clinical trials in patients undergoing ptca/pci , co-administration of angiomax with heparin , warfarin , thrombolytics or glycoprotein iib/iiia inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications .
None(e1,e2)	17	35	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	10	68	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	0	9	iron salts may reduce the bioavailability of carbidopa and levodopa .
None(e1,e2)	57	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	0	6	antihistamines may have additive effects with alcohol and other cns depressants , e.g. , hypnotics , sedatives , tranquilizers , antianxiety agents .
None(e1,e2)	7	33	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
effect(e1,e2)	9	16	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	12	16	other strong inhibitors of cyp3a4 ( e.g. , itraconazole , clarithromycin , nefazodone , troleandomycin , ritonavir , nelfinavir ) would be expected to behave similarly .
advise(e1,e2)	3	5	concomitant administration of alosetron and fluvoxamine is contraindicated .
None(e1,e2)	24	38	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	31	85	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	20	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	2	7	antacids containing magnesium , aluminum , or calcium ;
None(e1,e2)	17	19	compounds in these categories result in a decreased efficacy of bromocriptine mesylate : phenothiazines , haloperidol , metoclopramide , pimozide .
None(e1,e2)	24	76	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	10	acetylsalicylic_acid did not alter the clearance ( pharmacokinetics ) of iloprost .
None(e1,e2)	2	29	co-administration of botox and aminoglycosides or other agents interfering with neuromuscular transmission ( e.g. , curare-like compounds ) should only be performed with caution as the effect of the toxin may be potentiated .
None(e1,e2)	41	48	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin_analog ( e.g. , octreotide ) , sulfonamide_antibiotics .
None(e1,e2)	4	6	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	2	14	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic acid , and tolbutamide in vitro .
None(e1,e2)	29	44	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic_analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	3	20	therefore , if digoxin is administered with vaprisol , the clinician should be alert to the possibility of increases in digoxin levels .
None(e1,e2)	33	96	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	31	because of foscarnet s tendency to cause renal impairment , the use of foscavir should be avoided in combination with potentially nephrotoxic drugs such as aminoglycosides , amphotericin b and intravenous pentamidine unless the potential benefits outweigh the risks to the patient .
None(e1,e2)	13	15	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine_oxidase_inhibitors , tricyclic_antidepressants or phenothiazines may produce severe , prolonged hypotension or hypertension .
None(e1,e2)	8	41	interactions may also occur with the following : anti-depressants /anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	11	19	codeine in combination with other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , or other cns_depressants ( including alcohol ) has additive depressant effects .
None(e1,e2)	7	14	hiv protease inhibitors : the effect of amprenavir on total drug concentrations of other hiv_protease_inhibitors in subjects receiving both agents was evaluated using comparisons to historical data .
effect(e1,e2)	7	10	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	0	2	valproate : tiagabine causes a slight decrease ( about 10 % ) in steady-state valproate concentrations .
None(e1,e2)	61	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	63	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	6	25	in addition to bleeding associated with heparin and vitamin k antagonists , drugs that alter platelet function ( such as acetylsalicylic acid , dipyridamole and abciximab ) may increase the risk of bleeding if administered prior to , during , or after activase therapy .
None(e1,e2)	15	17	nabilone has been shown to have an additive cns depressant effect when given with either diazepam , secobarbitone_sodium , alcohol or codeine .
None(e1,e2)	37	71	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	12	16	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	20	31	therefore , co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	16	20	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
mechanism(e1,e2)	19	26	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin_hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	3	7	standard therapy includes antibiotics , such as penicillin and gentamicin ;
None(e1,e2)	14	28	in a ten-subject study , coadministration of diltiazem ( 120 mg bid ) with lovastatin resulted in a 3-4 times increase in mean lovastatin auc and cmax vs. lovastatin alone ;
effect(e1,e2)	0	6	antithyroid_agents may decrease thyroidal uptake of sodium_iodide_i131 , a rebound in uptake may occur up to 5 days after sudden withdrawal of carbimazole .
None(e1,e2)	8	26	drug-drug interactions given the primary cns effects of aripiprazole , caution should be used when abilify is taken in combination with other centrally acting drugs and alcohol .
None(e1,e2)	23	43	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin b , cyclosporine , non-steroidal anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
None(e1,e2)	7	10	concomitant treatment with methylxanthines ( aminophylline , theophylline ) , steroids , or diuretics may potentiate any hypokalemic effect of adrenergic agonists .
None(e1,e2)	15	20	in order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with taxol should be premedicated with corticosteroids ( such as dexamethasone ) , diphen-hydramine and h2 antagonists ( such as cimetidine or ranitidine ) .
None(e1,e2)	7	17	warfarin - administration of 40 mg/day racemic citalopram for 21 days did not affect the pharmacokinetics of warfarin , a cyp3a4 substrate .
None(e1,e2)	12	31	antibiotics : in vitro and/or in vivo data show that clarithromycin , erythromycin , and troleandomycin markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	42	56	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	13	34	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum_hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	21	27	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	17	43	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	10	49	in a single-dose crossover study examining lansoprazole 30 mg and omeprazole 20 mg each administered alone and concomitantly with sucralfate 1 gram , absorption of the proton pump inhibitors was delayed and their bioavailability was reduced by 17 % and 16 % , respectively , when administered concomitantly with sucralfate .
None(e1,e2)	23	138	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	5	10	in patients receiving mercaptopurine ( purinethol ) or azathioprine ( imuran ) , the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine .
None(e1,e2)	43	51	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	65	83	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	15	28	because both of these drugs have negative inotropic properties and the effects of coadministration with tambocor are unknown , neither disopyramide nor verapamil should be administered concurrently with tambocor unless , in the judgment of the physician , the benefits of this combination outweigh the risks .
None(e1,e2)	7	10	synergism between xanthine bronchodilators ( e.g. , theophylline ) , ephedrine , and other sympathomimetic bronchodilators has been reported .
None(e1,e2)	4	13	in patients taking an anticonvulsant ( eg , valproic acid , carbamazepine , phenobarbital or phenytoin ) , the concomitant use of mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant .
None(e1,e2)	59	80	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
mechanism(e1,e2)	0	7	lithium generally should not be given with diuretics because they reduce its renal clearance and add a high risk of lithium toxicity .
None(e1,e2)	14	23	in addition , fondaparinux neither influenced the pharmacodynamics of warfarin , acetylsalicylic acid , piroxicam , and digoxin , nor the pharmacokinetics of digoxin at steady state .
None(e1,e2)	18	31	ketoconazole ) , macrolide antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	85	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	9	21	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	0	31	hormonal_contraceptives , including oral , injectable , transdermal , and implantable contraceptives : an interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive ortho-novum produced average decreases of norethindrone and ethinyl estradiol levels of 14 % and 31 % , respectively .
mechanism(e1,e2)	18	33	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	1	9	when amiodarone is added to flecainide therapy , plasma flecainide levels may increase two-fold or more in some patients , if flecainide dosage is not reduced .
None(e1,e2)	0	15	probenecid : probenecid increases both free and bound ketoprofen by reducing the plasma clearance of ketoprofen to about one-third , as well as decreasing its protein binding .
None(e1,e2)	63	84	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	0	7	erythromycin : in hypercholesterolemic patients , steady-state cerivastatin auc and cmax increased approximately 50 % and 24 % respectively after 10 days with co-administration of erythromycin , a known inhibitor of cytochrome p450 3a4 .
None(e1,e2)	27	32	drug interactions with antacids administration of 120 mg of fexofenadine hydrochloride ( 2 x 60 mg capsule ) within 15 minutes of an aluminum and magnesium containing antacid ( maalox ) decreased fexofenadine auc by 41 % and cmax by 43 % .
None(e1,e2)	11	13	in vitro , buspirone does not displace tightly bound drugs like phenytoin , propranolol , and warfarin from serum proteins .
None(e1,e2)	23	61	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	19	21	sumatriptan : sumatriptan has been reported to cause coronary artery vasospasm , and its effect could be additive with d.h.e_._45 ( dihydroergotamine_mesylate ) injection , usp .
None(e1,e2)	17	19	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
None(e1,e2)	34	42	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	0	16	ritonavir and indinavir : upon concomitant administration of 5 mg of vardenafil with 600 mg bid ritonavir , the cmax and auc of ritonavir were reduced by approximately 20 % .
None(e1,e2)	0	12	ace_inhibitors : reports suggest that nsaids may diminish the antihypertensive effect of ace_inhibitors .
None(e1,e2)	13	19	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	3	7	in patients taking furosemide , nifedipine , diltiazem , ace inhibitors , verapamil , glyburide , propranolol , and various chemotherapy agents , no effect was shown on the clearance of hydrodolasetron .
None(e1,e2)	49	83	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	9	26	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	17	18	cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation , the discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin .
None(e1,e2)	27	37	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	24	32	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	20	26	omeprazole : the rate and extent of absorption of ciprofloxacin was bioequivalent when proquin xr was given alone or when proquin_xr was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion .
None(e1,e2)	28	39	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	1	7	because cholestyramine binds bile acids , cholestyramine resin may interfere with normal fat digestion and absorption and thus may prevent absorption of fat soluble vitamins such as a , d , e , and k .
None(e1,e2)	4	6	drug/laboratory test interferences : dicumarol and indanedione_anticoagulants , including anisindione , or their metabolites may color alkaline urine red-orange , which may interfere with spectrophotometrically determined urinary laboratory tests .
None(e1,e2)	5	6	selegiline - l-phenylalanine and the selective_mao_inhibitor selegiline may have synergistic antidepressant activity if used concomitantly .
None(e1,e2)	0	24	welchol was found to have no significant effect on the bioavailability of digoxin , lovastatin , metoprolol , quinidine , valproic acid , and warfarin .
None(e1,e2)	116	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	2	isoflurane or enflurane administered with nitrous oxide/oxygen to achieve 1.25 mac [ minimum alveolar concentration ] may prolong the clinically effective duration of action of initial and maintenance doses of nimbex and decrease the required infusion rate of nimbex .
mechanism(e1,e2)	29	38	1- nc denotes a mean change of less than 10 % 2- pediatrics 3- mean increase in adults at high trileptal doses in vivo , the plasma levels of phenytoin increased by up to 40 % , when trileptal was given at doses above 1200 mg/day .
None(e1,e2)	26	81	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin_sodium under-dosage .
None(e1,e2)	26	36	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
mechanism(e1,e2)	2	7	coadministration of itraconazole with oral midazolam or triazolam has resulted in elevated plasma concentrations of the latter two drugs .
None(e1,e2)	9	11	erythromycin has been reported to decrease the clearance of triazolam and midazolam and thus may increase the pharmacologic effect of these benzodiazepines .
None(e1,e2)	83	106	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	32	theophylline : following co-administration of two 250-mg dirithromycin tablets administered once daily with 200-mg theophylline tablets administered twice daily for 10 days to 14 healthy subjects , the steady-state plasma concentration of theophylline was not significantly altered .
None(e1,e2)	47	49	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	11	22	in addition , fondaparinux neither influenced the pharmacodynamics of warfarin , acetylsalicylic_acid , piroxicam , and digoxin , nor the pharmacokinetics of digoxin at steady state .
None(e1,e2)	80	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	29	81	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	16	27	both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when alfenta is administered in combination with other cns depressants such as barbiturates , tranquilizers , opioids , or inhalation general anesthetics .
None(e1,e2)	23	31	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	11	20	cephalosporins-cephalosporins containing side chains of n-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin k deficiency and hypoprothrombinemia .
None(e1,e2)	32	43	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
None(e1,e2)	28	37	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
advise(e1,e2)	7	17	to avoid this interaction , delavirdine or indinavir should be given 1 hour prior to dosing with videx .
None(e1,e2)	18	23	although not studied with alosetron , inhibition of n-acetyltransferase may have clinically relevant consequences for drugs such as isoniazid , procainamide , and hydralazine .
None(e1,e2)	21	45	warfarin : multiple oral doses of sonata ( 20 mg q24h for 13 days ) did not affect the pharmacokinetics of warfarin ( r+ ) - or ( s- ) -enantiomers or the pharmacodynamics ( prothrombin time ) following a single 25-mg oral dose of warfarin .
None(e1,e2)	57	80	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin_sodium under-dosage .
effect(e1,e2)	0	4	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	11	29	in vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the pk properties of anagrelide , nor does anagrelide affect the pk properties of digoxin or warfarin .
None(e1,e2)	12	51	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	10	22	since bacteriostatic drugs may interfere with the bactericidal action of penicillin , it is advisable to avoid giving tetracyclines in conjunction with penicillin .
None(e1,e2)	19	28	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
None(e1,e2)	26	53	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	3	18	and disulfiram when amitriptyline_hcl is given with anticholinergic agents or sympathomimetic drugs , including epinephrine combined with local anesthetics , close supervision and careful adjustment of dosages are required .
None(e1,e2)	0	2	bacteriostatic_antibiotics : chloramphenicol , erythromycins , sulfonamides , or tetracyclines may interfere with the bactericidal effect of penicillins .
None(e1,e2)	0	13	cimetidine , ranitidine : in normal volunteers ( n=9 ) , pretreatment with cimetidine or ranitidine did not affect flurbiprofen pharmacokinetics except that a small ( 13 % ) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with cimetidine .
None(e1,e2)	58	81	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic_acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	41	43	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	11	54	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	16	18	other potentially important drug interactions : benzodiazepines : benzodiazepines metabolized by hepatic oxidation ( e.g. , alprazolam , midazolam , triazolam elc . ) should be used with caution because the clearance of these drugs is likely to be reduced by fluvoxamine .
None(e1,e2)	13	15	dostinex should not be administered concurrently with d2-antagonists , such as phenothiazines , butyrophenones , thioxanthines , or metoclopramide .
None(e1,e2)	6	27	iron supplements and foods fortified with iron concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron ( as feso4 ) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80 % and 31 % , respectively .
None(e1,e2)	9	15	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide_diuretics and reducing diuretic absorption from the gastrointestinal tract
None(e1,e2)	4	15	concomitant administration with racemic citalopram citalopram - since escitalopram is the active isomer of racemic citalopram ( celexa ) , the two agents should not be coadministered .
None(e1,e2)	14	16	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	22	36	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	14	23	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	4	23	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	0	46	duloxetine may have a clinically important interaction with the following other drugs : alcohol : when duloxetine and ethanol were administered several hours apart so that peak concentrations of each would coincide , duloxetine did not increase the impairment of mental and motor skills caused by alcohol .
effect(e1,e2)	8	36	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral_hydrate * ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	92	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	15	30	if a patient requires tikosyn and anti-ulcer therapy , it is suggested that omeprazole , ranitidine , or antacids ( aluminum and magnesium hydroxides ) be used as alternatives to cimetidine , as these agents have no effect on the pharmacokinetic profile of tikosyn .
None(e1,e2)	25	27	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	24	51	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
int(e1,e2)	0	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	69	76	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	10	12	there were transient increases in liver alt and ast when cancidas and cyclosporine were co-administered .
None(e1,e2)	9	12	aspirin : animal studies wshow that aspirin given with nonsteroidal_anti-inflammatory_agents , including ibuprofen , yields a net decrease in anti-inflammatory activity with lowered blood levels of the non-aspirin drug .
None(e1,e2)	64	77	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin_c ; warfarin sodium under-dosage .
None(e1,e2)	5	7	include terfenadine , astemizole , cisapride , midazolam , and triazolam .
None(e1,e2)	55	62	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	81	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	30	52	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	25	42	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis_kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	14	38	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux_sodium .
None(e1,e2)	45	47	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	5	8	antidepressants ( tricyclic ) , atropine or other anticholinergic_agents , or digitalis glycosides : concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects .
mechanism(e1,e2)	16	60	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	50	96	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	5	15	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid-associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
None(e1,e2)	47	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	90	102	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	16	23	drugs that inhibit cytochrome p450iid6 , such as quinidine , might increase the plasma concentrations of flecainide in patients that are on chronic flecainide therapy ;
None(e1,e2)	69	110	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	3	antihypertensive_medication s and vasodilators : the following adverse events were experienced more commonly in patients receiving concomitant antihypertensive medications or vasodilators ( n = 94 ) compared to patients not receiving these concomitant drugs ( n = 456 ) : hypotension 10 % vs 4 % , myocardial infarction 3 % vs 1 % , serious pneumonia 5 % vs 3 % , serious falls 9 % vs 3 % , and bone and joint injuries 6 % vs 2 % .
None(e1,e2)	39	46	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic_antidepressants : flupenthixol increases the effect of tricyclic_antidepressants
None(e1,e2)	19	31	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	23	32	drug interactions with antacids administration of 120 mg of fexofenadine hydrochloride ( 2 x 60 mg capsule ) within 15 minutes of an aluminum and magnesium containing antacid ( maalox ) decreased fexofenadine auc by 41 % and cmax by 43 % .
None(e1,e2)	55	61	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
mechanism(e1,e2)	23	33	quinolone antibiotics : videx should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	6	14	antihistamines may have additive effects with alcohol and other cns depressants , e.g. , hypnotics , sedatives , tranquilizers , antianxiety agents .
None(e1,e2)	4	6	- the action of sulphonylureas and insulin may be enhanced by bezalip or bezalip retard .
None(e1,e2)	94	118	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	3	25	as with other antipsychotic_agents , it should be noted that haldol may be capable of potentiating cns depressants such as anesthetics , opiates , and alcohol .
None(e1,e2)	14	16	no significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide , digoxin , warfarin , cimetidine and phenobarbital .
None(e1,e2)	74	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	31	33	in a 12-week endoscopy study conducted in oa patients there was no difference in the cumulative incidence of endoscopic gastroduodenal ulcers in patients taking low-dose ( 81 mg ) enteric coated aspirin plus vioxx 25 mg daily , as compared to those taking ibuprofen 2400 mg daily alone .
None(e1,e2)	0	41	ketoconazole - combined administration of racemic citalopram ( 40 mg ) and ketoconazole ( 200 mg ) decreased the cmax and auc of ketoconazole by 21 % and 10 % , respectively , and did not significantly affect the pharmacokinetics of citalopram .
None(e1,e2)	5	28	cimetidine co-administration of felodipine with cimetidine ( a non-specific cyp-450 inhibitor ) resulted in an increase of approximately 50 % in the auc and the cmax , of felodipine .
None(e1,e2)	13	43	tell your doctor if you are taking any of the following drugs : blood_thinner s ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
mechanism(e1,e2)	4	6	mineral oil-concomitant intake of mineral_oil and vitamin_k may reduce the absorption of vitamin k .
None(e1,e2)	0	12	carbamazepine : tiagabine had no effect on the steady-state plasma concentrations of carbamazepine or its epoxide metabolite in patients with epilepsy .
None(e1,e2)	1	20	serum infliximab concentrations appeared to be unaffected by baseline use of medications for the treatment of crohn s disease including corticosteroids , antibiotics ( metronidazole or ciprofloxacin ) and aminosalicylates .
None(e1,e2)	20	29	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic_acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .
None(e1,e2)	13	67	the principal drugs given ( number of patients in parentheses ) were : cardiac_glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	7	16	in patients taking furosemide , nifedipine , diltiazem , ace inhibitors , verapamil , glyburide , propranolol , and various chemotherapy agents , no effect was shown on the clearance of hydrodolasetron .
None(e1,e2)	45	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	12	22	at 24 hours postdose , a similar proportion of patients treated with methotrexate alone ( 94 % ) and subsequently treated with methotrexate co-administered with 75 mg of rofecoxib ( 88 % ) had methotrexate plasma concentrations below the measurable limit ( 5 ng/ml ) .
None(e1,e2)	28	34	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine_oxidase_inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	57	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	18	45	cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation , the discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin .
None(e1,e2)	4	26	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	31	96	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	10	single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent , respectively .
None(e1,e2)	6	18	theophylline : the effect of steady-state fluvoxamine l50 mg bid on the pharmacokinetics of a single dose of theophylline ( 375 mg ) as 442 mg aminophylline was evaluated in 12 healthy non-smoking , male volunteers .
mechanism(e1,e2)	8	16	protease inhibitors : in vitro data indicate that indinavir and ritonavir markedly inhibit the metabolism of cisapride which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	16	32	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	31	41	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
effect(e1,e2)	18	31	as with some other nondepolarizing neuromuscular blocking agents , the time of onset of neuromuscular block induced by nuromax is lengthened and the duration of block is shortened in patients receiving phenytoin or carbamazepine .
None(e1,e2)	49	71	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	11	26	drug-drug interactions between keppra and other antiepileptic drugs ( aeds ) phenytoin keppra ( 3000 mg daily ) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy .
None(e1,e2)	26	29	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
advise(e1,e2)	10	16	at least 14 days should elapse between discontinuation of a mao_inhibitor and initiation of treatment with dexfenfluramine .
effect(e1,e2)	5	18	bacteriostatic antibiotics : chloramphenicol , erythromycins , sulfonamides , or tetracyclines may interfere with the bactericidal effect of penicillins .
advise(e1,e2)	4	21	therefore , co-administration of tricyclic_antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
mechanism(e1,e2)	32	34	this observed increase in the bioavailability of fexofenadine may be due to transport-related effects , such as p-glycoprotein . in vivo animal studies also suggest that in addition to enhancing absorption , ketoconazole decreases fexofenadine gastrointestinal secretion , while erythromycin may also decrease biliary excretion .
None(e1,e2)	59	78	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	3	8	the response to factrel may be blunted by phenothiazines and dopamine antagonists which cause a rise in prolactin .
None(e1,e2)	10	12	it is recommended to avoid concurrent administration of ethambutol with aluminum_hydroxide containing antacids for at least 4 hours following ethambutol administration .
None(e1,e2)	22	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	2	4	sedative/hypnotics : midazolam , triazolam
None(e1,e2)	8	32	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	35	59	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
advise(e1,e2)	6	14	refer to the package insert for lithium preparations before use of such preparations with chlorothiazide
None(e1,e2)	20	22	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
mechanism(e1,e2)	1	11	oral neomycin inhibits the gastrointestinal absorption of penicillin v , oral vitamin_b-12 , methotrexate and 5-fluorouracil .
None(e1,e2)	28	30	caution should be exercised if an hmg-coa reductase inhibitor is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones , such as ketoconazole , spironolactone , and cimetidine .
None(e1,e2)	4	21	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	33	116	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	23	32	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants .when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	0	11	erythromycin has been reported to significantly alter the metabolism of nonsedating antihistamines terfenadine and astemizole when taken concomitantly .
effect(e1,e2)	6	16	particular caution should be observed with digitalis_preparations since there are conflicting results for the effect of colestipol_hydrochloride on the availability of digoxin and digitoxin .
None(e1,e2)	36	56	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	44	47	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
effect(e1,e2)	8	27	certain drugs , including nonsteroidal anti-inflammatory agents ( nsaids ) , salicylates , monoamine oxidase inhibitors , and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic drugs .
None(e1,e2)	12	16	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	0	13	iron_supplements and foods fortified with iron concomitant administration of cefdinir with a therapeutic iron_supplement containing 60 mg of elemental iron ( as feso4 ) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80 % and 31 % , respectively .
None(e1,e2)	2	5	alcohol , barbiturates , or narcotics : potentiation of orthostatic hypotension may occur .
None(e1,e2)	0	22	ampicillin /amoxicillin : an increase in the frequency of skin rash has been reported among patients receiving ampicillin or amoxicillin concurrently with allopurinol compared to patients who are not receiving both drugs .
advise(e1,e2)	21	43	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	5	31	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	0	1	digoxin keppra ( 1000 mg twice daily ) did not influence the pharmacokinetics and pharmacodynamics ( ecg ) of digoxin given as a 0.25 mg dose every day .
None(e1,e2)	3	9	pharmacokinetic interactions between nisoldipine and beta-blockers ( atenolol , propranolol ) were variable and not significant .
None(e1,e2)	13	28	although the interaction between almotriptan and other potent cyp3a4 inhibitors ( e.g. , itraconazole , ritonavir , and erythromycin ) has not been studied , increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications .
None(e1,e2)	6	15	no dose adjustment is necessary when simulect is added to triple-immunosuppression regimens including cyclosporine , corticosteroids , and either azathioprine or mycophenolate mofetil .
None(e1,e2)	26	34	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine_oxidase_inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	2	5	cimetidine , caffeine , and erythromycin may increase plasma levels of clozapine , potentially resulting in adverse effects .
None(e1,e2)	23	25	particular caution should be observed with digitalis preparations since there are conflicting results for the effect of colestipol hydrochloride on the availability of digoxin and digitoxin .
None(e1,e2)	32	46	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	37	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
None(e1,e2)	36	43	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	23	130	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	10	15	potential drug interactions for doxylamine include , increased sedation if doxylamine is combined with other cns_depressant_drugs .
None(e1,e2)	32	41	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	4	6	the concomitant use of h2_blockers or proton_pump_inhibitors with sprycel is not recommended .
effect(e1,e2)	8	62	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	0	23	furosemide : clinical studies , as well as random observations , have shown that ibuprofen can reduce the natriuretic effect of furosemide and thiazides in some patients .
None(e1,e2)	32	54	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	15	23	the similarity of the tysabri -associated adverse event profile between study 1 ( without co-administered avonex ) and study 2 ( with co-administered avonex ) indicates that this alteration in clearance does not necessitate reduction of the tysabri dose to maintain safety , general ) .
int(e1,e2)	0	46	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	6	14	the gastrointestinal absorption of cimetidine and ranitidine is accelerated when they are coadministered with cisapride .
None(e1,e2)	21	110	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	74	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
effect(e1,e2)	0	18	beta-blockers , clonidine , lithium salts , and alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin .
mechanism(e1,e2)	11	13	therophylline : a recent study has shown that concomitan administration of isoniazid and theophylline may cause elevated plasma levels of theophylline , and in some instances a slight decrease in the elimination of isoniazid .
None(e1,e2)	92	102	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	3	8	effects of other antiepileptic_drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	9	18	effects of other antiepilepsy drugs ( aeds ) on gabitril : carbamazepine : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking carbamazepine with or without other enzyme- inducing aeds .
None(e1,e2)	38	43	in vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds that induce , inhibit , or are metabolized by cytochrome p450 3a4 , such as cyclosporine , terfenadine , ketoconazole , erythromycin , and troleandomycin .
None(e1,e2)	8	23	antacids or h 2 receptor antagonists : when dirithromycin is administered immediately following antacids or h 2 -receptor antagonists , the absorption of dirithromycin is slightly enhanced .
None(e1,e2)	33	55	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	6	26	these medications have included heparin , warfarin , beta-adrenergic receptor blockers , calcium channel antagonists , angiotensin converting enzyme inhibitors , intravenous and oral nitrates , ticlopidine , and aspirin .
None(e1,e2)	15	30	due to wide interindividual variability in the dose adjustment required , it is recommended that cyclosporine concentrations be monitored closely after initiation of carvedilol therapy and that the dose of cyclosporine be adjusted as appropriate .
None(e1,e2)	10	32	in in vivo studies , 10- to 30-mg/day doses of aripiprazole had no significant effect on metabolism by cyp2d6 ( dextromethorphan ) , cyp2c9 ( warfarin ) , cyp2c19 ( omeprazole , warfarin ) , and cyp3a4 ( dextromethorphan ) substrates .
None(e1,e2)	28	38	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
effect(e1,e2)	5	7	clonidine : concomitant administration of clonidine with agents_with_b-blocking_properties may potentiate blood-pressure- and heart-rate-lowering effects .
None(e1,e2)	14	20	erythromycin and clarithromycin ( and possibly other macrolide antibiotics ) and tetracycline may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .
None(e1,e2)	81	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	90	112	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	4	34	caution is advised when trisenox is coadministered with other medications that can prolong the qt interval ( e.g . certain antiarrhythmics or thioridazine ) or lead to electrolyte abnormalities ( such as diuretics or amphotericin_b ) .
None(e1,e2)	44	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	118	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	25	44	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim /sulfamethoxazole or zidovudine .
None(e1,e2)	0	15	vitamin_a and oral retinoids : concomitant administration of vitamin a and/or other oral retinoids with acitretin must be avoided because of the risk of hypervitaminosis a .
None(e1,e2)	13	43	if a patient requires tikosyn and anti-ulcer therapy , it is suggested that omeprazole , ranitidine , or antacids ( aluminum and magnesium hydroxides ) be used as alternatives to cimetidine , as these agents have no effect on the pharmacokinetic profile of tikosyn .
None(e1,e2)	26	38	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	13	15	in vitro studies indicate cyp3a4 isoform and cyp1a2 isoform mediate the metabolism of levobupivacaine to desbutyl_levobupivacaine and 3-hydroxy levobupivacaine , respectively .
None(e1,e2)	24	32	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	29	32	therefore , it is theoretically possible that lansoprazole may interfere with the absorption of drugs where gastric ph is an important determinant of bioavailability ( e.g . ketoconazole , ampicillin esters , iron salts , digoxin ) .
None(e1,e2)	41	124	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	5	31	erythromycin co-administration of felodipine ( plendil ) with erythromycin resulted in approximately 2.5- fold increase in the auc and cmax , and about 2- fold prolongation in the half- life of felodipine .
None(e1,e2)	87	130	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	39	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	10	16	other strong inhibitors of cyp3a4 ( e.g. , itraconazole , clarithromycin , nefazodone , troleandomycin , ritonavir , nelfinavir ) would be expected to behave similarly .
None(e1,e2)	59	74	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	31	77	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	17	42	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	21	23	furosemide : clinical studies , as well as random observations , have shown that ibuprofen can reduce the natriuretic effect of furosemide and thiazides in some patients .
effect(e1,e2)	3	16	concurrent use of butorphanol with central nervous system depressants ( e.g. , alcohol , barbiturates , tranquilizers , and antihistamines ) may result in increased central nervous system depressant effects .
None(e1,e2)	15	32	the iv methylprednisolone dose should be reduced by approximately 25 % , and the oral methylprednisolone dose should be reduced by approximately 50 % when coadministered with aprepitant to achieve exposures of methylprednisolone similar to those obtained when it is given without aprepitant .
None(e1,e2)	32	37	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
advise(e1,e2)	4	32	therefore , co-administration of tricyclic_antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	17	22	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	14	24	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	41	51	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	40	58	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	1	12	because anafranil is highly bound to serum protein , the administration of anafranil to patients taking other drugs that are highly bound to protein ( e.g. , warfarin , digoxin ) may cause an increase in plasma concentrations of these drugs , potentially resulting in adverse effects .
None(e1,e2)	35	37	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine_derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	69	85	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	32	carbamazepine : isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels carbamazepine levels should be determined prior to concurrent administration with isoniazid , signs and symptoms of carbamazepine toxicity should be monitored closely , and appropriate dosage adjustment of the anticonvulsant should be made .
effect(e1,e2)	22	34	a rare , but serious , constellation of symptoms , termed serotonin syndrome , has been reported with the concomitant use of selective_serotonin_reuptake_inhibitors ( ssris ) and agents for migraine therapy , such as imitrex ( sumatriptan succinate ) and dihydroergotamine .
None(e1,e2)	14	39	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	44	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	39	57	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	15	21	reports in the literature suggest that plasma levels of doxorubicin ( and its active metabolite doxorubicinol ) may be increased when paclitaxel and doxorubicin are used in combination .
None(e1,e2)	11	20	drugs that may alter imatinib plasma concentrations drugs that may increase imatinib plasma concentrations : caution is recommended when administering gleevec with inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , erythromycin , clarithromycin ) .
effect(e1,e2)	6	17	other depressasnts such as alcohol , barbiturates , and maois may enhance cns depression when administered with ethchlorvynol .
None(e1,e2)	25	30	in general , these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride , including anti-arrhythmic agents such as quinidine and procainamide , cardiac glycosides and tricyclic_anti-depressants .
None(e1,e2)	3	19	the administration of epinephrine should be avoided in the treatment of drug induced hypotension because of a possible reverse epinephrine effect .
None(e1,e2)	6	8	no pharmacokinetic interactions between dexmedetomidine and isoflurane , propofol , alfentanil , and midazolam have been demonstrated .
None(e1,e2)	0	39	central_nervous_system_depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	79	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	15	46	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	14	25	the following agents may increase certain actions or side effects of anticholinergic drugs . amantadine antiarrhythmic agents of class ( e.g . quinidine ) , antihistamines antipsychotic agents ( e.g . phenothiazines ) , benzodiazepines .
None(e1,e2)	26	35	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole_antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	68	73	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
advise(e1,e2)	14	47	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
None(e1,e2)	2	4	- a nonsteroidal_anti-inflammatory_drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	9	44	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium_sparing_diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
mechanism(e1,e2)	11	26	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	10	20	there are no significant effects on cefdinir pharmacokinetics if the antacid is administered 2 hours before or 2 hours after cefdinir .
None(e1,e2)	9	20	omeprazole : the rate and extent of absorption of ciprofloxacin was bioequivalent when proquin xr was given alone or when proquin_xr was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion .
None(e1,e2)	0	20	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	71	114	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	15	25	- anabolic steroids ( nandrolone [ e.g. , anabolin ] , oxandrolone [ e.g. , anavar ] , oxymetholone [ e.g. , anadrol ] , stanozolol [ e.g. , winstrol ] ) or
None(e1,e2)	43	59	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	37	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	2	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	15	32	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle_relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	20	22	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic_acid , and tolbutamide in vitro .
None(e1,e2)	6	10	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	7	19	plasma valproate concentration should be monitored when isoniazid and valproate are co administered , and appropriate dosage adjustments of valproate should be made .
None(e1,e2)	0	12	welchol was found to have no significant effect on the bioavailability of digoxin , lovastatin , metoprolol , quinidine , valproic acid , and warfarin .
None(e1,e2)	0	8	intestinal_adsorbents ( e. g. , charcoal ) and digestive_enzyme_preparations containing carbohydrate-splitting enzymes ( e. g. , amylase , pancreatin ) may reduce the effect of acarbose and should not be taken concomitantly .
mechanism(e1,e2)	2	10	because oral anticoagulants may interfere with the hepatic metabolism of phenytoin , toxic levels of the anticonvulsant may occur when an oral anticoagulant and phenytoin are administered concurrently .
None(e1,e2)	66	77	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	7	20	therapeutic concentrations of digoxin , warfarin , ibuprofen , naproxen , piroxicam , acetaminophen , phenytoin andtolbutamide did not alter ketorolac_tromethamine protein binding .
None(e1,e2)	51	56	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	29	37	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	1	80	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	59	116	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	20	warfarin : in a study in healthy volunteers , no clinically relevant pharmacokinetic or pharmacodynamic interaction between isradipine and racemic warfarin was seen when two single oral doses of warfarin ( 0.7 mg/kg body weight ) were administered during 11 days of multipledose treatment with 5 mg b.i.d . isradipine .
None(e1,e2)	7	9	however , the pharmacodynamics of coadministration of zaleplon and promethazine have not been evaluated .
None(e1,e2)	3	6	dimenhydrinate may decrease emetic response to apomorphine .
effect(e1,e2)	6	8	in rats , simultaneous ingestion of disulfiram and nitrite in the diet for 78 weeks has been reported to cause tumors , and it has been suggested that disulfiram may react with nitrites in the rat stomach to form a nitrosamine , which is tumorigenic .
None(e1,e2)	9	14	in rheumatoid arthritis , concomitant medications besides mtx were nonsteroidal_anti-inflammatory_agents , folic acid , corticosteroids and/or narcotics .
None(e1,e2)	17	23	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
None(e1,e2)	7	21	infusion requirements of nimbex in patients administered succinylcholine prior to infusions of nimbex were comparable to or slightly greater than when succinylcholine was not administered .
None(e1,e2)	46	58	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	39	66	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
mechanism(e1,e2)	17	22	particular caution should be observed with digitalis preparations since there are conflicting results for the effect of colestipol_hydrochloride on the availability of digoxin and digitoxin .
None(e1,e2)	4	16	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	35	65	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	30	32	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	0	10	h2-receptor_antagonists : co-administration of a single dose of intravenously administered famotidine ( 20 mg ) reduced the oral absorption of a single 400 mg dose of cefditoren pivoxil administered following a meal , as evidenced by a 27 % decrease in mean cmax and a 22 % decrease in mean auc .
None(e1,e2)	9	11	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	19	24	hypersensitivity reactions : patients with a history of severe hypersensitivity reactions to products containing cremophor el ( eg , cyclosporin for injection concentrate and teniposide for injection concentrate ) should not be treated with taxol .
None(e1,e2)	5	7	hctz 50 mg qd or hctz / triamterene 50/100 mg qd was co-administered with tikosyn ( 500 mcg bid ) for 5 days ( following 2 days of diuretic use at half dose ) .
None(e1,e2)	17	29	the risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine , fibric acid derivatives , niacin ( nicotinic acid ) , erythromycin , azole antifungals .
None(e1,e2)	0	5	inomax has been administered with tolazoline , dopamine , dobutamine , steroids , surfactant , and high-frequency ventilation .
None(e1,e2)	55	100	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	32	47	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	16	25	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	15	23	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
None(e1,e2)	28	57	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	40	42	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	35	39	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
